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Short abstract 
The cancer indicators and outcomes of rural Australians are generally less favourable than those of 
their urban counterparts, but the situation for farm residents is less well known. With a focus on farm 
residents, this study aimed to identify differences between farm, rural non-farm and urban residents in 
a large NSW cohort, in:  (1) incidence and mortality from major cancers; (2) screening rates, stage at 
diagnosis and selected cancer therapies; and (3) common risk factors associated with these cancers.   
Cancers of interest were breast, cervical, colorectal, lung and prostate cancers; melanoma and Non 
Hodgkins Lymphoma. The Sax Institute’s 45 and Up Study was used to define resident groups and to 
compare baseline cancer-related risk factors. Cancer mortality, incidence, stage at diagnoses, cancer 
screening practices and selected cancer treatments were compared through data linkage with routine 
state and national health datasets. Direct age-standardisation, proportional hazards regression and 
logistic regression were used to compare cancer indicators, controlling for common risk factors. 
Overall, farm residents had lower all cancer incidence and mortality risk than rural non-farm or 
urban counterparts, but differences were only significant for all cancer incidence in farm women 
compared to rural non-farm women. For specific cancers, breast cancer mortality risk was also 
significantly lower in farm women than rural non-farm women, but incidence and mortality risk for 
other cancers were not significantly different. However, whilst confidence intervals did not exclude 
unity, adjusted point estimates for incidence or mortality risk suggest that compared to other groups, 
farm residents had a similar or reduced risk of breast, colorectal and lung cancer; similar risk of NHL; 
and farm men similar or slightly raised risk of melanoma and prostate cancer. There were no significant 
differences in stage at diagnosis for prostate, breast and colorectal cancers. Small case numbers in the 
farm group were likely to have contributed to lack of significance of findings for some analyses.   
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Screening practices of farm and rural non-farm residents were generally similar; but both rural 
groups had significantly less frequent PSA tests, Pap tests, mammograms and colonoscopies than urban 
residents. Cancer-related surgical services for breast and colorectal cancer were comparable between 
all groups. Some findings for non-surgical therapies should be considered with caution, but both farm 
and rural non-farm residents were significantly less likely to access chemotherapy for breast cancer and 
brachytherapy for prostate cancer than urban counterparts.  
Strengths and limitations of the research are discussed. Pending confirmation of findings in other 
studies, results have implications for cancer screening and treatment services in rural Australia. The 
reasons why farm residents may have lower incidence and / or mortality risk for some cancers should 
also be considered for further research. 
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Long abstract 
Chapter 1:  
This chapter provides an introduction and background to the study, leading toward a statement of 
the research objectives. It begins with a brief summary of the impact of cancer, which is responsible for 
approximately one third of all deaths in Australia. As a category of disease, cancer can inflict sufferers 
with months or years of debilitating illness and complex treatment regimes. Societal impacts include 
health system costs, lost productivity and a considerable burden of disease. The most expensive cancers 
to society in Australia are lung, colorectal and breast cancers. The most commonly diagnosed cancers 
are prostate, colorectal and breast cancer, whilst lung, colorectal, prostate and breast cancer account 
for most deaths. However, overall death rates from cancer have declined in recent years, largely 
attributed to improvements in screening, diagnosis, treatment and survival outcomes for certain 
cancers.  
Health reports suggest that the incidence and mortality of several major cancers tend to be higher 
amongst the one-third of Australians residing outside major cities. Although there is no simple gradient 
of increasing cancer with increasing remoteness, people in major cities do tend to be the healthier for 
most cancer indicators. Rural Australians have been reported to have higher levels of smoking and 
alcohol use; an older demographic profile; a higher proportion of indigenous people; and education, 
employment and socio-economic disadvantage, which may contribute to poorer health and/or cancer 
indicators in rural areas. Geographic distance from services may also play a role. It is possible distance 
could impact on decisions regarding the types of medical treatment received, including referral to 
specialist cancer centres.  
Within rural Australia, there are approximately 93,000 farm families; one third of whom are located 
in NSW. People who live and /or work on farms have unique characteristics regarding employment, 
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lifestyle, potential environmental exposures and socio-economic factors; and constitute a sizeable rural 
population for which there is very limited information about cancer indicators and risk factors. Only two 
previous studies have been published on cancer risk in Australian farmers, suggesting the possibility of 
higher incidence or mortality from lymphohaematopoietic and prostate cancer. It is not known if farm 
exposures or differences in other risk factors may have contributed to this, or whether there are any 
differences in other cancers between farm residents and others, controlling for common risk factors.  
Focusing on farm residents, this study aims to identify if variations exist between farm, non-farm 
rural and urban residents in a large NSW cohort, in relation to: (1) incidence and mortality from selected 
major cancers; (2) screening rates, stage at diagnosis and selected cancer therapies; and (3) differences 
between groups in common risk factors associated with these cancers. There was also a secondary 
interest in whether rural groups differed from the urban group - particularly in relation to baseline risk 
factors and health service related indicators. A series of studies examine these issues, adding to the 
body of evidence on cancer risk in rural areas and identify potential disadvantage. Strengthening the 
evidence base on which health policy and resourcing decisions are potentially made, is an important 
role of epidemiological and health services research. 
Chapter 2 
The objectives of the literature review were to examine the evidence for differences between 
farmers and non-farmers in the incidence, mortality, screening, stage at diagnosis, treatment and 
survival outcomes for ‘all cancers’ and selected major cancers. Eligibility criteria were developed to 
guide selection of appropriate studies; and retrieval and quality assessment methods described. A set of 
summaries was developed, focusing on particular elements or cancers. The first was an overview of 
previous reviews of cancer incidence and mortality in farmers. Further summaries are based on primary 
studies relating to: (1) comparative cancer mortality/incidence; (2) a review focusing on prostate cancer 
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incidence and mortality in farmers published in a peer-reviewed journal; and (3) a summary of health 
service related studies comparing farm and non-farm groups. 
The evidence on cancer risk in farmers compared to non-farmers from previous reviews is 
suggestive of a deficit for all cancer, bladder, colorectal and lung cancers. An excess of risk in farmers 
was suggested for lip, prostate, some lymphohaematopoetic cancers and possibly brain cancers. 
However, the strength of evidence for excess or deficit of different cancers in farmers is relatively weak 
due to the low volume of studies for each cancer type; and inconsistent methodological approaches 
which make comparisons difficult.  
Our current review of primary studies published since 2002 also suggested farm groups had lower 
all cancer and lung cancer risk; and a deficit in colorectal cancer. Slightly reduced or neutral risk of 
breast cancer was suggested and neutral risk of melanoma. A neutral to excess risk was suggested for 
some lymphohaematopoietic cancers. Generally, the evidence for excess cancer risk in farm groups in 
our review was perhaps weaker than in previous, older reviews. Similar to previous reviews, however, 
there were limitations in the strength of conclusions which could be drawn, for methodological reasons.  
Prostate cancer risk was of particular interest due to an earlier report of elevated mortality risk in 
Australian farmers. A review focusing on prostate cancer risk in farmers was published in an 
international peer reviewed journal in 2014 (Cancer Epidemiology). Eighteen primary research articles 
were assessed. Four of ten mortality studies and two of nine incidence studies reported statistically 
significant increases in prostate cancer risk in farmers. However, nearly half of all studies reported non-
significant reductions in farmers’ risk. Additionally, one study reported significantly increased and 
decreased risk using different outcome measures. Results varied considerably by geographic region, 
study design and degree of control for confounders, affecting comparability and strength of findings. As 
for other cancers, the overall evidence for increased prostate cancer risk in farmers was weak.  
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Given the geographic dispersion of rural Australia, there is potential for health service related 
factors to have a considerable impact on cancer identification and treatment. A summary of findings 
was presented for stage at diagnosis and treatment; cancer survival and cancer screening between 
farmers and non-farmers. Whilst component studies were of reasonable quality, the volume and level 
of evidence on differences between farmers and others was generally low or insufficient. One of the 
objectives of the primary research project is to address this gap in knowledge by comprehensively 
assessing the epidemiology of cancer and comparative health service usage in NSW farm residents 
compared to others.  
Chapter 3 
This Chapter provides an overview of the study methods, including background information on the 
45 and Up Study; methods used to prepare the data for analyses; and a description of analytical 
methods. This was a large cohort study of mixed prospective and retrospective design, providing 
primary analysis of baseline survey data as well as follow-up analysis of secondary linked data. The 45 
and Up Study cohort was the primary dataset of interest and formed the basis for derivation and 
comparison of (a) farm residents; (b) non-farm rural residents; and (c) urban participants for a range of 
cancer and health-related variables. The sub-group of interest comprised those who stated they lived in 
a ‘house on farm’ in the 45 and up Study baseline questionnaire.  
The 45 and Up Study is managed by the Sax Institute in collaboration with major health agency 
partners, as listed within the ‘acknowledgements’. Eligible individuals were randomly sampled from the 
enrolment database of the Australian Department of Human Services (formerly Medicare Australia), 
which provides near complete coverage of the NSW population. Persons aged 45 and over and resident 
in NSW were invited to take part between January 2006 and December 2009. The overall response rate 
(17-18%) is comparable with other large cohort studies, although not truly representative of the general 
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NSW population. However, with over 267,000 participants, the cohort approximated 11% of the NSW 
population aged 45 years and over in 2009.  
Cancers of interest for different components of the research were breast, cervical, colorectal, lung 
and prostate cancers as well as melanoma and Non Hodgkins Lymphoma. Firstly, a comparison of self-
reported personal and behavioural risk factors of interest, as recorded on the 45 and Up Study baseline 
questionnaire, was completed. Secondly, a comparison of cancer mortality, incidence, stage at diagnoses, 
cancer screening practices and selected cancer treatments was made;  by linking data from the 45 and Up 
Study participant records with matching records from routine state and national health datasets.  
Secondary datasets used for the different component studies were the  Australian Coordinating 
Registry (ACR) Cause of Death Unit Record File (COD URF), Medicare Benefits Schedule (MBS), NSW 
Admitted Patients Data Collection (APDC), NSW Cancer Registry (NSW CR), NSW Pap Test Register  (PTR) 
and the NSW Register of Births, Deaths and Marriages (RBDM). Characteristics of each data dataset, data 
linkage processes and quality assurance processes are described.  
Derivation of the cohort variable was of particular importance. ‘Farm residents’ were defined as those 
who indicated that they lived in a ‘house on farm’ on the 45 and Up Study baseline questionnaire. Rural 
‘non-farm’ and urban residents were further defined by ARIA+/ ASGS category. Participants who did not 
live in a house on a farm whose ARIA+/ ASGS classification indicated they did not live in a ‘Major city’, 
were defined as rural non-farm residents. The remaining group of ‘urban residents’ were those who 
specified that they lived in a ‘Major City’.  
Methods of analysis for each component of the study are described. Analyses were conducted 
within SAS 9.3 and Microsoft Excel TM and included summary statistics of sub-group characteristics; 
derivation of direct age-standardised cancer incidence and mortality rates and ratios; use of 
proportional hazard regression to determine hazard ratios for selected cancers, controlling for 
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commonly known confounders; and logistic regression to compare cancer stage at diagnosis between 
sub-groups, MBS claims-based cancer screening frequency and cancer treatments in the NSW APDC. 
The following chapters reiterate some of the above information, to fulfill requirements of stand-alone 
manuscripts submitted for publication. In particular, more detail on analytical methods undertaken as 
they pertain to specific study components, is provided.  
Chapter 4 
This component study forms a standalone manuscript prepared for submission to a peer 
reviewed journal. The study addresses the first and third objectives of the overall research project. That 
is, to identify if variations exist between farm, non-farm rural and urban residents in the cohort, in 
relation to (1) mortality from selected major cancers; and (2) differences between groups in common 
risk factors associated with these cancers. This is important, to determine whether farm residents (or 
other groups) are disadvantaged regarding cancer health indicators and /or mortality, which may have 
implications for targeting of health services. The manuscript is entitled:  ‘Cancer risk factors and 
mortality in farm, rural non-farm and urban residents within the 45 and Up Study cohort.’  The abstract 
submitted with this manuscript is provided below. 
Introduction: People living in rural areas in Australia have poorer cancer outcomes than those 
in urban areas, but it is not known if this is the case for farm residents. Methods:  Data for farm, rural 
non-farm and urban participants of the 45 and Up Study cohort in New South Wales, Australia, were 
linked with state death registrations data for 2006 - 2012. Direct age-standardised mortality rate ratios 
for 267,074 participants were compared for all cancer and prostate, breast, lung and colorectal cancers, 
non-Hodgkins Lymphoma (NHL) and melanoma. Proportional hazards regression was used to estimate 
adjusted mortality hazard ratios for each cancer type, controlling for common risk factors. Results: 
Farm, rural non-farm and urban residents differed in a range of health related characteristics. Farm 
women had a significantly lower adjusted hazard ratio for breast cancer than rural non-farm women.  
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Confidence intervals for adjusted hazard of all cancer and other selected cancers did not exclude unity, 
but point estimates suggested farm residents had non-significantly lower all cancer and colorectal 
cancer mortality risk; similar lung cancer risk; and farm men slightly elevated melanoma and prostate 
cancer risk.  Conclusion: Farm women had a significantly lower breast cancer mortality risk than rural 
non-farm women, but differences between farm, rural non-farm and urban residents for all cancer or 
other selected cancers were not significant.  
Chapter 5 
This study was submitted as a standalone manuscript to an international peer reviewed journal in 
October 2016 (BMC Cancer). The study addresses the first objective of the overall research project, to 
identify if variations exist between farm, non-farm rural and urban residents in the cohort in relation to 
incidence of selected major cancers. Similar to the previous chapter, this is important, to identify 
whether farm residents (or other groups) are disadvantaged regarding cancer incidence, which may 
have implications to health services providing screening and treatment services. The manuscript is 
entitled:  ‘Cancer incidence in farm, rural non-farm and urban residents in the 45 and Up Study cohort, 
New South Wales, Australia.’  The abstract submitted with this manuscript is provided below. 
Background: It is not known if the incidence of common cancers in Australian farm residents is 
different to rural non-farm or urban residents. Methods: Data from farm, rural non-farm and urban 
participants of the 45 and Up Study cohort in New South Wales Australia, were linked with state cancer 
registry data for the years 2006 - 2009. Direct age-standardised incidence rate ratios were compared for 
all cancer, prostate, breast, colorectal cancer, melanoma and non-Hodgkin lymphoma (NHL). 
Proportional Hazards regression was used to generate incidence hazard ratios for each cancer type 
adjusted for relevant confounders. Results:  Farm women had a significantly lower all cancer hazard 
ratio than for rural non-farm women; but lower all cancer risk in farm men compared to rural non-farm 
and urban counterparts was not significant. When rural non-farm and urban groups were combined, the 
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all cancer adjusted hazard was significantly lower in both farm men and women. Confidence intervals 
did not exclude unity for differences in risk of prostate, breast, colorectal or lung cancers, NHL or 
melanoma, but farm residents had considerably lower lung cancer risk than other residents after 
controlling for smoking and other factors. Conclusions: All cancer risk was significantly lower in farm 
residents compared to combined rural non-farm and urban groups. Farm women also had a significantly 
lower all cancer adjusted hazard ratio than rural non-farm women. These differences appeared to be 
mainly due to lower lung cancer incidence rates in farm residents.  
Chapter 6 
This component study was submitted as a standalone manuscript to an Australian peer reviewed 
journal in December 2016 (Australian Journal of Rural Health). The manuscript addresses the second 
objective of the overall research project, to identify if variations exist between farm, non-farm rural and 
urban residents in the cohort, in relation to stage at diagnosis of prostate, breast and colorectal cancers. 
Again, this is important, to identify whether farm residents (or other groups), are disadvantaged 
regarding diagnosis and early identification of major cancers, which may have implications for primary 
health services including general medical practices, screening and diagnostic services. The manuscript is 
entitled:  ‘Stage of diagnosis of prostate, breast and colorectal cancer in farm residents compared to 
other rural and urban residents in New South Wales.’   The abstract submitted with this manuscript, is 
formatted to the Australian journal’s requirements.  
Objective: To determine if stage at diagnosis of prostate, breast and colorectal cancers differs 
between farm, rural non-farm and urban residents. Design: Data-linkage of baseline survey information 
from a large cohort study, with state cancer registry records from 2006-2009. Setting: New South Wales 
(NSW), Australia. Participants: NSW residents enrolled in the 45 and Up Study cohort. Main outcome 
measures: Adjusted Odds Ratio of non-localised cancer stage was modelled using binary logistic 
regression, controlling for commonly known cancer risk factors. Results:   Overall differences in the 
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odds ratios for later stage prostate, breast and colorectal cancer diagnosis in farm men and women 
compared to either rural non-farm or to urban counterparts, were not statistically significant; although 
farm men had twice the odds of either group of being diagnosed at later stage colorectal cancer. The 
odds of later stage prostate cancer for farm and urban men were similar, but rural non-farm men were 
significantly less likely than urban men to be diagnosed at later stage. Higher household income was 
associated with later stage breast and prostate cancer; and private health insurance with extras 
negatively associated with later stage prostate cancer. Conclusions:  Differences in stage of cancer 
diagnosis, particularly farm and rural non-farm men remain unexplained but were not statistically 
significant. Farm men may be at higher risk of later stage colorectal cancer diagnosis, which if confirmed 
has implications for research on possible reasons; and for the delivery of appropriate cancer diagnostic 
services in rural areas. 
Chapter 7 
This study forms a standalone manuscript submitted to an international peer reviewed journal in 
March 2017 (BMC Public Health). It also addresses the second objective of the overall research project; 
in this case to identify if variations exist between farm, non-farm rural and urban residents in the cohort 
in relation to screening for prostate, breast, colorectal and cervical cancers. This is important, to identify 
whether farm residents (or other groups) are disadvantaged regarding utilisation of screening services, 
which may impact upon the timely identification of screenable cancers. It may have implications for 
population-wide screening programs (e.g. Bowelscreen, Breastscreen); and other services that provide 
screening or diagnostic testing (general practices, Area Health Services, pathology services). The 
manuscript is entitled:  ‘Cancer screening practices in a cohort of Australian farm, rural non-farm and 
urban residents aged 45 years and over.’ The abstract for this manuscript is provided below in 
international journal format.  
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Background: Screening for breast, prostate, colorectal and cervical cancers can lead to earlier 
diagnosis and more effective treatment, but it is not known if cancer screening practices of farm 
residents in Australia differ from their rural or urban counterparts. Methods: Self-reported screening for 
prostate, breast and colorectal cancer were compared for farm, rural non-farm and urban participants 
of the 45 and Up Study cohort in New South Wales (NSW). Data for participants under 75 years of age 
and without prior cancer, were linked with NSW Pap Test Register records for cervical screening 
frequency from 2006-2012. Records were also linked with Medicare Benefits Schedule claims data for 
2004-2011 for visits to a General medical Practitioner (GP); and for breast, prostate and colorectal 
screening procedures. Age-adjusted comparisons were made using general linear regression and logistic 
regression. Results:  Farm residents were significantly less likely to visit a GP, but screening practices 
between farm and rural non-farm residents were generally similar. Urban residents had significantly 
more prostate specific antigen (PSA) tests, Pap tests, mammograms and colonoscopies than either of 
the other groups. Urban residents were also significantly more likely to report ever having a 
mammogram or colonoscopy. In contrast, farm and rural non-farm residents had significantly more 
Faecal Occult Blood Tests (FOBTs) than urban counterparts; and were around one third more likely than 
urban residents to report ever having a FOBT. Farm residents were most likely to report ever having a 
PSA test or ‘any’ form of colorectal screening test, with both rural groups significantly more likely to do 
so than urban residents. Conclusions:  Farm and rural non-farm residents had lower utilisation and 
perhaps reduced access to specialist or procedural screening services.  
Chapter 8 
This final component study forms a standalone manuscript prepared for submission to an Australian 
peer reviewed journal. The study addresses the second objective of the overall research project;  to 
identify if variations exist between farm, non-farm rural and urban residents in the cohort, in relation to 
selected treatments for prostate, breast and colorectal cancers. This is important, to identify whether 
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farm residents (or other groups) are disadvantaged regarding access or utilisation of different cancer 
therapies. This potentially has implications for general practices, Area Health Services and pathology 
services, which need to co-ordinate to provide optimal care. It may also provide baseline data for 
recently established Rural Cancer Centres and cancer networks, which have a base against which to 
measure improvements over time. The manuscript is entitled:  ‘A comparison of cancer therapies in a 
cohort of farm, rural non-farm and urban residents aged 45 years and over in New South Wales.’    The 
abstract for this manuscript is provided below, in Australian journal format.  
Objectives:   To determine if selected therapies for prostate, breast and colorectal cancer vary by 
farm, rural non-farm or urban residence. Design:  Data linkage of baseline survey information from the 
Sax Institutes’ 45 and Up Study cohort with data from the New South Wales (NSW) Admitted Patients 
Data Collection (APDC) for 2006-2012. Setting:   NSW. Participants:  Farm, rural non-farm and urban 
residents aged 45 years and over. Main outcome measures:  Surgical, chemotherapy, radiotherapy and 
brachytherapy procedures for those with a diagnosis of prostate, breast or colorectal cancer. Average 
distance to treating hospital and the odds of receiving selected therapies for each cancer was 
compared, controlling for selected variables. Results: Farm men were significantly more likely to have a 
prostatectomy for prostate cancer than rural non-farm men, but differences for breast and colorectal 
cancer surgery between resident groups were not significant. Farm and rural non-farm men had 
significantly lower odds of having brachytherapy for prostate cancer than urban men; and farm and 
rural non-farm women were significantly less likely to have chemotherapy for breast cancer than urban 
women. Rural non-farm residents were also significantly less likely to have chemotherapy for colorectal 
cancer than urban counterparts. Age, distance, income and health insurance factors contributed to 
differences in non-surgical care between groups. Conclusion:  Cancer-related surgical services for breast 
and colorectal cancer were generally comparable between groups. Farm and rural non-farm residents 
may have been disadvantaged in relation to non-surgical therapies for prostate, breast and colorectal 
cancer compared to urban residents.  
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Chapter 9 
The central aim of this body of work was to examine and compare cancer indicators in Australian 
farm residents compared to non-farm rural and urban residents. Information on the comparative cancer 
profile of Australian farm residents will contribute to the evidence base on which rural health policy and 
resourcing decisions are potentially made. Farmers and farm families have particular characteristics 
regarding their age profile, employment, lifestyle, potential environmental exposures and socio-
economic conditions. This raises questions as to whether farmers have a different cancer profile to 
other rural or urban people, despite being part of the larger rural and state populations.  
An overview of cancer in rural Australia provided context to the research. Generally, urban residents 
had lower cancer incidence and mortality than rural people. A range of socio-demographic 
characteristics have been suggested in influencing cancer indicators. Geographic distance from services 
may also contribute to delays in diagnosis and decisions regarding cancer treatment. Given limited 
Australian studies of cancer risk in farmers, a review of the international literature was undertaken. 
Overall deficits in all cancer, lung and colorectal cancer risk were suggested; and a deficit or neutral risk 
of breast cancer and neutral risk of melanoma. Mainly neutral but some excess risk was suggested for 
some lymphohaematopoietic cancers. Compared to earlier reports of higher prostate cancer risk in 
farmers in Australia, the overall evidence for elevated prostate cancer risk in farmers in the literature 
review was weak, partly due to disparate study methods. There was also insufficient evidence on 
differences in cancer screening, stage at diagnosis or treatment between farm and non-farm groups in 
the literature.  
Prior to this study, information on cancer indicators in Australian farm residents was extremely 
limited. A series of component studies were undertaken to examine differences between NSW farm, 
non-farm rural and urban residents in cancer incidence or mortality; stage of diagnosis, screening and 
selected cancer therapies; and of common risk factors that might be associated with these cancers. The 
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45 and Up Study cohort enabled identification of farm residents, not otherwise identifiable in standard 
population-wide health reports. Comparison of cancer indicators between groups was made possible 
through data linkage to administrative health datasets.  
Farm, rural non-farm and urban residents in the cohort differed in age and a range of 
characteristics, which were controlled for in multivariate regression models. Findings were generally 
consistent with those of the review. Overall, farm residents had lower all cancer incidence and mortality 
risk than rural non-farm or urban residents but differences were only significant for all cancer incidence 
in farm women compared to rural non-farm women. For specific cancers, breast cancer mortality risk 
was significantly lower in farm women than rural non-farm women, but differences for other cancers 
were not significant. Of these, farm residents had similar or reduced point estimates for breast, 
colorectal and lung cancer risk; similar risk of NHL; and farm men had similar or slightly raised risk of 
melanoma and prostate cancer. Small case numbers in the farm group were likely to have contributed 
to lack of significance of findings for some analyses.   
There were no significant differences in stage at diagnosis for prostate, breast and colorectal 
cancers; although the higher odds for later colorectal cancer in farm men warrants further investigation. 
Screening practices of farm and rural non-farm residents were similar, but results suggested that 
compared to urban residents, both rural groups had lower utilisation and perhaps reduced access to 
screening services. In general, cancer-related surgical services for breast and colorectal cancer were also 
comparable between groups. Whilst findings for chemotherapy and radiotherapy should be considered 
with caution due to data limitations, these suggest farm and rural non-farm residents may have been 
disadvantaged regarding non-surgical therapies for prostate, breast and colorectal cancer. This is 
consistent with findings of other studies on rural versus urban cancer services in Australia.  
Comparisons across several indicators for a particular cancer type can also assist in identifying 
patterns that may have implications for rural health services and resource allocation. Whilst 
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acknowledging that most differences between groups were not statistically significant, an exploratory 
discussion was undertaken on indicators across cancer types, raising questions for further 
consideration. However, suggested inferences need to be confirmed with greater case numbers over 
longer periods of time; and within other cohorts.  
Strengths of this research are discussed, including the robust sampling methods of the original 45 
and Up Study, the ability to identify farm residents in the cohort, the inclusion of cancer indicators in 
farm women, the ability to capture health system interactions through data linkage for a range of 
cancer-related indicators; and the ability to repeat these analyses over a longer period of time, to re-
assess findings.  
Limitations discussed include the level of representativeness of the NSW population. Importantly,  
small case numbers in the farm group have resulted in low power for some analyses contributing to 
wide confidence intervals and a bias toward insignificant findings. A cautious or conservative 
interpretation of findings is warranted. Some of these factors could be addressed with longer follow-up 
time. There were also inherent limitations in defining or interpreting what constitutes a farm resident, 
which may have contributed to a bias toward the null.  
A number of questions arise from the research. If confirmed by other studies, there is a need to 
address the suggested: (1) higher risk of later stage diagnosis of colorectal cancer in farm men; (2) lower 
rates of brachytherapy, chemotherapy and combined therapies for prostate cancer in farm men; and (3) 
wider rural disadvantage in non-surgical cancer treatments for prostate, colorectal and breast cancers 
and perhaps lung cancer. Furthermore, investigation of the possible reasons why farm residents might 
have generally better incidence and / or mortality profiles for breast, colorectal and lung cancers, could 
inform ways to reduce the impact of these cancers upon individuals and wider communities. Addressing 
these questions will contribute to a greater understanding of the epidemiology of cancer in Australian 
farm residents and the wider rural community.  
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Chapter 1:  Introduction  
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1.1   The prominence and impacts of cancer 
Cancers were responsible for around one third of all deaths in Australia in 2014.1  One in two men 
and one in three women will be diagnosed with some form of cancer by the age of 85 years.2-3 Most 
Australians will be affected by cancer either personally or through the experience of a close relative, 
during their lifetime. However, it has been suggested that improvements in screening, earlier stage 
cancer detection, diagnostic methods and treatment can have a significant impact on outcomes.4           
Cancer is a group of diseases characterised by abnormal division and uncontrolled growth of body 
cells, which can invade nearby tissues and spread to other parts of the body through the circulatory and 
lymphatic systems.4 Cancer can inflict sufferers with months or years of debilitating illness, hospital 
admissions, surgical procedures, chemotherapy and radiation treatments. For cancer survivors, there is 
often a cloud of uncertainty that the disease may recur.  
The impact of cancer upon individuals and families can be overwhelming in terms of pain, suffering 
and premature mortality, as well the considerable economic burden. Societal impacts include health 
system costs, lost productivity and other financial costs. Cancer-related services accounted for 
approximately $4.5 billion of the annual health expenditure in Australia for 2008-2009.5 More recent 
figures are only available for admitted patients, but suggest expenditure in the hospital sector of around 
$3 billion on cancer related diseases in 2012-2013.2 An economic report commissioned by the NSW 
Cancer Council in 2006 found that the total lifetime financial cost of cancer for those diagnosed in the 
previous year was equivalent to 1.3% of gross state product.6 Most of the economic cost of cancer 
relates to the burden of disease, of which individuals bore around 90%. Individuals and governments 
shared around 40% of the direct financial costs of cancer; whilst society, family, friends and employers 
made up the remainder. In terms of financial cost and total burden of disease, the most expensive 
cancers to society were lung, colorectal and breast cancers.6 
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1.2   An overview of cancer incidence and mortality in Australia 
Registration of cancers, excluding non-melanoma skin cancers (NMSC), is required by law in each 
Australian state and territory.4 Clinical and demographic information about people newly diagnosed 
with cancer is collected from hospitals, pathologists, oncologists, cancer treatment centres and nursing 
homes. This information is sent to the National Cancer Statistics Clearing House (NCSCH), and 
incorporated into the Australian Cancer Database.4 Operated by the Australian Institute of Health and 
Welfare (AIHW), the NCSCH operates under the supervision of the Australasian Association of Cancer 
Registries. The main source of cancer mortality data is the National Mortality Database which contains 
information on all deaths where cancer was the underlying cause. 
There will be an estimated 130,000 newly diagnosed cancer cases in 2016, the most common being 
prostate, colorectal and breast cancer, followed by melanoma and lung cancer.2  In the same year, there 
will be an estimated 46,900 deaths, with lung, colorectal and prostate cancer accounting for the most, 
followed by breast and pancreatic cancer.2 The incidence of many cancers rises considerably after 50 
years of age, which has implications for the ageing Australian population. While overall incidence of 
cancers have increased, death rates have declined by around one-fifth in the past thirty years.4 This has 
been attributed to improvements in screening, diagnosis, treatment and survival outcomes for certain 
cancers. Around 10% of all hospitalisations are related to cancer diagnosis and/or treatment.4  
Around one third of cancers in Australia have been attributed to commonly known risk factors. The 
most prominent risk factors are exposure to tobacco smoke and solar radiation, inadequate diet and 
overweight/obesity and alcohol. Modifying these are likely to significantly reduce the incidence and 
impact of lung and colorectal cancer, melanoma and breast cancer.7 It is not well documented how 
exposure to these factors might vary between urban, rural non-farm and farm resident populations. 
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1.3   Urban - rural differences in cancer indicators 
Approximately 71% of Australia’s 23.8 million people in 2015 lived in ‘Major cities’, as classified by 
the Australian Statistical Geography Standard (ASGS).8-9 A further 18% lived in inner regional areas, 9% 
in outer regional with 2.4% in remote or very remote areas. Differences in the regional cancer incidence 
and mortality over time have been published in a series of government statistical reports on cancer, 
rural health and social trends.4, 10-11  
1.3.1   Cancer Incidence 
Comparative incidence data are available for three overlapping periods for selected cancers by 
ASGC category spanning 2001 to 2009.4, 10-11 These data suggest that compared with major cities, the 
incidence of all cancers was significantly higher for both inner and outer regional areas; variable or not 
significantly different in remote areas; but significantly lower in very remote areas. A summary of 
incidence by major cancer type for regional and remote categories compared to major cities, is provided 
below.  
• Inner Regional areas: 
Inner regional areas consistently had the highest incidence of all cancers, melanoma, colorectal and 
prostate cancers, which were all significantly higher than the incidence rates in major cities. Inner 
regional areas also had significantly higher rates of lung cancer than major cities - although these were 
lower than outer regional, remote and very remote areas. Cervical cancer and lymphoma incidence 
rates fluctuated slightly but were generally similar to major cities.  
• Outer Regional areas: 
Outer regional areas were generally second to inner regional areas in terms of incidence rates for 
most of the selected cancers. Rates were significantly higher than major cities for all cancers, 
melanoma, colorectal, lung and prostate cancers - but not as high as the rates in inner regional areas. 
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Outer regional areas had significantly higher rates of cervical and lung cancer than major cities or inner 
regional areas - but not as high as remote and very remote areas.  
• Remote and very remote areas: 
Incidence rates for all cancers, melanoma, breast and prostate cancers, were generally lower in 
remote and very remote areas than regional and major cities. Conversely, incidence for cervical and 
lung cancers were significantly higher than other areas. Patterns varied for colorectal cancer and 
lymphoma in remote areas from 2008-2012, but were significantly lower in very remote areas than 
most other areas during the same period.  
1.3.2   Cancer mortality 
 The age-standardised mortality rate for all cancers combined declined over the period from 2002-
2012 in each area, but cancer mortality generally increased with remoteness.4, 10-11 Major cities had 
significantly lower death rates than inner regional areas, which in turn had significantly lower rates than 
outer regional areas. Mortality was highest in remote and very remote areas, being significantly higher 
than major cities, but not outer regional areas. A summary of comparative mortality for selected 
cancers by ASGS category is provided below, with reference to major cities. 
• Inner regional areas 
Inner regional areas had the highest rates for breast cancer, colorectal cancer, melanoma and non-
Hodgkins lymphoma (NHL) for at least part of the period from 2006-2012. Melanoma mortality rates 
were the highest and significantly higher than major cities over the whole period. Colorectal cancer 
mortality was highest in inner regional areas for 2008-2012 of all areas; and significantly higher in inner 
regional areas than in major cities over the whole period. Breast cancer was highest in inner regional 
areas from 2006-2010; and NHL mortality highest for 2006-2012, but rates for nHL were not significantly 
different to those for major cities.  
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• Outer regional areas 
Outer regional areas had the highest mortality rates for prostate cancer from 2006-2012; and for 
colorectal cancer from 2006-2010. These were both significantly higher than rates observed in major 
cities. People in outer regional areas also had significantly higher mortality due to melanoma and lung 
cancer than those in major cities.  
• Remote and very remote areas  
Over the whole period from 2002-2012, mortality was generally higher for all cancers, cervical and 
lung cancer in remote and very remote areas, compared to major cities. Conversely, colorectal cancer, 
melanoma and NHL mortality rates were generally lower. Patterns of comparative breast and prostate 
cancer mortality varied.  
1.3.3   A regional picture of cancer incidence and mortality 
In summary, when cancer incidence and mortality are considered together:   
• Major cities tended to have the lowest incidence and mortality rates for both lung and 
cervical cancer. 
• Inner and outer regional areas tended to have the highest incidence and mortality rates for 
melanoma, prostate and colorectal cancer.  
• Remote and very remote areas tended to have the highest incidence and mortality for 
cervical and lung cancer. They also had the lowest all cancer incidence, but highest all 
cancer mortality.  
• There were variable or inconsistent patterns of incidence and mortality rates by ASGS 
category for breast cancer and lymphoma. 
Generally, incidence and mortality rates for the selected cancers reflected similar patterns i.e. 
where incidence of a selected cancer was higher, mortality also tended to be higher. For the selected 
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cancers in both inner and outer regional areas, there was little suggestion of a ‘lower incidence/higher 
mortality’ pattern which is sometimes observed in socio-economically disadvantaged populations.12-13 
However, it is suggestive of such an effect for ‘all cancers’ in remote and very remote areas.  
Of particular interest over the period, was that the highest incidence and mortality rates for the 
most common cancers were in regional areas. With the exception of lung and cervical cancers, cancer 
incidence and mortality did not necessarily increase in a one-direction gradient from lower rates in 
major cities to higher rates with increasing remoteness.  
1.3.4   Cancer survival  
Cancer survival is generally considered a measure of the effectiveness of health systems.14 From 
2006-2010, all cancer survival generally decreased with remoteness, but differences were small and not 
significant. Five-year survival for all cancers was 67% in Major cities, 66% in Inner regional areas, 65% in 
Outer regional areas and 63% in Remote and Very remote areas.15 Survival from colorectal  prostate and 
lung cancer from 2006-2010 were highest in major cities, but breast cancer survival was marginally 
better in inner regional areas and melanoma survival highest in remote and very remote areas.16 Overall 
differences in the major cancers were small. Only lung cancer and colorectal cancer survival were 
significantly higher in major cities; and only breast cancer survival was significantly lower in remote/very 
remote areas compared to other areas.16 
1.3.5   Other cancer indicators  
Other indicators, such as cancer screening and treatment provide an insight into health service 
access and utilisation in different areas. Separation rates for chemotherapy, for example, have been 
reported to be significantly higher in regional areas than major cities, but significantly lower in remote 
areas.17 This is consistent with cancer incidence trends, which rise in regional areas and fall in remote 
areas. Women in regional areas were also reported to be significantly more likely to participate in 
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breast cancer screening compared with those in major cities, while women living in very remote areas 
were significantly less likely to be screened.17 
Considered together, these indicators suggest there is no simple trend of cancer ‘unwellness’ 
increasing from major cities toward very remote areas. If anything, a peak seems to occur in inner 
regional areas, sloping outward from that point by remoteness, with major cities being healthier for 
most indicators. Factors other than remoteness per se, appear to be important in influencing selected 
cancer rates.  
1.4   Possible reasons for differences between rural and urban people  
It has been suggested that rural Australians generally have poorer health outcomes and indicators 
than their urban counterparts.10, 12 Differences in cancer incidence and mortality by rural area may be 
influenced by a number of factors. People living in remote areas of Australia are reported to have higher 
rates of risky health behaviours, such as smoking, excessive alcohol use and poor nutrition; and may be 
disadvantaged in accessing primary health-care services.4, 11 Risk factors may vary by geographical area, 
with socio-economic disadvantage and the higher proportion of Indigenous Australians, being two 
important underlying influences on health status in rural Australia.1, 18 
Socio-economic status, inclusive of educational, employment and income disadvantage, is likely to 
have a considerable influence on cancer incidence and mortality in rural areas.12, 19 Disadvantaged 
groups consistently have poorer overall health status, with lower life expectancy, higher incidence, 
prevalence and risk factors for disease and greater rates of avoidable mortality. Additionally, they 
demonstrate greater use of doctors and hospitals, but are less likely to use preventive health services.12 
Higher incomes in major cities are consistent with there being a larger proportion of managerial and 
professional workers in these areas.19 The proportion of people living on lower incomes generally 
increases with remoteness. However,  after adjustment for housing costs, inner regional areas have 
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been reported to have a higher proportion of people from low income households, which also reflects 
their slightly older age profile.1, 12, 19 This corresponds with inner regional areas reported to have higher 
incidence of all cancers, melanoma, prostate, breast, and colorectal cancers; and higher mortality for 
NHL, melanoma, colorectal and breast cancers.4, 12 
Whilst the number of Indigenous Australians is similar between cities and regional areas, the 
proportion of Indigenous people increases with remoteness.19 Elevated smoking rates and higher 
incidence and mortality rates of lung and cervical cancer in very remote areas, coincide with the 
considerably greater incidence and mortality of these cancers for Indigenous Australians.4, 10 Likewise, 
the lower incidence for all cancers, NHL, colorectal and prostate cancers in very remote areas, are 
aligned with lower incidence of these cancers by Indigenous status; as are lower mortality from NHL 
colorectal and prostate cancers in very remote areas.4 One exception is breast cancer mortality, which 
was lower in very remote areas, but higher amongst Indigenous women. This may be related to later 
cancer stage at diagnosis amongst Aboriginal women in very remote areas; and /or difficulty in 
providing the required cancer services, for breast cancers13. Further, this may be compounded by 
considerable family and economic barriers to travelling and staying far from home for extended periods. 
In 2006, 40% of Indigenous Australians were in the bottom 20% of mean equivalent household 
incomes.10  
Geographic distance (the tyranny of distance), may play a role as rural Australians have been 
reported to have significantly lower levels of utilisation and/or access to health care services.12 
However, it is not known if issues of access to services for initial consultation and diagnosis result in 
presentation when cancers are at a later stage of development and are less amenable to treatment 
interventions.12  Further, it is possible that distance could impact on decisions regarding the types of 
medical treatment received; including referral to specialist cancer centres versus regional general 
hospitals.20  
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1.5   A demography of Australian farmers and farm families 1.5.1   Australian farmers 
Agriculture is a major employer in rural Australia, with around a quarter of men in outer regional 
and remote areas employed in the sector.12 Australian farmers can be considered a rural sub-
population, with unique characteristics insofar as their employment, lifestyle, potential environmental 
exposures and socio-economic factors. By occupation, farmers and farm managers: 
 
“... plan, organise, control, coordinate and perform farming operations in agricultural 
establishments. Tasks performed typically include planning and coordinating the operation of 
hatcheries and crop production; breeding and raising livestock; monitoring and maintaining the 
health of stock; identifying and controlling environmental toxins, weeds, pests and diseases; 
organising and conducting farming operations such as maintaining buildings, water supply and 
equipment; managing business capital, monitoring market activity and planning production to 
meet contract requirements and market demand.”21-22  
For ABS statistical purposes farmers are those who reported that their main occupation was a 
farmer or farm manager on census night. In 2011, there were 157,000 farmers in Australia, most being 
mixed crop and livestock farmers (22%), beef cattle farmers (20%), dairy farmers (8%) and sheep 
farmers (7%).23 Around one third of Australia’s estimated 120,000 farms are located in NSW.24 Farmers 
are generally older than other workers (median 53 yrs in 2011); more likely to continue working well 
beyond retirement age (23% aged 65 years or over); more likely to be self-employed; work longer hours 
(50% over 49 hours a week); and have lower disposable income with higher household wealth.19, 21, 23  
1.5.2 Farming families 
It has been estimated that  99% of farms in Australia are family businesses, passed on to successive 
generations.25 In 2011, there were 93,300 farming families in Australia where the family reference 
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person and /or their spouse or partner, reported that their main occupation was a farmer or farm 
manager.21 Generally, farm families are:19, 21 
• more likely to be a couple living by themselves (48%) than other families (38%). 
• slightly larger than other families, average 4.0 members compared to 3.7 for other families. 
• less likely to be one parent families,  3%  vs. 16% for other families. 
• likely to be supported by women:  
- one third of farmers are women.  
- one third of women in farm families also have off-farm work, whilst simultaneously 
supporting operation of the farm.  
• more locally connected, with volunteering rates twice as high as other families - partly 
related to service provider gaps in smaller communities and an older age-skew. 
The number of farming families has been steadily declining over recent decades.21 Contrary to 
popular belief, the greatest declines coincide with periods of better commodity prices, where improved 
financial capacity enables farmers to expand and buy-out neighbouring farms; whilst hard times see 
farmers delaying retirement or waiting until conditions improve.19, 21 However, poorer economic 
conditions for farm families are likely to affect the capacity to employ other farm workers, with a 
decline in farm worker numbers under poorer economic conditions.21   
In the absence of more recent data on the distribution of farm families, 2001 Census data suggests 
that around 6% of farm families are located near/around major cities, 34% reside in inner regional, 46% 
outer regional and 14% in remote and very remote areas.19 Most farming families live in inner and outer 
regional areas, but this varies with farm type. Intensive small farms (e.g. market gardens) and dairy 
farms, tend to be located closer to Major Cities and in Inner Regional areas; whilst over 50% of all sheep 
farmers and mixed crop/livestock families live in Outer Regional areas.19 Whilst more farming families 
lived in Major Cities than in Very Remote areas, farm families comprised 10% of all families in Very 
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Remote areas, compared to only 0.2% of families in Major Cities.21 As such, the health of this very small 
group is unlikely to affect the health indicators of Major Cities.  
There is a lack of definitive data on the proportion of occupational farmers, farm managers and 
farm workers and their families who actually live on farm. Using ‘urban centre’ as a measure, an 
estimated 13% of farming families lived off-farm in urban centres over 1,000 people in 2001, with the 
primary farmer travelling to work on farm.19 Another proxy indicator provided by census data is stated 
method of travel to work. In 2011, 58% of 42,595 farmers and farm managers in NSW, either walked to 
work or worked from home.26 This is likely to be a considerable under-estimation, as larger land-
holdings may require vehicular transport to farm work areas (which may be a preferred option for older 
farmers) and farmers may also own multiple landholdings requiring transport. Allowing for such 
shortcomings, a conservative mid-range estimate between the two sources might suggest that at least 
three quarters of commercial farmers live on farm.  
It is not known how many non-commercial or lifestyle farms there are in NSW, but a third of all 
commercial farms are less than 50 hectares in size.21 Farm exposures and activities may be similar, 
depending on whether work or leisure purposes dominate. Conversely, some farm family members and 
lifestyle farmers may have little to do with farming activity per se; and their lifestyle and access to 
services may be similar to other rural people. These are inherent limitations associated with defining 
farm and non-farm residents into neat categories of exposure or health risk. We do know however, that 
people who either live or work on farms have a unique set of characteristics associated with life and 
work on farm; and they constitute a sizeable rural population for which there is very limited information 
about cancer indicators and risk factors.  
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1.6   Previous studies of cancer in Australian farmers 
Whilst rural cancer incidence and mortality are reported in regular statistical reports on cancer in 
Australia,4, 10-11 only two studies have been published that specifically address these issues in farmers as 
an occupational or residentially defined group. A case-control study was conducted of 
lymphohaematopoietic cancers in Tasmania from 1972–80. Farmers, miners, foundry workers and 
hairdressers had elevated risk compared to other occupations, with risk to farmers varying with age at 
diagnosis, sex and region.27 Families of older farmers were also at higher risk. A related study of this 
cohort reported that farm residence in early life also yielded higher relative risks for chronic lymphocytic 
leukemia and acute myeloid leukemia, particularly in orcharding and dairying.28    
Another study compared ABS mortality data for male farmers aged 25-74 years, with other 
Australians between 1999-2002.29 Farmers had significantly higher mortality for all cancers and cancer 
of the prostate and lymphohaematopoietic systems than other Australian men. No other studies have 
reported on incidence and mortality by occupational grouping since the ABS ceased to report by this 
category in 2002. 
1.7   Cancer risk factors in farmers 
Previous studies have suggested higher rates of cancer mortality in rural areas may be attributed to 
higher risk alcohol consumption and smoking rates; plus educational, employment and income 
disadvantage.10-12, 21 However, there is limited information as to whether lifestyle or socio-economic risk 
factors for cancer differ between farmers and other rural people in Australia. No significant differences 
were noted in lifestyle factors between farm and non-farm participants at an agricultural field day 
health promotion program in rural NSW.30 Likewise, alcohol consumption patterns, waist circumference, 
overweight and obesity, physical activity and smoking behaviours between farm and non-farm groups 
were not dissimilar in the 2008 NSW Population Health Survey.31-32 Several of these factors will be 
explored further in the primary research study. 
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There are also a range of potential environmental cancer risks including pesticide and chemical 
exposures, commodity specific exposures and sun exposure that may occur in an agricultural setting.  
A recent review assessed 103 studies on farm pesticide exposures and cancer risks published from 1991-
2010 for selected cancer sites.33 When cross-checked with the Australian Pesticide and Veterinary 
Medicines Association (APVMA) online chemical register in November 2016, 7 of the 21 chemical 
formulations listed in the review as being associated with increased cancer risk were registered for use 
in Australia.33-34 The review concluded that some chemicals in every pesticide class were found to have 
significant associations with several cancer sites, particularly amongst chlorinated, organophosphate 
and carbamate insecticides and phenoxy and triazine herbicides. However, the review also pointed out 
that there are over 800 active ingredients and thousands of pesticide formulations on the market. 
Importantly, the review concluded that one of the ‘major challenges’ of epidemiology is the 
identification of whether specific compounds are responsible for specific cancer risks; and research 
should focus on specific exposures to individual pesticides and specific cancers, controlling for potential 
confounders. A lack of precision in exposure measures and inadequate replication of studies also 
contributed to the systemic methodological problems in detecting pesticide associations from 
epidemiological studies. 32      
Seventeen studies have been published since 2002 on associations between cancer risk and 
commodity type. There has been a lack of clear evidence on associations of different commodity groups 
with breast, colorectal or prostate cancers, or melanoma.35-38 Lymphohaematopoietic subtypes have 
been the most studied. Positive associations were more commonly reported for cropping and 
horticulture than for livestock in regards to lymphoma and leukaemia, although myeloma has been 
associated with sheep production.35-36, 39-41 Negative associations were more commonly reported for 
livestock groups than for cropping/horticulture groups. In particular, dairy exposure and lung cancer 
were found to be negatively associated in three out of four analyses; with the protective effects of 
endotoxin exposure one reason suggested for these findings.36, 42-43 
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Sun exposure is another risk factor likely to be greater for those living and working on farms. One 
recent Australian study assessed this in the context of occupational carcinogens across industry sectors. 
In agriculture, the most common environmental carcinogen was solar ultraviolet radiation associated 
with working outdoors. Exposure to diesel engine exhaust, benzene, polycyclic aromatic hydrocarbons 
were likely to be associated with using diesel powered equipment, refueling petrol powered equipment 
and repairing motors and farming equipment.44 
1.8   Health services access and utilisation 
Access to / utilisation of health services such as suitable screening, diagnosis and treatment facilities 
may be limited in rural areas, but it is not known if this is any different for farming families than for 
other rural people. In the absence of sufficient studies, questions remain as to if and why some cancers 
may be elevated in Australian farmers.  
1.9   Research objectives  
It is currently not known if elevated mortality rates for cancer previously reported in Australian 
farmers is related to higher incidence of these cancers, later presentation, later diagnosis or access to 
best treatment.27-29 Additionally, the relative contribution and/or association of behavioural, 
environmental, health service utilisation and other rural factors with cancer mortality and incidence in 
farmers is limited.  
Focusing on farm residents, this study aimed to identify if there are variations between NSW farm, 
rural non-farm and urban residents in the 45 and Up Study in relation to:  
1. Incidence and mortality from selected major cancers 
2. Screening rates, stage at diagnosis and selected cancer therapies  
3. Common risk factors associated with these cancers 
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In addition to the above, there was interest in whether the two rural groups might differ from the 
urban group - particularly in relation to baseline risk factors and health service related indicators. The 
series of studies undertaken will add to the body of evidence on cancer risk in these population groups. 
Identifying potential disadvantage and strengthening the evidence base on which health policy and 
resourcing decisions are made, is an important role of epidemiological and health services research. 
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Chapter 2:  Literature review 
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2.1   Objectives 
The objectives of this literature review were to examine differences between farmers and non-
farmers in the incidence, mortality, screening, stage at diagnosis, treatment and survival outcomes for 
‘all cancers’ and selected major cancers. A review of environmental risk factors associated with living or 
working on a farm and possible associations with cancer was initially considered. However, analysis of 
environmental risk factors could not be undertaken in the primary research project of this thesis, as 
exposure information was not available. Therefore, it was decided not to include this component as part 
of the literature review for this body of work.  
2.2    Methods of selection, identification and assessment of studies 
A review protocol was established prior to conducting the review to assist in the systematic 
identification and assessment of relevant studies. Eligibility criteria were also developed to guide 
selection of appropriate studies. The protocol and eligibility criteria are provided in the Appendix to 
Chapter 2.  
A broad initial search of the literature on cancer in farmers was undertaken to maximise capture. 
This yield was further compartmentalised into a set of smaller reviews, focusing on particular elements 
or cancers. The most detailed of these related to prostate cancer risk, the subject of a paper submitted 
for publication.  
English language abstracts of both primary studies and reviews were searched within Medline, Web 
of Science, BioMed Central, Cochrane library, Scopus, Embase, Informit, Proquest and Google Scholar. 
Search terms used were based on the following strings: 
• Farm* or Agricultur* or occupation*; AND  
• (cancer OR melanoma OR lymphoma); AND  
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• (incidence OR presentation OR diagnosis OR treatment OR screening OR mortality OR death 
OR survival OR risk).  
These search concepts were adapted for each database as required - and were confined to 
appearance in the title or abstract, so that cancer and ‘farming’ / ‘occupation’ were the focus of the 
research. The broader scope search had no year limits, but these were restricted for some of the sub-
reviews. The search was initially inclusive of all major cancer groupings with cancer status based on 
diagnoses using ICD9 or ICD10 classifications, as usually reported by population-based cancer registries.1 
Details on region and ‘farmer’ status were required. A summary of steps used to retrieve and categorise 
the literature are shown in Figure 2.1.  
Standard quality tools were used to guide selection, categorisation and assessment of individual 
articles. These were the (1) Strengthening of reporting of observational studies in epidemiology 
(STROBE) statement;2 the (2) Effective Public Health Practice Project Quality Assessment Tool for 
Quantitative Studies (EPHPP);3 (3) tools developed by the Critical Skills Appraisal Program (CASP);4 and 
the ‘Grading of Recommendations, Assessment, Development and Evaluation (GRADE)’  approach for 
assessing the quality of the body of evidence across studies.5 Criteria were also developed to 
standardise statements made by different component studies, on whether a significant excess or deficit 
of a selected cancer risk in farmers existed. Determination considered both the narrative conclusion of 
the study (or review study), as well as quantified results within the component study. These criteria 
appear in the Appendix to Chapter 2.  
For reviews and primary studies of incidence and mortality, the ratio or percentage of reviews 
reporting a clear excess or deficit of cancer risk in farmers, out of all reports, was determined and 
formed the basis of summary of findings.  
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2.2.1   Methods relating to review studies 
Reviews selected were confined to those addressing results of epidemiological, population-based 
studies - either of cohort, cross-sectional or case-control design. Narrative overviews, comments and 
issues papers were not included, nor reviews of health promotion evaluations; ecological studies, 
attitudinal and behavioural studies. Reviews with selective reporting of results were not included (e.g. 
reports of positive/significant results only); nor previous versions of reviews where updates were 
available.  
The methodology of reviews and their component studies was assessed to ensure review 
conclusions were based on component studies of sufficient quality.2-5 Appropriate non-farmer 
comparison groups needed to be defined. Other criteria were the reporting of findings for three or 
more diseases and/or results for several occupations; age-gender standardisation with risk estimates for 
several cancer sites; and studies with sufficient data for determining  confidence intervals. Risk 
estimates could be expressed as: 
• standardised mortality rates or ratios (SMR)  
• standardised incidence rates or ratios (SIR)  
• relative risk (RR)  
• hazard ratio (HR)  
• odds ratio (OR)  
2.2.2   Methods relating to primary studies  
This component of the review retrieved observational, epidemiological, population-based studies of 
cohort, cross-sectional or case-control designs. Regions, gender and age groups needed to be defined. 
Studies compared urban populations/participants and/or rural ‘non-farm’ groups with ‘farm’ groups. 
Farmer groups (men or women) were defined by: 
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• occupational grouping - ‘farmer’ or ‘farm / agricultural worker’ 
• farm labour/union membership  
• ‘farm’ residential status 
Non-farmer groups (men or women) were defined either by: 
• ‘non-farmer’ occupational grouping 
• ‘non-farm’ residence (rural or metropolitan)  
• ‘whole’ population or ‘all’ occupations in a jurisdiction 
Some further restrictions on the criteria for inclusion were placed on primary research articles. 
Firstly, only those arising from populations classified as ‘very highly developed’ according to the United 
Nations Index for Human Development were included.6 The rationale for this is to enable valid 
comparisons between findings for this review and earlier reviews, which also focused on farmers 
located in advanced economies.  
For primary studies, the scope was restricted to the more commonly occurring cancers, or those 
that previous reviews suggested might be more prevalent in farming populations. These were breast, 
colorectal, lung, lymphohaematopoietic cancers (lymphomas, myeloma, leukaemias), melanoma and 
prostate cancer. In addition, only articles published from 2003 onward were included. This decision was 
based on: (1) previous publication of a number of large reviews which had encompassed most of the 
literature before 2002; and (2) an interest in assessing whether some change in the risk profile of major 
cancers in farmers over the past 10 years had occurred, since previous reviews had been published. 
However, there were a lack of reviews and primary research articles on health service-related factors, 
such that restrictions on year of publication or cancer type for this category of studies was not applied.  
2.2.3   Retrieval and selection overview flowchart 
A flowchart summarising the retrieval, selection and categorisation of studies is shown in Figure2.1.  
61 
 
 
Figure 2.1: Retrieval and assessment flowchart for studies published 2003-2016 related to cancer 
incidence, mortality and health service factors in farm compared to non-farm groups 
 
•  2498 abstracts retrieved 
Search of electronic databases 
 
•  508 abstracts remaining 
 
Removal of 1990 ineligible abstracts 
 
Findings of 24 review studies summarised 
 
•  236 incidence and mortality studies 
•  31 stage of diagnosis, screening, treatment and survival studies                         
n(health service-related studies) 
•  217 risk factor studies 
Categorisation of 484 primary studies 
 
•  55 incidence and mortality studies remaining 
•  13 stage of diagnosis, screening, treatment and survival studies                                                                                                                 
(health service-related studies) remaining 
Removal of  217 risk factor and 199 other ineligible studies 
Findings of 55 incidence and mortality studies summarised 
Findings of 13 health service related studies summarised 
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2.3   Summary of findings from previous reviews 
The first summary is an overview of previous reviews of cancer incidence and mortality in farmers 
compared to non-farmers. Further summaries are based on primary studies relating to: (1) comparative 
cancer mortality/incidence; (2) a review focusing on prostate cancer incidence and mortality in farmers 
published in a peer-reviewed journal; and (3) a summary of health service related studies comparing 
farm and non-farm groups. 
 2.3.1   Cancer risk 
Twenty four reviews were identified addressing comparative cancer incidence and mortality in 
farmers, published between 1985 and 2016.7-29 Cancers where 50% or more of reviews reported a 
significant excess in farmers out of all reviews of such cancers, were lip cancer (5 of 6 reviews); multiple 
myeloma (6 of 7); Hodgkin’s lymphoma (5 of 6); leukaemia (3 of 6); prostate cancer (7 of 11); and brain 
cancer (4 of 8). Over 40% of reviews on melanoma, NHL and cancers of the stomach and nasopharanyx, 
also reported a significant excess risk in farm groups.  
Cancers where 50% or more of reviews reported a significant deficit in farmers were for all cancers 
combined (6 of 7 reviews); bladder cancer (5 of 7); lung cancer (6 of 9 reviews); esophageal cancer (3 of 
5) and colon cancer excluding rectum (4 of 6). Cancers showing no real difference between farmers and 
non-farmers were cancers of the female reproductive system, breast, non-melanoma skin cancers, 
rectum, testes, connective tissue and liver.  
Figure 2.2. indicates the general direction of cancer risk in farmers for some of the more common 
cancers, suggested by the percentage of reviews reporting significant excess and/or deficit out of all 
reports. Note that it is possible for each cancer to have two bars on the x axis, or no bar at all. For 
example, one out of nine lung cancer reviews (11%) reported a significant excess as represented by the 
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blue bar; whilst six of nine reviews (67%), reported a significant deficit of risk, represented by the red 
bar. No bars are shown for breast cancer, reflecting the neutral findings of reviews of this cancer.  
 
 
Figure 2.2: Summary of review study findings for risk excess or deficit of selected cancers in 
farmers compared to non-farmers from reviews published 1992-2014   
 2.3.2   Limitations and conclusions  
Others have described inherent problems in reviewing and comparing component studies that use 
disparate methodologies.7, 30 These issues include:   
• imprecise measures of ‘farm exposure’ (e.g. residency, occupation, registers, self-report, 
broad  groupings, approximating exposure times/degree or intensity of exposure   
• small number of studies, small sample sizes 
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• heterogeneity - variability in focus, scope, methods, measures, farming systems, regions, 
time-spans 
• difficulties identifying and controlling for unknown confounders (e.g. multiple exposures, 
socioeconomic variables, genetics)    
The evidence on cancer risk in farmers from previous reviews is suggestive of a deficit for all cancer, 
bladder, colorectal, lung and oesophageal cancers. Meanwhile the data suggest an excess risk for lip, 
prostate, some lymphohaematopoetic cancers and possibly brain cancers. However, the strength of 
evidence for excess or deficit of different cancers in farmers is relatively weak. This is largely due to the 
low volume of studies for each cancer type; and inconsistent methodological approaches which make 
comparisons difficult.  
2.4   Summary of findings from primary studies of cancer incidence and mortality   
Fifty five incidence and/or mortality studies published from 2003-2016 met the eligibility criteria 
addressing selected cancers. There were 41 incidence studies, 13 mortality studies and one study that 
reported on both incidence and mortality. Overall directions of findings for each selected cancer type 
are summarised in figures 2.3 and 2.4. These represent the percentage of articles reporting a significant 
excess or deficit of cancer risk in farm groups, out of all studies for each cancer.  
2.4.1   Cancer incidence  
The lymphohaematopoietic cancer grouping had the highest percentage of studies finding excess 
incidence in farm groups. Seven of 15 studies of leukaemia (46%) and six of 14 myeloma studies (43%) 
reported significant excesses in farmers, with remaining studies finding no significant differences. 
Lymphoma, including NHL was the most studied of the selected cancer groups, with six of 23 studies 
(26%) reporting an excess in farmers, but over two-thirds finding no difference between groups.  
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For prostate cancer, three of 12 studies (25%) also reported significant excess incidence, with one 
reporting a deficit in farm groups. On balance, studies suggested an overall deficit of all cancer, breast, 
colorectal, lung and melanoma cancers, in farm groups. Significant deficits were reported in six of seven 
studies of all cancer (86%) and seven of nine colorectal cancer studies (78%). Over half of all breast 
cancer studies (7 of 13) reported deficits in farm women, although two reported an excess. Findings for 
melanoma were mixed with three of nine studies (33%) reporting a deficit, one reporting an excess and 
five reporting no difference in melanoma incidence between farm and non-farm groups. Lung cancer 
incidence was significantly lower in farm groups in nine of 11 studies (82%), the most prominent of the 
selected cancers regarding reduced incidence in farmer groups.  
 
 
Figure 2.3: Direction of findings for incidence of selected cancers in farm compared to non-farm 
groups, from 42 studies published 2003-2016 
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2.4.2   Cancer mortality  
There were 14 studies comparing cancer mortality between farm and non-farm groups from 2003 to 
2016. Ten of these reported on all cancer mortality, of which three studies found an excess (30%); two 
found no difference (20%); and five studies (50%) reported a deficit in all cancer mortality in farm 
compared to non-farm groups.  
The only selected cancers with findings for excess mortality in farm groups were prostate and 
lymphohaematopoietic cancers. Three of 12 studies (25%) found a significant excess of 
lymphohaematopoietic cancer in farm groups; although eight (67%) reported no significant difference. 
Similarly, three of ten prostate cancer studies (30%) reported a significant excess in farm groups, 
although two studies reported deficits (20%); and five studies (50%) found no significant differences 
between farm and non-farm groups.  
For melanoma, none of the seven studies reported either an excess or deficit of mortality in farm 
groups. The remaining cancers reported deficits or neutral findings. Six of 10 lung cancer studies (60%); 
four of seven colorectal cancer studies (57%) and two of six breast cancer studies (33%), found deficits 
in mortality in farm compared to non-farm groups.  
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Figure 2.4: Direction of findings for mortality from selected cancers in farm compared to non-farm 
groups, from 14 studies published 2003-2016   
 2.4.3   Limitations and conclusions  
As for ‘previous reviews’, there were limitations in the strength of conclusions which could be 
drawn from our review of primary studies of cancer incidence and mortality. This was largely due to the 
heterogeneity of component studies; different methodologies used; the small numbers of studies 
reporting findings on particular cancers; and the difficulty component studies reliant on secondary data 
sources had in controlling for confounders.  
There were some consistencies with the findings of previous reviews - and some differences. The 
majority of studies have reported neutral findings, such that the strength of evidence for an excess risk 
in farm groups is perhaps weaker than in previous reviews. The overall direction of findings tends 
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toward neutral or negative risk in farm groups. In particular, this review suggests that for farm groups, 
there may be a: 
• deficit in all cancer and lung cancer risk, similar to conclusions of most previous reviews.  
• deficit in colorectal cancer, compared to mainly neutral/some deficit of risk suggested in 
previous reviews.  
• deficit or neutral risk of breast cancer, compared to neutral findings of previous reviews.  
• neutral risk of melanoma, compared to neutral/excess risk suggested in previous reviews.  
• neutral or mixed findings for prostate cancer, compared to neutral/excess risk suggested in 
previous reviews.  
• neutral to excess risk of some lymphohaematopoietic cancers, compared to an excess risk 
suggested in the majority of previous reviews.  
It is possible that the cancer incidence and mortality risk of farmers or farm groups has improved 
over the past decade. However, it is also possible that study measures have changed and greater 
control for confounders has been achieved in more recent studies. These issues are discussed more fully 
in the review of studies that focus on prostate cancer risk (Appendix to Chapter 2).  
Considering the broad scope of this review, only two components are presented in greater detail. 
These relate to: (1) prostate cancer incidence and mortality risk; and (2) comparison of health service 
related factors between farm and non-farm groups.  
2.4.4   Prostate cancer incidence and mortality risk     
Prostate cancer risk was explored more fully as it is the most frequently diagnosed cancer in men in 
the developed world;31and studies on cancer risk in farmers have historically been considered useful for 
providing insights into safe work practices and the development of cancers in the general population.9, 32 
Some have proposed that elevated cancer risk in farmers may be related to lifestyle factors or pesticide 
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exposures, but this remains unclear.15, 27 We had a particular interest and a capacity in our primary study 
to contribute to the evidence on the role of lifestyle risk factors in cancer risk in farmers. Meanwhile, 
prostate cancer incidence and mortality risk per se, was the subject of a paper published in 2014 and is 
included in the Appendix to Chapter 2.  
Publication 1: Depczynski, J and Lower T. ‘A review of prostate cancer incidence and mortality 
studies of farmers and non-farmers, 2002–2013’ Cancer Epidemiology. December 2014. Volume 
38, Issue 6, Pages 654–662. 
2.5   Summary of findings involving health service related factors  
Given the geographic dispersion of rural Australia, there is potential for health service related 
factors to have a considerable impact on cancer identification and treatment. A summary of findings are 
described below for (1) stage at diagnosis or treatment; (2) cancer survival outcomes; and (3) cancer 
screening. Additional information on each component study and the quality assessment process, are 
provided in the Appendix to Chapter 2. 
2.5.1   Stage at diagnosis and treatment  
Only five studies addressed the issue of differentials in stage of cancer diagnosis between farmers 
and non-farmers. Three studies found that farmers and/or agricultural worker groups were significantly 
more likely to be diagnosed at ‘later stage’ compared to non-farmers for all cancers combined, prostate 
cancer and testicular cancer.33-35 In contrast, there were mixed findings in studies that assessed 
colorectal cancer. For men, two related Californian studies found later stage colorectal cancer diagnosis 
in agricultural workers;33, 35 but a French study found no such differences between farmers and other 
social-professional groups.36 There were no significant differences in stage at diagnosis of colorectal 
cancer in women in any of these studies. 
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There were no significant differences in stage at diagnosis for laryngeal cancer between farmers/ 
agricultural workers and non-farmers, although different patterns of presentation were noted.33, 37 The 
two Californian studies found no significant differences between agricultural workers and non-farmers 
for melanoma, myeloma, NHL or cancers of the breast, cervix, lung, brain, liver, pancreas, soft tissue, 
stomach, thyroid, reproductive or urinary systems.33, 35 
Only one study reported on treatment differences between farmers and non-farmers. There were 
no significant differences for treatment of colorectal cancer by surgical resection between farm and 
non-farm men; but farm women were significantly less likely than other social-professional groups to 
undergo surgical resection for colorectal cancer.36   
2.5.2   Survival outcomes 
Five studies addressed the issue of differences in ‘survival outcomes’ between farmers and non-
farmers. One Californian study reported on crude survival rates in Californian agricultural workers and 
non-farmers for all cancer and 20 cancer sites.33 After adjusting for age and stage at diagnosis, male 
agricultural workers had better survival outcomes for NHL. A Swedish study in the 1980’s reported 
crude survival deficits in farmers for all cancer and for cancers of the bladder, colon, kidney, prostate, 
rectum and testes. However, this study did not control for confounders and did not report on the 
significance of differences presented.38 Therefore, caution is required with interpretation of these 
results and they shall not be considered in the balance of evidence. No significant differences were 
found in survival outcomes between farmers and non-farmers for laryngeal cancer.33, 37 There were 
mixed findings for colorectal cancer survival outcomes. After adjusting for confounders, two European 
studies reported poorer colorectal cancer survival outcomes for farmers;36, 39 with a Californian study 
finding no difference.33   
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2.5.3   Cancer screening 
Six studies from the United States addressed the issue of differences in ‘cancer screening’ between 
farmers and non-farmers. Two used ‘routine’ or ‘primary care’ check-up as an indicator for screening of 
‘any’ cancer.40-41 No difference in routine primary care check-ups were found for women; although one 
did report that farm men had less frequent check-ups than non-farm men.41 There was no difference for 
either gender in the frequency of ‘multiple’ screenings tests as recommended in respective guidelines 
(colorectal, prostate, skin cancer).41 Generally, there was insufficient evidence of a difference in 
screening for all cancers between farmers and non-farmers, at primary care or general health check-
ups.  
Breast cancer screening practices were assessed in five studies. One found that farm women in 
Wisconsin reported health insurance to be a problem in accessing preventative screening, but this did 
not affect mammogram screening rates per se.42 Another study likewise found no difference in either 
mammogram usage or clinical breast examinations amongst farm and non-farm women in Iowa.40 After 
controlling for related variables, residence was not associated with screening practices in Colorado, 
except farm women were less likely to have a recent breast examination than metropolitan women.43 
Another study in Iowa reported mixed results, with farm women 40-49 yrs more likely to have a 
mammogram in the past two years, but a higher proportion of non-farm women over 50 years had a 
mammogram in the past year.41 Higher mammogram usage in farm women compared to state data was 
reported in Michigan, but the comparability and significance of this difference was not made clear.44 On 
balance, most results were neutral, with little evidence of a difference in breast cancer screening rates 
between farm and non-farm women. 
Cervical cancer screening practices were also analysed in five studies. Farm residents in Wisconsin 
were significantly less likely to have Pap smears at recommended time intervals;42 and farm women in 
Kentucky and Louisiana had lower crude rates of cervical cancer screening compared to ‘adjusted’ state-
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wide data.45 Both these studies however, were of only fair quality with methodological shortcomings 
relating to reporting of results and/or comparison of crude rates for farmers with adjusted state data 
(see Appendix 2). There were no differences in screening in the latter study for women in Texas; 45 nor 
for women in a Colorado study.43 Likewise, there were no differences in screening reported in the more 
methodologically robust studies of women in Iowa.40-41 Given that the better quality studies had neutral 
findings, there is little evidence overall to support a difference in cervical screening rates between farm 
and non-farm women. 
Prostate and skin cancer screening rates were compared in only one study, from Iowa.41 Farmers 
over 50 years were significantly less likely to have had a prostate examination, although there was no 
significant difference when the larger 40+ years age group was assessed. However, both farm men and 
women over 40 years, were significantly more likely to have skin cancer screening than non-farmers, 
although the difference for men over 50 years became insignificant. Whilst suggestive of a difference in 
farmer/non-farmer screening rates amongst older men, more studies need to be conducted to confirm 
these findings for skin and prostate cancer.  
Colorectal cancer screening rates were analysed in two studies, with mixed findings. Farmers in one 
study were less likely to have had stool blood screening for colorectal cancer in the past year, but there 
was no difference compared to non-farmers after two years.40 Another study also found no difference 
between farmers and non-farmers in colorectal screening in those over 50 years of age, although older 
farm women were more likely to have had a sigmoidoscopy in the past five years than non-farm 
women.41 In the context of Australian recommendations for faecal occult blood testing (FOBT) for those 
50 years and over every two years,46 there is little evidence of a difference between farmers and non-
farmers, if using Australian guidelines as indicators.  
All six screening studies ran regression models to assess predictors for cancer screening. Farmer 
status was not a predictor of ‘multiple screening’ or mammogram usage;41-43 although one found it as a 
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predictor of non-compliance for breast examinations.43 There were mixed results in three studies as to 
whether farmer status was a predictor of cervical screening.42-43, 45 Other factors showing positive or 
mixed predictive value for non-compliance with screening were no preventative health insurance, age, 
income, educational level and having no primary health care provider.41-45 Factors showing no predictive 
value for screening compliance were ‘time to health care facility’, perceptions of general health, or a 
perception that health insurance was a problem to obtaining care.42-43, 45  
2.5.4   Limitations and conclusions  
Overall, there were very few studies that assessed differences in stage at diagnosis or treatment of 
cancers between farmer and non-farmers groups in this review. Whilst individual studies were generally 
of good quality, the quality of the body of evidence across studies based on the ‘GRADE’ Approach was 
low.5 This was largely due to limitations of observational study design typical of epidemiological 
research. Overall, the level of evidence on differences in stage at diagnosis between farmer and non-
farmers is low or insufficient, from both quantity and quality perspectives.  
For survival outcomes, individual studies were generally of good quality, with the exception of 
one.38 However, the quality of the body of evidence across studies remains low, due to the 
heterogeneity of studies and the insufficient number of studies addressing this question. Results 
suggest there may be a differential in colorectal cancer survival outcomes, but generally there was 
insufficient evidence of a difference in cancer survival outcomes between farmers and non-farmers for 
most selected cancers.  
Linked to the problem of heterogeneity and low volume of studies, comparing countries with 
different health systems and health insurance schemes may have contributed to the lack of a clear 
direction of findings. Policies and structures of health systems influence the quality and access of health 
services for different groups, which in turn affected stage, treatment and survival; and perhaps the 
likelihood of screening in different countries. 
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The quality of individual studies on comparative screening ranged from good;40-41 through to fair;42-
43, 45 to one study of borderline quality regarding its screening practices component.44 All studies were of 
cross-sectional or baseline survey design, with quality of the body of evidence across studies again low 
using the GRADE criteria.5 There were few studies addressing comparative screening practices of 
farmers and non-farmers. For colorectal, prostate and skin cancers, there were an insufficient number 
of studies to draw conclusions about comparative screening practices. There were more studies on 
breast and cervical screening, with little or no evidence for a difference in screening practices between 
farmers and non-farmers.40-42, 45 The overall evidence for a difference in screening practices between 
farmers and non-farmers is lacking; and where present, suggested little to no difference between farm 
and non-farm groups.  
This component review of health service related factors has established there is a general lack of 
knowledge on comparative stage of cancer diagnosis, treatment, survival and screening practices 
between farm and non-farm population groups. One of the objectives of the primary research project is 
to address this gap in knowledge by comprehensively assessing the epidemiology of cancer in NSW 
farmers.  
2.6   Appendix 2.6.1   Protocol for literature review  
The following protocol was developed prior to commencing the review and was adapted as 
necessary. Together with the eligibility criteria, this final version of the protocol version forms a general 
record of the review method.  
• Types of studies  
A range of observational, epidemiological study designs and reports of studies were considered for 
inclusion. These consisted of: 
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- Systematic reviews of observational studies  
- Retrospective and prospective cohort studies 
- Case-control studies  
- Cross-sectional studies 
• Types of participants / characteristics  
- At least one participant group must either live on or work on a farm  
- The study provides details on how ‘farmer’ status is defined 
- Cancer diagnoses use ICD classifications  
- Age groups should be specified 
- Settings or regions defined 
• Outcome measures  
Measures of incidence, risk, screening rates, stage of presentation, diagnosis, treatment, outcomes, 
mortality and survival rates for major cancers in farmers vs. others (all, urban, rural), focusing on the 
following cancer types: 
- Prostate  
- Breast  
- Colorectal 
- Lung 
- Melanoma 
- Lymphoma  
- Myeloma  
- Leukaemia  
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• Electronic searches for identification of studies  
Databases searched for identification of studies: 
- Medline  
- Embase  
- BioMed Central  
- Informit online  
- Cochrane library 
- Web of science (kw) 
- Scopus 
- Google Scholar 
- Proquest dissertations and theses 
- Hand search of reference lists of primary studies meeting review criteria 
- Search strings and databases accessed were recorded.  
• Selection of studies  
Search results to be merged using Endnote and duplicate records of the same report removed.  
- 1st round - Titles and abstracts examined to remove irrelevant reports  
- 2nd round - Full-text reports examined for compliance of studies with eligibility criteria. 
- Multiple reports of the same study linked. 
- Categorised by cancer type for: 
 Incidence/mortality (describing the excess/deficits) 
 Screening, stage of diagnosis, treatment and survival outcomes 
- 3rd round - refinement of eligibility criteria  
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Eligibility criteria for each study were assessed in an established order with the first ‘no’ response 
used as the primary reason for exclusion of the study (i.e. remaining criteria not assessed).  
• Data extraction and assessment of potential studies   
A data collection form was devised to assess studies according to set criteria. Assessment of 
methodological quality of individual studies was guided by: 
- The Effective Public Health Practice Project ‘Quality Assessment Tool for Quantitative 
Studies’3  
- The ‘STROBE statement’ guidelines for reporting observational studies2  
- Critical Appraisal Skills Programme (CASP) guides for appraisal of cohort studies, case-
control studies and reviews4  
The first and second of these (above), are cited by Cochrane Collaboration Handbook5 as useful 
guides and/or tools for assessing the quality of studies in public health studies. The third assisted in 
assessing the quality of particular epidemiological study designs. Domains of bias within studies 
assessed using these tools include selection, performance, detection, attrition and reporting bias.  
Whilst farm versus rural versus urban residency and farm occupation/activity are the comparison 
variables of interest, potential confounders considered in the assessment of bias in studies were age, 
gender, nationality/race, socio-economic variables (e.g. education, income, marital status), lifestyle 
factors (e.g. smoking, alcohol, diet, physical activity) and underlying health conditions. However, as it 
was deemed unlikely that information on most of these would be available, priority consideration was 
given to control of bias related to age and gender.  
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• Measures of exposure effect  
For studies presenting dichotomous data, effect measures for comparison between farmer and non-
farmer groups are odds ratio (OR), risk ratio (RR) or risk difference (RD). For continuous data, mean 
difference (MD) or standardized mean difference (SMD) between groups were assessed.  
• Assessment of heterogeneity and reporting biases   
A diversity of studies was expected and heterogeneity (clinical, methodological and statistical) 
expected to be high. Meta-analysis was not undertaken. Similar studies were grouped for comparative 
assessment. Publication bias was minimised by searching eight electronic databases and grey literature 
sources. Outcomes were not used as criteria for selection, such that significance of results did not affect 
study selection. Time (year) and language filters were not applied to searches, but were later refined 
according to study yield for incidence/mortality and risk factor studies - and after systematic review 
studies were assessed. 
• Data synthesis   
Each study was assessed according to eligibility and quality criteria listed in a data-collection sheet. 
A narrative summary was produced for each study. Studies were grouped by type, conditions of interest 
and quality of evidence.  
• Subgroup analysis and summary of findings 
Population subgroups for comparative analyses were: (1) farmer/farm resident; (2) rural non-farmer 
/non-farm resident; and (3) urban/other. Measures of interest for sub-group analyses were incidence, 
risk, screening rates, stages of presentation, diagnosis, treatment, outcomes, mortality and survival 
rates. ‘Summary of findings’ tables by study type were produced. Cancers of interest were listed, along 
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with numbers of participants/studies, comparative risk between population subgroups (farmer, rural 
non-farmer, other) and quality of the overall evidence using the ‘GRADE’ system.4   
2.6.2   Eligibility criteria for selection of studies 
Eligibility criteria developed to assess review and primary studies are shown in the following tables. 
 
Table 2.1: Eligibility criteria for review studies 
 
1 Addresses objectives of the current review 
2 Appropriate studies include reviews of primary cohort, case-control, cross-sectional studies  
  
Narrative overviews, comments & issues papers not included 
  
Evaluations of health promotion interventions not included 
  
Reviews of ecological studies; or qualitative attitudinal & behavioural studies not included 
  
Reviews with selective reporting of results not included (e.g. reports positive / significant 
results only) 
  
Previous versions of studies with updates on same cohort not included in same review 
3 Settings, regions specified 
4 Details on  ‘farmer’ status provided 
  
Occupations other than farming NOT included in 'farmer' group 
5 Cancer status  - diagnoses should use ICD10 classifications, as usually reported by central cancer 
registries 
  
Only include those with results for one or more of the 9 cancers of primary interest 
6 Incidence and mortality reviews : 
  
Findings for 3 or more diseases 
  
Appropriate non-farmer comparison groups  
  
Both positive & negative OR for several occupations (case-control) 
  
Component studies age-gender standardised with risk estimates for several cancer sites, 
elevated & decreased  
  
Component studies with risk estimates expressed as (SMR), (SIR), (RR), and (HR) in cohort 
and case–cohort studies, and (OR) in case–control studies.  
  
Component studies with sufficient data for determining  CI  
7 Meets threshold of quality using recognised quality appraisal tools 
  
STROBE2 
  
EPHPE3 
CASP4 
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Table 2.2: Eligibility criteria for primary studies 
 
1 Addresses objectives of this review 
2 Appropriate study design 
  
prospective cohort study  
  
retrospective cohort study  
  
case-control study 
  
cross-sectional studies 
3 Settings, regions & age groups specified 
4 Farmer status. At least one participant group must either: 
  
Live on a farm 
  
Work on a farm 
  
Details on  ‘farmer’ status provided 
5 Occupations other than farming NOT included in 'farmer' group 
6 Cancer status  - diagnoses should use ICD10 classifications, as usually reported by central cancer 
registries 
7 Meets finer details of inclusion/exclusion criteria: 
 
Include: Only those studies with results for one or more of the primary cancers of interest 
  
For incidence and mortality studies - only include studies published since 2003   
  
Appropriate non-farmer comparison group  
  
Both positive & negative OR for several occupations (case-control) 
  
Risk estimates for several cancer sites, elevated & decreased (cohort, mortality studies) 
  
Risk estimates expressed as (SMR), (SIR), (RR), and (HR) in cohort and case–cohort studies, 
and (OR) in case–control studies.  
  
Sufficient data for determining relative risk ratios & CI (cohort studies) 
  
Confounders adjusted were possible 
 
Exclude: For incidence and mortality studies - studies published before 2003   
  
Previous versions of studies with updates on same cohort not included 
  
Narrative style & selective reporting of results  
  
Evaluations of health promotion interventions  
  
Qualitative studies of attitudes & behaviours  
  
Farm density/proximity indicator (ecological)  
8 Meets threshold of quality using recognised quality appraisal tools 
  
STROBE2 
  
EPHPE3 
  CASP4  2.6.3   Criteria for assessment of significance and direction of findings in review component studies  
Criteria were developed to help standardise and assess the overall direction and strength of findings 
of component studies and are shown in Table 2.3.  
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Table 2.3: Criteria for standardising and assessing overall findings for excess or deficit of 
selected cancer risk in farm compared to non-farm population groups.  
 
Determination for overall 
review cancer risk = where 
majority of component studies 
fall + review conclusion 
Incidence or mortality measure of component studies  
(majority of studies) 
(PMR, SMR, SIR, OR, RR ) 
Conclusion 
Value 95% CI 
Clear excess >1 Minimum limit >1 P<.05 in statistical test 
Suggested excess >1 Minimum >0.97 Narrative statement 
No discernible difference Any Minimum <0.97 and Maximum >1.03 Narrative statement 
Suggested deficit <1 Maximum <1.03 Narrative statement 
Clear deficit <1 Maximum <1 P<.05 in statistical test 
 2.6.4 Summary of findings tables for reviews of health service factors
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Table 2.4a: Comparison of studies of cancer ‘stage of diagnosis’ and / or ‘treatment’ between farmers and non-farmers 
 
Primary author, 
year & study 
title 
Setting / 
what was done / 
study design 
F = Farmer 
AgW = Agricultural 
worker 
No. of 
farmers / 
non-
farmers 
 
Cancer site 
 
Indicator 
% group 
with 
indicator / 
predictor 
 
Statistical measure/ 
significance (RR, OR / 
95% CI  or p value) 
Quality tool 
assessment / 
Overall grading 
Key points 
 
Dodge, J. 2007. 
Cancer survival in 
California Hispanic 
farmworkers, 1988-
2001 
 
USA (AgW Hispanic) 
 
Data-linkage of farm 
workers union 
membership & state 
cancer registry, for 
Hispanics persons 
diagnosed with a first 
malignant tumour.  
 
Retrospective cohort 
study 
 
1,186 / 
178,718 
 
Cancer type 
 
 
 
All cancers 
   men (m)* 
   women (w) 
Brain/nervous (m) 
Breast  
Cervix  
Colorectal (m)* 
Colorectal (w) 
Corpus uterus  
Kidney (m) 
Kidney (w) 
Larynx (m) 
Liver (m) 
Lung-bronchial (m) 
Lung-bronchial (w) 
Melanoma (m)  
Myeloma (m) 
NHL (m) 
NHL (w) 
Ovary  
Pancreas (m)  
Prostate*  
Soft tissue (m) 
Stomach (m) 
Stomach (w) 
Thyroid (w) 
Urinary (m) 
 
 
Early stage 
tumor –  
in situ or 
localized  
 
% UFW 
farmworkers: 
% California 
Hispanics 
 
35.1% : 40.7% 
38.0% : 40.5% 
56.3% : 68.2% 
52.4% : 53.2% 
44.2% : 50.5% 
17.4% : 33.7% 
23.8% : 32.5%    
54.5% : 68.1%    
55.6% : 46.0%    
60.0% : 53.9%    
60.0% : 60.9%    
29.0% : 25.7% 
  8.6% : 11.2% 
  5.9% : 14.4%      
72.7% : 68.4% 
  8.3% :    6.4% 
35.0% : 25.5%    
28.6% : 26.0% 
33.3% : 19.4% 
   8.7% :   6.1% 
56.3% : 69.8% 
45.5% : 52.4%   
10.2% : 14.4% 
13.3% : 17.1%   
57.9% : 57.1%   
80.0% : 80.6% 
 
UFW farmworkers :  
California Hispanics 
 
RR (95% CI)  
 
RR= 0.86 (0.79 – 0.95) * 
RR= 0.94 (0.82 – 1.07) 
RR= 0.82 (0.53 – 1.27) 
RR= 0.99 (0.82 – 1.18) 
RR= 0.88 (0.65 – 1.19) 
RR= 0.52 (0.31 – 0.86)* 
RR= 0.73 (0.34 – 1.58) 
RR= 0.80 (0.55 – 1.17)  
RR= 1.21 (0.86 – 1.70) 
RR= 1.11 (0.67 – 1.85) 
RR= 0.99 (0.65 – 1.49) 
RR= 1.13 (0.65 – 1.97) 
RR= 0.77 (0.39 – 1.49) 
RR= 0.41 (0.06 – 2.74) 
RR= 1.06 (0.73 – 1.53) 
RR= 1.31 (0.20 – 8.62) 
RR= 1.37 (0.89 – 2.10) 
RR= 1.10 (0.48 – 2.52) 
RR= 1.72 (0.89 – 3.31) 
RR= 1.43 (0.38 – 5.43) 
RR= 0.81 (0.72 – 0.90)* 
RR= 0.87 (0.45 – 1.66) 
RR= 0.71 (0.33 – 1.63) 
RR= 0.78 (0.21 – 2.84) 
RR= 1.01 (0.69 – 1.49) 
RR= 0.99 (0.83 – 1.19) 
 
 
EPHPP – Strong  
STROBE – 2No        
CASP –  1No 
 
Grading: A 
Impression: Very good 
 
 
-   UFW men were generally diagnosed 
at an older age and more advanced 
disease stage than California Hispanics, 
important for colorectal cancer, which 
is highly preventable with routine 
screening.  
-   Compared to California Hispanics, 
UFW men experienced significantly 
lower proportions of early-stage 
diagnoses for all cancer sites combined 
and screenable colorectal, and prostate 
cancers.  
-   Women had lower proportions of 
early stage screenable colorectal and 
cervical cancers, but not significantly 
so. No difference for breast cancers. 
-   Conversely, non-Hodgkin’s 
lymphoma, ovarian, kidney, liver 
pancreatic cancers were more 
frequently diagnosed at early tumour 
stages in UFW versus California 
Hispanics, but not significantly so. 
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Mills P et al. 2001. 
Cancer incidence in 
the United 
Farmworkers of 
America (UFW), 
1987-1997. 
 
USA (Hispanic 
farmworkers) 
 
Data-linkage of farm 
worker union members 
& California state 
cancer registry. 
 
Retrospective cohort 
study 
 
 
 
 
 
 
68 / 2,126  
168 / 1,904  
76 / 2,547  
 
49 / 700  
 
15 / 583  
9 / 96  
 
 
 
 
 
 
Breast 
Cervical 
Prostate 
 
Colorectal (m)  
 
Colorectal (w) 
Melanoma (m) 
 
 
Early-stage 
tumours:  
in-situ or 
localized  
 
% Hispanic UFW 
farm workers / 
non-farmers  
(age adjusted) 
 
55% : 55% 
76% : 84% 
33% : 64% 
 
12% : 35% 
 
22% : 36% 
59% : 82% 
 
 
 
 
 
 
 
RR= 0.99 (0.78 – 1.28) 
RR= 0.91 (0.80 – 1.03) 
RR= 0.51 (0.41 – 0.64)* 
p< .0001* 
RR= 0.35 (0.16 – 0.75)* 
p< .01* 
RR= 0.55 (0.20 – 1.54) 
RR= 0.68 (0.37 – 1.22) 
 
EPHPP – Strong 
STROBE – 5No 
CASP – 0No 
 
Grading: A  
Impression: Very good 
 
 
 
 -   Hispanic farmworkers union (UFW) 
men had significantly later stage 
diagnosis of prostate and colorectal 
cancers than California Hispanics.  
-   No significant differences in stage of 
cancer diagnoses for women, in breast, 
colorectal or cervical cancers. 
 
Desoubeaux N et al. 
1997. Social 
environment and 
prognosis of 
colorectal cancer 
patients: A French 
population-based 
study 
 
France (F) 
 
Colorectal cancer 
patients diagnosed 
1978 - 1987 in Calvados 
district, France. Cancer 
registry-based. 
 
Retrospective cohort 
study 
 
250 /  
340,  
736,  
316 
 
Colorectal 
 
 
 
 
 
 
 
Colorectal 
 
Stage 1: 
Limited to 
organ. 
 
 
 
 
 
Treatment: 
Surgical  
resection / 
other 
 
% farmers / 
professionals 
 
Men: 
43.0% : 48.5% 
Women: 
35.2% : 43.0% 
 
Men: 
78.9% : 78.5% 
*Women: 
68.5% : 81.3% 
 
 
 
 
 
 
p=0.45 
 
p=0.40 
 
 
p=0.76 
 
p=.01* 
 
 
EPHPP – Strong  
STROBE – 2No        
CASP –  0No 
 
Grading: A 
Impression: Very good 
 
 
-   Four social classes assessed (only 
farmers & professionals shown). No 
significant differences between 4 
groups in proportion diagnosed with 
Stage 1 colorectal cancer, but poorer 
survival outcomes for farmers (see 
below).  
-  Farm women significantly less likely 
to be have surgical treatment (bowel 
resection) than any other class/group. 
No difference between 4 groups in 
bowel resection for men. 
 
McDuffie H et al. 
2007 
Host factors, 
occupation, and 
testicular cancer in 
Saskatchewan, 
Canada: 1979-2002 
 
Canada (F)   
 
Population-based 
cancer registry in 
Saskatchewan. 
 
Cross-sectional study 
 
72 / 349 
 
Testicular 
 
Diagnosis 
Stage 1, 1A -
1S, A (early 
stage) 
 
Regression of 
variables 
assoc. with 
Stage 2  
or above  
 
 
% farmers/ 
non-farmers 
59.7% : 68.8% 
 
 
 
Occupation:      
‘farmer’ 
Age: <26yrs 
Non-seminoma 
 
RR= 0.88 (0.73 – 1.07) 
p= 0.2 
 
 
 
 
OR= 1.76 (1.00 – 3.10)* 
 
OR= 2.12 (1.15 – 3.93)* 
OR= 1.99 (1.30 – 3.31)* 
 
 
 
 
EPHPP – Moderate 
STROBE – 2No 
CASP – 1No 
 
Grading: B 
Impression: Good 
 
Farmers significantly more likely to be 
diagnosed with testicular cancer at 
Stage 2 or above than non-farmers.  
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Morshed P et al. 
2008. Laryngeal 
Cancer In Farmers 
from Lublin Region 
of Poland. 
 
Poland (F) 
 
Medical record survey 
of patients with primary 
laryngeal squamous cell 
carcinoma diagnosed 
and treated in Lublin. 
 
Retrospective cohort 
study 
 
84 / 64 
 
Larynx - Laryngeal 
Squamous Cell 
Carcinoma 
 
 
Distribution: 
T1–T4 
N0–N3  
M0–M1 
G1–G3  
Stage I-IV 
 
Stage 1 
(early) 
 
 
ns 
ns 
ns 
*X2=6.23 df=2 
ns 
 
% Farmers / 
non-farmers 
17.9%: 15.6% 
 
 
p= 0.64 
p= 0.06 
p= 0.69 
p= 0.04 
p= 0.64 
 
 
 
RR= 1.12 (0.53 – 2.35) 
 
EPHPP – Moderate 
STROBE – 11N  
    +1 moderate bias 
CASP – 3No 
 
Grading: C 
Impression: Fair 
 
 
-   Significant differences in 
presentation pattern - farmers older, 
more males (unadjusted); and farmers 
tumours more localised, glottic, more 
differentiated, suggesting different 
exposure factors and progress of 
disease.  
 -  Univariate statistical significance for 
G stage (non-farmers worse) and near 
significance for N stage (p=0.06) (non-
farmers worse) and primary 
localisation of tumour (p=0.05) (non-
farmers supra-glottic). No significant 
differences in T, M, clinical stage, or 
smoking / alcohol use.  
 
 
Note: ns=not significant to .05 level
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Table 2.4b: Notes on quality assessment and scoring process for studies of cancer ‘stage of diagnosis’ and / or ‘treatment’  
 
Primary author  
& year 
Study Design 
EPHPP1 
criteria rating 
STROBE statement2: 
number of 'no'  
responses & biases 
CASP checklist3: 
number of 'no' 
responses 
Combined 
score 
Overall 
Quality 
Grading 
Overall impression 
Dodge 2007 Retro cohort Strong 2 No 1 No 4 A Very good 
Mills 2001 Retro cohort Strong 5 No 0 No 4 A Very good 
Desobeaux 1997 Retro cohort Strong 2 No 0 No 4 A Very good 
McDuffie 2007 Cross-sectional Moderate 2 No 1 No 6 B Good 
Morshed 2008 Retro cohort Moderate 11 No + 1 moderate bias 3 No 8 C Fair 
 
Scoring system Quality Assessment tools 
Criteria Score  
Retrospective cohort design 1 EPHPP:    Effective Public Health Practice Project criteria1 
Cross sectional design 2 STROBE:  Strengthening of reporting of Observational Studies in Epidemiology Statement2 
‘In-tool' quality levels (1-3)   CASP:      Critical Appraisal Skills Program checklist3 
   Green (normal font)  1 
    Yellow (italic font)  2 
   Red (bold, italic font) 3 
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Table 2.5a: Comparison of cancer ‘survival outcomes’ between farmers and non-farmers 
  
Primary author, 
year & study 
title 
Setting /  
what was done / 
study design 
F = Farmer 
AgW = Agricultural 
worker 
No. of 
farmers / 
non-
farmers 
Cancer site 
 
Indicator  
Relative % 
survival 
Statistical measure 
(RR death, OR, Surv, HR) 
95% CI  or p value 
 
Quality tool 
assessment / 
Overall grade 
Key results 
 
Eloranta, S. 2010. 
Does socioeconomic 
status influence the 
prospect of cure 
from colon cancer - 
A population-based 
study in Sweden 
1965-2000 
 
Sweden (F) 
 
Occupation-based SES 
assessment of all persons 
with colon cancer in 
national cancer registry 
1965-2000.  
Retrospective cohort 
study. 
 
5,902 /  
3,479 
19,878 
5,044  
24,570 
 
Colorectal 
 
 
 
 
Excess 
mortality (RR 
death) 
 
 
Relative odds 
cure 
 
Difference in 
median 
survival 
(months) 
 
 
 
 
 
- 
 
 
 
 
- 
 
 
- 
 
Farmers: Higher non-manual  
workers  
 
RR death 1.18 (1.11 – 1.26)*  
(RR near 1.50 within 6 
months of diagnosis, then 
near parity after) 
 
OR=    0.85 (  0.75 – 0.95)* 
 
 
OR= –2.62 (–4.36, – 0.88)*     
 
EPHPP – Strong  
STROBE – 2No        
CASP –  0No 
 
Grading: A 
Impression: Very good 
 
 
-  Farmers assessed as one of 5 SES 
groups- higher non-manual workers, 
self-employed, manual workers and 
lower non-manual workers.  
-   Farmers had the highest excess 
mortality, most pronounced within 6 
months of diagnosis. Farmers had the 
lowest odds of cure. All lower SES 
groups had similar but lower survival 
than the referent group (higher non 
manual workers).  
-   Confounder adjusted results suggest 
SES differences cannot be attributed 
solely to lead time bias. 
 
Dodge, J. 2007. 
Cancer survival in 
California Hispanic 
farmworkers, 1988-
2001 
 
USA (Agw Hispanic) 
 
Data-linkage of farm 
workers union 
membership & state 
cancer registry, for 
Hispanics persons 
diagnosed with a first 
malignant tumour.  
 
Retrospective cohort study 
 
1,186 / 
178,718 
 
Cancer type 
 
 
 
All cancers 
  men (m) 
  women (w) 
Brain/nervous (m) 
Breast  
Cervix  
Colorectal (m) 
Colorectal (w) 
Corpus uterus  
Kidney (m) 
Kidney (w) 
 
5 Year 
survival 
(observed) 
 
 
 
 
 
 
 
 
 
 
 
 
 
% UFW farm- 
workers: 
California 
Hispanics 
 
53.7% :  57.7% 
61.1% :  61.5% 
39.8% :  37.3% 
77.2% :  81.6% 
73.0% :  78.5% 
48.1% :  60.6% 
64.9% :  61.3% 
90.2% :  92.5% 
80.8% :  61.5% 
64.3% :  68.2% 
 
p value 
 
 
 
 
p= 0.02* 
p= 0.91 
p= 0.77 
p= 0.63 
p= 0.38 
p= 0.01* 
p= 0.99 
p= 0.61 
p= 0.17 
p= 0.67 
 
EPHPP – Strong  
STROBE – 2No        
CASP –  1No 
 
Grading: A 
Impression: Very good 
 
 
-   Crude 5-year cancer-specific survival 
rates were lower for Hispanic UFWA 
men compared to California Hispanic 
men for all cancer sites combined and 
colorectal cancer and higher for non-
Hodgkin's lymphoma.  
-   Only non-Hodgkin's lymphoma 
survival differences were significant 
after adjusting for age and stage at 
diagnosis. UFW men had a 66% 
decreased risk of death from non- 
Hodgkin’s lymphoma compared to 
California Hispanic men in the adjusted 
model.  
-    No statistically significant survival 
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Larynx (m) 
Leukaemia (m) 
Leukaemia  (w) 
Liver (m) 
Lung-bronchial (m) 
Lung-bronchial (w) 
Melanoma (m)  
Myeloma (m) 
NHL (m) 
NHL (w) 
Ovary  
Pancreas (m)  
Prostate  
Soft tissue (m) 
Stomach (m) 
Stomach (w) 
Thyroid (w) 
Urinary (m) 
 
 
 
 
 
 
Breast 
Cervix 
Colorectal (m) 
Colorectal (w)  
Lung-bronchial (m) 
Lung-bronchial (w) 
NHL (m)  
 
Prostate 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
78.6% :  75.9% 
29.3% :  42.2% 
44.4% :  40.1% 
21.1% :  22.1% 
12.4% :  13.9% 
25.8% :  18.8% 
66.7% :  74.8% 
38.6% :  36.5% 
86.7% :  57.6% 
82.5% :  62.7% 
58.7% :  49.4% 
   0.0% :    6.6% 
87.8% :  88.3% 
88.9% :  71.6% 
10.6% :  26.1% 
21.8% :  27.4% 
100%  :  95.5% 
88.1% :  82.9% 
 
 
 
 
 
 
- 
- 
- 
- 
- 
- 
- 
 
- 
p= 0.52 
p= 0.33 
p= 0.76 
p= 0.76 
p= 0.16 
p= 0.71 
p= 0.87 
p= 0.96 
p= 0.01* 
p= 0.38 
p= 0.63 
p= 0.99 
p= 0.59 
p= 0.65 
p= 0.27 
p= 0.82 
p= 0.38 
p= 0.25 
 
UFW farmworkers :  
California Hispanics / 
HR (death) adjusted age  
& stage / (95% CI) 
 
HR= 1.14 (0.73 – 1.79) 
HR= 1.15 (0.65 – 2.03) 
HR= 1.35 (0.93 – 1.95) 
HR= 1.01 (0.45 – 2.24) 
HR= 1.09 (0.86 – 1.40) 
HR= 0.81 (0.42 – 1.55) 
HR= 0.34 (0.14 – 0.81)* 
p =.02* 
HR= 0.75  (0.51 – 1.11) 
 
differences were detected between 
United Farm Workers of America and 
California Hispanic women.  
 
 
Desoubeaux N et al. 
1997. Social 
environment and 
prognosis of 
colorectal cancer 
patients: A French 
population-based 
study 
 
France (F) 
 
Colorectal cancer patients 
diagnosed 1978 - 1987 in 
Calvados district, France. 
Cancer registry-based. 
Retrospective cohort study 
 
250 / 340 
 
Colorectal 
 
5 year 
survival  
 
% farmers : 
professionals  
 
 
Men: 
30.6% : 42.9% 
 
 
 
RR death farmers : 
professionals 
 
 
RR death (adj. for age, stage 
& treatment) 
RR= 1.44 (1.02 –2.03)* 
 
 
EPHPP – Strong  
STROBE – 2No        
CASP –  0No 
 
Grading: A 
Impression: Very good 
 
 
-   Poorer prognosis among farmer 
group for both genders compared to 
higher social-professional group 
(managerial, teaching and self-
employed people).  
-   Differences not explained by 
variations in tumour stage at diagnosis 
or in treatment alone, or by potential 
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Women: 
27.0% : 48.2% 
 
 
RR death (adj. for age, stage 
& treatment) 
RR= 1.94 (1.26 – 3.00)* 
 
variations in co-morbidity associated 
with sex and age (adj for confounders) 
 
Morshed P et al. 
2008. Laryngeal 
Cancer In Farmers 
from Lublin Region 
of Poland. 
 
Poland (F) 
 
Medical record survey of 
patients with primary 
laryngeal squamous cell 
carcinoma diagnosed/ 
treated in Lublin. 
Retrospective cohort study 
 
 
84 / 64 
 
Larynx-Laryngeal 
Squamous Cell 
Carcinoma 
 
 
 
 
3 year 
survival  
 
5 year 
survival  
 
% farmers :  
non-farmers  
 
64.2% : 73.4%  
 
 
42.9% :  56.3% 
 
 
RR death farmers : non-
farmers 
 
p=0.97 
RR death= 1.08 (0.80 – 1.46) 
 
p=0.78 
RR death= 1.20 (0.82 – 1.75) 
 
 
EPHPP – Moderate 
STROBE – 11No 
    +1 moderate bias 
CASP – 3No 
 
Grading: C 
Impression: Fair 
 
 
For laryngeal cancer (LSCC), the 3-year 
and 5-year survival rate in farmers was 
slightly lower than non-farmers, but 
this difference and relative risk of 
death between groups was not 
statistically significant.  
 
Vagero et al 1987. 
Cancer survival and 
social class in 
Sweden 
 
Sweden (F) 
 
Survival analysis of 
national cancer registrants 
1961-1979 by social- 
occupational groupings.  
 
Retrospective cohort study 
 
4936 / 17661, 
36763 
(men) 
 
Cancer type 
(men only) 
 
 
 
 
 
All cancers   
Bladder 
Colon 
Kidney  
Lung  
Pancreas  
Prostate  
Rectum 
Stomach  
Testes 
 
5 Year 
survival 
probability 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Estimated 
probability 
(eyeball)  from 
survival curves 
Farm-men:  
white collar men 
 
est. 0.39: 0.42 
est. 0.71: 0.73 
est. 0.37: 0.48   
est. 0.40: 0.48   
est. 0.12: 0.10   
est. 0.03: 0.01   
est. 0.49: 0.55   
est. 0.32: 0.48   
est. 0.14: 0.13   
est. 0.62: 0.76   
 
Text description of survival 
probability:  
 
 
 
 
 
Farm men < white collar 
Farm men < white collar 
Farm men < white collar 
Farm men < white collar 
No real difference 
No real difference 
Farm men < white collar 
Farm men < white collar 
No real difference 
Farm men < white collar 
 
 
EPHPP – Moderate  
STROBE – 10N  
   +2 moderate biases      
CASP –  3No 
 
Grading: C 
Impression: Fair – 
some reporting issues 
 
-   There was a higher survival 
probability for white collar men than 
for blue collar men or self-employed 
farm men for all cancer, cancer of the 
colon, rectum, kidney, bladder, 
prostate & testes. For lung cancer, 
cancer of the stomach, and pancreatic 
cancer there were no detectable 
differences in survival probability.  
 
*NB. No tests of significance reported, 
No adjustment for confounders. Text 
description and ‘eyeball’ graphs of 
results presented only. Difficult to draw 
firm conclusions from the data.  
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Table 2.5b: Notes on quality assessment and scoring process for studies of cancer studies of survival outcomes 
 
Primary author  
& year 
Study Design 
EPHPP1 
criteria rating 
STROBE statement2: 
number of 'no'  
responses & biases 
CASP checklist3: 
number of 'no' 
responses 
EPHPP1 
criteria rating 
Overall 
Quality 
Grading 
Overall 
impression 
Eloranta 2010 Retro cohort Strong 2 No 0 No 4 A Very good 
Dodge 2007 Retro cohort Strong 2 No 1 No 4 A Very good 
Desobeaux  1997 Retro cohort Strong 2 No 0 No 4 A Very good 
Morshed 2008 Retro cohort Moderate 11 No + 1 moderate bias 3 No 8 C Fair 
Vagero 1987 Retro cohort Moderate 10 No + 2 moderate bias 3 No 9 C Fair 
 
Scoring system Quality Assessment tools 
Criteria Score  
Retrospective cohort design 1 EPHPP:    Effective Public Health Practice Project criteria1 
Cross sectional design 2 STROBE:  Strengthening of reporting of Observational Studies in Epidemiology Statement2 
‘In-tool' quality levels (1-3)   CASP:      Critical Appraisal Skills Program checklist3 
   Green (normal font)  1 
    Yellow (italic font)  2 
   Red (bold, italic font) 3 
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Table 2.6a: Comparison of studies of cancer screening between farmers and non-farmers 
 
Primary author, 
year & study 
title 
Setting /  
what was done / 
study design 
F = Farmer 
AgW = Agricultural 
worker 
No. of 
farmers / 
non-
farmers 
Cancer type 
screened 
 
Indicator 
% group with 
indicator/ 
predictor 
Statistical measure 
(RR, OR, HR) 
95% CI  or p value 
Quality tool 
assessment / 
Overall grade 
Key results 
 
Park H et al. 2002. 
Health risk factors 
among Iowa 
farmers 
 
 
USA (F) 
 
Compared prevalence of 
health risks among farmers 
and other workers from 
Computer Assisted 
Telephone Interviews as 
part of Iowa Behavioural 
Risk Factor Surveillance 
System 
 
Cross-sectional study  
 
 
2140 (all). No. 
in farm  / 
non-farm 
groups not 
reported 
 
Any 
 
 
 
 
 
Colorectal  
 
 
 
 
 
 
 
 
 
Breast 
 
 
 
 
 
 
 
 
Cervical 
 
 
Routine 
check-up  
 
(past year) 
( 1 yr+ ago) 
 
Faecal Occult 
Blood Test 
(FOBT)  
(past yr) 
(> 1 yr ago) 
 
Sigmoidoscopy  
(past yr) 
(> 1 yr) 
 
Mammogram  
(past yr) 
(> 1 yr) 
 
Clinical breast 
exam  
(past yr) 
(> 1 yr) 
 
Pap test  
(past yr) 
(> 1 yr) 
 
% Farmers:  
non-farmers 
 
Not reported 
 
 
Not reported 
 
 
 
 
 
Not reported 
 
 
 
Not reported 
 
 
 
Not reported 
 
 
 
 
Not reported 
 
 
OR adjusted for sex, age, 
school, marital status  
 
OR= 0.72 (0.17 – 3.07)  
OR= 0.99 (0.29 – 3.43)  
 
 
 
 
OR= 0.41 (0.17 – 1.00)* 
OR= 1.33 (0.63 – 2.79) 
 
 
OR= 1.44 (0.59 – 3.52) 
OR= 0.77 (0.36 – 1.66) 
 
 
OR= 1.22 (0.14 – 10.52) 
OR= 0.79 (0.06 – 11.03) 
 
 
 
OR= 0.80 (0.09 – 7.09) 
OR= 0.80 (0.05 – 12.60) 
 
 
OR= 0.57 (0.06 – 5 03) 
OR= 0.78 (0.06 – 9.73) 
 
EPHPP – Moderate  
STROBE – 6No        
CASP –  1No 
 
Grading: B 
Impression: Good 
 
 
-   Most health conditions, risk factors 
and screening behaviours were similar 
among farmers and other workers.  
-  Farmers were less likely to have had 
stool blood screening (FOBT) for 
colorectal cancer in the past year. 
-  There was no difference in screening 
between groups for breast or cervical 
cancer. 
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Muldoon J et al. 
1996 Utilization of 
cancer early 
detection services 
among farm and 
rural nonfarm 
adults in Iowa. 
 
USA (F) 
 
Home interviews of  farm 
and non-farm rural 
residents comparing use of 
cancer early detection 
services using Behavioural 
Risk Factor Surveillance 
System and National 
Health Interview Survey 
items. 
 
Cross-sectional study 
 
1126 / 1092 
 
Any 
 
 
 
 
 
 
 
 
 
 
 
Breast 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cervical  
 
 
Prostate 
 
 
 
 
Colorectal  
 
 
 
 
Primary care 
checkup in last 
12 months 
 
 
 
Preventive care 
covered by 
insurance 
 
 
 
Clinical Breast 
Exams 
Age 40+  
(past year) 
 
Mammogram 
 40-49 yrs  
   (past 2 yrs) 
 50 yrs + 
   (past year) 
 
Monthly Breast 
self-exam 
 
Pap Test 
(past 3 yrs) 
 
Prostate exam   
(past year) 
40yrs + 
50yrs + 
  
Faecal Occult 
Blood Test 
50yrs+   
(past year) 
 
% Farm:  
% non- farm 
 
Men: 
33.5% : 45.6% 
 
Women: 
52.4% : 56.8% 
 
Men: 
59.6% : 74.9% 
 
Women: 
62.4% : 75.5% 
 
53.8% : 53.7% 
 
 
63.3% : 49.8% 
 
42.2% : 54.3% 
 
 
48.2% : 51.8% 
 
 
78.0% : 79.0% 
 
 
 
 
34.5% : 38.1% 
40.7% : 49.3% 
 
 
 
Men 
16.7% : 17.8% 
 
 
 
 
 
OR= 0.60 (0.47 – 0.77)* 
 
 
OR= 0.84 (0.66 – 1.06) 
 
 
OR= 0.49 (0.36 –  0.67)* 
 
 
OR= 0.54 (0.40 – 0.72)* 
 
OR= 1.00 (0.78 – 1.28) 
 
 
OR= 1.74 (1.16 – 2.61)* 
 
OR= 0.62 (0.45 – 0.84)* 
 
 
OR= 0.92 (0.73 – 1.17) 
 
 
OR 0.95 (0.71 – 1.26) 
 
 
 
 
OR= 0.86 (0.65 – 1.13) 
OR= 0.70 (0.50 – 0.99)* 
 
 
 
 
OR= 0.93 (0.62 – 1.90) 
 
EPHPP – Moderate  
STROBE – 1No        
CASP –  0 No 
 
Grading: B 
Impression: Good 
 
 
-   Farmer group older on average and  
less likely to have preventive health 
services covered by health insurance.  
-  Farm men were less likely to have had 
a check-up during the past year, but no 
difference for women. 
-  Overall differences in screening 
behaviours were small.  
-  Farm women 40-49 yrs more likely to 
have mammogram in past 2 yrs, but the 
more non-farm women over 50yrs had 
mammogram in past year. 
- No difference between farmers and 
non-farmers for breast examinations or 
for Pap tests 
-  Farmers over 50yrs less likely to have 
had a prostate examination 
-  No difference in groups for FOBT for 
men or women, but farm women more 
likely to have a sigmoidoscopy.  
-  Farmers more likely to have had a skin 
examination. 
-    Controlling for demographic 
characteristics (age, income) and health 
insurance coverage, farm and rural 
nonfarm population were equally likely 
to use multiple screening according to 
approved guidelines.  
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Skin  
 
 
 
 
 
 
 
 
 
Combined 
skin/prostate/ 
Colorectal  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sigmoidoscopy 
50yrs+  
(past 5 yrs) 
 
 
Skin exam  
(past year) 
40yrs+ 
 
 
50yrs+ 
 
 
 
 
Multiple 
Tests (50yrs+ ) 
Skin & prostate 
exam / FOBT & 
Sigmoidoscopy 
screening (per 
recommended 
guidelines) 
 
 
Regression on 
variables 
associated with 
non-compliance 
with screening 
guidelines 
 
Women 
20.2 % : 20.3% 
 
Men 
21.5% : 21.8% 
Women 
23.7 % : 15.9% 
 
Men 
15.0% : 9.4% 
Women 
12.9% : 6.7% 
 
Men 
10.5% : 5.0% 
Women 
13.9% : 8.6% 
 
None of 4 
recommended 
tests 
 
Men 
51.2% : 45.4% 
Women 
11.5% : 10.3% 
 
 
Men: 
      
     Farmers /  
     non- farmers 
 
Income 
Education  
Increasing age   
(per year) 
No preventive 
care health 
 
OR= 1.00 (0.68 – 1.47) 
 
 
OR= 0.92 (0.67 – 1.45) 
 
OR= 1.64 (1.07 – 2.54)* 
 
 
OR= 1.70 (1.16 – 2.50)* 
 
OR= 2.05 (1.33 – 3.16)* 
 
 
OR= 1.49 (0.96 – 2.31) 
 
OR= 1.71 (1.02 – 2.87)* 
 
 
 
 
 
 
ns 
 
ns  
 
 
 
 
 
 
 
ns  
ns  
ns  
 
OR= 0.94 (0.93 – 0.97)* 
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insurance  
 
Women: 
 
Farmers /  
non- farmers 
 
Age  
Education 
    No preventive 
care health 
insurance  
Income: 
 <$15,000 
   $15–50,000 
 
 
 
 
 
 
 
 
OR= 0.68 (0.50 – 0.97)* 
ns  
ns 
 
 
OR= 0.46 (0.23 – 0.91)* 
OR= 0.37 (0.04 – 2.33)* 
OR= 0.11 (0.01 – 0.86)* 
   
 
McCarty, C. 2003 
Differences in 
preventive 
screening rates in 
Wisconsin farm and 
non-farm resident 
women 
 
USA (F) 
 
Proportion and predictors 
for rural women meeting 
recommendations for Pap 
tests. Questionnaire & 
electronic medical records.  
 
Cross-sectional study 
 
 
675 / 825 
 
Cervical 
 
 
 
 
 
 
Breast 
 
 
 
 
 
 
 
 
Both / any 
 
 
 
 
 
Regression 
predictors for 
Pap test in last 
3 yrs 
 
 
 
 
Regression  
predictors for  
mammogram last 
2 yrs (40yrs+) 
 
 
 
 
Reported 
Health 
insurance a 
problem for 
preventive 
screening 
 
 
Non-f arm 
residence 
Age (per yr) 
 
Health 
insurance a 
problem 
 
Non-farm 
residence 
Age (per yr) 
 
Health 
insurance a 
problem 
 
% Farm:  
non-farm 
women 
43.9% : 21.7%  
 
 
 
OR= 0.75 (0.59 – 0.96)* 
 
OR= 0.97 (0.96 – 0.98)* 
p<.05 
 
OR= 0.94 (0.72 – 1.21) 
 
 
OR= 0.73 (0.53 – 1.02)    
 
OR= 1.04 (1.02 – 1.06)*  
p< .05 
 
OR= 0.75 (0.53 – 1.05) 
 
 
 
 
 
p< .001* 
 
 
EPHPP – Moderate  
STROBE – 9 No   
    + 1 moderate bias        
CASP –  2 No 
 
Grade: C 
Impression: Fair 
 
 
-   3.7% of rural women had never had a 
Pap test, and 19.3% of women 40 yrs+ 
had never had a mammogram.  
-    Age was inversely related to Pap 
tests and positively correlated with 
mammograms 
-  (?) “Farm residents were significantly 
less likely to have Pap tests” at 
recommended time intervals 
(contradicts the results table) 
-  Farm women reported health 
insurance a problem, but health 
insurance did not affect mammogram 
screening rates 
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Kakefuda I 2006 
Comparisons of 
Colorado women's 
cancer screening 
practices by 
residence: 
Metropolitan, non-
metropolitan, and 
farm 
 
 
USA (F)  
 
Compared screening 
practices of metropolitan 
and rural women 
interviewed in  state-based 
or farm-based surveys  
 
Cross-sectional study 
 
299 / 956 
 
 
 
 
Cervical 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Breast 
 
 
 
 
 
Recent Pap test 
(past year) 
 
Regression on 
variables assoc. 
with NOT having 
Pap test in past 
year 
 
 
 
 
 
 
 
 
 
 
 
 
Mammogram 
(past 2 yrs) 
  40 yrs+ 
    
  All ages 
 
 
Regression on 
variables assoc. 
with NOT having 
mammogram  in 
past 2 yrs 
 
 
 
 
% Farm: rural: 
metropolitan 
 
63.2%: 61.2% : 
67.1% 
 
Farm residence 
Race/ethnicity 
Marital status 
General health 
Financial 
Age groups 
over 30yrs 
Education: 
   Incomplete  
      High school  
   Incomplete 
      College grad 
No medical 
insurance 
No primary 
medical care 
place 
 
 
73.7%: 62.0%: 
73.9% 
62.2%: 44.7%: 
51.63% 
 
Farm residence 
Race/ethnicity 
Marital status 
General health 
Financial 
Age < 30yrs 
Education < 
College grad 
 
 
 
 
ns 
 
 
ns  OR 1.41 (0.96 – 2.08)   
ns 
ns 
ns 
ns 
 
OR> 1.71 (1.02 – 2.86)* 
 
 
OR> 1.96 (1.02 – 3.79)* 
 
OR> 1.89 (1.30 – 2.75)* 
 
OR= 1.86 (1.11 – 3.11)* 
 
OR= 5.28 (2.99 – 9.34)* 
 
 
 
ns  
 
p< .01* 
 
 
ns  OR= 1.15 (0.08 – 1.66) 
ns 
ns 
ns 
ns 
OR> 7.49 (5.11 – 10.97)* 
 
OR> 1.66 (1.15 –   2.39)* 
 
EPHPP – Weak 
STROBE – 1 No  
   + 2 moderate biases        
CASP –  1No 
 
Grading: C 
Impression: Fair  
 
-   Farm women were more likely to be 
white, older, report their health as very 
good, have medical insurance than 
other rural women, which influenced 
screening. 
-   After controlling for related variables, 
residence was not associated with the 
screening practices, except farm 
women were less likely to have a recent 
breast examination than metropolitan 
women. When non-metropolitan and 
farm women were combined, there was 
no association between residence and 
having had a physical breast 
examination. 
-  Some sampling issues 
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Breast  
examination  
(past year) 
  40 yrs+ 
   
  All ages 
 
 
Regression on 
variables assoc. 
with NOT having 
exam in past  
year 
 
 
 
No medical 
insurance 
No primary 
medical 
place 
 
 
 
64.6%: 66.0%: 
69.3% 
67.2%: 64.2%: 
69.2% 
 
Race/ethnicity 
General health 
Age  
Farm residence 
Marital status 
Financial 
Education: 
<High school 
graduation 
No medical 
insurance 
No primary 
medical care 
place 
 
 
OR= 2.74 (1.58 –  4.76)* 
 
OR= 4.97 (2.62 –  9.44)* 
 
 
 
 
ns 
 
ns 
 
 
ns 
ns 
ns 
OR= 1.50 (1.07 – 2.10)* 
OR= 1.38 (1.03 – 1.86)* 
OR= 1.77 (1.15 – 2.74)* 
 
OR= 2.20 (1.31 – 3.70)* 
 
OR= 1.81 (1.16 – 2.82)* 
 
OR= 5.27 (3.17 – 8.73)* 
 
Carruth A. 2006. 
The impact of farm 
lifestyle and health 
characteristics: 
cervical cancer 
screening among 
southern 
farmwomen 
 
USA (F) 
 
Compared predictors for 
and proportion of 
farmwomen >or=18 yrs 
who failed to obtain a Pap 
test within the past 3 
years, within Computer 
Assisted Telephone 
Interviews Behavioural 
 
2324 / No. of 
non-farmers 
not reported 
 
Cervical 
 
Failure to 
obtain Pap test 
in past 3 yrs in: 
 
 
 
Texas 
 
Louisiana 
 
 
Farm women   
crude failure 
rate % : State 
adjusted failure 
rate % 
 
Farmers  19.6%  
State       19.6% 
Farmers  27.9%  
State       15.2% 
 
95%CI for % failure rate 
 
 
 
 
 
(15.6 – 22.6)   
(16.3 – 22.9)   
(24.5 – 31.3)* 
(12.3 – 18.1) 
 
EPHPP – Weak  
STROBE – 5 No  
    + 1 moderate bias        
CASP –  3 No 
 
Grading: D 
Impression: Fair  
 
-  Failure of farm women to obtain 
cervical cancer screening in Texas was 
comparable to state BRFSS rates, but 
significantly greater in the other states. 
Failure rates for farm women were at 
least 6% greater in Kentucky and 12% 
greater in Louisiana than state failure 
rates.  
-   Farm lifestyle predicting failure to 
obtain cervical cancer screening were 
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Risk Factor Surveillance 
System data for Kentucky, 
Texas and Louisiana. 
 
Cross-sectional study 
Kentucky 
 
 
Farmer group 
only: regression 
on variables 
associated with 
failure to obtain: 
Pap test in last  
3 yrs  
Farmers  26.8%  
State       20.5% 
 
Home on farm 
Role – no off-
farm work. &  
<7 farm tasks 
EducatIon 
< High school  
High school  
Age  
40-49 yrs 
50-59 yrs 
60-64 yrs 
>65 yrs 
No health  
insurance 
Ever had a:        
mammogram 
    breast exam 
Marital status 
Time to health   
care facility 
 
(23.9 – 29.4)* 
(17.8 – 23.2) 
 
OR= 1.78 (1.32 – 2.38)* 
 
OR= 1.74 (1.00 – 3.20)* 
 
 
OR= 1.99 (1.46 – 2.69)* 
OR= 1.51 (1.78 – 1.93)* 
 
OR= 3.01 (1.90 – 4.77)*  
OR= 4.01 (2.55 – 6.33)* 
OR= 6.04 (3.71 – 9.93)* 
OR= 7.46 (4.06 –11.93)* 
 
OR= 1.47 (1.05 – 2.05)* 
 
OR= 0.28 (0.20 – 0.39)* 
OR= 0.44 (0.29 – 0.64)* 
OR= 0.49 (0.34 – 0.71)* 
ns 
having a house on the farm, engaging  
in no off-farm work and minimal 
involvement in farm tasks.  
-  Failure increased with age & lack of 
insurance. Failure decreased with 
education, previous mammogram or 
breast examination & being married. 
-  Time to health facility was ns, 
although social-geographic isolation 
and minimal role involvement on the 
farm may contribute to the likelihood 
women do not seek cervical cancer 
screening. 
– Some comparison issues 
 
Rosenman K 1995. 
U.S. farm women's 
participation in 
breast cancer 
screening practices 
 
 
USA (F) 
 
Survey of farmers in 4 
Michigan counties on 
breast cancer screening in 
1992 and compared 
screening rates to state 
data from 1989 (secondary 
source) ? 
 
Cross-sectional baseline 
survey 
 
 
680 / 
(secondary 
data  source) 
 
Breast 
 
 
 
 
 
 
Clinical breast 
exam: 
  Past year 
  Past 3yrs 
  Ever 
 
Mammogram 
(40yrs+): 
  Past year 
 
% Farm:  
% State 
(secondary 
data source) 
 
 
 
66.6%:  - 
86.2%:  - 
88.1%:  - 
 
 
 
51.9%:   - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EPHPP – Weak 
STROBE – 12 No  
   + 3 moderate biases        
CASP –  5 No 
 
Grade E: 
Impression: Poor   
 
-  F arm women in this survey had 
breast cancer screening at rates similar 
to or above those in the general 
population. (But significance levels not 
reported & are unlikely to be). 
-  Mammogram usage increased with 
higher education, income, and 
insurance coverage and decreased in 
women age 75 years or older  
-  Because of a limited response rate 
(63.5%) and the relative affluence of 
the farming community in these 4 
counties, results are probably not 
generalizable to all populations of farm 
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  Past 3yrs 
  Ever 
 
(50yrs+): 
  Past year 
   
Farm group only: 
Regression on 
variables assoc. 
with mammo-
gram (40yrs+) in 
past 3 years 
   
 
 
 
 
 
 
 
 
 
73.7%:   - 
80.6%: 74.3% 
 
 
62.4%: 57.9% 
 
Age (ref 40-49) 
   50-74yrs 
   75yrs+  
Insurance (ref 
none)      
   low 
   high 
Education (ref 
< High school)  
   College 
   High school 
 
Income (ref  
< $25,000) 
$25 – 50,000 
> $50,000 
 
 
sig not reported 
 
 
sig not reported 
 
 
OR> 2.46 (1.27 – 4.73)*  
ns 
 
 
OR= 4.48 (2.26 – 8.86)* 
ns 
 
 
OR= 2.12 (1.10 – 4.08)* 
ns 
 
 
 
OR= 1.92 (1.17 – 3.14)* 
ns 
or rural women. 
– sampling issues & indirect 
comparisons to secondary data 
 
 
 
Note:   ns=not significant to .05 level
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Table 2.6b: Quality assessment and scoring of studies of cancer screening between farmers and non-farmers. 
 
Primary author  
& year 
Study Design 
EPHPP1 
criteria rating 
STROBE statement2: 
number of 'no'  
responses & biases 
CASP checklist3: 
number of 'no' 
responses 
Combined 
score 
Overall 
Quality 
Grading 
Overall 
impression 
Park 2002 Cross-sectional Moderate 6 No 1 No 6 B Good 
Muldoon 1996 Cross-sectional Moderate 1 No 0 No 6 B Good 
McCarty 2003 Cross-sectional Moderate 9 No + 1 moderate bias 2 No 8 C Fair 
Kakefuda 2006 Cross-sectional Weak 1 No + 2 moderate bias 1 No 9 C Fair 
Carruth 2006 Cross-sectional Weak 5 No + 1 moderate bias 3 No 10 D Fair 
Roseman 1995 Cross-sectional Weak 12 No + 3 moderate bias 5 No 11 E Poor 
 
Scoring system Quality Assessment tools 
Criteria Score  
Retrospective cohort design 1 EPHPP:    Effective Public Health Practice Project criteria1 
Cross sectional design 2 STROBE:  Strengthening of reporting of Observational Studies in Epidemiology Statement2 
‘In-tool' quality levels (1-3)   CASP:      Critical Appraisal Skills Program checklist3 
   Green (normal font)  1 
    Yellow (italic font)  2 
   Red (bold, italic font) 3 
 
Footnotes to Tables: 
1. Effective Public Health Practice Project: Quality Assessment Tool for Quantitative Studies. . Hamilton, Ontario: McMaster University; 2010. 
2. Elm E AD, Egger M,  Pocock S,  Gotzsche P and Vanderbrouke J: The strengthening of reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. 
.Journal of Clinical Epidemiology 2008, 61:344-349. 
3. Public Health Resource Unit. Critical Appraisal Skills Programme (CASP) England Public Health Resource Unit, England 2006. 
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           Article:  A review of prostate cancer incidence and mortality studies of farmers and non-farmers, 2002-2013: Publication 1.  
 
Appendix item 2.6.5 
 
 
 
 
 
 
 
 
This manuscript that was published in Cancer Epidemiology in December2014 
 
 
Depczynski J, Lower T. A review of prostate cancer incidence and mortality studies of farmers and 
non-farmers, 2002-2013. Cancer Epidemiology 2014, 38(6):654-662. 
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2.6.5.1   Abstract  
Objectives: To review the recent literature on the incidence and mortality of prostate cancer in 
farmers compared to non-farmers. Methods:  Searches were conducted in seven electronic 
databases for observational studies published from 2002-2013. Studies were assessed against 
eligibility criteria and a narrative summary of findings presented. Results: Eighteen primary research 
articles were included in the review. Four of ten mortality studies and two of nine incidence studies 
reported statistically significant increases in prostate cancer risk in farmers. However, nearly half of 
all studies reported non-significant reductions in farmers’ risk. Additionally, one study reported 
significantly increased and decreased risk using different outcome measures. Results varied 
considerably by geographic region, study design and degree of control for confounders, affecting 
comparability and strength of findings. Conclusions: The overall evidence for increased prostate 
cancer risk in farmers was weak.  
Keywords: prostate cancer; farmer; agricultural worker; incidence; mortality  
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2.6.5.2   Introduction  
Prostate cancer is the most frequently diagnosed cancer in men in the developed world.47 It is 
commonly diagnosed as result of Prostate Specific Antigen (PSA) screening and generally progresses 
more slowly than other cancers. Nonetheless, it is the second most common cause of cancer death 
in Australia (2011),47 Britain (2011)48 and the United States (2009);49 and third most common in 
Canada (2008),50  the European Union (2009)51 and New Zealand (2010).52  
There has been ongoing interest in the possibility that pesticide and other agricultural exposures 
may be related to a higher risk of prostate and other cancers.9, 11, 32, 53 Farmers are exposed to a 
range of potential chemical and biological carcinogens in the course of their work, so studies on 
cancer risk in farmers were considered useful for informing safe work practices; as well as for 
providing insights into development of cancers in the general population.9, 32 As a potentially high 
risk occupational group, they were the focus of a number of reviews on cancer risk in the latter part 
of the 20th Century.7, 9, 15, 27, 32, 54-55  
One third of 28 studies reviewed in 1996 found statistically significant increases in prostate 
cancer mortality in farmers compared to non-farmers.27 Three meta-analyses published between 
1997 and 2003 also reported increased prostate cancer rate ratios in farmers (1.07 -1.13). However, 
results have varied considerably by study design, outcome measures used and geographical 
location.7, 15, 54  Previous reviews noted that pooled rate ratios of risk for European studies tend to be 
lower than for American studies;7, 54 and meta-ratios for Standardised Mortality Rates or Ratios 
(SMR) were not significant in contrast to increased risk in studies that used Proportionate Mortality 
Ratios (PMR). One review suggested that the broad range of study methods and findings in the past, 
provide limited usefulness for assessing carcinogenic exposures.7 Others propose that elevated 
cancer risk in farmers may be related to lifestyle factors or pesticide exposures, but this remains 
unclear.7, 15, 27, 54 
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In recent years, better information on farm exposures has enabled more research on 
associations between cancer and particular pesticide products.53, 55-57 Important as these 
developments are, it has been suggested that pesticides are not likely to explain observed cancer 
patterns in farmers.11 Either way, monitoring the incidence and mortality of cancer in farmers over 
time, may well assist safety authorities assess progress toward reducing potentially harmful 
occupational exposures; or provide insight on other directions for research. 
The aim of this review is to compare the incidence and mortality of prostate cancer in farmers 
and non-farmers in more recent studies. Only studies published after January 2002 were considered, 
thereby excluding studies already incorporated into previous reviews and meta-analyses. 7, 10, 15, 27, 54 
Studies were restricted to countries classified as ‘very highly developed’, based on the 2010 
United Nations Human Development Index (UN HDI).6 This was to enable comparison with findings 
of earlier reviews which also focused on advanced economies; but also to assess risk for cohorts 
operating within similar agricultural systems. That is, whilst farming operations will vary with the 
commodity produced (e.g. wool, grains), it is proposed that it is the level of economic development 
that is more likely to differentiate the tasks, experience and potential cancer risks of subsistence 
farmers in the developing world, from the commercial farmer cohorts of advanced economies. The 
latter were considered more comparable regarding farming practices, financial capacity, access to 
health services and legislated safety standards (e.g. regarding pesticides). It is not to suggest that by 
exclusion the cancer experience of farmers in less developed countries is any less important, or 
could not be the subject of parallel analysis.  
2.6.5.3   Methods  
The eligibility criteria for studies included in the review are listed below.  
• Studies were restricted to publication between January 2002 and December 2013.  
103 
 
• Study designs included were prospective and retrospective cohort studies, case-control 
studies and cross-sectional studies. Excluded designs were clinical or biomedical studies 
focusing on cures and treatments; evaluations of health promotion interventions; qualitative 
studies of attitudes and behaviours; reviews, overviews and selective reports summarising 
other studies; and ecological studies where exposure measures are based on farm 
density/proximity indicators.  
• Populations of study were located within the 42 countries with ‘very high human 
development’ listed in the UN HDI index (2010).  
• Farmers were defined by residential status (living on a farm), by occupational listing or by 
membership of a relevant association or registry. Where not described, ‘farming’ was 
considered to mean performance of agricultural operations to grow crops or raise livestock. 
Comparison groups were adequately described to ensure ‘non-farmer’ status. 
• Occupations other than farming were NOT included in the 'farmer' group, with the exception 
of 'agricultural pesticide applicators' where they are not differentiated from farmers. 
Forestry and fishery workers were not considered to be farmers in the general sense of the 
term, nor included in farmer groups.  
• Risk factor studies, health service utilisation studies and those that did not include specific 
data on prostate cancer incidence or mortality in farmers, were not included.  
• Outcome measures considered were standardised mortality rate or ratio (SMR), relative 
standardised mortality ratio (rSMR), standardised incidence rate or ratio (SIR), proportionate 
mortality ratio (PMR), odds ratio (OR), hazard ratio (HR), relative risk or risk ratio (RR). The 
seldom used ‘rSMR’ was defined as a calculation of the SMR for each cause relative to the 
SMR for all other causes.58 Studies were required to report 95% confidence intervals to be 
considered for inclusion.  
• Cancer diagnoses based on ICD9 or ICD10 classifications.  
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• Research articles were not included if updates on the same cohort were published in later 
years.  
Searches for English language abstracts were conducted on Web of Knowledge (Medline), 
Biomed Central, Scopus, Embase, Informit, Google Scholar and Proquest Dissertations & Theses. 
Search concepts and terms used in databases were: (1) Farm* or Agricultur* or occupation*; AND (2) 
(cancer OR melanoma OR lymphoma); AND (3) (incidence OR presentation OR diagnosis OR 
treatment OR screening OR mortality OR death OR survival OR risk). These were adapted for each 
search tool as required and were confined to appearance in the title or abstract, so that cancer and 
‘farming’ or ‘occupation’ were the focus of the research. The search was limited to the 12 calendar 
year period from 2002 to 2013 and was inclusive of all major cancer groupings and ‘risk factors’. This 
was done to ensure articles with a slightly different focus that included information about prostate 
cancer risk, were also considered.  
Search results were collated and merged using Endnote® X3 with duplicate records removed. 
Titles and abstracts were initially examined to remove any obviously irrelevant articles, such as 
commentaries or case studies. Potentially eligible full-text articles were retrieved and examined for 
compliance with the criteria.  
All study papers identified by the principal researcher as meeting the inclusion criteria were 
subsequently assessed by a second researcher against the eligibility criteria. Additionally, for studies 
defined by the principal researcher as not meeting the criteria for inclusion, abstracts were read and 
classified independently by the second researcher. Where there was disagreement on the 
classification, further investigation of the relevant papers and discussion between the two 
researchers resolved the assessment.  
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A meta-analysis was not performed, as only a small number of eligible studies were retrieved 
and these assessed a variety of outcome measures. Individual studies were appraised with reference 
to the ‘Strobe’ Statement for quality reporting of observational studies and two recognised appraisal 
tools.2-4 These tools were used to guide development of the eligibility criteria and summary tables, 
which were ordered by mortality/incidence measures and geographic region.  
Identification and control of potential confounders was considered a measure of study quality 
and noted accordingly. Whilst the ‘GRADE’ system was initially considered in assessing quality of 
evidence across studies, this was later deemed inappropriate for a review of observational studies, 
as the ‘quality of evidence’ from such studies is usually classified as ‘LOW’. 5 Therefore, a narrative 
summary of the strength of evidence for differences in prostate cancer risk between farmers and 
non-farmers is provided.  
2.6.5.4   Results  
A total of 2241 abstracts were retrieved for the defined publication period. Duplicate articles, 
and those with ineligible study groups or designs, were excluded (n=1773). This included 34 studies 
of cohorts not within ‘very highly developed nations’ and left 468 full-text primary research articles 
for further scrutiny.6 
Risk factor studies (n=194) and health service related studies (n=31) that did not include data on 
incidence or mortality were further excluded. Studies that did not include specific information on 
prostate cancer in farmers, or did not report levels of statistical significance or confidence intervals, 
were also excluded (n=225). This left 18 primary articles for inclusion, of which nine reported on 
farmers’ prostate cancer mortality, eight reported on incidence and one reported on both prostate 
cancer mortality and incidence. The final search was completed in February 2014.  
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•  Mortality  
A total of ten studies reported on differences in prostate cancer mortality between farmers and 
non-farmers (Table 2.7).  
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Table 2.7: Published studies reporting on differences in prostate cancer mortality between farmers and non-farmer groups (January 2002- December 2013) 
 
Primary author, 
year, title of study 
 
 
Country 
 
Farm occupational 
sub-categories 
Study design Study summary 
 
Total 
farmers in 
cohort 
(+/- cases : 
controls) 
 
Non-farmer 
comparison 
group 
No. 
farmer 
deaths 
Outcome 
measure 
Rate ratio 
(95% CI) 
Limitations 
 
European studies 
 
Frost et al 2011.  
 
 
United Kingdom 
 
Agricultural workers,  
Pesticide applicators1 
 
Retrospective 
cohort study 
Rates for working age farmers 
who were certified agricultural 
pesticide users  in the UK (1987-
2004) 
 
62,960 
 
Rest of UK 
population 
 
33 
 
SMR 
 
 0.80 (0.57, 1.12) 
 
- unclear if commercial pesticide 
applicators are included  
 
- ratio based on small number of cancer 
deaths 
 
 
Office of National 
Statistics 2009 
 
 
 
 
United Kingdom 
 
 Farmers,  
Agricultural workers 
 
Retrospective 
cohort study 
 
Ratios for all occupations from 
death certificates for those aged 
16-74 years (1991-2000). 
 
Not 
reported 
 
UK  
All  other 
occupations 
 
1,177 
 
PMR 
 
1.14 (1.08, 1.21)* 
 
- no separation of farmers vs. agricultural 
workers 
 
- based on last occupation 
 
- selective presentation of results for 
many occupations and diseases 
 
- limited discussion on the prostate 
cancer  
 
 
Mastrangelo et al 
2005 
 
 
 
Italy 
 
Dairy farmers 
 
Retrospective 
cohort study 
 
Rates for major cancers in Italian 
dairy farmers 14 yrs & over 
(1970-1998) 
 
2,561 
 
Veneto 
regional 
population, 
Italy 
 
 
16 
 
SMR 
 
0.69 (0.39, 1.15) 
 
- ratio based on small number of cancer 
deaths 
 
 
Bucchi et al 2004 
 
 
 
Italy 
Farmers, Agricultural 
workers 
 
Retrospective 
cohort study 
 
Rates for farmers & agricultural 
workers (all ages) from the Forlì 
region in Italy (1969-1993) 
 
36,579 
 
Forli regional 
population, 
Italy 
 
293 
 
SMR 
 
0.94 (0.76, 1.16) 
 
- no separation of farmers vs. agricultural 
workers 
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Non European studies 
 
 
Fragar et al 2011  
 
 
 
Australia 
 
Farmers, 
Farm managers 
 
 Retrospective 
cohort study 
 
Rates for farmers & farm 
managers aged 25-75yrs (1999-
2002) 
 
124,0104 
 
Australian 
population 
 
200 
 
SMR 
 
2.40 (1.70,  3.28)* 
 
- limited discussion on findings (short 
report)  
 
Waggoner   et al 
2011 
 
 
 
USA 
 
Farmers,  
Pesticide applicators2 
 
Prospective 
cohort study 
 
Rates for working age farmers / 
pesticide applicators (1993-
2007) 
 
62,190 
 
Iowa, Nth 
Carolina 
population, 
USA 
 
171 
 
SMR 
 
 
 
rSMR 
 
0.81 (0.70,  0.95)* 
 
 
 
1.53 (1.31, 1.78)* 
 
 
- rationale and usefulness of rSMR as a 
measure 
 
Dodge et al 2007 
 
 
 
USA  
 
Agricultural workers 
 
Retrospective 
cohort study 
 
Ratios (among Californian 
Hispanic United Farm Union 
Members (working age), relative 
to other California 
Hispanics (1988-2001). 
 
 
not 
reported 
 
 
Californian 
Hispanic cancer 
registrants 
 
256 
 
HRc 
 
0.75 (0.51, 1.11) 
 
- denominator UFW data  not reported 
 
 
Abusaa et al 2004 
 
 
 
 
USA 
 
Farmers,  
Agricultural workers 
 
Retrospective 
cohort study 
 
Ratios for Mississippi farmers 
aged 20-79 yrs (1995-1999) by 
race and region. 
 
not 
reported 
 
Mississippi all 
occupations, 
USA 
 
102 
 
PMR 
 
2.43 (1.98, 2.92)* 
 
- testicular & penile cancers included in 
ICD grouping 
 
- no separation of farmers vs. agricultural 
workers 
 
- unknown population denominator 
 
- some results table / text mismatches 
 
- speculative discussion on associations 
with secondary ecological data (not in 
results)  
 
 
Fleming et al 2003 
 
 
USA 
 
 
Retrospective 
cohort / nested 
 
Cox regression mortality 
analyses adjusted for survey 
 
7746 
199: 1122 
 
Non-farmer 
National Health 
 
571 
 
RR 
 
1.3 (0.8, 2.2) 
 
- limited discussion on the prostate 
cancer findings 
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 Farmers,  
Agricultural workers 
case-control  
study 
design, on mortality-linked 
National Health Interview Survey 
data on persons 18yrs & over, 
for 1986-1994 
 
Interview 
Survey cohort, 
USA 
 
Lee et al 2002 
 
 
 
USA 
 
 Crop farmers, 
Livestock farmers 
 
Retrospective 
cohort study 
 
Ratios for all diseases for crop 
and livestock farmers, compared 
to those for all decedents in 24 
US states (1984-1993) 
 
Not 
reported 
 
All other 
decedents in 
National 
Centre for 
Health 
Statistics 
deaths 
database 
 
Crop farmers 
n=6,544 
 
15-64yrs 
65yrs+ 
All 
 
Livestock 
farmers 
n=1,765 
 
15-64yrs 
65yrs+ 
All 
 
 
PMR 
 
 
 
 
 
 
 
 
1.21 (1.06, 1.38)* 
1.01 (0.98, 1.03) 
1.01 (0.99, 1.03) 
 
 
 
 
 
1.42 (1.10, 1.80)* 
1.23 (1.18, 1.28)* 
  1.23 (1.18, 1.28)* 
 
 
- unknown population denominator 
 
- based on last occupation 
 
- limited discussion on the prostate 
cancer   findings 
 
 
Table 2.7 and 2.8 Notes and abbreviations: 
1. Participants were those who held Certificates of Competence under the Control of Pesticides Regulations 1986."Item 8. For the purposes of this Schedule (3), it shall be the duty of every employer to ensure that any 
person in his employment who may be required to use a pesticide during the course of that employment, is provided with such instruction and guidance as is necessary to enable that person to achieve the standard of 
competence recognised by the Ministers, and otherwise to comply with the requirements in and under these regulations." 
2. Results shown for farm-based/private pesticide applicators only (excludes commercial pesticide applicators) 
3. Number not reported, retrieved from author 
4. Outcome measures: SMR - (Age) Standardised mortality rate or ratio; ASR - Age standardised mortality ratio (European); rSMR - relative Standardised mortality ratio; PMR - Proportional mortality ratio, used where 
accurate denominator data (census) not available; SIR - Standardised incident rate or ratio; RR - Relative risk ratio (age-adjusted); OR - Odds ratio; HR - Hazard ratio   
5. Rate ratio adjusted variables:  a. region; b. region & family history of prostate cancer; c. region, stage of diagnosis 
* Statistically significant result 
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Five of the ten mortality studies reported increased prostate cancer mortality in farmers; 59-63 
four reported decreased mortality;33, 64-66 and one reported both an increase and decrease within the 
same cohort, using alternative outcome measures.58 The proportion of studies with significant 
results tended to vary by region and outcome measures used.  
Only one of the four European studies reported increased mortality in farmers with 95% 
confidence limits above unity.63 The other three reported lower mortality ratios in farmers that were 
not statistically significant.64-66 In contrast, four of the six non-European studies reported increased 
mortality in farmers, two having lower 95% confidence limits above unity.59-60 One study had 
significant increases for some subgroups of farmers but not others, whilst results of the other study 
were not statistically significant.61-62 Only one non-European study reported a decrease in farmer 
mortality, but this was not statistically significant. The remaining study had internally inconsistent 
findings, with both significantly increased and decreased prostate cancer mortality for the same 
farmer cohort.58  
Studies that used PMR presented a different picture to those that made direct mortality rate 
comparisons. All three studies comparing PMR, reported statistically significant increases in farmer 
mortality.60-61,63 In contrast, only one of the four studies that used SMR (alone), reported a 
statistically significant increase.59 The study with inconsistent internal findings, reported a 
significantly decreased SMR for prostate cancer in farmers, yet a significantly increased ‘relative 
SMR’ for the same cohort.58 
• Incidence  
Five of nine incidence studies (Table 2.8) reported increased prostate cancer incidence in 
farmers compared to non-farmers;64, 67-70 but only two of these were statistically significant, both 
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from North America.69-70 None of the four studies reporting decreased incidence in farmers were 
statistically significant.71-74  
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Table 2.8: Published studies reporting on differences in prostate cancer incidence between farmers and non-farmer groups (Jan 2002- Dec 2013) 
 
Primary author, 
year, title of study 
 
Country / 
Occupational 
sub-group 
Study design What was done 
Total 
farmers in 
cohort 
(+/- cases : 
controls) 
Non-farmer 
comparison 
group (age-
matched) 
No. farmer 
incident 
cases 
(+/- sub-
groups) 
Outcome 
measure 
Rate ratio 
95% CI 
Limitations 
 
 
European studies 
 
 
Frost et al 2011 
 
 
 
United Kingdom 
 
Agricultural workers,  
Pesticide applicators1 
 
 
Retrospective 
cohort study 
 
Rates for  agricultural pesticide 
users  (1987-2004) 
 
62,960 
 
UK population 
 
205 
 
SIR 
 
1.07 (0.93, 1.22) 
 
- possible PSA test/access bias 
 
- unclear if study group includes farmers 
per se. 
 
 
Pukkala et al 2009 
 
 
 
Denmark, Finland, 
Iceland, Norway and 
Sweden  
 
Farmers,  
Agricultural workers 
 
 
Retrospective 
cohort study 
 
Rates by occupation for 5 Nordic 
countries for men aged 30-64 yrs 
(1961 to 2005), 
 
not 
reported 
 
National 
populations of 5 
Nordic 
countries 
 
41,025 
 
SIR 
 
0.99 (0.98, 1.00) 
 
- possible PSA test access bias  
 
- no separation of farmers vs. agricultural 
workers 
 
-  age limit 64 yrs 
 
Laakkonen et al 
2008  
 
 
 
Finland 
 
Farmers, 
Agricultural workers 
 
 
Retrospective 
cohort study 
 
Rates of Finnish farmers, by type 
of farm (1995-2005) 
 
 
33,025 
 
FIN population 
 
1,309 
 
SIR 
 
0.98 (0.93, 1.03) 
 
- possible PSA test access bias 
 
- no separation of farmers vs. agricultural 
workers 
 
Rafnsson et al 2006 
 
 
Iceland 
 
Sheep farmers 
 
Retrospective 
cohort study 
 
Rates in a  compulsory sheep-
dipping registry (1962-
2003)compared with the general 
population of Iceland  
 
 
7,882 
 
ICE population 
 
541 
 
SIR 
 
0.92 (0.85, 1.00) 
 
- possible PSA test access bias 
 
 - results comparable to  other lindane-
dipping sheep farmers only 
 
Zeegers et al 2004 
 
 
 
Netherlands 
 
Farmers, 
Agricultural workers 
 
Prospective 
cohort / nested 
case-control 
study 
 
Total of 58,279 men (55-69 yrs) 
completed a questionnaire in 
1986 on cancer risk factors &job 
history. Cancer incidence was 
 
765 
 
Netherlands 
population-
based study 
sub-cohort. 
 
Ever farmer 
n=54 
 
Baseline 
 
RR 
 
0.86 (0.53,  1.14) 
 
 
0.75 (0.39, 1.46) 
 
- possible PSA test access bias 
 
- unclear if cohort are self-employed 
farmers, agricultural workers or both. 
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 followed to 1993. Cases were 
compared with sub-cohort 
controls for multivariate adjusted 
cancer incidence 
 
farmer n=27 
 
Longest job 
farmer n=27 
 
 
 
0.70  (0.36,,1.36) 
 
- relatively short follow-up;  small 
number incident cases per job title; and 
wide confidence intervals 
 
 
Settimi et al 2003 
 
 
 
Italy 
 
Farmers, 
Agricultural workers 
 
Case control 
study 
 
A hospital-based multi-site case-
control study was carried out in 5 
rural areas (990-92). Prostate 
cancer cases and ‘other cancer’ 
controls 20-75yrs of age were 
interviewed. 
 
343 
 
124:659 
 
Rural hospital 
cancer controls 
 
64 
 
ORb 
 
1.40  (0.9, 2.0) 
 
- possible PSA test access bias 
 
- no separation of farmers vs. agricultural 
workers 
 
- relatively small number of incident 
cases  
 
- risk component of study analysed at 
‘ecological’ level 
 
 
Bouchardy et al 
2002 
 
 
 
Switzerland 
 
Farmers, 
Agricultural workers 
 
Retrospective 
cohort / case-
referent  study 
 
Case referent study, as no 
occupational denominator data 
available. Other cancer 
registrants were case referents. 
Cancer cases were 25-65 yrs in 5 
Swiss states from (1980 -1993). 
Odds ratios for cancer type by 
occupation were estimated in 
reference to all other 
occupations, using logistic 
regression. Results were + /- a 
socio-economic (SES) indicator.  
 
 
1,393 
485: 8,641 
 
Other cancer 
registry 
referents from 
other 
occupations 
 
 Agriculture 
& animal 
producers 
(all): n=485 
 
•  Adj. age, 
registry, 
urbanity, 
nationality 
•  Add. adj. 
SES group 
 
Farmers & 
animal 
producers  
(only): n=310 
 
•  Adj. age, 
registry, 
urbanity, 
nationality 
•  Add. adj. 
SES group 
 
 
ORa 
 
 
 
 
 
 
 
1.2 (0.9, 1.2) 
 
 
 
1.2 (1.0, 1.2) 
 
 
 
 
 
 
 
1.2 (1.0, 1.3) 
 
 
 
1.2 (1.0, 1.4) 
(p<.05)* 
 
- possible PSA test access bias 
 
- no separation of farmers vs. agricultural 
workers 
 
- age data limits (< 65yrs ) required 
exclusion of  8.5% of cases, with 
implications for prostate cancer of ‘older 
persons’. 
 
- high proportion of unclassified 
occupations 
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North American studies 
 
 
Koutros et al 2010 
 
An update of cancer 
incidence in the 
agricultural health 
study 
 
 
USA  
 
Farmers,  
Pesticide applicators2 
 
Prospective 
cohort study 
 
Rates amongst farmers / 
pesticide applicators (1993 to 
2006) 
 
52,394 
 
Iowa & North 
Carolina 
populations 
 
Iowa  n=979 
 
NC  n=740 
 
All  n=1,719 
 
SIR 
 
1.22 (1.15, 1.30)* 
 
1.16 (1.08, 1.24)* 
 
1.19 (1.14, 1.25)* 
 
 
- possible PSA test access bias  
 
Meyer et al 2007  
 
A case-control study 
of farming and 
prostate cancer in 
African-American 
and Caucasian men 
 
 
USA 
 
Farmers, 
 Agricultural workers 
 
Case control 
study 
 
Farming-related activities were 
analysed for prostate cancer 
cases and controls (65-79yrs) 
matched for age, race and region 
in South Carolina, USA (999-
2001). Adj.odds ratios (aOR) were 
estimated using by logistic 
regression. 
 
 
411 
405:392 
 
South Carolina 
population 
controls. 
 
 
Caucasian 
n=117 
 
African-
American 
n=107 
 
All 
n=224 
 
ORa 
 
1.8 (1.3, 2.7)* 
 
 
 
1.0 (0.6, 1.6)   
 
 
 
1.40 (1.10, 1.90)* 
 
 
- possible PSA test access bias 
 
- selection bias: response fair & less able 
to locate African-Americans  
 
- recall bias may favour cases over 
controls 
 
- no separation of farmers vs. agricultural 
workers 
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Of the seven European studies, three found increased incidence;64, 67-68 and four found 
decreased incidence of prostate cancer in farmers.71-74 None of these results were statistically 
significant, although results for two studies with decreased rates; 71, 73 and one with increased rates 
in farmers,68 were of borderline significance where the upper or lower 95% confidence limit 
(respectively), was equal to one.  
2.6.5.5   Discussion  
Whilst the findings were based on a comprehensive search and review of the available literature, 
only eighteen studies were eligible for inclusion. Over one third of mortality studies and nearly a 
quarter of incidence studies reviewed, reported statistically significant increases in prostate cancer 
risk in farmers compared to non-farmers. Similar to previous reviews there was considerable 
heterogeneity by geographic region, study design and degree of control for confounders.7, 15, 54 
Likewise, a greater proportion of North American studies reported excesses in prostate cancer 
mortality than European studies; and more European studies used SMR outcome measures. 
Given these inconsistencies and the small number of relevant studies retrieved, the volume and 
strength of the evidence for increased prostate cancer risk in farmers is weak or lacking; and 
probably less supportive of an excess of prostate cancer risk in farmers than previous reviews.7, 15, 54 
Geographical location and study design have been cited previously as important predictors for 
prostate cancer risk across studies, with a statistical interaction between these being reported.7, 15, 54   
Increased risk was generally reported in studies that used PMR compared to SMR.54   
PMR tends to be used in studies that lack cohort or population denominator data. However, it is 
susceptible to over-estimating differences in mortality when a group has lower cancer mortality for 
all cancer and some common specific cancers (e.g. lung) such as has been reported for farmers.75  
Aquavella et al has suggested that an observed general reduction in the RR of prostate cancer in 
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farmers since the 1980’s, could at least in part be due to the reduced influence of studies that use 
PMR within meta-analyses.7  This may partly explain the low level of evidence for increased prostate 
cancer mortality in farmers in this review, in which only three of the eighteen studies used PMR.  
Alternatively, some have suggested that large cohort studies using SMR, are prone to ‘mask’ or 
under-estimate differences between groups, as they often lack information about confounding 
factors and are prone to the ‘healthy worker effect’.75 This effect is more likely for occupationally 
defined groups where overall cancer mortality is lower than that of the comparison population, 
which is the case for most studies of farmers. The opposing trends of PMR and SMR outcome 
measures have been noted in previous reviews and for prostate cancer mortality of farmers within 
the Agricultural Health Study cohort.58  
There were a range of limitations that have affected this study. Firstly, only English language 
articles were assessed, so that some publication bias is possible. There was also a general lack of 
detail around job title and occupational classifications. Studies used different occupational coding 
systems and/or national standards.76-79 Definitions of farmers and agricultural workers were often 
assumed rather than described in most articles, and selection of farmer cohorts was inconsistent 
across studies. Farmers and / or agricultural workers could be defined by ‘occupation codes’, by 
residential status, union membership or membership of pesticide registries; could be grouped 
together or assessed separately.  
Studies also lacked detail on farming practice / exposures, which limits the ability to identify and 
control for potentially important confounders. Some confounders that were addressed through 
regression or cohort stratification were age, rural/regional differences; 68 socio-economic status (e.g. 
education, income, marital status);68, 71, 74 years in farming;70, 72 Caucasian vs. African American 
race;70 lifestyle factors and family history of prostate cancer;74 raising of animals;68 and stage of 
diagnosis.33 Smaller studies that controlled for such confounders however, sometimes had 
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insufficient power to detect weaker associations as statistically significant.67, 74 In contrast, larger 
population-wide studies may have had more precise confidence limits, but lacked detail on 
confounders.64, 71-72     
It is well known that prostate cancer more commonly presents in older age groups. However, 
despite the use of age-standardisation to control for age differences between groups within studies, 
the inclusion or exclusion of older age groups in a cohort, may affect comparison between studies. 
Inclusion of older age groups could mask a stronger association confined to younger age groups.54  In 
addition, farmers often work well beyond conventional retirement age, but studies that 
differentiated groups by occupation codes, may not have included age-groups beyond traditional 
working age parameters, possibly rendering differences between farm and non-farm groups more 
difficult to detect.68  If studies that use occupational coding and SMRs potentially under-estimate risk 
differences,59 then any reported excess of prostate cancer in farmers using these parameters is 
particularly concerning, as they suggest an even higher risk in farmers is possible.  
Exposure to pesticides was reported in a number of studies.67, 70, 73 These exposures are explored 
in a wider body of literature on cancer-pesticide associations that, in general, do not report on 
differences in incidence and mortality between farmers and non-farmers and are not within the 
scope of this review. However, the initial search did suggest that many more risk factor studies have 
been conducted over the past decade than incidence-mortality studies; and that most of these 
addressed pesticides. This may be in response to the previous research that had suggested a 
possible excess cancer risk in farmers; the large proportion of pesticide association studies 
originating from the Agricultural Health Study cohort;56 and perhaps an extension of inquiry in the 
field, fuelled by recent progress in the understanding of biochemical and hormone-related 
carcinogenesis. 
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Future improvements in data linkage systems may also help address problems with lack of detail 
on some confounders. Inclusion and control for health service related variables (e.g. screening) may 
be possible. The impact of increased prostate specific antigen (PSA) testing on incidence rates has 
been identified broadly in population studies;80 and may be relevant in the context of farmers.71-72 
Whilst some studies suggest PSA testing may be less common among men living in rural areas,81-82 
any studies specifically addressing PSA screening rates in farmers compared to non-farmers were not 
found. One study did report that farmers over 50yrs were less likely to have had a digital rectal 
examination of the prostate (an alternative screening technique).41 If it is subsequently found that 
farmers do have lower PSA screening rates, it would suggest a bias toward the null for any 
comparative incidence ratios not adjusted for this effect. The implication is that an excess of 
prostate cancer incidence might still exist in farmers of ‘very highly developed’ countries, but is 
being masked by differential PSA screening rates. 
Future mortality studies, might also consider reporting both SMR and PMR measures, so the 
comparative impacts of ‘masking’ and ‘healthy worker’ bias upon risk estimates can be better 
assessed; and more valid comparisons with other studies made. Farmer cohorts need to be more 
carefully defined and differentiated beyond occupational coding. Similarly non-farmers of rural and 
urban origin must be better discerned. Although costs can be restrictive, large retrospective cohort 
studies need to be balanced by a greater number of more rigorously designed prospective studies, 
with improved detail on farm exposures and potential confounders. Regression analysis can then 
more systematically determine if any observed differences in prostate cancer risk might be 
attributable to specific farm exposures or characteristics of being a ‘farmer’.  
2.6.5.6   Conclusion 
This review found that around one third of mortality studies and one quarter of incidence 
studies reported significantly increased prostate cancer risk in farmers. There were a number of 
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study limitations and considerable heterogeneity by geographical region, design and outcome 
measures used, which affected the strength of evidence. Overall, the level of evidence for an excess 
of prostate cancer risk in farmers was weak. Future studies with more tightly controlled and 
consistent designs may provide further evidence regarding prostate cancer risk of farmers. 
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3.1   Study design 
This cohort study was a mixed prospective and retrospective analysis of linked data. The 45 and 
Up Study cohort was the primary dataset of interest and formed the basis for comparisons of (a) 
farm residents; (b) non-farm rural residents; and (c) urban participants for a range of cancer and 
health-related variables. The sub-group of primary interest were those who stated they lived in a 
‘house on farm’ in the 45 and up Study baseline questionnaire.  
Cancers of interest for different components of the research were:  
• Breast cancer 
• Cervical cancer  
• Colorectal cancer 
• Lung cancer 
• Melanoma 
• Non Hodgkins Lymphoma  
• Prostate cancer 
There were two main components to the research. Firstly, there was a comparison of self- 
reported personal and behavioural risk factors of interest, as recorded on the 45 and Up Study 
baseline questionnaire. These were age, family history of cancer, household income, private 
insurance status, screening practices, diet, obesity, smoking and alcohol consumption. Secondly, a 
comparison of cancer mortality, incidence, stage at diagnoses, cancer screening practices and 
selected cancer treatments obtained via data linkage of participant records from the 45 and Up 
Study, with matching records from routine state and national health datasets.  
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3.1.1   The 45 and Up Study 
The 45 and Up Study dataset has been made available to approved research projects from a 
range of institutions to conduct purpose-specific health research. The original concept was 
developed by a multi-institutional research collaboration, co-ordinated through the Sax Institute in 
New South Wales (NSW). A major partner is the Cancer Council NSW; and other partners include the 
National Heart Foundation of Australia (NSW Division); NSW Ministry of Health; NSW Government 
Family & Community Services – Ageing, Carers and the Disability Council NSW; the Australian Red 
Cross Blood Service; and the participants of the 45 and Up Study.1-2 
3.1.2   Sampling and recruitment 
The sampling frame for the 45 and Up Study was the general population of the state of New 
South Wales, Australia. Those turning or aged 45 and over and resident in NSW were randomly 
sampled from the Australian Department of Human Services database (formerly Medicare Australia), 
which provides near complete coverage of the NSW population.2 
Between January 2006 and December 2009, eligible individuals were invited to take part in the 
study via mail, which comprised of a letter of invitation, information leaflet, study questionnaire, 
consent form and a reply paid envelope. Participants joined the study by returning the completed 
questionnaire with signed consent form that allowed follow-up and linkage to routine health 
databases. Compared to urban and younger participants, individuals aged 80 years and over and 
residents of rural and remote areas, were oversampled by a ratio of 2:1. This was to ensure 
adequate numbers and representation of these smaller population groups.1-2   
The overall response rate for sampled individuals was approximately 17-18% allowing for mailing 
address errors. This rate is also variable across the different age/gender/location groups sampled. 
Individuals who had not been randomly sampled, but who met the eligibility criteria, could volunteer 
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to be part of the study by calling the study helpline. Approximately 0.5% of the final cohort 
volunteered to take part via this method.1-2 
The priority of the Study was to maximise heterogeneity of exposure, rather than 
representativeness; and whilst the response rate is comparable with other large cohort studies 
requiring consent for data linkage, it is not likely to be truly representative of the general population.  
The complete sample size is subject to periodic revision and the version of the data project 
researchers received at the time of provisioning, but approximates 267,000. This represents 
approximately 11% of the NSW population aged 45 years and over in 2009.1-2 
3.2   Approval processes 
Permission to access primary and secondary datasets was obtained from relevant data 
custodians, conditional upon meeting standard ethics principles for participant confidentiality and 
security of data. A range of scientific committee and ethics approvals were required prior to 
commencing the study. The original ethics approval obtained for the 45 and Up Study was granted 
by the University of New South Wales Human Research Ethics Committee (HREC). Separate 
participant consent was not required as part of this sub-study, because it was previously obtained as 
part of recruitment into the original 45 and Up Study cohort.  
A preliminary approval for the sub-study was granted by the 45 and Up Study Scientific Advisory 
Committee, before submission of a full ethics application. Post-graduate research approval was also 
sought and granted from the University of Sydney Human Research Ethics Committee, which 
deferred authority to proceed according to conditions required by the NSW Population and Health 
Services Research Ethics Committee. Application for and approval for linkage of data was granted by 
the Centre for Health Record Linkage (CHeReL Ref: 2011.63). Final Ethics Committee Approval was 
granted for the project by the NSW Population and Health Services Research Ethics Committee 
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(PHSREC Ethics Approval Number 2012/07/408). As part of this approval, conditional support and/or 
sign-off was required of the following data custodians: 
• Cancer Institute of NSW  
• Department of Human Services (formerly Medicare Australia)  
• NSW Ministry of Health  
• NSW Pap Test Registry 
• NSW Registry of Births, Deaths and Marriages 
• The Sax Institute 
3.3 Data access, linkage, security and preparation 3.3.1    Source datasets 
The 45 and Up Study baseline survey formed the primary dataset of interest and provided: 
• the primary means to identify, define and compare the three resident groups of interest  
• self report data on a range of cancer related health variables  
• records which could be further linked to secondary health datasets, to obtain further 
information on cancer indicators and other health service utilisation data over time.  
Records of 45 and Up Study participants were identified within other routinely collected data in the:    
• Australian Coordinating Registry (ACR) Cause of Death Unit Record File (COD URF)  
• Medicare Benefits Schedule (MBS) 
• NSW Admitted Patients Data Collection (APDC) 
• NSW Cancer Registry (NSW CR) 
• NSW Pap Test Register  (PTR) 
• NSW Register of Births, Deaths and Marriages (RBDM) 
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The Australian Coordinating Registry Cause of Death Unit Record File (COD URF) is a dataset 
jointly complied by the NSW RBDM and the ABS (NSW). The RBDM registers all births and deaths in 
NSW. When a person is deceased, a Medical Certificate with Cause of Death is forwarded to the 
Registry, is recorded (uncoded) and a death registration number assigned. The RBDM then forwards 
the identifiable un-coded text information from the Medical Certificate Cause of Death, to the 
Australian Bureau of Statistics (ABS), which codes all the data. Cause of death is coded according to 
the International Statistical Classification of Diseases and Related Problems (ICD-9-CM or ICD-10-
AM). Once the mortality data for a given year is complete and 'clean', the ABS removes personal 
identifiers (name and street address) to form the Australian Coordinating Registry COD URF.3-5 This 
information was used to analyse cancer-specific mortality of the cohort. In addition, the RBDM 
deaths registration data provided a means to validate deaths and death dates in other datasets, such 
as the APDC and NSW CR. 
The MBS is part of the Medicare Benefits Scheme administered by the Australian Department of 
Human Services (formerly Medicare Australia); and is a record of all government funded health 
services itemised and subsidised by the Australian Government.6-7 This includes consultations for 
General Practitioners, diagnostic tests such as X-rays and pathology, plus most surgical and 
therapeutic procedures performed by registered medical or health professionals. The MBS data 
were used to assess visitations to General Practitioners and cancer screening procedures. 
The APDC includes records for all hospital separations from every NSW public and private 
hospital plus day procedure centres.3-4 Records include a range of demographic data and 
administrative items, as well as other information such as cancer stage at diagnoses and procedures 
performed. The APDC data were used for comparison of hospitalisation for selected cancer 
therapies. 
135 
 
The NSW Cancer Registry maintains records of all cases of cancer diagnosed in NSW residents. 
Records include demographic data, staging information, year of diagnosis, and other coded 
information such as reason for death and morphology.3-4, 8 The NSW CR data were used to identify 
persons who developed cancer and corresponding cancer stage at diagnosis. 
The Pap Test Register collects data on women who have a pap test in NSW and contains details 
of the woman undergoing the test and results of Pap tests, cervical histology tests or HPV DNA 
tests.3-4, 9  The PTR data were used to assess variations in cervical screening behaviours of the three 
cohorts. 
3.3.2    Data linkage 
Linkage of records for participants across datasets was both retrospective and prospective, 
depending on the date of recruitment of the participant into the 45 and Up Study; and the years of 
data covered in linked datasets. Names and selected demographic information from participants of 
the 45 and Up Study are combined into a file for matching with Master Linkage Key (MLK) records 
from other datasets.4   
Linkage of the 45 and Up cohort data to the MBS data is done by the Sax Institute using a unique 
identifier provided to the Department of Human Services, which then released de-identified data to 
this study, as an approved project.1, 10 Linkage to records within datasets under NSW state 
jurisdiction was conducted by the NSW Centre for Health Record Linkage (CHeReL). A description of 
these methods follows, for which details are also available on the CHeReL website.11  
3.3.3    Master Linkage Key 
To maintain participant confidentiality and privacy, health information is separated from 
personal identifying information, but has the potential to be linked between datasets through use of 
a Master Linkage Key (MLK). The MLK is continuously updated by the CheReL and available for 22 
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major NSW and ACT health datasets held by data custodians who have service agreements with the 
CHeReL to provide the service. The MLK process ensures that CHeReL staff performing the linkage 
use demographic variables but do not have access to clinical information about individuals. Data 
custodians only have access to data within their data collections. Researchers receive data which 
contains no identifying variables, or variables which provide a link back to the CHeReL MLK.11-12  
The Master Linkage Key uses identifying information in datasets, such as name, address, date of 
birth and gender (no health data), to generate a unique personal identifier or code number, that 
enables the identification of records for the same person located in each dataset (i.e. the 45 and Up  
Study, APDC, NSW CR, PTR and RBDM death registrations). This information is provided by data 
custodians to the CHeReL to construct the MLK on an ongoing basis. No health data is transferred in 
this process.11-12   
Records within the datasets were linked using probabilistic record linkage methods and 
ChoiceMaker software.13 ChoiceMaker uses ‘blocking’ and ‘scoring’ to identify definite and possible 
matches. During blocking, ChoiceMaker searches the target datasets for records which are possible 
matches to each other. There are two types of blocking. The exact blocking algorithm requires 
records to have the same set of valid fields and the same values for these fields. The automated 
blocking algorithm builds a set of conditions that are used to find as many records as possible that 
potentially match each other. Scoring employs a combination of a probabilistic decision, which is 
computed using a machine learning technique and absolute rules. This includes upper and lower 
probability cut-offs to determine the final decision as to whether each potential match denotes or 
possibly denotes the same person. Upper and lower probability cut-offs initially start at 0.75 and 
0.25 for a linkage and are adjusted for each individual linkage to ensure false links are kept to a 
minimum. Record groups with probabilities in between the cut-offs are subject to clerical review.11-13   
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The RBDM death records in the MLK extract were deterministically linked to COD URF records. 
This linkage was carried out using a five-step procedure:4, 13 
First pass    year of registration, encrypted registration number and exact date of death. 
Second pass  year of registration, encrypted registration number and either: 
  1 day difference in date of death or 
   same year of death or 
 date of birth. 
Third pass  year of registration, date of death, sex, postcode and date of birth. 
Fourth pass   year of registration, date of death, sex, date of birth. 
Fifth pass   date of death, sex and date of birth. 
 Initial data extractions for this study used MLK Version 2013_02 (45 and Up Study, APDC) and 
updated extractions MLK Version 2013_11 (NSW CR) and MLK Version 2015_13 (RBDM deaths and 
COD URF). Once linkages were finalised, the CHeReL created Project Person Numbers (PPN) for each 
person identified in the linkage and assigned PPNs to all 45 and Up Study, APDC, NSW CR, RBDM 
Death and PTR records. The CHeReL returned the PPN and the encrypted record number from the 
source databases to the data custodian. The data custodians supply datasets comprising the 
approved information from the source database plus the PPN to study researchers, who merged the 
datasets using the PPN for the purposes of the research project.4 
3.3.4    Data linkage errors 
Data obtained for administrative purposes, are known to be subject to human error regarding 
data entry (e.g. spelling, typographic). These can result in data linkage errors. The MLK is regularly 
checked for false positive linkages, with a false positive rate = 3/1,000 CHeReL PPN identifications 
(0.3%).4 For this study comprising of 267,119 persons from the 45 and Up Study, this converts to 
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linkage errors for approximately 800 persons. Detailed information about processes to minimise 
linkage errors  is available from the CHeReL website.11  
3.3.5    Data provision, access and ongoing security 
This study received data relating to 267,119 participants of the original 45 and Up Study cohort. 
Initial data were received in May 2013, with provision of updates from some databases received in 
October 2013 (NSW CR) and in December 2015 (RBDM and COD URF).4 A summary of records 
returned to Study Investigators appears in Table 3.1. 
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Table 3.1: Records returned to study investigators from data custodians   
 
Measure Record type Number 
45 and Up Study 
records 
All 45 and Up records 
267,119 records 
(267,119 persons) 
MBS records MBS records  6 Jan 2004 - 31 Dec 2011 
46,012,797 
records 
(265,532 persons) 
APDC records 
APDC records that linked to the 45 and Up records 
Separation date: 1 Feb 2006 - 30 Jun 2012 
984,548 records 
(189,276 persons) 
NSW CR records 
(Updated Oct 2013) 
NSW CR records that linked to the 45 and Up records 
Notification date: 1 Feb 2006 - 31 Dec 2009 
13,445 records 
(12,997 persons) 
PTR records 
PTR records that linked to 45 and Up records 
Test years: 2 Jan 2006 - 7 Mar 2013 
234,673 records 
(78,510 persons) 
RBDM Death records 
(Updated 2015) 
RBDM Death records that linked to the 45 and Up records 
Death date: 1 Feb 2006 - 30 Jun 2013   
16,692 records 
(16,602 persons) 
COD URF 
(Updated 2015) 
COD URF records that linked to RDBM death records* 
Death date: 1 Jan 2006 - 31 Dec 2013 
16,603 records 
(16,592 persons) 
Total Project Person Numbers (PPN) 
 (267,119 
persons) 
 
Encrypted and password protected data files were uploaded via a curated gateway to the Secure 
Unified Research Environment (SURE). The SURE is a secure computing environment operated 
through the Sax Institute, where project researchers log in to a research space remotely via an 
encrypted internet connection from a local computer. Researchers access and analyse data files 
provided by the data custodians within the SURE, thereby meeting the strict privacy and 
confidentiality conditions of ethics approvals and the terms of the SURE user agreement. All files 
moving into and out of the workspace were reviewed by the SURE curator to ensure no identifying 
information is transferred in or out of the workspace.14 
3.4 Data scope and management of inconsistencies 
Deaths and hospitalisations that occur outside of NSW for NSW residents are not captured / 
included in NSW datasets linked by the CHeReL.4 There are also some inconsistencies inherent in the 
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data due to software recognition transcription or data operator errors and whether PPN linkage was 
correct or not (e.g. dates of birth, death etc.).  
3.4.1    Data custodian logic checks, missing data 
The Sax Institute conducted some routine data checking on 45 and Up Study before data 
provision to systematically flag or minimise some errors where these did not interfere with data 
integrity. The following logic checks were undertaken by data custodians and data was recoded 
where appropriate.15 
• If a participant entered a text response in a numerically coded field that could not be 
translated and numerically re-coded, values of invalid (99999) were applied. 
• For age response questions, an automatic logic check was applied against the age at 
recruitment. For example, if the age entered on a response about a past event was 
greater than recruitment age, the response was coded invalid (99999).  
• In questions which require a numeric response, if participants entered a range (e.g. 3-4). 
An average has been calculated in these instances, to produce a fraction.  
• Range checks have been applied on certain numeric fields with truncation at upper and 
lower limits, to improve manageability and minimise data loss.  
• For all female records, male-specific variables were left missing (rather than 0 or invalid) 
and vice versa.  
Missing values in the 45 and Up Study data were indicated by a blank ( ) when a participant 
failed to put a cross or number in a box when they should have. Conversely, invalid values were 
entered by electronic or manual data transcribers, when participants wrote in an implausible value 
for the response in question. For example, invalid values that failed range checks were coded 99999 
for numeric response fields and X for alphanumeric fields. Details on invalid ranges applied in these 
range checks for each variable can be found in the 45 and Up Study Data Dictionary.11, 16  
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Some correction of invalid values was possible because it is known from targeted checks on data 
quality that a sizeable proportion of them are due to operator error. This checking has entailed 
selection of invalid values and consulting scanned copies of questionnaires in which they occurred. 
In the sample checked, the invalid values were equally distributed between transcription errors and 
out-of-range responses given by participants themselves. 15-16   
The NSW Cancer Registry and Pap Test Register also conduct routine data quality control 
measures before release of data.8-9 These include monitoring notification or transmission rates by 
notifying General Practitioner or pathology laboratory, to ensure mandatory notification and 
reporting activity is maintained. Data entry validation checks and cross checks of data items, identity 
verification with the NSW Electoral Roll (by Pap test registry), periodic checks of coding accuracy and 
reliability, reconciliation of information from multiple sources, examination of multiple registrations, 
collaboration with pathologists, test providers, medical experts and other cancer registries and use 
of international  coding and program conventions.3, 8-9, 17 
3.4.2    Other checks and data cleaning by researchers 
As well as general logic checks performed by data custodians, we conducted routine data and 
logic checks throughout the analysis - especially after merging of datasets. Similar to most research 
projects using 45 and Up Study data, this study has excluded records with missing or invalid values 
for important variables from analyses, whilst reporting the total number of records available for 
each analysis. Due to the size of the dataset, this approach has generally not had a material impact 
on the statistical precision of the results of the analysis in other studies based on the 45 and Up 
Study data.3 However, where the creation of subsets of data has resulted in smaller baseline samples 
available for analyses compared to all possible records, the potential for bias has been noted in the 
results, such as when missing cases represented more than 10% of the available sample for any 
particular analyses. This is consistent with the approach taken in other studies on this cohort.18   
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Data sorting and summary statistics were run in SAS 9.3TM software for numeric variables,  
plausibility of dates across datasets checked;  and  frequency tables run for categorical variables to 
help identify duplicate records; missing data; large numbers, illogical combinations of demographic 
and clinical variables (e.g. male pap smears) and other unlikely combinations. Duplicate data were 
identified for further scrutiny or removal. 
Inconsistent records across datasets may have resulted from transcription errors at data entry 
level or were false positives in the data linkage process. For example, if a person had a death date 
before hospital admission date, this may have been a date entry error in either dataset or a linkage 
of records from two different people. The latter can occur because the CHeReL carries out linkage 
using demographic variables and does not have access to the clinical component of records to 
conduct logic checks using clinical information.4 In some instances, cross-checking with a third 
dataset could resolve inconsistencies (e.g. where death date could be confirmed elsewhere); but 
where uncertainty remained as to which type of error had occurred after cross-checking, such 
records were removed from analyses.  
3.5 Definition and description of key variables 
Description of variables used in this study including wording of questions and response coding, is 
available in the various data dictionaries provided by data custodians for different datasets.  
• 45 and Up Study Data dictionary3, 15  
• ABS mortality data - variable information3, 5 
• APDC Admitted Patient Data - variable information3, 19 
• NSW Cancer Registry Data Dictionary3, 8, 17  
• NSW RBDM death registrations - variable information3, 5  
• The Sax MBS Data dictionary6   
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Other documents with a description of items and variables include the 45 and Up Study baseline 
questionnaire databooks and the MBS Schedule.7, 20  
3.5.1    Accessibility/Remoteness Index of Australia (ARIA+) and ‘distance to health service’ 
Two purpose-specific variables required for this study were supplied by the data custodians via 
the ChereL. These were the Accessibility/Remoteness Index of Australia (ARIA+); and the ‘distance to 
health service’ data. The method for calculating distances from non-disclosed residential addresses 
to nearest hospital was as follows:  
“The CHeReL calculated distances by obtaining latitude and longitude co-ordinates 
(geocodes) for hospitals and residential addresses for APDC records from the Ministry of Health. 
The geodesic distance between the residential address and hospital was calculated for each 
record where this information was available, using the Transact SQL ‘STDistance’ function, 
which gives a close approximation of the geodesic (great circle) distance between two points on 
the earth’s surface. For 1,103 records, no distances could be calculated.” 4  
ARIA+ is a Australian Statistical Geography Standard (ASGS) endorsed measure of remoteness, 
derived from road distances between populated localities and Service Centres.21-22 An ARIA+ score 
for each participant was required to differentiate between rural and urban residents. These scores 
enabled each participant to be assigned to one of the following ASGS ‘Remoteness Area’ categories: 
• Major City 
• Inner Regional  
• Outer Regional  
• Remote  
• Very Remote  
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3.5.2    Derivation of the ‘cohort’ variable 
Sub-groups were defined for the 267,119 participant records of the ‘45 & Up Study’ supplied to 
study researchers in May 2013. Two questionnaire variables were used to derive the new ‘cohort’ 
variable. These were: 
1.  Restricted Variable Name:   ARIA plus_mean 
Variable label:  Accessibility/Remoteness Index of Australia (2006) ARIA+ mean (derived 
from postcode at recruitment) 
 
2.  Variable name:   Current housing 
Variable label:   What best describes your current housing? 
Question number:   14 (version 1) or 15 (version 2)  
SAS format label:   3 = House on Farm (of 8 options)  
 ‘Farm residents’ were defined as those who indicated that they live in a ‘house on farm’ on the 
45 and Up Study baseline questionnaire. Rural ‘non-farm’ and urban residents were further defined 
by ARIA+/ ASGS category. Those participants who did not live in a house on a farm whose ARIA+/ 
ASGS classification indicated they did not live in a ‘Major city’, were defined as rural non-farm 
residents. The remaining group, defined as ‘urban residents’, were those who specified that they 
lived in a major city.  
There were 194 participant records for which an ARIA+ score was not available to determine 
their ASGS classification. In this case, residential postcodes and /or the location and distance to any 
treating hospitals of linked APDC records were checked to determine allocation to residential sub-
group. Frequency tables and logic checks were then conducted on all records to ensure no 
participants were missing or misclassified by the resident group derivation. 
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3.6 Limitations of datasets 3.6.1   Validity, representativeness and generalisability 
It was important that the cohort as a whole and each resident sub-group, adequately 
represented their respective groups in the population. As only internal comparisons were 
conducted, this was less for reasons of generalisability than for preservation of the characteristics 
and exposures that differentiate or define farm residents from other rural and urban people.  This is 
essential to the objectives and internal validity of the research in comparing groups; the latter 
enhanced by efforts to minimise random variation, systematic bias and confounding. However, 
representativeness of the cohort and its sub-groups, may enable some generalisations to be made 
regarding possible differences in the wider population under certain conditions.   
In the first instance, representativeness of the 45 and Up cohort as a whole should be 
considered. A statement on limitations regarding the 45 and Up data, has been released from the 
Sax Institute:  
“Because of the nature of cohort studies, including the “healthy cohort effect”, the 45 and 
Up Study will not necessarily be representative of the general NSW population 45 and over, nor 
is it designed to be. Research projects using the Study relate to internal comparisons within the 
cohort, which, provided sufficient heterogeneity of exposure is present, are valid and underlie 
the many contributions that cohort studies have made to the understanding of health world-
wide, despite being derived from specific population sub-groups..... The 45 and Up Study is 
likely to be among the most representative large-scale cohort studies conducted world-wide.” 20 
For associations between 45 and Up Study variables, or between one 45 and Up Study variable 
and a data item from a linked dataset, however, a higher level of generalisability has been reported; 
with results directly comparable with results of other studies of the same population.16, 23    
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The 45 and Up Study questionnaire was only available in English, limiting participation of people 
with insufficient literacy in English. However, the study population is still relatively heterogeneous, 
with a good spread of responses across most variables. Importantly for this study, the oversampling 
of people from rural areas and 80 years and over (with no upper age limit), has enabled an adequate  
number of these sub-groups for internal comparisons within the cohort.1 The 45 and Up Study 
cohort constitutes approximately one in ten NSW residents aged 45 years and over.20 This is likely to 
be a higher ratio for the farm and rural non-farm cohorts, due to the oversampling of rural areas.  
This may affect the proportions of rural to urban people in the cohort compared to the wider 
population, but as comparisons are internal, this is not a particular issue.   
More importantly, the definition of a farm resident was open to interpretation by participants 
completing the 45 and Up Study baseline questionnaire, with subsequent allocation to each sub-
group depended upon this and ARIA+ index. This may well affect both the representativeness of sub-
groups and internal validity of comparisons made, contributing to a bias toward the null for some 
analyses. It is also not known what proportion of those who stated they lived on a ‘house on farm’ 
live on commercial farms compared to lifestyle farms or acreage. Demographic and lifestyle 
characteristics and environmental exposures may vary for those living on a farm, depending upon 
whether work or leisure activities dominate. Differences in health related factors between farm and 
rural non-farm residents may only be small, due to this mix in the characteristics of those who live 
on-farm.  
3.6.2   Cancer incident data limitations 
The NSW CR advised that due to delays in receiving mortality data from the ABS, under-
reporting of cancer incident cases for 2009 of approximately 1.7% for all cancers is expected. This is 
because a proportion of cancer cases are only identified and coded as new cases, on receipt of 
Australian Bureau of Statistics (ABS) death data. These are known as ‘Death Certificate Only’ (DCO) 
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cases, which were not registered as cancer cases at the time of diagnosis. Under-reporting rates for 
specific cancers analysed in this study by age group, are outlined in Table 3.2.24 Notwithstanding this 
limitation, it is unlikely to impact this analysis to any great degree, as the focus was a comparison 
between cohorts, with under-reporting not likely to impact one group more than another. 
Table 3.2: Proportion of NSW ‘death certificate only’ cancer cases, 2004- 2008 by tumour and age 
 
Code Tumor Group %DCO* 5 Year Agegrp DCO% 
C910 Acute lymphoblastic leukaemia  0.4% 45-49 years 0.2% 
C920 Acute myeloid leukaemia  1.8% 50-54 years 0.3% 
C71 Brain  1.6% 55-59 years 0.2% 
C50 Breast  0.7% 60-64 years 0.3% 
C72 Central nervous system  1.4% 65-69 years 0.6% 
C53 Cervix  1.0% 70-74 years 1.0% 
C18 Colon  1.4% 75-79 years 1.7% 
C69 Eye  0.4% 80-84 years 3.5% 
C334 Lung  3.2%   
C43 Melanoma of skin  0.2%   
C8890 Multiple myeloma  3.1%   
C82 Non-Hodgkin's lymphoma  1.0%   
C919 Other lymphoid leukaemias  4.5%   
C929 Other myeloid leukaemia  3.0%   
C61 Prostate  0.9%   
C1921 Rectum, rectosigmoid, anus  0.6%   
3.7 Analysis 
The following section provides an overall description of analysis methods. Further details are 
provided in following chapters, relating to specific components of the study.  
3.7.1    Characteristics of farm, rural non-farm and urban residents in the 45 and Up Study cohort 
Summary characteristics of the cohort by sub-group and gender were summarised for a range of 
health-related, behavioural and socio-economic variables. Descriptive and basic analytical statistics 
were generated in SAS 9.3TM using the PROC FREQ, PROC MEANS, PROC UNIVARIATE, PROC ANOVA  
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functions; and CHISQ and TEST and CL options. Cohort variables of particular interest compared and 
used in further analyses were: 
• Age and sex 
• Body Mass Index:  categorical  variable derived for ‘overweight or obese’  status 
• Smoking:  categorical variable derived for ‘current, past or never smoker‘ status 
• Alcohol consumption:  categorical variables derived reflecting ‘at risk’ alcohol 
consumption guidelines. These were ‘number of drinks per week’ -  used to derive  a 
variable defined as risk consumption of more than 2 alcohol drinks per day; and ‘number 
of days per week’ -  used to derive a variable defined as risk consumption of less than 2 
alcohol free days per week.25 
• Annual household income:  in the absence of the access-restricted SEIFA variable,  a 
binary income indicator defined by an annual household income of $70,000 or more 
approximated the 2006 average household income in NSW.26 
• Self reported screening / and years ago:  status and categorical frequency variables 
derived for prostate, breast and bowel cancers reflecting recommended screening 
frequency guidelines (i.e. every 2 years ).27-29  
• Self reported cancer :  for exclusion purposes 
• First degree relative (mother, father, brother/sister) with selected cancers - to derive  
‘family history’ risk factor variable for breast, bowel, prostate cancers and melanoma 
• Red meat consumption: variable derived reflecting recommended dietary guidelines30  
• Sun exposure weekdays: variable derived for working week sun exposure reflecting 
recreational versus occupational patterns and exposure risk31 
• Private health insurance with extras status 
• Tannability:  related to melanoma risk factors  
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Self reported incidence of cancer was not be used to validate NSW CR incident data, as the 
former was effectively a measure of prevalence within the cohort (presence of cancer prior to survey 
completion). Diagnosis of self reported cancer may have occurred well before recruitment into the 
study (pre 2005-2009). In addition, self reported existence (prevalence) of cancer was only valid for 
the point in time or ‘year’ in which the survey was conducted, whereas NSW CR data extended from 
the time of recruitment until 2009, attrition or death. 
3.7.2    Cancer incidence and mortality rates and ratios  
Cause of death data from January 2006 to December 2012 was checked against RBDM data for 
verification of death dates and removal of duplicate records. The mortality dataset was then merged 
with the 45 and Up Study dataset and further logic and date checks conducted. For each selected 
cancer, person-years for each participant over the period were calculated from the date of 
recruitment to date of death or censorship date of 31st December 2012. The ‘Lexis macro’ was used 
within SAS 9.3TM to split person-years for each participant across 5-year age-bands at risk, 
commencing from age at recruitment.32-33 This enabled correct allocation of risk time to each age 
strata, as the person aged. Thirty three records for which recruitment dates were found to be 
incorrect were removed, as person-years could not be calculated.  
Similar methods were employed for preparation of data to calculate cancer incidence rates and 
ratios. In this case, 45 and Up Study data were merged with NSW CR data for the 2006-2009 period. 
For selected cancers, person-years were calculated commencing from 1st February 2006 to 
censorship or the 14th day of the month of diagnosis, since the actual date of diagnosis was not 
provided. Separate analyses on cancer-specific subsets of data, with different person-year 
calculations for each cancer type, enabled persons who were registered with the NSW CR with more 
than one type of cancer to be accommodated. Cancer codes used to identify particular cancers for 
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incidence and mortality ratios were as listed in relevant data dictionaries;3 and consistent with 
ICD10-AM listings.34 
For each cancer and gender, frequencies of observed incident and mortality events were 
determined using SAS 9.3TM. Person-years for different age-at-risk strata were also generated and 
both values used to create age-standardisation tables. Direct and indirect age-standardisation 
methods were used to calculate incidence and mortality rates and ratios for each gender and  each 
sub-cohort for the selected cancers, according to methods described by Taylor et al.35 Variance of 
observed counts were calculated based on the Poisson distribution, where there were fewer than 30 
observed cases or events.35  Incidence and mortality rates and ratios were generated for prostate, 
breast, colorectal, lung, melanoma, non-Hodgkins Lymphoma (NHL), multiple myeloma, myeloid 
leukaemia, lymphocytic leukaemia and eye/brain/central nervous system cancers and cervical 
cancers. However, only the first six cancers were reported upon, due to low case numbers of the less 
common cancers in the farm group. 
In this study the reference population used for comparison of age-standardised incident and 
mortality rates and ratios was the whole 45 and Up Study cohort, to ensure valid internal 
comparisons as described previously.1, 20 For indirect age-standardisation, the age-specific rates of 
the standard population (45 and Up Study cohort) are applied to the age structure of the subject 
population (resident sub-group) to give an expected number of events. The observed number of 
events is then compared to that expected and expressed as an incidence or mortality ratio 
(observed/expected). Compared to direct age-standardisation, the variance is minimised and 
confidence intervals are narrower, helpful for determining statistical significance for smaller 
populations.35    
Direct age-standardisation methods apply the age-specific structure of sub-groups to the age 
structure of the standard population, to give an overall rate that would have occurred in the subject 
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population if it had the standard age-profile. This is only possible in datasets where observed events 
were known by age-group, which was the case in our study. Direct age-standardisation is the 
preferred method for comparing sub-groups against each other; and for comparisons over time. A 
disadvantage of this method is that calculated rates can become unstable with a small number of 
events.35 Results using both methods were compared, but direct age-standardisation rates and ratios 
were deemed the most appropriate and are reported in this thesis. 
3.7.3    Cancer incidence and mortality hazard ratios 
Cox Proportional Hazards regression was used to determine potential differences in incidence or 
mortality by gender, between farm, rural non-farm and urban residents, controlling for other 
variables. The selected cancers modelled were the same as those for standardised mortality and 
incidence ratios, being prostate, breast, colorectal and lung cancer, melanoma and NHL.  
Modelling was performed using log rank tests and proportional hazards regression in SAS 9.3TM. 
Whilst not all variables were used in all models, the following variables were initially considered for 
inclusion:  
• Cohort (farm, rural non-farm and urban residence) - the variable of primary interest 
• Annual household income over $70,000  
• Overweight  status -  Body Mass Index>25 
• Alcohol risk drinking status - drinks (risk>2+/day),  days (risk> 5 /week)  
• Smoking - ever, past, current 
• Family history of cancer - prostate, breast, lung, colorectal cancer and melanoma 
• Sun exposure category - (< 1 hour, 2-3 hours, 4hours+) 
• Red meat consumption category - (<3 serves, 3-4 serves, 4+ serves/week)  
• Tannability (melanoma only) 
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Variables with univariate p< .25 were included in the base model with appropriate dummy 
variables and interaction terms. Models were progressively assessed using backward elimination 
methods to the .05 level, with non-significant variables also checked for confounding effects on 
hazard ratios of cohort groups. Residual plots were examined to ensure that the assumptions of 
proportional hazards regression were met. 
Analyses using Cox Regression and presented as adjusted hazard ratios in this study, were able 
to control for a range of factors. Thus the adjusted hazard ratios may be considered more 
informative than standardised incidence and mortality rate ratios as a measure of incidence and 
mortality risk in this study. However, SMR and SIR results are also included in the analysis to allow 
for (1) direct comparisons with other studies which have used these measures in the absence of risk 
factor information; (2) to gauge the effects of these additional risk factors compared to age alone; 
(3) to cross-check consistency of results when using different outcome measures.   
3.7.4    Stage at diagnosis  
The ‘stage at diagnosis’ variable was derived from  ‘degree of spread’, as described in the NSW 
CR data dictionary.17 This binary categorical variable was defined by ‘Stage 2 or above’ status. Chi-
squared analyses for more common cancers were conducted for both stage at diagnosis and 
screening frequency categories, against a range of other variables. Only prostate, breast and 
colorectal cancer cases were assessed for stage at diagnosis, due to the low number of less common 
cancers newly diagnosed within the cohort over the 2006-2009 period.  
Logistic regression was used to model potential differences in stage at diagnosis between farm, 
rural non-farm and urban cohorts, controlling for other variables. Variables considered were those 
listed for incidence and mortality, plus a range of health, economic and behavioural risk factors. In 
addition, the effect of selected cancer screening was considered. Cases where stage was not 
recorded were excluded from analysis. Binary logistic regression was used to calculate adjusted odds 
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ratios for later stage cancer, controlling for selected risk factors. Variables with univariate p values < 
.25 were included in the base model, with all possible interaction terms. Models were progressively 
reduced using a backward elimination approach, removing non-significant variables (at the .05 level), 
accounting for any non-significant confounders. Residual plots were examined to identify cases with 
undue influence in regression models.  
3.7.5    Cancer screening 
Frequency of screening for breast, prostate, cervical and bowel cancers were compared using a 
range of datasets for parallel comparison. These consisted of the self reported frequency of 
screening in the 45 and Up Study (2006-2009); number of screening test items and General 
Practitioner visits claimed through the MBS (2004-2011); and the number of cervical screening tests 
in the NSW Pap Test Register (2006-2013). Binary logistic regression was used to model effects on 
self reported screening using similar methods as described for stage at diagnosis. The age-adjusted 
average number of screening tests and visits to General Practitioners over the specified periods were 
also compared using analysis of covariance.  
3.7.6    Cancer treatments in the NSW Admitted Patients Data Collection 
Data from the NSW APDC were used to compare surgical, chemotherapy, radiotherapy and 
brachytherapy procedures for those with a diagnosis of prostate, breast or colorectal cancer over 
the period. Average distance to treating hospital for each therapy was determined and binary 
logistic regression was used to compare the odds of receiving treatment by resident group for each 
cancer, controlling for selected variables. Criteria for inclusion, significance levels and elimination 
methods were as described for stage at diagnosis. Procedures assessed were excision of breast 
lesion, mastectomy, radical prostatectomy, radiotherapy, chemotherapy and brachytherapy, as 
defined within the APDC data dictionary.3     
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In conclusion, this Chapter has primarily focused on the methods used to prepare the data for 
analyses. Further details about the datasets and variables used in this study can be found on the 
appropriate websites and data dictionaries referenced throughout the chapter. The following 
chapters will reiterate these methods in part, as necessary to fulfill requirements for manuscripts 
submitted for publication. Further detail on analytical methods undertaken as they pertain to 
specific study components, is also provided.  
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4.1   Abstract   
Introduction: People living in rural areas in Australia have poorer cancer outcomes than 
those in urban areas, but it is not known if this is the case for farm residents. Methods:  Data for 
farm, rural non-farm and urban participants of the 45 and Up Study cohort in New South Wales, 
Australia, were linked with state death registrations data for 2006 - 2012. Direct age-standardised 
mortality ratios for 267,074 participants were compared for all cancer and prostate, breast, lung and 
colorectal cancers, non-Hodgkins Lymphoma (NHL) and melanoma. Proportional hazards regression 
was used to estimate adjusted mortality hazard ratios for each cancer type, controlling for common 
risk factors. Results: Farm, rural non-farm and urban residents differed in a range of health related 
characteristics. Farm women had a significantly lower adjusted hazard ratio for breast cancer than 
rural non-farm women. Confidence intervals for adjusted hazard of all cancer and other selected 
cancers did not exclude unity, but point estimates suggested farm residents had non-significantly 
lower all cancer and colorectal cancer mortality risk; similar lung cancer risk; and farm men slightly 
elevated melanoma and prostate cancer risk.  Conclusion:  Farm women had a significantly lower 
breast cancer mortality risk than rural non-farm women, but differences between farm, rural non-
farm and urban residents for all cancer or other selected cancers were not significant.  
 
Keywords:  Farm* risk, mortality, cancer, prostate, breast, melanoma, lung, colorectal, NHL 
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4.2   Introduction 
Cancers are responsible for approximately one third of all deaths in Australia, with lung, lympho- 
haematopoietic, colorectal, prostate and breast cancers responsible for most deaths.1-2 Rural 
Australians have higher mortality from all cancer, melanoma, lung, prostate and colorectal cancer 
than those who live in major cities.3 Cancer mortality statistics have been reported by rurality based 
on the Accessibility/Remoteness Index of Australia (ARIA+), but this does not identify farm residents 
as a sub-group.3-6 There is currently no information available on cancer mortality differences 
between farm, rural non-farm and urban residents in Australia.  
There were around 43,500 farm businesses registered in the state of New South Wales (NSW) in 
2010-20117 and approximately 35,000 farmers and farm workers aged 45 years or over. Almost 90% 
of Australian farms in 2010-11 were family businesses run by owner-operators or contributing family 
workers.8 A previous Australian study of mortality in male farmers reported a significantly higher 
standardised mortality ratio (SMR) for prostate cancer; and non-significant elevations in other 
cancers, compared to the national population.9 International studies of cancer mortality in farmers 
have reported mixed findings.10-23 Compared to earlier reports, more recent studies have tended to 
be less conclusive regarding excess cancer risk in farmers.9, 24-31 It is not known if this is due to an 
improved mortality profile or a general change in study measures and designs. Methodological 
problems include small sample sizes, lack of control for confounders and a range of locations and 
time periods, such that the number of comparative studies on which to form conclusions on any 
particular cancer is small.16, 32 As most studies have been occupationally based, this has also meant 
there is less information about cancers amongst women on farms, many of whom work unpaid on-
farm as well as engage in off-farm work to support family incomes.33    
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An analysis of comparative cancer mortality in farmers that addresses some of these issues is 
overdue for Australia. This study aimed to identify differences in cancer mortality from common 
cancers, between farm, non-farm rural and urban residents; controlling for selected risk factors 
previously associated with cancer mortality. 
4.3   Methods 
This data linkage study was based on the 45 and Up Study cohort, comprising 267,119 residents 
of NSW, Australia; and managed by the Sax Institute, in collaboration with major health agency 
partners.                                                                   
4.3.1   Sampling and recruitment 
Between January 2006 and December 2009, eligible NSW individuals 45 years and over, were 
randomly sampled from the Australian Department of Human Services database, which provides near 
complete coverage of the NSW population, Persons aged 80 years and over and residents of rural and 
remote areas were oversampled by a ratio of 2:1. Subjects were mailed a questionnaire with consent 
form for follow-up and data linkage to routine health databases. An additional 0.5% of the final 
cohort comprised volunteers who contacted the Study hotline to participate. The overall response 
rate for sampled individuals was 17-18%; representing approximately 11% of the NSW population 
aged 45 years and over.34 Further information about the study cohort is available from the 45 and 
Up Study website.35  
4.3.2   Datasets, data linkage and checks 
Participant records from the 45 and Up Study provided information on residence (farm, rural or 
urban), age, family history of cancer, household income, screening practices, diet, obesity, sun 
exposure, smoking and alcohol consumption. Cancer mortality for the three resident sub-groups was 
compared by data linkage with deaths registrations in the NSW Registry of Births, Deaths and 
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Marriages (RBDM); and the Cause of Death Unit Record Filea
Routine data frequency and logic checks were undertaken to check for plausibility of dates and 
ranges, duplicate records,  missing data, large numbers and  illogical combinations of demographic, 
clinical variables and other unlikely combinations. Records with missing or invalid values for 
important variables of interest were excluded from analyses; and noted where these represented 
more than 10% of the available sample. Inconsistent data resulting from transcription errors or false 
positive linkages (e.g. death date before recruitment date), which could not be resolved by cross-
checking were also removed from analysis. Description of survey questions, response coding and 
sample checking procedures can be found in the NSW Mortality and 45 and Up data dictionaries.39-40  
 held by the NSW Ministry of Health’s 
Secure Analytics for Population Health Research and Intelligence. Cause of death was coded 
according to the International Statistical Classification of Diseases and Related Problems Tenth 
Revision (ICD-10).36 Data linkage was conducted by the NSW Centre for Health Record Linkage, using 
a probabilistic record linkage method.37 Detailed information on data linkage methods is available 
elsewhere.38   
4.3.3   Derivation of the ‘cohort-defining’ variable  
 ‘Farm residents’ were defined as those who indicated that they lived in a ‘house on farm’ in the 
45 and Up Study baseline questionnaire. Rural ‘non-farm’ and urban residents were further defined 
using ARIA+ classification, by postcode of residence at recruitment.3, 5 Those participants whose 
ARIA+ classification indicated they did not live in a ‘Major city’, excluding those who also specified 
that they lived in a 'house on farm', were defined as rural non-farm residents. The remaining ‘urban’ 
participants were those who lived in a ‘Major city’. Cross-tabulation and logic checks were 
conducted on this derivation to ensure no participants were missing or misclassified. Where ARIA+ 
                                                          
a The Cause of Death Unit Record File (COD URF) is provided by the Australian Coordinating Registry for COD URF on behalf of 
Australian Registries of Births, Deaths and Marriages, Australian Coroners and the National Coronial Information System 
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was not recorded, allocation was determined by cross-checking postcode of residence in a linked 
hospital dataset. 
4.3.4   Analytical procedures 
Frequency and analytical procedures were conducted using in SAS 9.3™ analytical software and 
Microsoft Excel 2007.™ 41-42  Summary descriptive statistics by cohort and gender were generated for 
selected health and lifestyle risk factors. Where relevant, adjusted means were calculated using least 
squares methods. Some variables were re-classified to align with current national health or 
workplace recommendations; or those in place at the time of recruitment.43-48 These related to 
smoking status, risky alcohol consumption, overweight and obesity, red meat consumption and 
weekday sun exposure. Household income was categorised to approximate levels above or below 
the 2006 average household income in NSW in 2006.49  Tannability, the response of participants’ skin 
when repeatedly exposed to sunlight in summer without protection (never, mild, moderate, very), 
was considered for melanoma models only. 
For each selected cancer, person-years for each participant were calculated from the date of 
recruitment to date of death or censorship at 31st December 2012. Person-years for each participant 
were split across 5-year age-bands at risk, commencing from age at recruitment, to enable allocation 
of risk time to each age stratum, as the person aged.50-51 Observed mortality events and total 
person-years for each cancer were determined by gender, age-band-at-risk stratum and cohort. 
Direct age-standardisation methods were used to calculate mortality rates and ratios. Variances of 
observed counts were calculated based on the Normal approximation or the Poisson distribution 
where less than 30 observed events occurred.52 Consistent with 45 and Up Study Collaboration 
recommendations, only internal comparisons between sub-groups within the cohort were made, 
with the reference population being the whole 45 and Up Study cohort.34 Direct age-standardised 
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mortality rates and ratios were generated for all cancers and the cancers of interest - prostate, 
breast, colorectal and lung, melanoma and non-Hodgkins Lymphoma (NHL).  
Cox Proportional Hazards regression was used to model potential differences in mortality for 
selected cancers by cohort, controlling for risk factors.53 Variables with univariate logrank p values < 
.25 were included in the base model. Interaction terms between variables of interest in the base 
model and cohort were created and tested for effect modification. Models were progressively 
assessed using backward elimination methods to the .05 level, with non-significant variables also 
checked for confounding effects on hazard ratios of cohort groups. Residual plots were examined to 
ensure that the assumptions of proportional hazards regression were met.  
4.4   Results 
Information from the 45 and Up Study survey questionnaire was available for 267,119 
participants. Forty five participant records were removed for which dates of recruitment, age or 
gender information across datasets was incomplete or inconsistent. Analysis was undertaken for the 
remaining 267,074 participants, who were followed for 1,128,162 person-years (mean 4.2 years 
/person, max 7.4 years).  
Summary characteristics of the cohort for each gender are shown in Table 1. Farm residents 
were notably younger than rural non-farm and urban residents. Averages for other quantitative 
variables were adjusted for age. Differences in smoking status, alcohol consumption, 
overweight/obesity, tannability and family history of selected cancers were generally small. In 
contrast, farm residents had noticeably higher average sun exposure and red meat consumption; 
and considerably more urban residents had annual household incomes over the median level.  
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Table 4.1: Selected characteristics of farm, rural non-farm and urban residents reported in the 45 and Up Study baseline questionnaire 
 
Total Farm Rural Urban Total Farm Rural Urban 
    n %  or %  or %  or n %  or %  or %  or
 mean (95 % CI)  mean (95 % CI)  mean (95 % CI)  mean (95 % CI)  mean (95 % CI)  mean (95 % CI)
Age at recruitment (years)
  45-49 10,698                 10.2% 8.4% 8.6% 16,654              14.0% 11.4% 11.4%
  50-54 17,630                 16.2% 13.2% 14.9% 25,285              21.3% 16.9% 17.9%
  55-59 19,748                 18.4% 15.6% 15.9% 25,706              22.3% 17.3% 18.0%
  60-64 19,206                 18.9% 15.9% 14.6% 22,118              17.3% 16.0% 14.6%
  65-69 17,340                 15.6% 15.3% 12.4% 17,766              12.3% 13.9% 10.8%
  70-74 13,480                 9.8% 12.4% 9.5% 12,534              6.5% 9.9% 7.9%
  75-79 10,192                 5.9% 9.4% 7.4% 8,649                3.6% 6.8% 5.6%
  80-84 10,983                 3.8% 7.2% 11.4% 8,791                1.9% 4.8% 8.3%
  85+ 4,605                   1.1% 2.7% 5.2% 5,689                0.7% 3.0% 5.6%
Average age 123,882              61.2 (61.0 - 61.4) 63.7 (63.6 - 63.8) 64.3  (64.2 - 64.4) 143,192           58.6 (58.5 - 58.8) 61.8 (61.7 - 61.8) 62.5 (62.4 - 62.5)
Smoking status (n) 123,820               143,140            
  Never 54,963                 48.2% 41.8% 46.4% 85,481              61.4% 57.9% 61.4%
  Past 59,413                 44.0% 50.1% 46.6% 47,774              32.1% 34.4% 32.5%
  Current 9,444                   7.8% 8.2% 7.1% 9,885                6.5% 7.7% 6.1%
Alcohol consumption - drinks 
   > 2 drinks/day 28,904                 24.4% 25.8% 21.5% 8,542                6.7% 6.2% 5.9%
 Av. drinks / week (age adjusted)  121,791              9.9  (9.7 - 10.1) 10.5 (10.4 - 10.6) 9.2  (9.1 - 9.3) 139,564            4.6 (4.5 - 4.7) 4.5 (4.4 - 4.5) 4.4 (4.4 - 4.5)
Alcohol consumption -  days 
   > 5 days/week 39,036                 36.7% 34.9% 31.6% 25,551              22.7% 20.2% 19.6%
   Av. days / week (age adjusted)  116,529              3.8  (3.8 - 3.9) 3.7 (3.7 - 3.7) 3.5 (3.5 - 3.5) 127,087            a 2.8 (2.8 - 2.9) 2.6 (2.6 - 2.6) 2.6 (2.6 -2.6)
Body Mass Index (BMI)  
   BMI >25  79,310                 69.4% 70.8% 65.8% 72,682              54.5% 58.5% 52.4%
   Av. BMI (age adjusted) 115,985              27.0 (26.9 - 27.1) 27.5 (27.4 - 27.5) 27.0 (26.9 - 27.0) 130,927            26.5 (26.4 - 26.6) 27.0 (27.0 - 27.1) 26.3 (26.3 - 26.4)
Characteristics 
Men Women
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Annual income over $70,000 (n) 103,830                b 105,384             c
    34,334                  29.6% 26.3% 40.5% 28,477                    28.0% 21.2% 33.4%
Sun exposure  (hours / week) 
  Less than 1 hour 5,635                    1.7% 3.6% 6.6% 11,727                4.7% 7.5% 10.7%
  1 - 4 hours 58,423                  25.0% 46.5% 58.2% 92,732                58.7% 69.0% 70.4%
  More than 4 hours 51,889                  73.3% 49.9% 35.2% 30,253                36.6% 23.5% 18.9%
  Av. hours / week (age adjusted)  115,947                6.0 ( 5.9 - 6.0) 4.1 (4.0 - 4.1) 3.2 (3.2 - 3.2) 134,712             3.3 ( 3.3 - 3.4) 2.6 (2.6 - 2.6) 2.3 (2.3 - 2.4)
Family history of cancer    (n) 123,878                143,184             
  Prostate cancer   13,595                  13.3% 11.5% 10.0% 18,013                12.5% 12.9% 12.2%
  Colo-rectal cancer  16,488                  13.9% 13.8% 12.7% 20,418                14.4% 14.8% 13.7%
  Lung cancer  11,993                  8.6% 10.1% 9.4% 15,715                10.7% 11.4% 10.6%
  Melanoma   9,420                    9.2% 7.9% 7.1% 14,628                11.9% 10.6% 9.5%
Meat consumption (serves /wk)  
  Less than 2 serves 15,044                  8.7% 11.4% 14.3% 23,174                12.4% 16.2% 18.1%
  2-3  serves 51,890                  31.7% 41.8% 46.6% 65,296                37.2% 46.8% 49.4%
  More than 3 serves 53,021                  59.5% 46.8% 39.1% 49,681                50.4% 36.9% 32.4%
  Av. serves (age adjusted)   119,955                4.7 (4.7 - 4.8) 3.8 (3.8 - 3.8) 3.4 (3.4 - 3.4) 138,151                  3.8 (3.8 - 3.9) 3.2 (3.2 - 3.2) 3.0 (3.0 - 3.0)
Tannability   (n) 121,474                139,710             
  Get very tanned 39,036                  36.6% 33.2% 30.4% 32,535                26.4% 23.1% 22.9%
  Moderately tanned 52,277                  43.7% 43.2% 42.7% 53,586                40.0% 38.4% 38.0%
  Mildly/occasionally tan 22,211                  14.9% 17.4% 19.7% 35,726                23.4% 25.6% 25.9%
  Never tan / freckle 7,950                    4.8% 6.2% 7.2% 17,863                10.1% 12.9% 13.2%
 
a. 11% missing 
b. 16% data missing 
c. 26% missing 
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4.4.1   Mortality in men 
Age-standardised mortality rate ratios and hazard ratios for each cancer are shown in Tables 2 
and 3. The all cancer mortality rate ratio was significantly lower in farm men. The adjusted hazard 
ratio for all cancer was also lower in farm men, but not significantly so when controlling for 
additional risk factors. There were no significant differences in either the SMR or adjusted hazard 
ratio for men between cohorts for any of the individual cancers tested, with the exception of lung 
cancer. Rural non-farm men had a significantly higher lung cancer SMR but the adjusted hazard ratio 
was not significantly different to other men. Farm men had lower colorectal cancer and NHL 
mortality that was not significant; and non-significant elevations in prostate cancer. When adjusted 
for sun exposure and tannability, melanoma in farm men was higher, but not significantly so.  
4.4.2   Mortality in women 
Although not significantly different to other groups, farm women had the lowest SMR and 
adjusted hazard ratio for all cancers. Farm women also had the lowest SMR and adjusted hazard 
ratio for colorectal and lung cancer. In contrast, farm women had the highest adjusted hazard ratio 
for NHL controlling for age and other factors, though this was not significant. The SMR for breast 
cancer (SMR 60.49, 33.72 - 98.63) and melanoma (SMR=14.71, 0.37 - 81.95) in farm women was 
significantly lower than unity. Melanoma risk was not modelled because there were less than 5 cases 
within the farm group. However, the adjusted hazard ratio for breast cancer mortality in farm 
women was significantly lower than that for rural non-farm women (1.69, 1.00 – 2.87) controlling for 
age, family history, smoking and sun exposure.  
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 Table 4.2: All cancers and selected cancer mortality in farm, rural non-farm and urban men of the 45 and Up Study cohort, 2006-2012 
Cancer Type Cohort Residence  Cases  Standardised   Adjusted Hazard ratios (95% CI) for variables remaining
(ICD10)a n=123,882  Mortality Rate Ratio   Hazard Ratio  in final model (excl. age) / further notes
& no. deaths p-years=522,121  (95%Cl)  (95%Cl )  
All neoplasms    Farm                     193                                                            80.5                                                         1.00 •      Age
b  
(C00 - D48) n= 9,281   (68.1 – 93.0)   (ref) •      Alcohol consumption (> 5 days/wk)  
n= 4,207 yes vs no     HR= 0.84 (0.78 – 0.91)  
•      Smoking status  
Rural non-farm                 1,945                                                          104.6                                                         1.14 never           HR= 1.00 ref 
n= 57,330  (99.9 – 109.3)  (0.96 – 1.36) past              HR= 1.45 (1.33 – 1.57)
current        HR= 2.76 (2.40 – 3.18)
•      Overweight/obesity status
Urban                 2,069                                                            98.4                                                         1.10 yes vs no     HR= 0.89 (0.83 – 0.96)
n= 57,271  (94.1 – 102.6)  (0.92 – 1.32) •      Weekday sun exposure 
< 1  hr           HR= 1.32 (1.10 – 1.59)
1 - 4 hrs        HR= 1.00 ref
> 4 hrs          HR= 0.89 (0.83 –  0.97) 
•      Annual household income over $70,000 / year 
yes vs no      HR= 0.75 (0.67 –  0.85)
Prostate            Farm                       37                                                          123.0                                                         1.00 •      Age
b  
 (C61)  (78.8 – 167.2)   (ref) •      Family history prostate cancer 
n= 649 yes vs no     HR= 1.95 (1.58 – 2.40)  
Rural non-farm                     288                                                          103.8                                                         0.89 •      Weekday sun exposure 
 (91.6 – 116.0)  (0.62 – 1.27)  < 1  hr           HR= 1.95 (1.38 – 2.77)
1 - 4 hrs        HR= 1.00 ref
Urban                     324                                                            94.7                                                         0.81 > 4 hrs          HR= 1.03 (0.87 – 1.22) 
 (84.2 – 105.2)  (0.57 – 1.16)  
Colorectal Farm                       15                                                            65.0                                                         1.00 •      Age
b  
(C18 - C21)   (34.7 – 109.8)   (ref) •      Smoking status  
n= 354 never           HR= 1.00 ref 
Rural non-farm                     159                                                          100.8                                                         1.39 past              HR= 1.26 (1.01 – 1.59)
 (84.9 – 116.7)  (0.82 – 2.37) current        HR= 1.83 (1.18 – 2.82)
Urban                     180                                                          105.2                                                         1.49 
 (89.6 – 120.8)  (0.87 –  2.52) 
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Lung              Farm                           33                                                                 76.5                                                                  1.00 •     Age
b  
(C34)  (48.3 – 104.7)  (ref)  •     Smoking status  
n= 716 never               HR= 1.00 ref 
Rural non-farm                        366                                                              112.5                                                                  1.14 past                 HR= 4.95 (3.65 – 6.70)
 (100.9 – 124.2)   (0.78 – 1.70) current            HR= 18.19 (12.89 – 25.68)
•     Alcohol risk (> 2 drinks/day)  
Urban                        317                                                                 90.4                                                                  0.98 yes vs no        HR= 1.33 (1.06 – 1.67)
 (80.3 – 100.5)  (0.66 –  1.46) •      Alcohol risk (> 5 days/week)  
yes vs no        HR= 0.75 (0.61 – 0.93)
•      Annual household income over $70,000 / year
yes vs no        HR= 0.64 (0.47 – 0.86)
Melanoma   Farm                           15                                                                 98.6                                                                  1.00 •     Age
b  
(C43)   (53.8 – 164.6)  (ref)  •     Weekday sun exposure 
n= 219 < 1 hr               HR= 2.23 (1.18 – 4.21)
Rural non-farm                           99                                                              100.5                                                                  0.93 1 - 4 hrs           HR= 1.00 ref
 (80.4 – 120.6)   (0.52 – 1.68) > 4 hrs              HR= 1.56 (1.15 – 2.10) 
•     Tannability  (when skin repeatedly exposed to 
Urban                        105                                                                 97.0                                                                  0.89 sunlight in summer without protection)  
 (78.2 – 115.8)  (0.49 – 1.61) very tan                     HR= 1.00  ref
moderate tan           HR= 1.22 (0.83 – 1.78)
mild tan                     HR= 2.01 (1.39 – 3.16)
never tan/freckle     HR= 2.69 (1.64 – 4.41)
Non-Hodgkins Farm                             7                                                                 76.3                                                                  1.00 •     Age
b  
Lymphoma   (27.35 – 163.02)  (ref)  •      Alcohol risk (> 2 drinks/day)  
(C82 - C85) yes vs no        HR= 0.40 (0.21 – 0.75)
n= 149 Rural non-farm                           61                                                                 92.7                                                                  1.36 •      Annual household income over $70,000 / year  
 (69.15 – 116.28)  (0.54 – 3.41) remained  a non-significant confounder  p=.21
Urban                           81                                                              108.9                                                                  1.54 
 (84.79 – 132.92)   (0.61 – 3.85) 
 
a. ICD10 - International Statistical Classification of Diseases and Related Health Problems, Tenth Revision 
b. All models were significant for age (by five-year age groups), for which hazard ratios are not reported. All remaining variables significant to p<.01 level unless stated otherwise. 
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Table 4.3:  All cancers and selected cancer mortality in farm, rural non-farm and urban women of the 45 and Up Study cohort, 2006-2012 
 
Cancer Type Cohort Residence  Cases  Standardised   Adjusted Hazard ratios (95% CI) for variables remaining
(ICD10)a n=143,192  Mortality Rate Ratio   Hazard Ratio  in final model (excl. age) / other notes
& no. deaths p-years=606,041  (95%Cl)  (95%Cl )  
All neoplasms    Farm                       107                                                         81.9                                                           1.00 •       Age
b  
(C00 - D48) n= 10,549  (63.5 – 100.2)  (ref) •       Smoking status  
n= 2,463   never         HR= 1.00 ref 
  past            HR= 1.48 (1.33 – 1.65)
Rural non-farm                    1,188                                                      102.1                                                           1.17   current      HR= 2.63 (2.19 –  3.15)
n= 69,463  (96.3 – 108.0) (0.92 – 1.50) •      Weekday sun exposure 
  < 1  hr        HR= 1.24 (1.04 – 1.47)
  1 - 4 hrs     HR= 1.00 ref
Urban                    1,168                                                      100.5                                                           1.19   > 4 hrs       HR= 0.92 (0.81 – 1.04) 
n= 63,180  (96.64 – 106.30)  (0.93 – 1.53) •      Annual household income over $70,000 / year   
 yes vs no    HR= 0.84 (0.71 – 0.99)
Breast Farm                          18                                                         60.5                                                           1.00 •        Age
b  
(C50)  (33.7 – 98.6)  (ref) •        Family history breast cancer 
n= 424   yes vs no   HR= 1.81 (1.42 – 2.31)
Rural non-farm                       215                                                      105.6                                                           1.69 •        Smoking status 
 (91.3 – 119.8)  (1.00 – 2.87)    never         HR= 1.00 ref 
  past            HR= 1.31 (1.06 – 1.61)
Urban                       191                                                         99.6                                                           1.56   current      HR= 1.17 (0.75 – 1.82)
 (85.3 – 113.9)  (0.92 – 2.66)  •        Weekday sun exposure
  < 1 hr         HR= 1.91 (1.27 – 2.87)
  1 - 4 hrs     HR= 1.67 (1.23 – 2.21)
  > 4 hrs       HR= 1.00 ref  
Colorectal cancer Farm                            9                                                         65.7                                                           1.00 •        Age
b  
(C18 - C21)  (26.8 – 130.2)  (ref) 
n= 246
Rural non-farm                       117                                                      101.6                                                           1.44 
(83.0 – 120.2)  (0.73 – 2.83) 
Urban                       120                                                         98.8                                                           1.41 
 (80.8 – 116.7)  (0.71 – 2.79) 
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Lung              Farm                           19                                                        78.4                                                            1.00 •        Age
b  
n= 716  (ref)    never        HR= 1.00 ref 
  past           HR= 4.12 (3.03 – 5.60)
Rural non-farm                         202                                                     101.4                                                            1.04   current     HR= 16.84 (11.81 – 24.02)
 (87.3 – 115.6)  (0.59 – 1.85) •        Weekday sun exposure
  < 1 hr         HR= 1.67 (1.14 – 2.45)
Urban                         194                                                     102.3                                                            1.14   1 - 4 hrs     HR= 1.00 ref
 (87.7 – 116.9)  (0.64 –  2.03)   > 4hrs        HR= 1.17 (0.88 – 1.56) 
•       Annual household income over $70,000 / year   
 remained  a non significant confounder p=.49
Melanoma   Farm  <5                                                        14.7                                                            1.00 
 (C43)  (0.37 – 81.95)  (ref)  
n= 219
Rural non-farm                           39                                                     108.6  na na
 (74.27 – 142.96) 
Urban                           34                                                     100.1  na 
 (65.98 – 134.20) 
Non-Hodgkin Farm                             6                                                     168.5                                                            1.00 •        Age
b  
Lymphoma   (55.7 – 378.1)  (ref)  •        Weekday sun exposure
(C82 - C85)   < 1 hr         HR= 3.48 (190 – 6.36)*
n= 149 Rural non-farm                           35                                                        86.8                                                            0.64   1 - 4 hrs     HR= 1.00 ref
 (57.6 – 115.9)  (0.25 – 1.66)   > 4hrs        HR= 1.86 (1.13 -  3.08)*
Urban                           48                                                     111.3                                                            0.92 
 (79.3 – 143.3)  (0.36 – 2.36) 
 
a. ICD10 - International Statistical Classification of Diseases and Related Health Problems, Tenth Revision 
b. All models were significant for age and were stratified by five-year age groups, for which stratified hazard ratios are not reported. All remaining variables significant to p<.01 level unless stated otherwise. 
c. Not available due to small number of cases  
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4.4.3   Risk factors  
Several risk factors remained significant in adjusted mortality models. In particular, smoking 
status remained significant in lung, breast and male colorectal cancer mortality models. The adjusted 
hazard ratio for current smoking in men was 18 times that of never smokers (HR= 18.19, 12.89 - 
25.68); and 16 times that of never smokers amongst women (HR= 16.84, 11.81 - 24.02). Red meat 
consumption did not remain in final colorectal cancer models. However, household income did 
remain in lung cancer models. Adjusted hazard ratios for sun exposure were higher for minimal sun 
exposure than for high exposure and remained in final models for breast, lung cancer and NHL 
models in women; and in prostate cancer and melanoma mortality models for men.  
4.5   Discussion 
Results presented as an adjusted hazard ratio are considered more informative than SMR, since 
they account for additional risk factors other than age. However, SMR allows for more direct 
comparisons with previous studies that have used this measure; offers a gauge of the effect of age 
alone on mortality compared to when additional factors are considered; and is a general check for 
consistency of results using different outcome measures.   
Whilst farm men had a significantly lower all cancer SMR, (four-fifths that of other men), 
differences in all cancer adjusted hazard ratios were less marked. Farm women had a similar SMR 
and adjusted hazard ratio, the former of borderline significance compared to all women, but not 
sub-groups. The most significant finding for specific cancers in this study was related to breast 
cancer mortality in farm women. This was significantly lower than unity controlling for age alone; 
and was also significantly lower than rural non-farm women, controlling for additional risk factors. 
Colorectal cancer mortality was lower in farm women than other groups, but not significantly so; 
and lung cancer mortality was similar between women when controlling for other factors. With less 
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than five deaths due to melanoma having occurred in the farm group, the finding for a significantly 
lower SMR in farm women needs to be considered with caution, as some instability in mortality 
ratios can arise using direct age-standardisation methods if case numbers are small.52 There were no 
significant differences in either mortality incidence or adjusted hazard ratios amongst men for any of 
the individual cancers tested, with the exception of the lung cancer SMR which was highest amongst 
rural non-farm men. Whilst not significant, there were slight elevations in prostate cancer and 
melanoma mortality risk in farm men, and reduced mortality for colorectal cancer and NHL 
mortality.  
4.5.1   Risk factors 
Previous studies have suggested higher rates of cancer mortality in rural areas may be attributed 
to higher risk alcohol consumption and smoking rates, less access or utilisation of health services; 
and educational, employment and income disadvantage.4, 6, 54-55 Disadvantaged groups have 
consistently been reported to have lower life expectancy, higher incidence, prevalence and risk 
factors for disease and greater rates of avoidable mortality.6 56 Rural non-farm residents in this 
cohort, particularly men, had the highest levels of risk in relation to smoking, obesity and income 
disadvantage. Smoking may be a particularly important issue amongst rural non-farm residents on 
lower incomes.  
Alcohol consumption greater than 5 days/week was negatively associated with lung cancer 
mortality in men. Some benefit from the consumption of small amounts of alcohol by older adults on 
a daily basis, has been noted elsewhere.45 Contrary to this, greater than two alcoholic drinks/day 
was positively associated with lung cancer mortality in the adjusted model. Variance inflation factors 
and standard errors in the base model were not excessive, but a there may have been a degree of 
collinearity between this variable and others in the model. There was a general lack of evidence for 
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an association between excessive alcohol consumption and lung cancer in the literature, so findings 
for this risk factor should be considered with caution.43  
There was no evidence for an association between red meat consumption and colorectal cancer 
mortality in this study, contrary to evidence suggesting this elsewhere.57 The higher level of weekday 
sun exposure in farm residents may reflect a more active outdoor lifestyle compared to the 
intermittent exposure of non-farm residents. Notably, the hazardous effects of minimal sun 
exposure in final models for NHL, breast and lung cancer in women; and melanoma and prostate 
cancer in men, are consistent with other studies suggesting links between sun exposure, Vitamin D 
levels and reduced risk in these cancers.58-62 Very low sun exposure may also be a proxy indicator of 
an inactive indoor lifestyle with its own cancer health risks. 
4.5.2   Mortality in farm residents 
Whilst a few studies have reported increased all cancer risk in farmers,9-10, 63-64 most findings 
point to a lower overall cancer mortality.12-14, 16, 19, 24, 28, 31, 65 Higher sun exposure, or the more 
physical outdoor activity it represents, may have contributed to the lower all cancer mortality in 
farm residents. Compared to other occupational groups in Australia, farmers are older, work longer 
hours and are more likely to be self-employed, with lower disposable income, yet higher household 
wealth.4 These characteristics suggest a healthy worker effect may be at play amongst farm 
residents which has been acknowledged for farm cohorts elsewhere.12, 28, 31, 66 However, as opposed 
to an occupationally defined cohort, healthy worker bias for the farm residents’ should be tempered 
by the presence of retirees, lifestyle farmers and family members. In addition, the cohort profile 
suggests urban residents overall had fewer lifestyle risk factors than farm residents - supporting the 
view that a healthy worker bias has been minimised in this cohort.  
Whilst countless factors remain untested, the cohort profile suggests that outdoor activity may 
have had some role to play in all cancer risk being lower in farm residents; and perhaps, in relation 
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to lower (though not significant) colorectal cancer risk. Lower colorectal cancer in farmers has 
commonly been reported elsewhere, with greater physical activity and healthier diet postulated as 
possible explanations.12-14, 16, 24, 28, 31, 65, 67  The higher average red meat consumption in farmers found 
in this study remained within a moderate consumption range so does not necessarily contradict 
evidence on associations between high red meat consumption and colorectal cancer.43 Questions 
remain as to why farm men had lower all cancer and colorectal cancer.  
Most studies of breast cancer in farm women have found either reduced SMR12, 31 or no 
significant difference in mortality compared to others.27-28, 63, 68 The inverse relationship between 
breast cancer mortality and sun exposure in this study was unexpected, but whether acting for its 
own sake or as a proxy, the protective benefit of sun exposure for farm women clearly does not 
explain the remaining difference between groups in the final model. Breast cancer screening has 
been associated with a 15-30% reduction in mortality in women aged 50-69 years of age.69 A 
previous study on cancer screening in the 45 and Up Study cohort found that rural women were 
more likely to have had a mammogram than urban women.70 Participation in the national 
population-based breast cancer screening program (Breastscreen Australia), is also higher in regional 
compared to urban areas, although lowest in remote areas.71 Farm women may have been the 
driving force behind, and benefited most from, higher rates of breast screening in regional Australia.  
Reduced lung cancer mortality in farmers has also been reported often, with lower smoking 
rates in farmers sometimes suggested as a contributing factor.12, 24-25, 28, 31, 72-73 Smoking accounted 
for a considerable portion of the difference in risk between groups in this study; and lung cancer 
mortality in farmers was less marked after controlling for this and other factors. There has also been 
suggestion that exposure to farm endotoxins has some protective benefit against lung cancer in 
farmers, but this was not assessed in our study.25, 73-76  
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The melanoma mortality hazard ratio was slightly higher in farm men, but not significantly 
different to other rural non-farm and urban counterparts, when controlled for significantly higher 
levels of tannability and weekday sun exposure amongst farm residents. This suggests that regular, 
moderate sun exposure typical of farming may have played some protective role - although greater 
case numbers and follow-up time would be required to confirm this. Nonetheless, any mild 
protective benefit of occupational exposure does not necessarily contradict the importance of sun 
protection, especially against intense, periodic sunburn. Sun protection attitudes and behaviours 
have improved in recent years in Australia, which has one of the highest rates of melanoma in the 
world.77    
Slightly elevated prostate cancer mortality risk in farm men in this study, whilst not significant, 
was consistent with some other findings.24-25, 28 Others have reported significantly higher prostate 
cancer risk in farmers.9, 11-12, 14-16, 26, 66, 78-79 Pesticide exposures are a common explanation put 
forward, in a plethora of studies investigating pesticide-cancer associations that are outside the 
scope of this study. Notwithstanding this, a recent review suggests the overall evidence for 
increased prostate cancer mortality in farmers compared to others is not strong, partly due to 
limitations in study design.32  
Findings for NHL in this study were mixed and inconclusive; consistent with mixed findings in 
several studies.12, 16, 28 Whether this is due to changes in study measures, methods and limitations, or 
real reductions in mortality risk between farm residents and other groups remains to be seen. A 
number of large prospective cohort studies in development across the world may soon better 
answer such questions.12, 31, 80  
4.5.3   Limitations 
There are some limitations of note regarding this study. Firstly, since the farm resident group 
represented only one-tenth of the overall cohort, the number of deaths over the follow-up period 
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for some cancers was relatively small. These issues were particularly apparent for lung and 
colorectal cancers, NHL and melanoma in the farm resident group. Low power for some analyses has 
resulted in relatively low precision and wide confidence intervals that affect the statistical 
significance of findings, potentially leading to a bias toward the null.  Therefore, the discussion for 
these cancers is largely exploratory and focuses on trends suggested by point estimates.  In this 
context, larger, more consistent differences between groups should be given most weight.  Greater 
precision will be possible given a longer follow-up period, but trends in current results do provide 
some insight and direction for further work. 
Secondly, the 45 and Up Study is not representative of the general NSW population 45 and over.  
However, its size and robust sampling methods have ensured an adequate number of rural and farm 
residents are able to be internally compared; and it is amongst the most representative large-scale 
cohort studies in the world.34 A higher level of generalisability has also been suggested where 
associations between 45 and Up Study variables and items from linked data sets has occurred.81  
Lastly, the definition of a ‘farm resident’ in this study was open to the respondent’s 
interpretation of what constitutes a farm. This may have affected the representativeness of sub-
groups and internal validity of some comparisons, contributing to a bias toward the null for some 
analyses. The number of people who live on non-commercial farms in NSW is also not known, nor 
what proportion of the farm resident group in this study that they comprise. Whilst small farm 
holdings make up the majority of farming enterprises in Australia, exposures may vary depending on 
whether commercial or recreational purposes are dominant.33 Errors arising from misclassification 
however, are likely to dilute any effect farm ‘exposure’ might have on the outcome, leading to an 
underestimate of any relationship between farm residence and mortality. However, unlike many 
occupational studies, this study has been able to combine the benefits of a comparatively large 
sample size, with the ability to control for commonly known risk factors.  
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4.6   Conclusion 
Farm, rural non-farm and urban residents differed in a range of health related characteristics.    
Whilst farm men had significantly lower all cancer SMR and rural non-farm men had significantly 
higher lung cancer SMR than other groups, there were no significant differences in this measure for 
NHL, colorectal, prostate cancer or melanoma.  When controlling for additional risk factors, adjusted 
hazard ratios indicated no significant differences in the odds of mortality between farm, rural non-
farm or urban men, either from all cancer or the other selected cancers.  
The SMR for breast cancer and melanoma in farm women was significantly lower than unity, but 
there were no significant differences in this measure for all cancer, lung and colorectal cancer or 
NHL. Controlling for additional risk factors, farm women had a significantly lower adjusted hazard for 
breast cancer compared to rural non-farm women; but differences were not significant for other 
cancers.   
Farm residents in this cohort had a lower mortality risk for all cancer than rural non-farm and 
urban residents, although results were not significant. Likewise, there were no significant differences 
in mortality risk for selected common cancers between resident groups after adjusting for a range of 
commonly known risk factors, with the exception of significantly lower breast cancer mortality in 
farm women. 
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5.1   Abstract  
Background: It is not known if the incidence of common cancers in Australian farm residents is 
different to rural non-farm or urban residents. Methods: Data from farm, rural non-farm and urban 
participants of the 45 and Up Study cohort in New South Wales Australia, were linked with state 
cancer registry data for the years 2006 - 2009. Direct age-standardised incidence rate ratios were 
compared for all cancer, prostate, breast, colorectal cancer, melanoma and non-Hodgkin lymphoma 
(NHL). Proportional Hazards regression was used to generate incidence hazard ratios for each cancer 
type adjusted for relevant confounders. Results: Farm women had a significantly lower all cancer 
hazard ratio than for rural non-farm women; but lower all cancer risk in farm men compared to rural 
non-farm and urban counterparts was not significant. When rural non-farm and urban groups were 
combined, the all cancer adjusted hazard was significantly lower in both farm men and women. 
Confidence intervals did not exclude unity for differences in risk of prostate, breast, colorectal or 
lung cancers, NHL or melanoma but farm residents had considerably lower lung cancer risk than 
other residents after controlling for smoking and other factors. Conclusions: All cancer risk was 
significantly lower in farm residents compared to combined rural non-farm and urban groups. Farm 
women had a significantly lower all cancer adjusted hazard ratio than rural non-farm women. These 
differences appeared to be mainly due to lower lung cancer incidence in farm residents.  
 
Keywords:  Farm*, incidence, cancer, prostate, breast, melanoma, lung, colorectal, non-Hodgkin 
lymphoma 
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5.2   Introduction 
Registration of all cancers, excluding non-melanoma skin cancers, is a legal requirement in all 
Australian States.1-2 The most commonly diagnosed cancers in Australia include prostate, colorectal, 
breast, lung cancer, melanoma and lymphoma.3 The distribution of these cancers varies across rural 
and urban areas. Between 2005-2009, incidence of prostate, colorectal, breast cancer, melanoma 
and non-Hodgkin lymphoma (NHL) was highest in inner regional areas and lung cancer highest in 
very remote areas.3  
Cancer incidence is regularly reported by remoteness or accessibility to services,4 but not in a 
way that would distinguish those who do and do not live on farms. There is some limited 
information on mortality in male Australian farmers by occupation,5 however no information on 
cancer incidence for those who live on farms compared to others in rural areas or in cities in 
Australia, is known.  
International studies have reported mixed findings on comparative cancer incidence between 
farmer and non-farmer groups. Most recent studies have reported reduced cancer incidence in 
farmers for all cancer, lung, breast and colorectal cancers.6-14 Meanwhile, most studies of prostate 
and lymphohaematopoietic cancers have reported neutral findings. However, around one fifth of 
lymphoma studies, a quarter of prostate cancer studies and almost half of myeloma and leukaemia 
studies report significant excesses of cancer incidence in farmer groups.6-8, 10-11, 14-26 Findings also vary 
by location, study design and degree of control for confounders which can affect comparability and 
the strength of conclusions drawn.27-28 The current study aims to add to this knowledge by 
comparing the incidence of common cancers in NSW farm, rural non-farm and urban residents.  
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5.3 Methods 
This data linkage study was based on the 45 and Up Study cohort, consisting of 267,119 
residents of NSW, Australia aged 45 years and over. The cohort data is maintained and managed by 
the Sax Institute, in collaboration with health agency partners. This study assessed cancer incidence 
for prostate, breast, colorectal, lung, melanoma and NHL, amongst farm, non-farm rural and urban 
residents, controlling for selected risk factors previously associated with cancer.  
5.3.1 Sampling and recruitment 
Between January 2006 and December 2009, eligible NSW individuals 45 years and over, were 
randomly sampled from the Australian Department of Human Services database, which provides near 
complete coverage of the NSW population. Persons aged 80 years and over and residents of rural and 
remote areas were oversampled by a ratio of 2:1. Subjects were mailed a questionnaire with consent 
form for follow-up and data linkage to routine health databases. An additional 0.5% of the final 
cohort comprised volunteers who contacted the Study hotline to participate. The overall response 
rate for sampled individuals was 17-18%; representing approximately 11% of the NSW population 
aged 45 years and over.29 Further information about the study cohort is available from the 45 and 
Up Study website.30  
5.3.2 Datasets and linkage  
Participant records from the 45 and Up Study cohort provided information on residence (farm, 
rural or urban), age, family history of cancer, household income, screening practices, diet, obesity, 
sun exposure, smoking and alcohol consumption. Cancer incident cases amongst participants were 
identified through linkage to the NSW Cancer Registry (CCR) data, which contains records of all cases 
of cancer diagnosed in NSW residents, excluding non-melanoma skin cancers. Records were 
available for all new cancer notifications for the period 1st February 2006 (2006 was the first year in 
which 45 and Up Study participants were recruited) to 31st December 2009. Cancer type is derived 
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and coded according to International Statistical Classification of Diseases Ninth Edition (ICD-9) 
cancer groupings.31 Data quality control measures conducted by the CCR are reported elsewhere.2 A 
small proportion of cancer cases were identified and coded only on receipt of the Cause of Death 
Unit Record File.b
Data linkage was conducted by the NSW Centre for Health Record Linkage, using a probabilistic 
record linkage method. Detailed information on data linkage methods is available elsewhere.33-34 On 
reception of data, checks were undertaken for plausibility of dates and ranges, duplicate records, 
missing data, large numbers and illogical combinations of demographic, clinical variables and other 
unlikely combinations across datasets. Records with missing or invalid values for important variables 
of interest were excluded from analyses; and noted where these represented more than 10% of the 
available sample. Inconsistent data resulting from transcription errors or false positive linkages 
which could not be resolved by cross-checking across datasets were also removed from analysis. 
Description of all survey questions, response coding and sample checking procedures can be found 
in relevant data dictionaries.31, 35  
 For the year 2009 only, delays in receiving deaths data is likely to have caused 
under-reporting of <1% to 3.2% of cancer incident cases for the cancers of interest.32 
5.3.3 Definition of variables  
‘Farm residents’ were defined as those who indicated that they lived in a ‘house on farm’ in the 
45 and Up Study baseline questionnaire. Rural ‘non-farm’ and urban residents were further defined 
using the Accessibility/Remoteness Index of Australia (ARIA+) from postcode of residence at 
recruitment.4, 36 Those participants whose ARIA+ classification indicated they did not live in a ‘Major 
city’, excluding those who also specified that they lived in a 'house on farm', were defined as rural 
non-farm residents. The remaining ‘urban’ participants were those who lived in a ‘Major city’. Where 
                                                          
b The Cause of Death Unit Record File (COD URF) is held by the NSW Ministry of Health Secure Analytics for Population Health 
Research and Intelligence and provided by the Australian Coordinating Registry for COD URF on behalf of Australian Registries of Births, 
Deaths and Marriages, Australian Coroners and the National Coronial Information System 
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ARIA+ was not recorded, allocation was determined by cross-checking with postcode of residence 
and distances to treating hospitals in a linked hospital dataset. 
Characteristics of the cohort in relation to risk factors of interest, were age, family history of 
cancer and other factors categorised in accordance with current national health or workplace 
recommendations.37-43 These categories were: smoking status current, past, never; risky alcohol 
consumption >5 days/week, >2 drink/day; overweight and obesity status where Body Mass 
Index>25; red meat consumption <3-4<+ serves/week; and weekday sun exposure <1-4<+ 
hrs/week). Tannability, the response of participants skin when repeatedly exposed to sunlight in 
summer without protection (never, mild, moderate, very), was considered for melanoma models 
only. Household income was stratified to approximate levels above or below the 2006 average 
annual household income of $70,000 in NSW in 2006.44    
5.3.4 Analytical procedures 
Analyses were conducted using SAS 9.3™45 software and Microsoft Excel 2007™.46 For incidence 
ratios, person-years were calculated commencing from 1st February 2006 to censorship date, or the 
14th day of the month of notification of a selected cancer. Cancer-specific subsets were used for each 
cancer type, to allow for persons registered with more than one type of cancer. Person-years for 
each participant were split across 5-year age-bands at risk, commencing from age at recruitment, to 
enable allocation of risk time to each age strata, as the person aged.47-48  
Direct age-standardisation methods were used to calculate standardised incidence ratios (SIR). 
Variance of observed counts were based on the Normal approximation or the Poisson distribution 
where less than 30 events occurred within a resident group.49 Consistent with 45 and Up Study 
Collaboration recommendations, only internal comparisons between sub-groups within the cohort 
were made, with the reference population being the whole 45 and Up Study cohort.29 Standardised 
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incidence ratios were generated for all cancers and the cancers of interest, being prostate, breast, 
colorectal and lung cancers, melanoma and NHL.  
Cox Proportional Hazards regression was used to model potential differences in incidence of 
selected cancers by cohort, controlling for risk factors.50 Variables with univariate logrank p values < 
.25 were included in the base model. Interaction terms between variables in the base model and 
cohort were created and tested for effect modification. Models were progressively tested using 
backward elimination methods to the .05 level of significance; with non-significant variables also 
checked for confounding effects on the hazard ratios of cohort groups. Residual plots were 
examined to ensure assumptions of proportional hazards regression were met.  
Sensitivity analyses were conducted using a smaller subset of data, where participants with prior 
cancer were removed and time to event for all records was limited to time since completing the 
questionnaire. However, results are primarily presented for the larger dataset, with reference to the 
comparison dataset as appropriate.  
5.4   Results 
Information from the 45 and Up Study survey questionnaire was available for 267,119 
participants. Forty five records were removed for which dates of recruitment, age or gender 
information across datasets was incomplete or inconsistent. The remaining 267,074 participants 
were followed for 1,006,229 person-years (mean 3.8 years /person, max 3.9 years). Age-
standardised incidence ratios and hazard ratios by gender for each cancer are shown in Tables 1 and 
2. Summary characteristics of the cohort are available elsewhere.51  
197 
 
Table 5.1: Cancer incidence and hazard ratios of farm, rural non-farm and urban men, 2006-2009 
 
 
Cancer Type (ICD9)a Cohort Residence  Cases Standardised Adjusted Hazard ratios (95% CI) for variables remaining
No. incident cases / n=123,882 Incident Rate Ratio Hazard Ratio in final model (excl. age) / other notes
Total person-years (95%Cl) (95%Cl ) 
All malignant neoplasms Farm                           496 91.7 1.00 •      Age
b
(excl. NMSC)b n= 9,281  (83.1 – 100.3) (ref) •      Smoking status  
never         HR= 1.00  ref 
C00 - C98 (excl. C44) Rural non-farm                        3,814 102.9 1.09 past            HR= 1.09 (1.04 – 1.15)
n= 57,330 (99.6 – 106.1) (0.99 – 1.21) current      HR= 1.11 (0.99 – 1.23)
n= 7,957 •      Annual household income $70,000 and over
P- years= 463,068 Urban                        3,647 98.0 1.08 yes vs no   HR= 0.92 (0.86 – 0.98)  
n= 57,271 (94.8 – 101.2) (0.97 – 1.20)
Prostate Farm                           252 98.5 1.00 •       Age 
b
(85.7 – 111.3) (ref) •       Family history prostate cancer 
(C61)  yes vs no  HR= 1.83 (1.68 – 1.99) 
Rural non-farm                        1,780 102.8 1.06 •       Smoking status  
n= 3,647 (98.0 – 107.6) (0.93 – 1.21)  never        HR= 1.00  ref 
P- years= 470,298  past           HR= 0.96 (0.89 – 1.02)
Urban                        1,615 97.2 1.01  current     HR= 0.80 (0.68 – 0.93)
(92.4 – 102.0) (0.88 – 1.16) 
Colorectal Farm                              62 100.3 1.00 •       Age
b
 (72.2 – 128.5) (ref) •       Family history colorectal cancer 
    (C18 - C21)  yes vs no  HR=1.31 (1.12 – 1.54) 
Rural non-farm                           512 106.0 1.12 •      Smoking status 
n= 1,040 (96.7 – 115.3) (0.86 – 1.46) never        HR= 1.00  ref 
P- years= 475,307 past           HR= 1.30 (1.14 – 1.48)
Urban                           466 95.0 1.02 current     HR= 1.26 (0.96 – 1.66)
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Lung Farm                            19 71.4 1.00 •      Age
b
(39.7 – 116.1) (ref) •      Family history lung cancer 
(C34) yes vs no  HR= 1.46 (1.06 – 2.01)  
Rural non-farm                          207 105.1 1.19 •      Smoking status  
n= 426 (90.6 – 119.5) (0.70 – 2.02) never         HR= 1.00 ref 
P- years= 476,776 past            HR= 6.52 (4.31 – 9.87)
Urban                          200 95.6 1.22 current      HR= 18.77 (11.72 – 30.05)
(82.2 – 109.1) (0.71 – 2.09) •      Annual household income over $70,000  
Yes vs no  HR= 0.48 (0.32 – 0.73)
Melanoma Farm                            75 108.5 1.00 •      Age
b
 (81.3 – 135.6) (ref) •      Family history  melanoma 
(C43) yes vs no   HR=2.06 (1.71 – 2.47) 
Rural non-farm                          491 101.6 0.90 •      Smoking status  
n= 1,051 (92.5 – 110.6) (0.71 – 1.15) never         HR=1.00 ref 
P- years= 475,264 past            HR= 0.83 (0.73 – 0.94)
Urban                          485 98.4 0.87 current      HR= 0.56 (0.40 – 0.79)
(89.5 – 107.2) (0.68 – 1.11) •      Tannability (response of skin repeatedly exposed
to sunlight in summer without protection)  
very tan                     HR=1.00  ref
moderate tan           HR=1.52 (1.29 – 1.80)
mild tan                     HR= 2.16 (1.80 – 2.59)
never tan/freckle     HR= 2.39 (1.90 – 3.01)
Non-Hodgkin Lymphoma Farm                            14 64.6 1.00 •      Age 
b
(34.8 – 109.2) (ref) •      Annual household income  $70,000 / year and over 
(C82 - C85) and red meat consumption remained as  
Rural non-farm                          117 93.7 0.88 non-significant confounders
n= 269 (76.6 – 110.8) (0.50 – 1.55)
P- years= 476,768
Urban                          138 106.5 0.96
(88.5 – 124.4) (0.56 – 1.73)
 
a. ICD9 - International Statistical Classification of Diseases, Ninth Revision 
b. b. All models included age stratified by five-year age-bands at risk. Age remained significant in all models, but stratified hazard ratios are not reported 
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Table 5.2: Cancer incidence and hazard ratios of farm, rural non-farm and urban women 2006-2009 
-
Cancer Type (ICD9)a Cohort Residence  Cases Standardised Adjusted Hazard ratios (95% CI) for variables remaining
No. incident cases / n=143,192 Incident Rate Ratio Hazard Ratio in final model (excl. age) / other notes
Total person-years (95%Cl) (95%Cl ) 
All malignant neoplasms Farm                        107                                         81.9                                           1.00 •      Age 
b
(excl. NMSC)b n= 10,549  (63.5 – 100.2)  (ref) •      Overweight & obesity status  
yes vs no HR= 1.06 (1.00 – 1.13)
C00 - C98 (excl. C44) Rural non-farm                     1,188                                      102.1                                           1.14 •      Smoking status
n= 69,463  (96.3 – 108.0)  (1.01 - 1.29) never       HR= 1.00 ref 
n= 5,011 past          HR= 1.19 (1.12 – 1.27)
P- years= 513,232 Urban                     1,168                                      100.5                                           1.12 current    HR= 1.11 (0.98 – 1.25)
n= 63,180  (96.6 – 106.3)  (0.99 – 1.27) 
Breast             Farm                        117                                         87.0                                           1.00 •       Age 
b
 (69.6 – 104.5)  (ref) •       Family history breast cancer 
(C50) yes vs no HR= 1.58 (1.39 – 1.79)
Rural non-farm                        863                                      100.5                                           1.06 •      Overweight & obesity status
n= 1,762  (93.8 – 107.3)  (0.87 – 1.29)  yes vs no HR=1.13 (1.03 – 1.25)
P- years= 548,760 •      Smoking status  
Urban                        782                                      101.6                                           1.06 never       HR= 1.00 ref 
 (94.5 – 108.8)   (0.86 – 1.29)          past          HR= 1.11 (1.00 – 1.23)
current    HR= 0.78 (0.62 – 0.98)
•      Weekday sun exposure 
< 1 hr        HR= 1.33 (1.10 – 1.61)
1 - 4 hrs    HR= 1.12 (0.99 – 1.27)
> 4 hrs       HR= 1.00 ref  
Colorectal Farm                          48                                         97.3                                           1.00 •      Age
b
 (33.4 – 128.3)  (ref) •      Family history colorectal cancer 
    (C18 - C21) yes vs no  HR= 1.27 (1.07 – 1.52)
Rural non-farm                        411                                      104.7                                           1.03 •      Smoking status  
n= 815  (94.9 – 114.9)  (0.76 – 1.40) never        HR= 1.00 ref 
P- years=550,743 past          HR= 1.21 (1.06 – 1.41)
Urban                        356                                         95.4                                           0.95 current     HR= 0.93 (0.65 – 1.33)
 (85.4 – 105.5)  (0.70 – 1.29) 
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Lung Farm                               7                                             48.1                                              1.00 •      Age
b
 (8.8 – 117.8)  (ref) •      Smoking status  
(C34) never          HR= 1.00 ref 
Rural non-farm                          157                                           106.3                                              1.82 past             HR= 3.58 (2.54 – 5.07)
n=300  (89.5 – 123.0)  (0.80 – 4.15) current       HR= 9.51 (6.17 – 14.65)
P- years= 551,870 •       Annual household income $70,000 and over / yr
Urban                          136                                           101.8                                              1.83  remained as a non-significant confounder (p=.09)
 (84.5 – 119.1)  (0.80 – 4.22) 
Melanoma Farm                            41                                           103.3                                              1.00 •      Age
b p<.01
 (65.4 – 141.2)  (ref) •      Family history melanoma  
(C43) yes vs. no   HR= 2.08 (1.68 – 2.57)
Rural non-farm                          332                                           110.3                                              1.11 •       Weekday sun exposure 
n=622  (98.3 – 122.2)  (0.79 – 1.56) < 1 hr           HR= 1.20 (0.89 – 1.61)
P- years= 551,022 1 - 4 hrs      HR= 1.00 ref
Urban                          249                                             89.6                                              0.95 > 4 hrs         HR= 1.32 (1.09 – 1.60)
 (78.4 – 100.8)  (0.67 – 1.34) •      Tannability  (response of skin repeatedly exposed
to sunlight in summer without protection) 
 very tan                       HR= 1.00  ref
 moderate tan             HR= 1.46 (1.13 – 1.89)
 mild tan                       HR= 1.76 (1.35 – 2.29)
 never tan/freckle       HR= 2.32 (1.74 – 3.09)
Non-Hodgkin's Lymphoma Farm                            13                                           122.4                                              1.00 •      Age
b
 (55.5 – 210.0)   (ref) •      Annual household income $70,000 and over / yr 
(C82 - C85) remained  a  non-significant confounder (p=.62)
Rural non-farm                            93                                             91.8                                              1.15 
n= 211  (73.0 – 110.6)  (0.55 – 2.39) 
 
Urban                          105                                           108.8                                              1.30 
 (87.8 – 130.0)  (0.62 – 2.70) 
 
a. ICD9 - International Statistical Classification of Diseases, Ninth Revision 
b. All models included age stratified by five-year age-bands at risk. Age remained significant in all models, but stratified hazard ratios are not reported 
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5.4.1   Cancer incidence  
The age-standardised all cancer incidence ratio and the adjusted hazard of cancer diagnosis in 
farm men was almost 10% lower than in rural non-farm and urban men, although not significant 
between subgroups. However, when rural non-farm and urban men are combined as a group to 
increase precision, the hazard ratio was 1.08 (1.01-1.17) compared to farm men. Farm men also had 
the lowest lung cancer and highest melanoma incidence, but these were not significantly different to 
either the rural non-farm or urban groups. There was little difference between farm men and other 
groups for NHL, prostate or colorectal cancer incidence. 
All cancer incidence was lowest in farm women.  The SIR was 20% lower than either of the other 
groups, although differences were not significant. However, when controlling for other factors, the 
all cancer adjusted hazard ratio for farm women was significantly lower than that for rural non-farm, 
but not urban women. Similar to men, the hazard ratio relative to a combined rural non-farm and 
urban group was 1.13 (1.04-1.23), significantly higher than that of farm women. There were no 
significant differences in SIR or adjusted hazard ratios between residence groups for women, for any 
of the individual cancers tested. However, whilst confidence intervals did not exclude unity, both the 
incidence and adjusted hazard of lung cancer in farm women were around half that of other women. 
Results for the sensitivity analyses were generally consistent with findings for the main analyses for 
both men and women. 
5.4.2   Potential risk factors  
Farm residents in this cohort were younger than rural non-farm and urban residents, with age 
controlled for in all adjusted hazard models. Family history was associated with most of the selected 
cancers, although this information was not available for NHL. Smoking status was significantly 
associated with lung cancer, with the adjusted hazard ratio for current smoking 18 times that of 
never smokers in men; and 9 times that of never smokers amongst women. In contrast, current 
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smoking was negatively associated with prostate cancer and melanoma in men; as was income for 
lung and all cancer in men. Tannability was negatively associated with melanoma in both genders. 
For women, higher sun exposure appeared weakly protective against breast cancer, but increased 
risk for melanoma. Overweight and obesity were associated with greater likelihood of both all 
cancer and breast cancer in women. Income and red meat consumption were non-significant 
confounders for some cancers; whilst alcohol consumption was not associated with any of the 
cancers of interest.  
5.5    Discussion 
Adjusted hazard ratios and SIR are both discussed, but it is recommended more weight be given 
to the adjusted hazard ratios, as they control for additional risk factors. Age-standardised all cancer 
incidence and adjusted hazard of a cancer diagnosis was lower in farm men, but differences were 
not statistically significant when compared to rural non-farm or to urban men separately. Farm 
women had non-significantly lower all cancer incidence; but the adjusted hazard of a cancer 
diagnosis in farm women was significantly lower than rural non-farm women, controlling for other 
factors. There were no significant differences in either the age-standardised incidence or adjusted 
hazard ratio between cohorts for any of the individual cancers tested; although the incidence and 
adjusted hazard of lung cancer in farm women was around half that of other women. In this study, 
smoking had the highest relative risk of all risk factors in adjusted hazard models, having a 
particularly strong association with lung cancer. However, men who were current smokers were half 
as likely to be diagnosed with melanoma; and women with higher weekday sun exposure were least 
likely to be diagnosed with breast cancer.  
5.5.1   Incidence 
Consistent with the direction of our findings, most reviews and recent studies have reported 
reduced all cancer incidence in farmers.8, 10-14, 52-53 Some have attributed decreased cancer risk in 
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farmers to a ‘healthy worker’ effect; a phenomenon observed when comparing occupational groups 
with the general population, that by nature exclude those who are unable to work for health 
reasons.8, 10, 54-55 Most farm businesses in Australia are family operations with ongoing generational 
commitment resulting in older farmers continuing to work into and past normal retirement age.56 
However, this study compared groups on a residential basis which may have ameliorated 
occupational bias to some extent. Smoking, alcohol and income-related indicators presented 
elsewhere, were generally more favourable in this cohort amongst urban residents.51 Greater 
physical activity in farm residents in this cohort was suggested by their higher weekday sun 
exposure51 and may have been a contributing factor to lower all cancer incidence, as has been 
suggested elsewhere.53  
Despite the small number of farm resident cases in this study for men and women, the lower 
lung cancer incidence and relative risk in farm residents support data from other studies reporting 
on farmers.6-13 Lower smoking rates in farmers have been suggested as the relevant factor, but this 
was not the case in this cohort, considering that urban men had lower current smoking rates51; and 
lower cancer incidence in farmers remained even after controlling for smoking in the analyses. 
Exposure to farm animals and environmental endotoxins have also been reported as possible 
explanations for lower lung cancer incidence in farmers, however this was not assessed as part of 
this study.57-60  
There was little discernible difference between groups in our study for the other selected 
cancers. Most recent studies of colorectal cancer in farmers have reported reduced incidence or risk 
in farmers. These have predominantly been large occupational cohort studies with a minimum 
follow-up of ten years.8-14 Four of these studies reported reduced risk of breast cancer in farm 
women, as did two other studies of similar design.6-7 The only recent reports of excess breast and 
colorectal cancer in farm groups, have been from smaller case-control studies.61-62  
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Findings for breast, melanoma and prostate cancer in farmers have been mixed, with several 
reporting no significant differences between farm and non-farm groups.8, 10-13, 63-66 Neutral findings 
have been reported for the majority of comparative studies of lymphoma in farmers published in the 
ten years to 2013.8, 10-14, 20, 22, 24, 67-73 However, more recent case-control studies have reported an 
excess of lymphomas in farm groups,15, 17-18, 61  similar to earlier reviews of case control studies.52-53, 74 
One prominent meta-analysis highlighted the inconsistencies of results brought about by 
variations in study design, risk measures, farmer definitions and geographic location.52 A positive 
bias can occur in studies that use proportionate measures of risk in populations where the overall 
number of cases is small; and in case-control studies with non-population based controls.52 This 
could help explain why such studies tend to report increased prostate cancer and NHL risk in 
farmers, compared to cohort studies, which more often report neutral or reduced risk.52 This effect 
was confirmed in a more recent review of prostate cancer risk in farmers published in 2014.28 Since 
then, two more studies reflecting these issues have reported opposing results;6, 25 and a new meta-
analysis limited to case-control studies, not unexpectedly reported higher risk in farmers.15 In 
contrast, negative bias can be an issue in large cohort or occupational studies, if there is limited 
information about possible confounders. 
5.5.2 Risk factors 
Other studies have suggested increased cancer incidence in rural areas may be attributed to 
higher smoking and alcohol use, lower access to or utilisation of health services; and employment or 
income disadvantage.75-76 A greater proportion of rural non-farm residents in this cohort were 
current smokers and had lower incomes.51 However, as expected when controlling for these factors, 
there was no evidence of a difference in lung cancer risk between rural non-farm and urban men in 
the adjusted model. In addition, whilst findings were not significant, these risk factors did not 
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explain the lower likelihood of lung cancer in farm residents compared to the other groups. 
Confirmation of this effect with a larger farm resident sample is warranted.  
Nevertheless, findings support what is already known about the hazardous effect of smoking 
upon lung cancer and all cancer; and health promotion priorities of Australian health systems toward 
prevention and reduction of tobacco use, especially amongst groups with a higher prevalence of 
smoking.77 The negative associations between smoking and breast cancer, prostate cancer and 
melanoma in men may have been an artefact of the relatively short follow-up period. However, a 
recent meta-analyses has also reported negative links between smoking and prostate cancer 
incidence and unclear links to breast cancer.78-79 There have been reports of negative associations 
between smoking and melanoma - although the biological mechanisms are unclear.80-82 Overall, the 
negative associations with smoking had a relatively minor impact upon the relative patterns of risk 
between resident groups. 
A related study of cancer mortality risk in this cohort, found that compared to very low 
exposure, weekday sun exposure of 1- 4 hrs was protective against NHL, prostate, breast, melanoma 
and lung cancer mortality.51 This was also the case for melanoma incidence in this study. Others 
have similarly reported inverse melanoma risk with occupational or weekday patterns of sun 
exposure, as opposed to the more intermittent patterns giving rise to sunburn that raises melanoma 
risk.83 However, 4 hours+ sun exposure was most protective against breast cancer. Other studies 
have also suggested links between sun exposure, Vitamin D levels and reduced risk of breast 
cancer.84-86 However, it is also possible that moderate sun exposure represented greater relative 
health and outdoor physical activity, which is promoted in Australian cancer prevention guidelines.37  
Several studies have explored positive associations between cancer incidence and farm 
environmental exposures, such as pesticides. However, these are outside the scope of this study, as 
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they do not generally compare farm and non-farm groups; and farm exposure information was not 
available in this dataset.  
The negative significant association between lung cancer in men and income, is consistent with 
findings elsewhere, relating to higher levels of smoking in lower socio-economic groups.87  
Overweight and obesity was associated with breast cancer in this study, also consistent with reports 
in the health literature.37 However, contrary to evidence of links between alcohol consumption and 
breast, colorectal and other cancers, this was not associated with any of the selected cancers in this 
cohort.37  
5.5.3 Limitations 
There are a number of limitations in this study that may have affected the results. Firstly, the 
relatively short period of follow-up and subsequent small number of incident cancers for the period 
for which data were available, especially in the farm group, resulted in low power and wide 
confidence intervals for some analyses. This may have impacted upon the significance of findings, 
leading to a bias toward the null. Discussion of results with confidence intervals that include unity 
should be considered exploratory; and larger, consistent differences given more weight.  
Nevertheless, results still offer insight into potential differences and guidance for further work. 
In order to maximize both cases numbers and follow-up time, this study consisted of all records 
of cancer for participants who could potentially receive a diagnosis of cancer at any time in the 
2006-2009 study period; that is, cancer diagnosis in some participants could have preceded their 
enrolment in the 45 and Up Study. This may have effected behavioural risk factors at recruitment 
(e.g. smoking). However, such an effect is likely to be non-differential relating to residence; and 
results of the sensitivity analyses were consistent with and support the main findings.  
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The 45 and Up Study cohort, whilst a large cohort with robust sampling methods, is not 
necessarily representative of the population of NSW aged 45 and over.29 However, little evidence of 
bias was observed in associations between risk factors and disease seen in the 45 and Up Study 
population.88 Finally, the definition of a ‘farm resident’ in this study was also open to respondents’ 
interpretation of ‘farm’, which could include small holdings used for commercial, recreational or 
both purposes. Exposures could be quite different depending on which of these purposes was 
dominant. Farm exposure differences and errors arising from misclassification of residence, are likely 
to have lessened any differences between resident groups, but not likely to have systematically 
affected non-residential risk factors. Therefore, any potential bias is likely toward the null and an 
underestimation of a relationship between farm residence and cancer incidence. 
5.6   Conclusion 
This study is the first to examine differences in incidence of cancer between farm, rural non-farm 
and urban residents in Australia. Controlling for a range of risk factors, farm women had significantly 
lower odds of all cancer than rural non-farm women.  Farm men had lower all cancer risk, but this 
was not statistically significant compared to rural non-farm and urban men.  When combining rural 
non-farm and urban groups, the all cancer adjusted hazard was significantly lower in both farm men 
and women, due to increased precision. 
Differences between groups in the risk of prostate, breast, colorectal or lung cancers, NHL or 
melanoma, where not significant after controlling for commonly known risk factors. However, 
notwithstanding small case numbers and a lack of statistical significance, farm women had around 
half the odds of other women in being diagnosed with lung cancer, controlling for smoking and other 
factors. Differences in all cancer risk appeared to be mainly due to lower lung cancer incidence in 
farm residents.  
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Table 5.3: Comparison of case numbers and adjusted hazard ratios for main analyses compared to sensitivity analyses for incidence of selected cancers in men 
 
Cancer Type  
(ICD9)a 
 
Cohort  
residence 
n=123,882 
Newly diagnosed cases registered in NSW CR 2006-2009 (main analyses) 
Newly diagnosed cases registered in NSW CR from recruitment to 2009 and  
excluding any self-reported prior cancer (sensitivity analyses) 
Cancer 
cases 
Adjusted 
hazard ratio 
 (95%Cl ) 
Adjusted hazard ratios for variables  
in final model   
Cancer 
cases 
Adjusted 
hazard ratio 
 (95%Cl ) 
Adjusted hazard ratios for variables 
 in final model 
Prostate             
(C61) 
Farm 252 
1.00  
(ref) 
 
• Age b 
• Family history prostate cancer  
yes vs no HR= 1.83 (1.68 - 1.99)  
• Smoking status   
never        HR= 1.00  ref  
past           HR= 0.96 (0.89 - 1.02) 
current     HR= 0.80 (0.68 - 0.93) 
105 1.00 
 (ref) 
• Age b 
• Family history prostate cancer  
yes vs no HR= 1.85 (1.60  – 2.14)  
• Smoking status   
never         HR= 1.00  ref  
past          HR= 0.86 (0.78 –  0.97) 
current     HR= 0.62 (0.47 –  0.82) 
• Sun exposure hrs/day 
< 1 hr        HR= 1.00 ref 
1– 4 hrs    HR= 1.35 (0.95 – 1.91) 
 > 4 hrs     HR= 1.54 (1.01 – 2.18) 
Rural non-farm 1,780 
1.06  
(0.93 – 1.21)  
653 1.01  
(0.81 – 1.25)  
Urban 1,615 
1.01  
(0.88 – 1.16)  
618 1.05  
(0.84 – 1.31) 
Colorectal  
(C18 - C21) 
 
Farm 62 
1.00  
(ref) 
 
• Ageb 
• Family history colorectal cancer  
yes vs no  HR=1.31 (1.12 - 1.54)  
• Smoking status  
never        HR= 1.00  ref  
past           HR= 1.30 (1.14 - 1.48) 
current     HR= 1.26 (0.96 - 1.66) 
22 1.00 
 (ref) 
 
• Ageb 
• Alcohol risk (>2 drinks/day)  
yes vs no HR= 1.27 (1.00 – 1.60) 
• Smoking status   
never         HR= 1.00 ref  
past          HR= 1.33 (1.06 –  1.68) 
current     HR= 1.59 (1.05 –  2.39) 
Rural non-farm 512 
1.12  
(0.86 – 1.46) 
178 0.99  
(0.73 – 1.32)  
Urban 466 
1.02  
(0.78 – 1.33) 
166 0.83 
 (0.61 – 1.13)          
Lung  
(C34) 
Farm 19 
1.00  
(ref) 
• Ageb 
• Family history lung cancer  
yes vs no  HR= 1.46 (1.06 - 2.01)   
• Smoking status   
never        HR= 1.00 ref  
past           HR= 6.52 (4.31 - 9.87) 
current     HR= 18.77 (11.72 - 30.05) 
• Annual household income over $70,000   
yes vs no  HR= 0.48 (0.32 - 0.73) 
7 1.00  
(ref) 
• Ageb 
• Alcohol risk (>2 drinks/day) 
yes vs no HR= 1.51 (1.08 – 2.12)   
• Smoking status   
never        HR= 1.00 ref  
past         HR= 8.23 (4.00  – 16.97) 
current    HR= 36.23(16.90  – 77.69) 
• Annual household income over $70,000 /yr  
yes vs no HR= 0.46 (0.25 – 0.86) 
Rural non-farm 207 
1.19  
(0.70 – 2.02) 
112 1.72  
(0.75 – 3.94) 
Urban 200 
1.22  
(0.71 – 2.09) 
89 1.53  
(0.66 – 3.54) 
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Melanoma  
(C43) 
Farm 75 
1.00 
 (ref) 
 
• Ageb 
• Family history  melanoma  
yes vs no HR= 2.06 (1.71 - 2.47)  
• Smoking status   
never        HR= 1.00 ref  
past           HR= 0.83 (0.73 - 0.94) 
current     HR= 0.56 (0.40 - 0.79) 
• Tannability (response of skin repeatedly exposed 
to sunlight in summer without protection)   
very tan                     HR= 1.00  ref 
moderate tan          HR= 1.52 (1.29 - 1.80) 
mild tan                    HR= 2.16 (1.80 - 2.59) 
never tan/freckle  HR= 2.39 (1.90 - 3.01) 
26 1.00  
(ref) 
 
• Ageb 
• Family history  melanoma  
yes vs no HR=1.83 (1.31 - 2.57)  
• Smoking status   
never        HR= 1.00 ref  
past         HR= 0.78 (0.64 - 0.97) 
current    HR= 0.58 (0.34 - 0.99) 
• Tannability (response of skin repeatedly exposed to 
sunlight in summer without protection)   
very tan                  HR= 1.00  ref 
moderate tan        HR= 1.94 (1.46- 2.57) 
mild tan                  HR= 2.37 (1.72 - 3.26) 
never tan/freckle  HR= 2.69 (1.80 - 4.03) 
Rural non-farm 491 
0.90  
(0.71 – 1.15) 
180 1.00  
(0.66 – 1.52) 
Urban 485 
0.87  
(0.68 – 1.11) 
174 0.94  
(0.62 – 1.43) 
Non-Hodgkin 
Lymphoma   
(C82 - C85) 
Farm 14 
1.00  
(ref) 
 
• Age b 
• Annual household income $70,000/yr and over 
(p=.37) and red meat consumption (p=.12 )  
remained as non-significant confounders  
5 1.00  
(ref) 
 
• Age b 
• Annual household income $70,000/yr and over (p=.14)  
and smoking status (p=.10) remained as   
non-significant confounders  
Rural non-farm 117 
0.88  
(0.50 – 1.55) 
44 0.89  
(0.35 – 2.29) 
Urban 138 
0.96  
(0.56 – 1.73) 
54 1.05  
(0.41 – 2.67) 
 
a. ICD9 - International Statistical Classification of Diseases, Ninth Revision 
b. All models included age stratified by five-year age-bands at risk. Age remained significant in all models, but stratified hazard ratios are not reported 
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Table 5.4: Comparison of case numbers and adjusted hazard ratios for main analyses compared to sensitivity analyses for incidence of selected cancers in women 
 
Cancer Type  
(ICD9)a 
 
Cohort  
residence 
n=123,882 
Newly diagnosed cases registered in NSW CR 2006-2009 (main analyses) 
Newly diagnosed cases registered in NSW CR from recruitment to 2009 and 
excluding cases with self-reported prior cancer (sensitivity analyses) 
Cancer 
cases 
Adjusted 
hazard ratio 
 (95%Cl ) 
Adjusted hazard ratios for variables  
in final model   
Cancer 
cases 
Adjusted 
hazard ratio 
 (95%Cl ) 
Adjusted hazard ratios for variables  
in final model 
Breast            
(C50) 
Farm 117 
1.00  
(ref) 
 
• Age b 
• Family history breast cancer  
yes vs no  HR= 1.58 (1.39 – 1.79) 
• Overweight & obesity status 
yes vs no  HR= 1.13 (1.03 – 1.25) 
• Smoking status   
never         HR= 1.00 ref  
past            HR= 1.11 (1.00 – 1.23) 
current      HR= 0.78 (0.62 – 0.98) 
• Weekday sun exposure  
< 1 hr         HR= 1.33 (1.10 – 1.61) 
1 - 4 hrs     HR= 1.12 (0.99 – 1.27) 
> 4 hrs       HR= 1.00 ref   
56 1.00 
 (ref) 
 
• Age b 
• Alcohol risk (>2 drinks/day) 
yes vs no  HR=1.49 (1.12 - 1.97) 
• Weekday sun exposure  
< 1 hr        HR= 1.00 ref 
1- 4 hrs    HR= 0.75 (0.58 – 0.97) 
> 4 hrs      HR= 0.72 (0.54 – 0.97) 
Rural non-farm 863 
1.06  
(0.87 – 1.29)  
351 0.99  
(0.73 – 1.32)  
Urban 782 
1.06 
 (0.86 – 1.29)          
269 0.83 
 (0.61 – 1.13)          
Colorectal  
(C18 - C21) 
 
Farm 48 
1.00  
(ref) 
 
• Ageb 
• Family history colorectal cancer  
yes vs no  HR=1.27 (1.07 - 1.52) 
• Smoking status   
never         HR= 1.00 ref  
past            HR= 1.21 (1.06 - 1.41) 
current      HR= 0.93 (0.65 - 1.33) 
22 1.00 
 (ref) 
 
• Ageb 
• Smoking status   
never        HR= 1.00 ref  
past          HR= 1.58 (1.25 - 1.99) 
current     HR= 1.21 (0.70 – 2.10) 
Rural non-farm 411 
1.03  
(0.76 – 1.40) 
150 0.85  
(0.54 – 1.35) 
Urban 356 
0.95  
(0.70 – 1.29) 
134 0.81  
(0.51 – 1.30) 
Lung  
(C34) 
Farm 7 
1.00  
(ref) 
 
• Ageb 
• Smoking status   
never        HR= 1.00 ref  
past           HR= 3.58 (2.54 - 5.07) 
current     HR= 9.51 (6.17 - 14.65) 
• Annual household income  $70,000/ yr and over 
remained a non-significant confounder (p=.09) 
<5 1.00 
 (ref) 
 
• Ageb 
• Smoking status   
never        HR= 1.00 ref  
past          HR= 3.38 (2.01 - 5.67) 
current     HR= 16.72 (9.43 – 29.65) 
• Annual household income  $70,000 / yr and over  
remained a non-significant confounder (p=.35) 
Rural non-farm 157 
1.82  
(0.80 – 4.15) 
79 1.76  
(0.55 – 5.67) 
Urban 136 
1.83  
(0.80 – 4.22) 
71 1.95  
(0..60 – 6.31) 
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Melanoma  
(C43) 
 
Farm 41 
1.00 
 (ref) 
 
• Ageb p<.01 
• Family history melanoma   
yes vs no  HR=2.08 (1.68 – 2.57) 
• Weekday sun exposure  
< 1 hr         HR= 1.20 (0.89 – 1.61) 
1- 4 hrs      HR= 1.00 ref 
> 4 hrs       HR= 1.32 (1.09 – 1.60) 
• Tannability  (response of skin repeatedly exposed 
to sunlight in summer without protection)  
very tan                  HR= 1.00  ref 
moderate tan        HR= 1.46 (1.13 – 1.89) 
mild tan                  HR= 1.76 (1.35 – 2.29) 
never tan/freckle HR= 2.32 (1.74 – 3.09) 
23 1.00 
 (ref) 
 
• Ageb p<.01 
• Family history melanoma   
yes vs no  HR= 1.60 (1.09 – 2.34) 
• Weekday sun exposure  
< 1 hr        HR= 1.04(0.63 – 1.73) 
1-4 hrs      HR= 1.00 ref 
> 4hrs       HR= 1.42 (1.05 – 1.94) 
• Tannability  (response of skin repeatedly exposed to 
sunlight in summer without protection)  
very tan                  HR= 1.00  ref 
moderate tan        HR= 2.71 (1.67 – 4.40) 
mild tan                  HR= 2.74 (1.65 – 4.56) 
never tan/freckle  HR= 4.15 (2.43 – 7.09) 
Rural non-farm 332 
1.11  
(0.79 – 1.56) 
122 0.77  
(0.49 – 1.23) 
Urban 249 
0.95  
(0.67 – 1.34) 
83 0.63  
(0.39 – 1.02) 
Non-Hodgkin 
Lymphoma   
(C82 - C85) 
Farm 13 
1.00  
(ref) 
 
• Ageb 
• Annual household income  $70,000  and over 
remained  a  non-significant confounder  (p=.62) 
<5 1.00 
 (ref) 
 
• Ageb 
Rural non-farm 93 
1.15  
(0.55 – 2.39) 
32 1.45  
(0.44 – 4.75) 
Urban 105 
1.30  
(0.62 - 2.70) 
37 1.81  
(0.56 – 5.91) 
 
a. ICD9 - International Statistical Classification of Diseases, Ninth Revision 
b. All models included age stratified by five-year age-bands at risk. Age remained significant in all models, but stratified hazard ratios are not reported 
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6.1   Abstract 
Objective: To determine if stage at diagnosis of prostate, breast and colorectal cancers differs 
between farm, rural non-farm and urban residents. Design: Data-linkage of baseline survey 
information from a large cohort study, with state cancer registry records from 2006-2009. Setting: 
New South Wales (NSW), Australia. Participants: NSW residents enrolled in the 45 and Up Study 
cohort. Main outcome measures: Adjusted Odds Ratio of non-localised cancer stage was modelled 
using binary logistic regression, controlling for commonly known cancer risk factors. Results:   
Overall, differences in the odds ratios for later stage prostate, breast and colorectal cancer diagnosis 
in farm men and women compared to rural non-farm or urban counterparts, were not statistically 
significant; although farm men had twice the odds of either group of being diagnosed at later stage 
colorectal cancer. The odds of later stage prostate cancer for farm and urban men were similar, but 
rural non-farm men were significantly less likely than urban men to be diagnosed at later stage. 
Higher household income was associated with later stage breast and prostate cancer; and private 
health insurance with extras negatively associated with later stage prostate cancer. Conclusions:  
Differences in stage of cancer diagnosis, particularly between farm and rural non-farm men remain 
unexplained, but were not statistically significant. Farm men may be at higher risk of later stage 
colorectal cancer diagnosis, which if confirmed has implications for research on possible reasons; 
and for the delivery of appropriate cancer diagnostic services in rural areas. 
 
Keywords:  epidemiology, rural health services delivery, rural oncology, rural population health, 
research 
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6.2   Introduction 
The most commonly diagnosed cancers in Australia are prostate, breast and colorectal cancers, 
which are also amongst the most highly amenable to screening and early diagnosis.1 Earlier stage of 
diagnosis is a strong predictor of cancer survival, which has also been found to be poorer in rural 
areas.2-3  Reports on cancer in rural Australia seldom differentiate between farm and rural non-farm 
residents. However, recent analyses of the 45 and Up Study cohort, found little difference in 
prostate, breast or colorectal cancer incidence between farm and rural non-farm residents.4     
 International studies have generally reported reduced cancer risk in farmers compared to 
others for breast and colorectal cancers, with mixed results for prostate cancer.5-7 Stage at diagnosis 
has only been reported in two cohorts involving farmers in the international literature.6, 8 This study 
will examine if stage at diagnosis differs between farm, rural non-farm and urban residents for 
prostate, breast and colorectal cancers. Findings may have implications for further research on 
health seeking behaviors; and the delivery of appropriate diagnostic services in rural areas.  
6.3 Methods 
This data linkage study was based on information from participants of the 45 and Up Study 
cohort, managed by the Sax Institute in collaboration with major Australian health agency partners. 
The cohort comprises 267,119 people aged 45 years and over, enrolled between January 2006 and 
December 2009. Details on the 45 and Up Study are available elsewhere.9 10  
The 45 and Up Study baseline questionnaire provided a range of information used to define the 
resident sub-groups; and on personal risk factors of participants. Records were linked with NSW 
Cancer Registry (NSW CR) data for February 2006 to December 2009. Cancer is a notifiable condition 
in NSW, with population-wide capture and information on stage collected. Further information on  
the NSW CR data collection and quality measures are published elsewhere.11 Data linkage was 
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conducted by the NSW Centre for Health Record Linkage using probabilistic record linkage 
methods.12 Logic checks were undertaken to check for data inconsistencies within and across 
datasets, with suspect records removed from analyses. 
Participants with a cancer registration recorded in the NSW CR before the study recruitment 
date, or who had reported having ever been told by a doctor they had breast, prostate or other 
cancer (excluding skin cancer), were removed from analysis. This was to reduce the impact of 
changes in risk factors such as screening that may have arisen in response to a recent cancer 
diagnosis. However, sensitivity analyses comprised of all cases from 2006-2009, regardless of 
recruitment date.  
6.3.1   Definition of variables  
‘Farm residents’ were defined as those who indicated that they lived in a ‘house on farm’ on the 
45 and Up Study baseline questionnaire. Rural ‘non-farm’ and urban residents were further defined 
using the Accessibility/Remoteness Index of Australia (ARIA+).13 Rural non-farm participants were 
those whose ARIA+ classification indicated they did not live in a ‘Major city’, excluding those who 
also specified that they lived in a 'house on farm.'  Urban residents were those who lived in a ‘Major 
city’. Where ARIA+ was not recorded, allocation was determined by cross-checking postcode of 
residence and distances to hospital services in data-linked hospital datasets. 
The stage at diagnosis variable was taken from the ‘degree of spread’ variable defined in the 
NSW CR data dictionary.11 Tumours localised to the tissue of origin (Stage 1 - ‘early stage’) were 
differentiated from those with regional spread to adjacent organs and/or regional lymph nodes, 
distant metastases or unknown sites (Stage 2 or above - ’later stage’). Risk factors considered for 
analysis were age at diagnosis, family history of cancer, private health insurance with extras status; 
and annual household income stratified by average annual household income in NSW in 2006.14 
Commonly known modifiable risk factors for cancer were categorised to reflect national health or 
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workplace recommendations of the time.15-17 These were comprised of smoking as current, past, 
never; risky alcohol consumption of >5 days/week or >2 drink/day; overweight status (including 
obesity) with Body Mass Index>25; red meat consumption >3-4 serves/week; weekday sun exposure 
>1 hr/day<4 hr; and screening frequency <2 yrs, >2 yrs, unknown year or never.  
6.3.2   Analytical procedures 
Analyses were conducted using SAS 9.3™ software. Descriptive statistics were generated and 
binary logistic regression used to calculate adjusted odds ratios (OR) for later stage cancer diagnosis 
of breast, prostate and colorectal cancers, controlling for common cancer risk factors. As the primary 
target of interest, the farm resident group was used as the referent in the first instance.  However, in 
order to compare odds ratios between rural non-farm and urban residents, secondary analyses were 
also undertaken using the urban group as the referent. Cases where stage was not recorded were 
excluded from analysis. Variables with univariate p values < .25 were included in the base model, 
with all possible interaction terms. Models were progressively reduced using a backward elimination 
approach, removing non-significant variables (at the .05 level), accounting for any non-significant 
confounders. Residual plots were examined to identify cases with undue influence in regression 
models.  
6.4 Results 
A total of 3270 persons from the 45 and Up Study cohort were diagnosed with either prostate, 
breast or colorectal cancer between recruitment and 31st December 2009. Proportions and odds 
ratios for later stage prostate, breast and colorectal cancers are shown for each resident group in 
Table 6.1. Variables in the final model were adjusted for all other remaining variables. Finally, 
additional odds ratios are provided for the rural non-farm group, compared to the urban group as 
referent. 
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Table 6.1: Non-localised stage of diagnosis for prostate, breast and colorectal cancers in farm, rural non-farm and urban residents, 2006-2009 
 
Cancer Type (ICD9)a 
Total cancer cases where 
diagnosis after recruitment 
Resident group Total n 
Cases diagnosed 
after recruitment 
& cancer stage 
known  
Cases (%) of 
non-localised 
(Stage 2+) 
cancer 
Adjusted  
odds ratio 
for non-localised 
cancer (95%Cl) 
Adjusted odds ratios (95% CI) for 
 non-localised cancer in categories of variables  
remaining significant in final model 
Prostate cancer (C61) 
 
Total n= 1,628 
Stage known n= 1,005 (61.7%) 
Farm 9,281 79 
14  
(17.7%) 
1.00 (ref) 
 
• Annual household income over $70,000    
yes vs no  OR= 1.74 (1.15 – 2.63)   
 
• Private insurance with extras   
yes vs no  OR= 0.63 ( 0.43 – 0.93)   
 
• Significant difference rural non-farm vs. urban 
OR= 0.66 (0.45 – 0.98)   
Rural non-farm 57,342 478 
65 
(13.6%) 
0.64 
(0.32 - 1.29) 
Urban 57,286 448 
82 
 (18.3%) 
0.97 
(0.49 - 1.93) 
Breast (C50) 
(women) 
 
Total cases= 754 
Stage known n= 726 (96.2%)  
Farm 10,551 59 
24  
(40.7%) 
1.00 (ref) 
 
• Annual household income over $70,000    
yes vs no OR= 1.51 (1.03 - 2.21)   
Rural non-farm  69,469 373 
152  
(40.8%) 
1.11 
(0.59 - 2.06) 
Urban  63,190 294 
129  
(43.9%) 
1.17 
(0.62 - 2.22) 
Colorectal (C18-C21) 
(men) 
 
Total n= 502 
Stage known n= 461 (91.8%) 
Farm 9,281 28 
20 
 (71.4%) 
1.00 (ref) 
 
• No other significant factors 
Rural non-farm 57,342 219 
116 
 (53.0) 
0.45 
(0.19 - 1.07) 
Urban 57,286 214 
118 
 (55.1%) 
0.49 
(0.21 - 1.17) 
Colorectal (C18-C21) 
(women) 
 
Total cases= 386 
Stage known n= 350 (90.7%) 
Farm   10,551 21  
13  
(61.9%) 
1.00 (ref) 
 
• No other significant factors 
Rural non-farm  69,469 169 
112  
(66.3%) 
1.21 
(0.47 - 3.09) 
Urban  63,190 160 
96  
(60.0%) 
0.92 
(0.36 - 2.35) 
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Cancer stage was known for almost two-thirds of prostate cancer cases. After controlling for 
household income and private health insurance with extras status, there was little difference in the 
adjusted odds of later stage prostate cancer between farm and urban men. However, the adjusted 
odds for rural non-farm men was two-thirds that of farm men (OR 0.64, 95%CI 0.32 – 1.29) and 
urban men (OR 0.66, 95%CI 0.45 - 0.98). Stage was recorded for over 90% of colorectal cancer cases 
in men.  Although not statistically significant, the proportion of farm men diagnosed at later stage 
was 16-18% higher than that of other men. Farm men also had twice the odds of being diagnosed at 
later stage of colorectal cancer than rural non-farm (OR=2.22, 95% CI 0.93-5.26) and urban men 
(OR=2.04, 95% CI 0.85-4.76), when the latter groups are used as referents.  
For women, cancer stage was recorded for over 90% of breast and colorectal cases. Farm 
women were least likely to be diagnosed with later stage breast cancer adjusted for household 
income, although differences between groups were small. For colorectal cancer, farm women were 
somewhat less likely than rural non-farm women and more likely than urban women to be 
diagnosed at later stage. Again, differences between groups were not significant. 
Higher household income was associated with later prostate and breast cancer stage; and 
private health insurance with extras negatively associated with later stage prostate cancer. No risk 
factors remained in adjusted models for colorectal cancer stage in either men or women. Results of 
sensitivity analyses were generally consistent with main findings for colorectal cancer, although 
confounders remained in prostate and breast cancer models.  
6.5 Discussion 
Proportions and odds of later stage prostate, breast or colorectal cancer in farm residents, were 
not significantly different from those of rural non-farm or urban residents. Farm men however, had 
twice the odds of the other groups of being diagnosed with later stage colorectal cancer. In contrast, 
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rural non-farm men were only two-thirds as likely as other groups to be diagnosed at later stage 
prostate cancer; significantly less so than urban men. These findings were not explained by the risk 
factors considered in the models. Household income was a significant positive correlate of late stage 
prostate cancer and breast cancer. Conversely, private health insurance with extras illustrated a 
significant negative correlation with advanced prostate cancer. 
No other studies have compared cancer stage using these three sub-groups in the literature, 
although two-group comparisons have been made between ‘farmers vs. others’ and ‘rural vs. urban’ 
groups. Since farm residents in the Australian literature have not previously been differentiated 
from the larger ‘rural’ group of which they form part, comparisons with urban groups will not be 
exactly the same. However, some studies have reported later stage prostate and colorectal cancer 
diagnosis in rural Australians, compared to urban counterparts.18-19 This contrasts with our findings 
for prostate cancer, but is supportive of findings for colorectal cancer in farm versus urban men. 
Similar to our findings for breast cancer, no significant differences in stage were found between rural 
and urban women in a South Australian study.20   
There is only limited information in the literature elsewhere specific to stage of cancer diagnosis 
in farm residents. Compared to population counterparts, risk of later stage prostate, breast or 
colorectal cancer diagnosis was not found in Californian Hispanic farm-workers; nor for colorectal 
cancer stage in French farm men and women.6, 8 Findings in our study were similar to these cohorts 
for women, although slightly different for men. However, compared to our study, the French and 
Californian cohorts were younger and defined by occupation not residence.  
Socio-economic disparities have been reported to affect stage of cancer diagnosis and it has 
been suggested rural location may multiply economic difficulties related to accessing distant health 
services.3 19 Later stage diagnosis for some cancers has been associated with greater distance from 
specialist diagnostic and treatment centres. This may relate to lag times between screening or initial 
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symptoms and definitive diagnosis. It is possible this contributes to later stage colorectal cancer 
diagnosis in farm men, but does not really explain why patterns of risk were different between farm 
and rural non-farm men, for colorectal and prostate cancer. Of note, higher household income was 
significantly associated with later stage prostate and breast cancer, which tends to contradict the 
socio-economic disparity argument. Whilst not always the case, lower levels of cancer screening 
have also been reported in rural Australia.21 However, these factors were accounted for in the 
modelling process, so do not explain remaining differences between groups. 
There was little difference in screening practices between farm and rural non-farm residents 
found in the larger 45 and Up cohort, suggesting population-based screening does not explain the 
differences in stage of presentation between farm and rural non-farm men observed here.  
However, farm men were significantly less likely to visit a GP, which may have impacted upon 
prompt access and referral to specialist colonoscopy services.22 Since the majority of farms in 
Australia are small family owned businesses,23 farm-related  responsibilities and commitments may 
make it more difficult for farm residents to take time off to attend specialist appointments or access 
cancer treatment facilities. However, there was no documented evidence of this found in the 
literature. Further research on health seeking behaviours and diagnostic services in rural areas, may 
help to explain apparent differences in colorectal cancer stage between farm and rural non-farm 
men.   
Another possible factor contributing to later stage colorectal cancer diagnosis in farm men is 
environmental exposure that may lead to more rapid disease progression. One study has examined 
associations between farm pesticide exposure and cancer stage, finding an association with later 
stage prostate cancer.24 In contrast, farm men in our study had a similar prostate cancer stage 
profile to urban men, so observed patterns remain largely unexplained.  
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Limitations in this study include the short period of follow-up and relatively small farm case 
numbers that will have affected the width of confidence intervals for some analyses and potentially 
masked the significance of findings. However, since most differences did not reach statistical 
significance, discussion should be considered exploratory. Secondly, one-third of prostate cancer 
cases were of unknown stage, although this proportion was similar across groups. Reasons for the 
comparatively high proportion of unknown prostate cancer stage in the NSW CR data collection have 
been described elsewhere and our findings on this are consistent with others.25 This reduces the 
case numbers available for analysis and the level of confidence that the proportion of later stage 
cancer correctly reflects that for all prostate cancer cases.   
Thirdly, whilst a large and robust study with little evidence of risk factor bias, the 45 and Up 
Study cohort is not necessarily representative of the population of NSW aged 45 and over.9 
However, this is unlikely to affect associations between Study variables and disease outcomes, as  
only internal comparisons were made.26 Lastly, the definition of a ‘farm resident’ in this study was 
open to respondents’ interpretation of a ‘farm’ and could include small holdings used for 
commercial, recreational or both purposes. Farm residents are a heterogenous group and whilst 
small farm holdings make up the majority of farming enterprises in Australia, farm exposures could 
vary according to remoteness, primary production type or the proportion of activity deemed 
commercial.23 The wide scope of farming and lack of clear definition around what constitutes a farm 
resident, has potentially led to an underestimation of any relationship between farm residence and 
cancer stage. Addressing difficulties in differentiating farm residents from others in administrative 
health datasets, may improve the precision of comparisons made in future studies.  
6.6 Conclusion 
Overall, differences in the likelihood of later stage prostate, breast and colorectal cancer 
diagnosis in farm men and women compared to rural non-farm and urban counterparts, were not 
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statistically significant. However, whilst the odds of later stage prostate cancer for farm and urban 
men was similar, rural non-farm men were significantly less likely than urban men to be diagnosed at 
later stage. In contrast, and whilst not significant, farm men had twice the odds of either group of 
being diagnosed at later stage colorectal cancer. Higher household income was positively associated 
with later stage prostate and breast cancer; and private health insurance with extras negatively 
associated with prostate cancer. However, patterns of risk between farm and rural non-farm men 
remain largely unexplained. Further research over a longer follow-up period or larger cohort is 
needed to confirm findings. An exploration of possible differences in health seeking behaviours and 
farm exposures is also warranted; which may have implications for screening programs and the 
delivery of earlier, more appropriate diagnostic services in rural areas. 
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Table 6.2: Comparison of non-localised stage of diagnosis for prostate, breast and colorectal cancers in farm, rural non-farm and urban residents, when diagnosis 
after recruitment (main analyses) versus diagnosis 2006-2009 (sensitivity analyses)   
 
 Main analyses Sensitivity analyses 
 
Cancer 
Type 
(ICD9)a 
 
 
Resident 
group 
 
  Total n Cases diagnosed 
after recruitment 
& no prior cancer 
(stage known) 
Cases (%) 
non-localised 
cancer 
(Stage 2+) 
Adjusted 
odds ratio for 
non-localised 
cancer (95%Cl) 
Adjusted odds ratios (95% CI) 
for non-localised cancer in 
categories of variables 
remaining significant in  
final model 
Cases diagnosed 
2006-2009 incl. 
self-reported 
prior cancer 
(stage known) 
Cases (%) 
non-localised 
cancer 
(Stage 2+) 
Adjusted 
odds ratiofor 
non-localised 
cancer (95%Cl) 
Adjusted odds ratios (95% CI) 
for non-localised cancer in 
categories of variables remaining 
significant in final model 
 
Prostate  
(C61) 
 
 
Farm 9,281 79 
14 
 (17.7%) 
1.00  
(ref) 
 
 
• Annual household income over 
$70,000  Yes vs. no   
OR=1.74 (1.15 – 2.63)   
• Private insurance with extras   
Yes vs. no  
 OR=0.63 ( 0.43 – 0.93)   
• Rural non-farm vs. urban  
OR 0.66 (0.45 – 0.98)   
167 
30 
 (18.0%) 
1.00  
(ref) 
 
• PSA screening frequency p=.04 
(trend) but no categories significant 
compared to referent < 2yrs 
• Private insurance with extras  
yes vs no OR= 0.66 (0.51 – 0.86) 
• (Alcohol consumption > 5days/wk 
yes vs no OR= 0.62 (0.42 –  0.94) 
confounded by cohort x alcohol 
interaction) 
Rural  
non-farm 
57,342 478 
65 
(13.6%) 
0.64  
(0.32 – 1.29) 
1,129 
127 
(11.3%) 
0.89  
(0.45 – 1.75) 
Urban 57,286 448 
82 
 (18.3%) 
0.97 
 (0.49 – 1.93)  
1,013 
148 
 (14.6%) 
1.45  
(0.74 – 2.83)  
 
Breast  
(C50) 
(women) 
  
Farm 10,551 59 
24  
(40.7%) 
1.00  
(ref) 
 
 
• Annual household income over 
$70,000  Yes vs. no   
OR=1.51 (1.03 - 2.21)   
112 
47 
 (41.9%) 
1.00 
 (ref) 
 
• Age at diagnosis  
OR= 0.98 (0.97 – 0.99) 
• Last breast screening: 
< 2yrs OR= 1.00  ref  
       > 2yrs OR= 1.61 (1.09  – 2.39)            
Unknown yr OR= 1.82 (0.80 – 4.15) 
       Never OR= 1.58 (0.89 – 2.79) 
•  Private insurance with extras  
       yes vs no OR= 0.74 (0.58 – 0.93) 
• (Household income over $70,000 / 
year not  significant but  confounded 
by  significant cohort x income 
interaction terms) 
Rural 
non-farm  
69,469 373 
152  
(40.8%) 
1.11   
(0.59 – 2.06) 
838 
352  
(42.0%) 
1.61  
 (0.91 – 2.87) 
Urban  63,190 294 
129  
(43.9%) 
1.17 
 (0.62 – 2.22)  
759 
325  
(42.8%) 
1.88 
 (1.04 – 3.38)  
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Colorectal 
(C18 - C21) 
(men) 
 
Farm 9,281 28 
20 
 (71.4%) 
1.00 
 (ref) 
 
 
• No other significant factors 112 36  
(65.5%) 
1.00  
(ref)  
 
• Last colorectal screening  
< 2yrs OR= 1.00 ref  
     > 2yrs OR= 0.87 (0.55 – 1.38)           
     Unknown yr OR= 3.15 (1.01 – 9.82) 
     Never  OR= 1.34 (1.03  –  1.86)  
• Private insurance with extras 
yes vs no OR=0.76 ( 0.58 – 0.99) 
Rural  
non-farm 
57,342 219 
116  
(53.0) 
0.45 
 (0.19 - 1.07) 
352 
255 
 (53.2%) 
0.56  
(0.31 – 1.01) 
Urban 57,286 214 
118  
(55.1%) 
0.49 
 (0.21 - 1.17) 
325 
235  
(53.4%) 
0.58  
(0.32 – 1.06) 
Colorectal 
(C18 - C21) 
(women) 
Farm   10,551 21  
13  
(61.9%) 
1.00  
(ref) 
 
 
• No other significant factors 47 24  
(51.1%) 
1.00 
 (ref) 
 
• Last colorectal screening:  
< 2yrs  OR= 1.00 ref  
      > 2yrs  OR= 1.61 (1.09  – 2.39) 
      Unknown yr OR= 1.82(0.80 – 4.15) 
 Never OR= 1.58 (0.89 – 2.79) 
Rural  
non-farm  
69,469 169 
112  
(66.3%) 
1.21  
(0.47 - 3.09) 
374 
222  
(59.4%) 
1.38  
(0.75 – 2.54) 
Urban  63,190 160 
96  
(60.0%) 
0.92   
(0.36 - 2.35) 
337 
205  
(60.8%) 
1.56   
(0.84 - 2.89) 
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7.1    Abstract 
Background: Screening for breast, prostate, colorectal and cervical cancers can lead to earlier 
diagnosis and more effective treatment, but it is not known if cancer screening practices of farm residents 
in Australia differ from their rural or urban counterparts. Methods: Self-reported screening for prostate, 
breast and colorectal cancer were compared for farm, rural non-farm and urban participants of the 45 
and Up Study cohort in New South Wales (NSW). Data for participants under 75 years of age and without 
prior cancer, were linked with NSW Pap Test Register records for cervical screening frequency from 2006-
2012. Records were also linked with Medicare Benefits Schedule claims data for 2004-2011, for visits to a 
General medical Practitioner (GP); and for breast, prostate and colorectal screening procedures. Age-
adjusted comparisons were made using general linear regression and logistic regression. Results:  Farm 
residents were significantly less likely to visit a GP, but screening practices between farm and rural non-
farm residents were generally similar. Urban residents had significantly more prostate specific antigen 
(PSA) tests, Pap tests, mammograms and colonoscopies than either of the other groups. Urban residents 
were also significantly more likely to report ever having a mammogram or colonoscopy. In contrast, farm 
and rural non-farm residents had significantly more Faecal Occult Blood Tests (FOBTs) than urban 
counterparts; and were around one third more likely than urban residents to report ever having a FOBT. 
Farm residents were most likely to report ever having a PSA test or ‘any’ form of colorectal screening test; 
with both rural groups significantly more likely to do so than urban residents. Conclusions:  Farm and 
rural non-farm residents had lower utilisation and perhaps reduced access to specialist or procedural 
screening services.  
Keywords:  Farm*, cancer, screening, rural, prostate, breast, colorectal, bowel  
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7.2   Introduction 
Better outcomes for some of the most common cancers, breast, prostate, colorectal and cervical 
cancers, can be achieved by use of screening tests in defined, at risk groups. Screening aims to identify 
early signs of cancer before symptoms emerge; and can lead to effective early treatment and significant 
reductions in progression to metastases or mortality.1-7 Cancer screening in Australia is conducted 
through age and sex specific population-based programs, as well as through individual consultation with 
medical and allied health practitioners.1, 8   
It has been suggested that higher mortality and incidence of some cancers in rural areas, may be due 
to reduced access to health services, perhaps because of lack of screening or delayed diagnosis of 
symptomatic cancers, although the evidence for this is mixed.9-15 Information on heath service utilisation 
by farm residents is scant, because standard health reports do not distinguish between this group and 
other rural people. This study explores differences in cancer screening and utilisation of General medical 
Practitioners (GPs) by farm, rural non-farm and urban residents of the 45 and Up Study cohort, in New 
South Wales (NSW), Australia. Findings may assist those conducting rural cancer screening programs or 
aiming to achieve earlier diagnosis of symptomatic cancers in rural residents.  
7.3   Methods 
Information from the 45 and Up Study baseline questionnaire was linked with data from two 
administrative health datasets. The 45 and Up Study is managed by the Sax Institute, in collaboration with 
major health agency partners. It comprises of 267,119 NSW residents aged 45 years or over who enrolled 
in the Study between January 2006 and December 2009. Eligible individuals were randomly sampled from 
the enrolment database of the Australian Department of Human Services (formerly Medicare Australia), 
which provides near complete coverage of the NSW population. Details of the 45 and Up Study cohort, 
sampling, recruitment, variable definitions and data quality measures are available elsewhere.16-18 
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Baseline questionnaire information was used to define participants as farm, rural non-farm and urban 
groups; and to obtain self-report information on prostate, breast and colorectal cancer screening 
practices. Linkage of the 45 and Up Study cohort data to Medicare Benefits Schedule (MBS) claims data 
for 2004-2011, was done by the Sax Institute using a unique identifier that was provided to the Australian 
Department of Human Services (DHS). The MBS is a national database of all medical and allied health 
consultations and procedures provided by registered health professionals and subsidised by the 
Australian Government. Participant records were also linked with data in the NSW Pap Test Register for 
2006 - 2012, by the NSW Centre for Health Record Linkage, using probabilistic linkage methods.19 Data 
logic checks were undertaken to check for inconsistencies within and across datasets, with suspect 
records removed from analyses.  
Records of participants with prior diagnosis of cancer were removed from analysis and only 
participants 45 to 75 years of age were included in the primary analysis, as this is the age group in which 
most cancer screening is recommended.20-22 Sensitivity analyses included all ages.  
‘Farm residents’ were defined as those who indicated in the 45 and Up Study baseline questionnaire 
that they lived in a ‘house on farm’. Rural ‘non-farm’ and urban residents were further defined using the 
Accessibility/Remoteness Index of Australia (ARIA+) from postcode of residence at recruitment.23 Those 
participants who did not live in a house on a farm whose ARIA+ classification indicated they did not live in 
a ‘Major city’, were defined as rural non-farm residents. Those whose ARIA+ classification indicated they 
lived in a ‘Major city’ were urban residents. Where ARIA+ was not recorded, allocation was determined by 
cross-checking with postcode of residence and distances to treating hospitals in linked hospital datasets. 
Participants reported whether they had ever had a Prostate Specific Antigen test (PSA test) for 
prostate screening; or a mammogram for breast screening. For colorectal cancer, participants were asked 
whether they had ever had a Faecal Occult Blood Test (FOBT), colonoscopy or sigmoidoscopy. Participants 
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who reported screening were further asked when their last screening test was conducted, which was 
categorised as within the past 2 years, more than 2 years ago, in an unknown year or never.  
Cervical screening frequency was determined using the number of Pap tests registered in the NSW 
Pap Test Register from 2006-2012 for each woman. Average frequency of visits to a GP were determined 
using total visits per person for 2004-2011 as identified by 2011 MBS  item description codes (2-52, 192-
200, 597, 599, 2496-2560, 4999-5068).24 Average frequency of screening tests over the period were 
determined in the MBS for PSA tests (MBS code 66655), bilateral mammograms (59300-59301), 
colonoscopies (32090) and FOBTs (66764). Mammograms claimed through the MBS are primarily 
undertaken for diagnostic purposes, but claims for bilateral mammograms are known to sometimes be 
screening mammograms. 
Analysis was conducted using SAS 9.3™25. General linear regression modelling was used to calculate 
mean number of GP visits, PSA tests, mammograms, colonoscopies, FOBT’s and Pap tests in the periods 
studied for each residence group, adjusted for age. Binary logistic regression was used to assess the odds 
of ever having screened for prostate, breast and colorectal cancer (any, FOBT, colonoscopy); and the odds 
for having screened in the ‘last 2 years’ out of those who screened.  
7.4   Results 
Farm men and women in the cohort were 3 to 4 years younger than rural non-farm and urban 
counterparts. Those aged under 75 years comprised approximately 80% of the cohort. Table 1 and Table 2 
show for each gender,  the average age-adjusted GP visits (per year), PSA tests, bilateral mammograms, 
colonoscopies, FOBT’s and Pap-tests per person; as well as the proportions and age-adjusted odds ratios 
for self-reported ‘ever’ and ‘last’ prostate, breast and colorectal screening.  
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Table 7.1: Visits to General medical Practitioners (GP) and cancer screening practices of farm, rural non-farm and urban men 45-74 years 
 
Characteristic or cancer - related health activity           Total n    Farm        Rural            Urban 
Average age of participants in years, excl. prior cancer cases ( 95%CI) 101,577 61.5 (61.2 – 61.7) 63.8 (63.7 – 63.9) 64.2 (64.1 – 64.3) 
Number of participants aged less than 75 yrs (%)  84,174 7,168 (91.2%) 39,242 (84.2%) 37,764 (80.2%) 
 
 
   
1. Visits to General Practitioners (GPs) on MBS (Jan 2004 - Dec 2011)1 
 
   
  Average GP visits /yr (age-adjusted)  74,949 0.79 (0.76 – 0.81) 0.82 (0.81 – 0.83) 0.87 (0.86 – 0.88) 
 
 
   
2. Prostate cancer screening  
 
   
PSA Tests in MBS  (Jan 2004 - Dec 2011) 1 
 
   
 %  men less than 75 yrs of age who had at least one test  78,813 5,094 (74.6%) 27,151 (74.6%) 26,454 (74.4%) 
Average no. PSA tests / person (age-adjusted)  78,813 1.43 (1.41 – 1.46) 1.45 (1.43 – 1.46) 1.48 (1.46 – 1.49) 
Self-reported prostate cancer screening in men < 75yrs 2 
 
   
Ever had a PSA test (yes n %) 83,674 4,931 (69.5%) 27,593 (70.6%) 25,265 (67.4%) 
Age-adjusted OR (yes) 83,672 1.00 0.99 (0.93 – 1.05) 0.91 (0.86 – 0.96) 
 
 
 
Rural non-farm vs urban OR=1.09 (1.05 – 1.12)] 
Frequency of screening3: last test < 2 years ago (n %) 83,176 4,067 (57.6%) 22,847 (58.8%) 20,973 (56.3%) 
Age-adjusted OR: last test < 2 years ago of those who screened 57,291 1.00 0.99 (0.91 – 1.08) 0.97 (0.89 – 1.05) 
 
 
 
Rural non-farm vs urban OR=1.02 (0.98 – 1.07) 
3. Colorectal cancer screening 
 
   
Screening tests recorded in MBS (Jan 2004 - Dec 2011) 1 
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FOBT’s 
 
   
%  men less than 75 yrs of age who had at least one FOBT  79,402 246 (3.6%) 1,201 (3.3%) 952 (2.7%) 
Average no. FOBT tests / person (age-adjusted)  78,813 0.06 (0.05 – 0.06) 0.05 (0.05 – 0.05) 0.04 (0.04 – 0.04) 
Colonoscopies 
 
   
%  men <75 yrs who had at least one colonoscopy 79,402 1,044 (15.2%) 5,574 (15.2%) 7,348 (20.5%) 
Average no. colonoscopies / person (age-adjusted) 78,813 0.19 (0.17 – 0.20) 0.19 (0.18 – 0.19) 0.26 (0.25 – 0.26) 
Self reported colorectal cancer screening  in men < 75yrs2   
 
   
Ever had any bowel cancer screening test4 (yes n %) 83,799 3,713 (52.2%) 20,548 (52.5%) 18,135 (48.3%) 
Age-adjusted OR (yes) 83,797 1.00 0.96 (0.91 – 1.01) 0.85 (0.81 – 0.90) 
 
 
 
Rural non-farm vs urban OR=1.13 (1.10 – 1.16) 
Ever had a FOBT test (yes n %) 85,537 2,211 (30.5%) 12,657 (31.7%) 9,653 (25.2%) 
Age-adjusted OR (yes) 85,535 1.00 1.02 (0.96 – 1.08) 0.76 (0.72 – 0.81) 
 
 
 
Rural non-farm vs urban OR=1.34 (1.29 – 1.38) 
Ever had a colonoscopy (yes n %) 85,536 2,078 (28.7%) 11,640 (29.2%) 11,400 (29.7%) 
Age-adjusted OR (yes)  85,534 1.00 0.99 (0.93 - 1.04) 1.05 (1.00 – 1.11) 
 
 
 
Rural non-farm vs urban OR=0.93 (0.91 – 0.96) 
Frequency of screening3: last test < 2 years ago (n %) 83,412 2,440 (34.5%) 13,684 (35.1%) 11,981 (32.0%) 
Age-adjusted OR: last test < 2 years ago of those who screened 42060 1.00 0.97 (0.90 – 1.04) 0.99 (0.92 – 1.07) 
 
 
 
Rural non-farm vs urban OR=0.98 (0.94 – 1.02) 
 
1. Claims made by health service providers for items on government subsidised Medicare Benefits Schedule (MBS), 2004-2011, excluding prior cancer cases 
2. Self reported responses to 45 and Up Study baseline questionnaire, excluding prior cancer cases 
3. Where frequency reported 
4. FOBT, colonoscopy or sigmoidoscopy 
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Table 7.2: Visits to General medical Practitioners (GP) and cancer screening practices of farm, rural non-farm and urban women 45-74 years 
 
Characteristic or cancer - related health activity Total n         Farm           Rural             Urban 
Average age of participants in years, excl. prior cancer cases ( 95%CI) 121,136 59.2 (59.0 – 59.4) 62.4 (62.3 – 62.5) 63.0 (62.8 – 63.1) 
Number of participants aged less than 75 yrs (%)  103,165 8,636 (94.5%) 50,535 (86.5%) 43,994 (82.2%) 
     
1. Visits to General Practitioners (GPs) in MBS  (Jan 2004 - Dec 2011)1 
    
Average GP visits /yr (age-adjusted)  94,218 0.67 (0.65 – 0.69) 0.73 (0.72 – 0.74) 0.80 (0.79 – 0.81) 
     
    
2. Breast cancer screening 
    
Mammograms recorded in MBS  (Jan 2004 - Dec 2011)12 
    
%  women who had at least one mammogram  98,469 1,782 (21.2%) 10,029 (20.9%) 10,127 (24.0%) 
Average no. mammograms / person  (age-adjusted)  97,775 0.40 (0.37 – 0.42) 0.39 (0.38 – 0.40) 0.49 (0.48 – 0.50) 
Self-reported breast cancer screening3  
    
Ever had a mammogram (yes n %) 102,434 7,557 (88.4%) 44,892 (89.3%) 38,986 (89.4%) 
Age-adjusted OR   102,425 1.00 0.99 (0.92 – 1.06) 1.09 (1.01 – 1.17) 
   
Rural non-farm vs urban OR=0.91 (0.87 – 0.95)] 
Frequency of screening4: last test < 2 years ago (n %) 101,568 6,111 (72.0%) 36,180 (72.6%) 31,459 (72.8%) 
Age-adjusted OR: last test < 2 years ago of those who screened 90,572 1.00 1.04 (0.97 – 1.11) 1.02 (0.95 – 1.08) 
   
Rural non-farm vs urban OR=1.02 (0.99 – 1.06) 
3. Colorectal screening 
    
Screening tests recorded in MBS (Jan 2004 - Dec 2011)1 
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 FOBT’s 
   
%  women <75yrs who had at least one FOBT  98,469 260 (3.1%) 1,421 (3.0%) 935 (2.2%) 
Average no. FOBTs / person (age-adjusted)  97,775 0.04 (0.04 – 0.05) 0.04 (0.04 – 0.04) 0.03 (0.03 – 0.03) 
 Colonoscopies 
    
%  women<75yrs who had at least one colonoscopy  98,469 1,448 (17.3%) 8,471 (17.7%) 9,757 (23.2%) 
Average no. colonoscopies / person (age-adjusted)  97,775 0.22 (0.20 – 0.23) 0.21 (0.21 - 0.22) 0.29 (0.28 – 0.29) 
Self reported colorectal screening3 
    
Ever had any bowel screening test5 (yes n %) 102,036 3,900 (45.7%) 23,427 (46.8%) 19,098 (44.0%) 
Age-adjusted OR   102,027 1.00 0.97 (0.93 – 1.12) 0.90 (0.86 – 0.95) 
   
Rural non-farm vs urban OR=1.07 (1.05 – 1.10) 
Ever had a FOBT test (yes n %) 104,508 2,168 (24.9%) 12,301 (24.0%) 8,787 (19.7%) 
Age-adjusted OR 104,499 1.00 0.89 (0.85 – 0.94) 0.72 (0.68 – 0.76) 
   
Rural non-farm vs urban OR=1.24 (1.20 – 1.28) 
Ever had a colonoscopy (yes n %) 104,506 2,399 (27.6%) 15,340 (29.9%) 13,285 (29.8%) 
Age-adjusted OR 104,497 1.00 1.05 (1.00 – 1.11) 1.09 (1.04 – 1.15) 
   
Rural non-farm vs urban OR=0.97 (0.94 – 0.99) 
Frequency of screening4: last test < 2 years ago (n %) 101,556 2,475 (29.1%) 14,922 (30.0%) 12,155 (28.1%) 
Age-adjusted OR: last test < 2 years ago of those who screened 45,970 1.00 0.99 (0.92 – 1.06) 0.99 (0.92 – 1.07) 
   
Rural non-farm vs urban OR=1.00 (0.96 – 1.04) 
4. Cervical screening6  -  NSW Pap Test Register   
  Jan 2006 – March 2013      
    
%  aged <75 yrs who screened at least once   112,092  6,514 (68.9%) 35,096 (63.9%) 33,059 (69.3%) 
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Average Pap tests/person (age adjusted) 112,092 1.98 (1.94 – 2.00) 1.87 (1.86 – 1.89) 2.07 (2.05 – 2.09) 
                  Average Pap tests/person excl. those who never screened 
                  (age-adjusted) 
 
74,669 2.91 (2.87 – 2.94) 2.90 (2.89 – 2.91) 3.01 (3.00 – 3.02) 
 
 
1. Claims made by health service providers for items on government subsidised Medicare Benefits Schedule (MBS), 2004-2011, excluding prior cancer cases 
2 Participants screened through Breastscreen Australia do not appear as claims in MBS data 
3 Self reported responses to 45 and Up Study baseline questionnaire, excluding prior cancer cases 
4 Where frequency reported 
5 FOBT, colonoscopy or sigmoidoscopy 
6 Pap Test Register cervical screening data does not exclude those with a prior cancer 
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7.4.1   Visits to General Practitioners 
On average farm men and women in the screening age group were less likely to visit a GP over the 
period than rural non-farm counterparts, with this difference being significant for women. Farm and rural 
non-farm men and women were significantly less likely than urban residents to visit a GP.  
7.4.2   Cancer screening in men 
Farm and rural non-farm men did not differ significantly from each other in the average number of 
PSA tests over the 2004-2011 period; or in the odds of ever having had a test for prostate cancer. Urban 
men had significantly more PSA tests per person than farm men, but the differences were small. In 
contrast, the odds of reporting ever having had a PSA test were 9% higher in farm and rural non-farm men 
than urban men. Whilst not significant, both groups also had higher odds than urban men of having had a 
screening test in the last 2 years. 
For colorectal cancer, variations in screening test usage between farm and rural non-farm groups 
were also similar, but significantly different to urban men. The odds of having an FOBT for both groups 
was approximately one-third greater than for urban men. Farm men also had significantly greater odds of 
reporting ever having ‘any’ colorectal screening test than urban men; and were most likely to report being 
screened in the last 2 years, although differences in the latter were marginal. In contrast, urban men had 
significantly greater odds of having a colonoscopy.   
7.4.3   Cancer screening in women 
Similarly, farm and rural non-farm women did not differ significantly from each other in the average 
number, or odds of having had a mammogram. Urban women had significantly more mammograms 
recorded in the MBS data; as well as 9% greater odds of reporting ever having a mammogram, than the 
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other two groups. Rural non-farm women were most likely to report having had a mammogram in the last 
2 years, although differences were not significant and relatively small.  
There was little difference between farm and rural non-farm women in the number or odds of having 
an FOBT or colonoscopy. However, urban women had significantly fewer FOBT’s than either of the other 
groups. Urban women also had significantly lower odds of reporting ever having had an FOBT, or to have 
had ‘any’ colorectal screening test in the past 2 years. Conversely, urban women had significantly more 
colonoscopies and greater odds of ever having had a colonoscopy than farm or rural non-farm 
counterparts. There was little difference between groups in self-reported frequency of a having had a 
colorectal screening test. 
Urban women had significantly more Pap tests than farm women, who in turn had significantly more 
tests than rural non-farm women. Excluding women who did not have any Pap tests, urban women still 
had more tests on average over the period, but differences between farm and rural non-farm women 
were no longer significant. 
Results and screening patterns between groups in the sensitivity analyses that included all ages were 
similar to those of the primary analyses.  
7.5   Discussion 
Farm residents visited a GP the least often, but this may be of limited practical significance. Overall 
differences in screening between farm and rural non-farm residents were mostly non-significant, although 
screening patterns were sometimes different for urban residents. Trends across groups in MBS data did 
not always correspond with trends in the self-report data, such as for PSA tests. However, tests recorded 
in the MBS could have been for either diagnostic or screening purposes, so the use of different measures 
in each dataset may have contributed to some inconsistencies.  
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Urban residents had significantly more colonoscopies per person and greater odds of a colonoscopy, 
significantly so for men. Differences between farm and rural non-farm residents in utilisation of FOBTs 
and colonoscopies were marginal. Importantly, both groups had one-third greater odds of having an FOBT 
than urban counterparts; and were more likely to report having had ‘any’ colorectal screening test. Urban 
women had significantly more Pap tests than farm and rural non-farm women. Results of sensitivity 
analyses were generally consistent with main findings. 
There are three population-based screening programs currently in operation in Australia; 
BreastScreen Australia, the National Cervical Screening Program, and the National Bowel Cancer 
Screening Program.1, 8 Breast and colorectal screening, along with PSA testing, may also be conducted by 
private practitioners, based on individual risk factors.26 However, although asymptomatic individuals in 
target age-groups are encouraged to screen, similar tests are conducted on people displaying symptoms. 
Therefore, it cannot be claimed that all mammograms, PSA tests, FOBTs or colonoscopies in the MBS 
were for screening purposes - nor how the term ‘screening’ is understood when participants self-report 
their testing. Misclassification is most likely to have occurred in the direction of ‘screening’, when 
asymptomatic screening by public health definitions, did not actually occur. This may have led to an 
overestimate of screening rates per se, although this is likely to have affected residence groups equally.  
Removing prior cancer cases and those over 75 years attempted to minimise misclassification errors. 
7.5.1   General Practitioners 
In Australia, GP’s are usually the first point of contact for healthcare including arrangement of tests 
for both diagnostic and screening purposes.27 National health expenditure data on GP services, pathology, 
imaging and specialist services demonstrates an age-standardised decrease in expenditure per person, 
with increasing remoteness from urban centres.14 However, little difference between rural and urban 
residents was found in a self-report study of GP attendance in South Australia.15     
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Only two reports have been reported on utilisation of GP services by Australian farm residents. No 
significant differences in GP attendance were noted between farmers and comparison groups in rural 
NSW and Queensland.28-29 One US study likewise found little difference between farmers and others in GP 
attendance30; although another found that farm men were less likely to have had a primary care check-up 
in the past year than non-farm men.31 Most of these studies, however, were of cross-sectional design and 
comprised less than 1000 farm residents. In contrast, our study was more substantial in size and able to 
retrieve data on consultations over an 8 year period. Nevertheless, people may visit a GP attendance for a 
variety of reasons other than screening – so there may be many reasons why farm residents might be less 
likely to attend a GP. These may include reduced access to or supply of GP services, or alternatives offered 
by hospital-based health services;14, 32 although such issues are likely to affect rural non-farm residents in 
a similar way. Alternatively, farm residents may enjoy a healthier state of well-being, reflecting a healthy 
worker effect or a more outdoor, physically active lifestyle, as suggested elsewhere.33  Further discussion 
of these factors lies outside the scope of the data and this discussion.  
7.5.2   Screening 
Some Australian studies have reported lower cancer screening rates in rural compared to urban 
areas,9-10 whilst others have reported little difference.11-13 Participation rates in population-based breast, 
cervical and colorectal cancer screening programs, have generally been higher in regional rather than 
urban areas, although lowest in very remote areas.20-22   
The low proportion of mammograms in the MBS compared to self-report data, is likely a reflection of 
the extensive role of Breastscreen Australia in providing population-based screening, which are not 
included in MBS claims data. By either measure, urban women underwent more breast screening, but 
differences between groups remained relatively small and we cannot discount that participants were also 
reporting on diagnostic mammograms. Greater use of mammograms amongst urban women in the MBS 
may also reflect greater availability and use of private diagnostic services in urban areas.  
253 
 
MBS data indicated that urban residents were also significantly more likely to have had a 
colonoscopy. As for mammograms, it is not known what proportion of colonoscopies in the MBS data are 
for diagnostic purposes, which is an inherent difficulty with administrative health datasets described by 
others.34-36 One study using patient perceptions and another using medical records, both found that 
around one third of colonoscopies were for screening purposes; a further third for surveillance and the 
remainder for diagnostic and related purposes.34, 37  Another study reported that up to a half of 
endoscopies were for screening.38  Our study removed prior cancer cases so the proportion for 
surveillance purposes is likely to be reduced.  
Self-reported use of colonoscopy for screening purposes, has previously been shown to be reasonably 
accurate.34, 39 In addition, colonoscopies recorded in Australian administrative datasets have also been 
shown to be quite accurate.40  By both MBS and self-report measures in our study, there was a consistent 
trend for greater use of colonoscopies by urban residents. This may partly reflect greater availability of 
colonoscopy services in urban areas as an alternative to FOBT as a screening tool; which has the time 
saving potential to remove suspect lesions during the procedure. In contrast and perhaps reflecting lower 
availability of colonoscopy services, FOBTs were significantly more likely to have been used in farm and 
rural non-farm and farm residents than urban counterparts. This is consistent with results for 
participation by rurality in the National Bowel Cancer Screening Program, which uses the FOBT as the 
screening tool.21     
Six studies were identified in the international literature that compared screening practices between 
farm and non-farm comparison groups. The only study reporting on prostate cancer screening, found that 
farm residents in Iowa were less likely to have had a prostate examination than rural non-farm 
counterparts.31 For colorectal cancer, there were no significant differences between farm and rural non-
farm residents in the same cohort; although another study found farmers were less likely to have an FOBT 
in the past year than other workers.30  
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Most studies of breast cancer screening have reported similar practices between farm and non-farm 
groups;30, 41-43 or if lower in farmers, this was related more to age, education and health insurance factors 
than farm residence itself.31, 42 For cervical screening, two studies reported similar practices between farm 
and other women;30-31 whilst two others found farm women less likely to have had cervical screening than 
other rural women.41, 44 It was proposed that social isolation of farm women rather than geographic 
distance to services, may have contributed to the latter. Overall, whilst reports in the international 
literature were few and results mixed, there was little evidence that cancer screening practices between 
farm residents and others differed to any great extent. These conclusions are generally consistent with 
the findings of our study, especially regarding the relatively small differences between farm and rural 
non-farm residents.  
7.5.3    Limitations 
Results need to be considered in light of the interpretation of self-report and MBS data for different 
cancers already discussed. It should also be noted that the 45 and Up Study cohort is not strictly 
representative of the corresponding population of NSW, although linkage with population datasets has 
shown that biases are limited.16, 45 The definition of a ‘farm resident’ in this study was also open to 
respondents’ interpretation of a ‘farm’ and could include small holdings used for commercial, recreational 
or both purposes. As such, exposures, practices and lifestyles of farm residents could vary accordingly, 
with differences between residents in these respects not always clearly defined.46 This may have affected 
representativeness of sub-groups and internal validity of comparisons made. However, errors arising from 
misclassification of resident group are likely to be non-differential and independent of other risk factors, 
leading to a null bias and underestimation of relationships between farm residence and cancer screening. 
7.6   Conclusions 
Farm residents were significantly less likely to visit a GP, but screening practices between farm and 
rural non-farm residents were generally similar. As a group, urban residents had significantly more PSA 
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tests and procedural screening tests such as mammograms, colonoscopies and Pap tests. In contrast, rural 
non-farm and farm residents were significantly more likely than urban residents to self-report having a 
PSA test or FOBT; and had significantly more FOBT’s claimed through the MBS than their urban 
counterparts. This suggests farm and rural non-farm residents may have had reduced preference, access 
or opportunity for cancer screening that required specialist services. 
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Table 7.3: Visits to General medical Practitioners (GP) and cancer screening practices of farm, rural non-farm and urban men 45-74 years (main analyses), 
compared to all men aged 45 years and over (sensitivity analyses) 
 
Characteristic or cancer - related health activity 
Age <75 years and excluding prior cancer All men 45 years and over 
          Total n Farm Rural Urban       Total n Farm Rural Urban 
1. Visits to General Practitioners (GPs) on MBS    
(Jan 2004 - Dec 2011)1 
    
    
Average GP visits /yr (age-adjusted)  74,949 0.79 (0.76 – 0.81) 0.82 (0.81 – 0.83) 0.87 (0.86 – 0.88) 123,148* 1.18 (1.15 – 1.21) 1.24 (1.23 – 1.25) 1.30 (1.29 – 1.31) 
2. Prostate cancer screening  
    
    
    PSA Tests in MBS  (Jan 2004 - Dec 2011) 1 
    
    
%  men who had at least one test  78,813 74.6% 74.6% 74.4% 123,909* 73.5% 72.3% 71.0% 
Average no. PSA tests / person (age-adjusted)  78,813 1.43 (1.41 – 1.46) 1.45 (1.43 – 1.46) 1.48 (1.46 – 1.49) 123,148* 1.45 (1.42 – 1.47) 1.43 (1.42 – 1.44) 1.40 (1.39 – 1.41) 
   Self-reported prostate cancer screening in men2 
    
    
Ever had a PSA test (yes %) 83,674 69.5% 70.6% 67.4% 98,850 69.7% 71.2% 68.6% 
Age-adjusted OR (yes) 83,672 1.00 0.99 (0.93 – 1.05) 0.91 (0.86 – 0.96) 98,848  1.00 0.99 (0.94 – 1.05) 0.86 (0.82 – 0.91) 
Frequency of screening: last test < 2 years ago (%) 83,176 57.6% 58.8% 56.3% 98,904 57.3% 58.2% 55.6% 
Age-adjusted OR: last test < 2 years ago of those 
who screened 
57,291 1.00 0.99 (0.91 – 1.08) 0.97 (0.89 – 1.05) 68,308 1.00 0.99 (0.94 – 1.04) 0.88 0.84 – 0.93) 
3. Colorectal cancer screening 
    
    
 Screening tests recorded in MBS  
(Jan 2004 - Dec 2011) 1     
    
    FOBT’s 
    
    
%  men who had at least one FOBT  79,402 3.6% 3.3% 2.7% 123,909* 16.2% 19.0% 13.4% 
Average no. FOBT tests / person (age-adjusted)  78,813 0.06 (0.05 – 0.06) 0.05 (0.05 – 0.05) 0.04 (0.04 – 0.04) 123,148* 0.25 (0.23 – 0.26) 0.29 (0.28 – 0.29) 0.19 (0.18 – 0.20) 
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   Colonoscopies 
    
    
%  men who had at least one colonoscopy 79,402 15.2% 15.2% 20.5% 123,909* 23.8% 23.5% 30.1% 
Average no. colonoscopies / person (age-adjusted) 78,813 0.19 (0.17 – 0.20) 0.19 (0.18 – 0.19) 0.26 (0.25 – 0.26) 123,148* 0.38 (0.36 – 0.39) 0.36 (0.35 – 0.37) 0.47 (0.46 – 0.47) 
   Self reported colorectal cancer screening  in men2   
    
    
Ever had any bowel cancer screening test4 (yes %) 83,799 52.2% 52.5% 48.3% 99,109 52.4% 53.0% 48.9% 
Age-adjusted OR (yes) 83,797 1.00 0.96 (0.91 – 1.01) 0.85 (0.81 – 0.90) 99,107 1.00 0.97 (0.92 – 1.01) 0.81 (0.77 – 0.85) 
Frequency of screening: last test < 2 years ago (%) 83,412 34.5% 35.1%  32.0% 98,533 33.9% 34.6% 31.3% 
Age-adjusted OR: last test < 2 years ago, of those  
who screened 
42,060 1.00 0.97 (0.90 – 1.04) 0.99 (0.92 – 1.07) 50,083 1.00 0.99 (0.95 – 1.05) 0.85 (0.81 – 0.90) 
 
1 Claims made by health service providers for items on government subsidised Medicare Benefits Schedule (MBS), 2004-2011 
2 Self reported responses to 45 and Up Study baseline questionnaire, excluding prior cancer cases 
3 Where frequency reported 
4 FOBT, colonoscopy or sigmoidoscopy 
**     Some data include cases of self reported prior cancer (1) Sensitivity analyses of MBS claims and (2) All analyses of NSW Pap Test Register data 
 
 
258 
 
Table 7.4: Visits to General medical Practitioners (GP) and cancer screening practices of farm, rural non-farm and urban women 45-74 years (main analyses), 
compared to all women aged 45 years and over (sensitivity analyses) 
 
Characteristic or cancer - related health activity 
Age <75 years and excluding prior cancer All women 45 years and over (incl. prior cancer) 
           Total n Farm Rural Urban         Total n Farm Rural Urban 
1. Visits to General Practitioners (GPs) on MBS    
        (Jan 2004 - Dec 2011)1 
    
    
  Average GP visits /yr (age-adjusted)  94,218 0.67 (0.65 – 0.69) 0.73 (0.72 – 0.74) 0.80 (0.79 – 0.81) 142,369* 0.89 (0.86 – 0.91) 0.94 (0.93 – 0.94) 1.02 (1.01 – 1.03) 
2. Breast cancer screening  
    
    
Mammograms in MBS  (Jan 2004 - Dec 2011) 1 
    
    
   %  women who had at least one test  98,469 21.2% 20.9% 24.0% 143,210* 23.8% 23.3% 25.5% 
   Average no. mammograms/ person (age-adjusted)  97,775 0.40 (0.37 – 0.42) 0.39 (0.38 – 0.40) 0.49 (0.48 – 0.50) 142,369* 0.53 (0.51 – 0.56) 0.56 (0.55 – 0.57) 0.65 (0.64 – 0.67) 
Self-reported breast cancer screening in women2 
    
    
  Ever had a mammogram (yes %) 102,434 88.4% 89.3% 89.4% 118,502 88.2% 88.9% 88.6% 
  Age-adjusted OR (yes) 102,425 1.00 0.99 (0.92 – 1.06) 1.09 (1.01 – 1.17)    118,493 1.00 0.94 (0.88 – 1.01) 0.99 (0.92 – 1.06) 
  Frequency of screening: last test < 2 years ago (%) 101,568 72.0% 72.6% 72.8% 117,279  69.8% 66.8% 64.6% 
  Age-adjusted OR: last test < 2 years ago, of those who   
screened 
90,572 1.00 1.04 (0.97 – 1.11) 1.02 (0.95 – 1.08) 93,889 1.00 0.96 (0.91 – 1.01) 0.87 (0.83 – 0.92) 
3. Colorectal cancer screening 
    
    
  Screening tests recorded in MBS (Jan 2004 - Dec 2011) 1 
    
    
   FOBT’s 
    
    
%  women who had at least one FOBT  98,469 3.1%) 3.0% 2.2% 143,210* 14.4% 16.8% 12.0% 
Average no. FOBT tests / person (age-adjusted)  97,775 0.04 (0.04 – 0.05) 0.04 (0.04 – 0.04) 0.03 (0.03 – 0.03) 142,369* 0.20 (0.19 – 0.22) 0.24 (0.23 – 0.24) 0.16 (0.16 – 0.17) 
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   Colonoscopies 
    
    
%  women who had at least one colonoscopy 98,469 17.3% 17.7% 23.2% 143,210* 22.2% 22.6% 29.0% 
Average no. colonoscopies / person (age-adjusted) 97,775 0.22 (0.20 – 0.23) 0.21 (0.21 - 0.22) 0.29 (0.28 – 0.29) 142,369* 0.32 (0.30 – 0.33) 0.32 (0.32 – 0.33) 0.42 (0.42 – 0.42) 
  Self reported colorectal cancer screening  in women2   
    
    
Ever had any bowel cancer screening test4 (yes %) 102,036 45.7% 46.8% 44.0% 117,891 45.6% 47.2% 44.7% 
Age-adjusted OR (yes) 102,027 1.00 0.97 (0.93 – 1.12) 0.90 (0.86 – 0.95) 117,882 1.00 0.98 (0.94 – 1.03) 0.87 (0.83 – 0.91) 
Frequency of screening: last test < 2 years ago (%) 101,556 29.1% 30.0% 28.1% 117,187 28.7% 29.2% 27.0% 
Age-adjusted OR: last test < 2 years ago of those who 
screened 
45,970 1.00 0.99 (0.92 – 1.06) 0.99 (0.92 – 1.07) 53,507 1.00 0.99 (0.95 – 1.05) 0.89 (0.84 – 0.93) 
4. Cervical screening6  -  NSW Pap Test Register** 
  Jan 2006 – March 2013      
        
%  who screened at least once   112,092 68.9% 63.9% 69.3% 143,210 63.2% 52.7% 54.8% 
Average Pap tests/person (age adjusted) 112,092 1.98 (1.94 – 2.00) 1.87 (1.86 – 1.89) 2.07 (2.05 – 2.09) 143,201 1.59 (1.56 – 1.62) 1.49 (1.48 – 1.50) 1.66 (1.65 – 1.67) 
Average Pap tests/person excl. those who never 
screened (age-adjusted) 
 
74,669 2.91 (2.87 – 2.94) 2.90 2.89 – 2.91) 3.01 (3.00 – 3.02) 77,898 2.86 (2.83 – 2.89) 2.85 (2.83 – 2.86) 2.95 2.94 – 2.97) 
 
 
1. Claims made by health service providers for items on government subsidised Medicare Benefits Schedule (MBS), 2004-2011 
2. Participants screened through Breastscreen Australia do not appear as claims in MBS data 
3. Self reported responses to 45 and Up Study baseline questionnaire, excluding prior cancer cases 
4. Where frequency reported 
5. FOBT, colonoscopy or sigmoidoscopy 
6. Pap Test Register cervical screening and GP visitation data include those with prior cancer 
**     Some data include cases of self reported prior cancer (1) Sensitivity analyses of MBS claims and (2) All analyses of NSW Pap Test Register data 
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8.1   Abstract  
Objectives:   To determine if selected therapies for prostate, breast and colorectal cancer vary by 
farm, rural non-farm or urban residence. Design:  Data linkage of baseline survey information from the 
Sax Institutes’ 45 and Up Study cohort with data from the New South Wales (NSW) Admitted Patients 
Data Collection (APDC) for 2006-2012. Setting: NSW. Participants:  Farm, rural non-farm and urban 
residents aged 45 years and over. Main outcome measures:  Surgical, chemotherapy, radiotherapy and 
brachytherapy procedures for those with a diagnosis of prostate, breast or colorectal cancer. Average 
distance to treating hospital and the odds of receiving selected therapies for each cancer were compared, 
controlling for selected variables. Results: Farm men were significantly more likely to have a 
prostatectomy for prostate cancer than rural non-farm men, but differences for breast and colorectal 
cancer surgery between resident groups were not significant. Farm and rural non-farm men had 
significantly lower odds of brachytherapy for prostate cancer than urban men; whilst farm and rural non-
farm women were significantly less likely to have chemotherapy for breast cancer than urban women.  
Rural non-farm residents, were also significantly less likely to have chemotherapy for colorectal cancer 
than urban counterparts. Age, distance, income and health insurance factors contributed to differences in 
non-surgical care between groups.  Conclusion:  Cancer-related surgical services for breast and colorectal 
cancer were generally comparable between groups. Farm and rural non-farm residents may have been 
disadvantaged in relation to non-surgical therapies for prostate, breast and colorectal cancer compared to 
urban residents.  
 Keywords:  Farm*, cancer, treatment, *therapy, rural, prostate, breast, colorectal, bowel  
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8.2   Introduction 
Improved survival rates for prostate, breast and colorectal cancers in Australia over the past 30 years, 
has been largely attributed to better diagnostic methods, earlier detection and improvements in cancer 
treatment.1 However, cancer treatments vary in complexity and availability to the general population. 
Poorer cancer survival in rural areas has been partly attributed to geographic and socio-economic 
difficulties rural people have in accessing optimal cancer treatments.2 National data generally 
demonstrates decreased expenditure on specialist services per person with increasing remoteness from 
urban centres.3 However, it is not known if farm residents experience more or less difficulty accessing 
cancer services than other rural or urban people. We sought to determine if utilisation of therapies for 
prostate, breast and colorectal cancer, differed between farm, rural non-farm and urban people in New 
South Wales (NSW).  
8.3   Methods 8.3.1   Datasets and linkage 
Information from the Sax Institute’s 45 and Up Study baseline questionnaire was used to define risk 
factors of interest and categorise participants into farm, rural and urban comparison groups. The cohort 
comprises 267,119 NSW residents aged 45 years or over enrolled between January 2006 and December 
2009. Eligible individuals were randomly sampled from the enrolment database of the Australian 
Department of Human Services (formerly Medicare Australia), which provides near complete coverage of 
the NSW population. Details on 45 and Up Study methods are available elsewhere.4-5    
The 45 and Up Study data were linked with corresponding data the NSW Admitted Patients Data 
Collection (APDC) for January 2006 - December 2012. The APDC records all inpatient separations from 
NSW public and private hospitals, multi-purpose services, private day procedure centres and public 
nursing homes.6 Linkage of records between datasets was conducted using probabilistic data linkage 
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methods, by the NSW Centre for Health Record Linkage (CHeReL). The CHeReL also provided geocode-
derived distances between the non-disclosed residential address and treating hospital for each record.7   
8.3.2   Definition of variables 
 ‘Farm residents’ were defined as those who indicated they lived in a ‘house on farm’ on the 45 and 
Up Study baseline questionnaire. Rural ‘non-farm’ and urban residents were further defined using the 
Accessibility/Remoteness Index of Australia (ARIA+) from postcode of residence at recruitment.8 Those 
participants whose ARIA+ classification indicated they did not live in a ‘Major city’, excluding those who 
also specified that they lived in a 'house on farm', were defined as rural non-farm residents. The 
remaining ‘urban’ participants were those who lived in a ‘Major city’. Where ARIA+ was not recorded, 
allocation was determined by cross-checking with postcode of residence and distance to treating 
hospitals.  
Variables of interest considered for inclusion in logistic regression models were age; distance from 
home address to treating hospital (kilometres); private health insurance with extras status; and annual 
household income $70,000 or more. The latter was categorised to approximate levels above or below the 
NSW 2006 average annual household income of $70,000.9  
Cancer status was established where a prostate, breast or colorectal cancer diagnosis was recorded in 
any one of 55 diagnoses code fields of any APDC admission record over the period. Therapeutic 
procedures were identified within in any one of 51 procedure code fields on the APDC record. Diagnosis 
and procedure codes are based on the ICD10-AM and Medical Benefits Schedule (MBS)classification 
systems.6     
Therapeutic procedures for each selected cancer were categorised into surgical, chemotherapy, 
radiotherapy and brachytherapy groupings. Surgical procedures for women with breast cancer were 
defined separately for mastectomies (procedure codes 31518-00 - 31524-00) and excision of breast 
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lesions (31500-00 - 31515-00). Surgical procedures for men with prostate cancer were defined by radical 
or laparoscopic prostatectomy (37209-00 - 37211-09). Surgeries for colorectal cancer for both men and 
women were defined by procedures relating to colectomies, resections or excision of colorectal tumours 
(32000-00 - 32069-00; 32099-00 - 32108-00). Trans-urethral resections of prostate, colonoscopies and 
aspirational biopsies were excluded from surgical procedure definitions. Brachytherapy implantation 
procedures (15327-00 - 15338-00) were compared for prostate cancer cases; and radiotherapy 
procedures (15100-00 - 15269-09) compared for those with a prostate, breast or colorectal cancer 
admission. Chemotherapy was limited to the administration of anti-neoplastic pharmacological agents 
only (96199-00, 96200-00, 96201-00, 96202-00, 96203-00, 96204-00, 96205-00, 96206-00, 96207-00, 
96208-00, 96209-00). However, sensitivity analyses were conducted using wider categories of 
chemotherapy, such as administration of steroids, anti-infective agents or nutritional pharmacological 
therapies (96199-00 – 96209-09).  
First procedure records for each person were used to calculate the average distance to hospital for 
each resident group. For logistic regression models, the average distance over all records for each person 
was used. Due to the magnitude of this variable, parameter estimates for distance to hospital are 
presented per 10km to assist with interpretation.  
8.3.3   Analysis 
Analysis was conducted using SAS 9.3.™ Frequencies and averages distances from home to hospital 
were calculated for farm, rural non-farm and urban residents who underwent the specified treatments for 
each cancer. Binary logistic regression was used to calculate adjusted odds ratios for selected treatments 
for each resident group. Variables with p-values < .25 on univariate analyses were included in the base 
model. Effect estimates and standard errors were compared between univariate and multivariable 
models; and variance inflation factors calculated to ensure collinearity did not exist between variables. 
Interactions between resident group and other factors were created and tested to assess effect 
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modification. Models were progressively reduced using a backward elimination approach (.05 level), 
removing non-significant variables and accounting for any non-significant confounders. Residual plots 
were examined to identify cases with undue influence in regression models. The difference between 
groups in the final adjusted odds ratio represents a difference not explained by factors left in the final 
model, but due to the effect of group residence or unknown factors. 
8.4   Results 
Tables 8.1 and 8.2 present the proportions of farm, rural non-farm and urban residents who 
underwent particular cancer therapies for each cancer type, the odds ratio for each therapy type and the 
average distance from home residence to hospital for a particular treatment.  
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Table 8.1: Procedures performed on farm, rural non-farm and urban men, who had a prostate or colorectal cancer diagnosis on any APDC admission record 2006-2012 
 
Procedures for those with selected cancer diagnosis            Total n                Farm                Rural             Urban Factors remaining in adjusted model 
1. Prostate cancer 
     
1.1 Prostatectomy -  radical or laproscopic    
   (Procedure codes 37209-00 - 37211-00) 
     
    n (%) of men with a diagnosis who had a procedure* 5,637 170 (45.8%) 901 (34.4%) 951 (35.9%) 
 
• Age  OR= 0.88 (0.87 – 0.89) 
• Private insurance with extras   
yes vs no OR= 1.17 (1.03 – 1.33)               Av. distance (km) (95%CI) from residence to health service for a first procedure
   2,019 142.1 (122.4 – 161.8) 93.1 (85.9 – 100.4) 14.1 (12.8 – 15.5) 
    Unadjusted OR (95%CI)  5,634 1.00 0.62 ( 0.50 – 0.78) 0.66 (0.53 – 0.83) 
    Adjusted OR (95%CI)  5,634 1.00 0.74 (0.58 – 0.95) 0.83 (0.64 – 1.06) 
1.2 Chemotherapy - anti-neoplastic agents only   
(Procedure codes:  96199-00,  96200-00, 96201-00, 96202-00, 96203-00,   
96204-00, 96205-00, 96206-00, 96207-00, 96208-00, 96209-00)     
 
    n (%) of men with a diagnosis who had a procedure* 5,638 8 (2.2%) 78 (3.0%) 119 (4.5%) 
 
• Age OR= 1.04 (1.03 – 1.06) 
• Private insurance with extras  
yes vs no OR= 1.56 (1.15 – 2.10] 
• [Av. distance to health service (per 10 km) 
was a  non-significant confounder 
OR= 0.96 (0.93 – 1.00) ] 
              Av. distance (km) (95%CI) from residence to health service for a first  procedure 164 56.05 (22.0 – 90.1) 49.0 (30.0 – 68.0) 11.0 (8.0 – 14.1) 
    Unadjusted OR (95%CI) for procedure 5,600 1.00 1.37 (0.66 – 2.86) 2.08 (1.01 – 4.30) 
    Adjusted OR (95%CI) for procedure 5,600 1.00 1.14 (0.54 – 2.42) 1.33 (0.62 – 2.88) 
1.3 Radiotherapy  
 (Procedure codes: 15100-00 - 15269-09)   
    
 
      n (%) of men with a diagnosis who had a procedure*   5,638 8 (2.2%) 48 (1.8%) 81 (3.1%) 
 
• Age  OR=1.06 (1.04 – 1.08) 
• Private insurance with extras  
yes vs no OR= 0.61 (0.40 – 0.92) 
• [Annual household income over $70,000/yr   
yes vs no  OR= 0.90 (0.51– 1.60) a non- 
significant confounder] 
      Av. distance (km) (95%CI) from residence to health service for a first procedure 128 198.6 (82.3 – 314.8) 128.8 (86.8 – 170.8) 7.5 (6.2 – 8.7) 
      Unadjusted OR (95%CI) for procedure [Rural vs. urban OR=0.59 (0.41 – 0.85)] 4,672 1.00 0.67 (0.29 – 1.50) 1.24 (0.56 – 2.73) 
      Adjusted OR (95%CI) for procedure 4,672 1.00 0.54 (0.24-1.24) 1.01 (0.45 – 2.25) 
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1.4 Brachytherapy - implantations 
   (Procedure codes:  15327-00 - 15338-00)   
    
 
      n (%) of men with a cancer diagnosis who had a procedure*  5,637 18 (4.9%) 108 (4.1%) 185 (7.0%) 
 
• Annual household income over $70,000   
yes vs no  OR= 1.38 (1.01 – 1.77)   
• Private insurance with extras  
yes vs no OR= 1.83 (1.36 – 2.45) 
• Av. distance to health service (per 10 km) 
OR= 1.06 (1.04 – 1.08) 
• Cohort: rural non-farm vs. urban  
OR= 0.46 (0.34 – 0.63) 
               Av. distance (km) (95%CI) from residence to health service for a first procedure 311 270.6 (182.0 – 359.2) 183.7 (160.4 – 206.9) 20.4 (16.0 – 24.9) 
      Unadjusted OR (95%CI) for procedure   4,641 1.00 1.03 (0.55 – 1.89) 1.70 (0.93 – 3.11) 
      Adjusted OR (95%CI) for procedure 4,641 1.00 1.34 (0.72 – 2.25) 2.90 (1.51 – 5.56) 
2. Colorectal cancer  
    
 
2.1        Colorectal surgery – colectomies, resections, excisions  
    (Procedure codes:  32000-00 – 32069-00,  32099-00 – 32108-00) 
    
 
      n (%) of men with diagnosis who had a procedure   1,878 76 (79.2%) 664 (72.4%) 642 (74.2%) 
 
• Age OR= 0.99 (0.98 – 1.00) 
      Av. distance (km) (95%CI) from residence to health service for a first procedure 1,367 78.1 (59.0 – 97.1) 54.0 (47.5 – 60.4) 9.6 (8.2 – 11.0) 
      Unadjusted OR (95%CI) for procedure 1,878 1.00 0.69 (0.41 – 1.15) 0.76 (0.45 – 1.27) 
      Adjusted OR (95%CI) for procedure  1,878 1.00 0.71 (0.42 – 1.18) 0.79 (0.47 – 1.32) 
2.2 Chemotherapy - anti-neoplastic agents only 
(Procedure codes:  96199-00, 96200-00, 96201-00, 96202-00, 96203-00,  96204-
00, 96205-00, 96206-00, 96207-00, 96208-00, 96209-00)     
 
      n (%) of men with a cancer diagnosis who had a procedure*  1,878 9 (9.4%) 86 (9.4%) 145 (16.8%) 
 
• Age OR= 0.98 (0.96 – 0.995) 
• Private insurance with extras  
yes vs no OR= 2.97 (2.11 – 4.17) 
•  [Annual household income over $70,000   
yes vs no  OR= 1.30 (0.89 – 1.90)  ns]  
•  [Av distance to health service (per 10 km) 
OR= 0.97 (0.93 - 1.02) a non-significant    
confounder] 
• Cohort: rural non-farm vs. urban  
OR= 0.62 (0.44– 0.90) 
      Av. distance (km) (95%CI) from residence to health service for a first procedure 221 64.2 (0  – 156.5) 48.4 (30.4 – 66.5) 9.6 (7.8 – 11.4) 
      Unadjusted OR (95%CI) for procedure  [Rural vs. urban OR=0.62 (0.49 – 0.78)] 1,510 1.00 0.80 (0.38 – 1.66) 1.60 (0.78 – 3.29) 
      Adjusted OR (95%CI) for procedure   1,510 1.00 0.78 (0.37 – 1.67) 1.25 (0.58 – 2.72) 
2.3 Radiotherapy  
   (Procedure codes 15100-00 - 15269-09) 
    
 
     n (%) of men with diagnosis who had a procedure  1,878 <5 14 (1.5%) 25 (2.9%)  
     Av. distance (km) (95%CI) from residence to health service for a first procedure 37 168.2 (-) 125.6 (43.6 – 207.5) 8.3 (4.7 – 11.9) 
 
* Chi-square test of proportions between resident groups significant to .05 level. 
   Bold text – Odds ratio significant compared to farm resident referent group to .05 level 
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Table 8.2: Procedures performed on farm, rural non-farm and urban women, who had a breast or colorectal cancer diagnosis on any APDC admission record 2006-2012 
 
Procedures for those with selected cancer diagnosis              Total n               Farm           Rural       Urban Factors remaining in adjusted model 
1. Breast cancer  
     
1.1 Mastectomy  
   (Procedure codes 31518-00 – 31527-00) 
     
     %  of women with diagnosis who had procedure 3,188 63 (35.0%) 542 (35.8%) 530 (35.5%) 
 
• Age OR= 1.01 (1.00 – 1.01) 
     Av. distance (km) (95% CI) from residence to health service for first procedure 1,117 98.4 (67.8 – 128.9) 53.3 (46.2 – 60.3) 11.4 (9.6 – 13.2) 
     Unadjusted OR (95% CI) for procedure 3,188 1.00 1.04 (0.75 – 1.43) 1.02 (0.74 – 1.41) 
     Adjusted OR (95% CI) for procedure  3,188 1.00 1.01 (0.73 – 1.39) 0.99 (0.72 – 1.37) 
1.2 Excision, re-excision or open biopsy of lesion 
    (Procedure codes 31500-00 – 31515-00) 
    
 
      n / %  of women with diagnosis who had procedure 3,188 112 (62.2%) 910 (60.1%) 893 (59.8%) 
 
• Age OR= 0.98 (0.97 – 0.99) 
• Annual household income over $70,000/yr 
yes vs no OR= 1.29  (1.04 – 1.60) 
      Av. distance (km) (95% CI) from residence to health service for first procedure 1,842 96.7 (76.9 – 116.4) 51.0 (46.0 – 56.1) 11.2 (9.6 – 12.9) 
      Unadjusted OR (95% CI) for procedure 2,343 1.00 0.96 (0.66 – 1.40) 0.96 (0.66 – 1.39) 
      Adjusted OR (95% CI) for procedure  2,343 1.00 1.06 (0.73 – 1.55) 1.03 (0.70 – 1.50) 
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1.3 Chemotherapy - anti-neoplastic agents only  
(Procedure codes 96199-00, 96200-00, 96201-00, 96202-00, 96203-00, 96204-
00, 96205-00, 96206-00, 96207-00, 96208-00, 96209-00)      
      %  of women with diagnosis who had procedure*  3,188 22 (12.2%) 234 (15.5%) 382 (25.6%) 
 
• Age OR= 0.97 (0.96 – 0.98) 
• Annual household income over $70,000/yr 
yes vs no OR= 1.37 (1.07 – 1.75) 
• Private health insurance with extras 
yes vs no OR= 2.42 (1.91 – 3.05) 
• Av distance to health service (per 10 km) 
OR= 0.97 (0.94 – 0.995)   
• Cohort: rural non-farm vs. urban  
OR= 0.70 (0.55 – 0.88) 
      Av. distance (km) (95% CI) from residence to health service for first procedure 624 57.4 (29.4 – 85.5) 49.9 (38.0 – 61.7) 9.5 (8.5 – 10.5) 
      Unadjusted OR (95% CI) for procedure   2,330 1.00 1.38 (0.78 – 2.41) 2.58 (1.48 – 4.49) 
      Adjusted OR (95% CI) for procedure 2,330 1.00 1.56 (0.88 – 2.77) 2.24 (1.25 – 4.04) 
1.4 Radiotherapy  
    (Procedure codes: 15100-00 - 15269-09) 
    
 
      %  of women with diagnosis who had procedure 3,188 < 5 (<…% 32 (2.1%) 38 (2.5%) 
 
      Av. distance (km) (95% CI) from residence to health service for first procedure 71  62.8 (-) 138.9 (83.9 – 193.9) 7.9 (5.3 – 10.5) 
 
2. Colorectal cancer 
    
 
2.1 Colorectal surgery – colectomies, resections & excisions 
    (Procedure codes: 32000-00 – 32069-00, 32099-00 – 32108-00) 
    
 
      %  of women with diagnosis who had procedure 1,401 61 (76.3%) 549 (77.2%) 489 (80.2%) 
 
• Nil 
      Av. distance (km) (95% CI) from residence to health service for first procedure 1,089 92.9 (63.4 – 122.4) 55.9 (48.4 – 63.4) 10.7 (7.0 – 14.5) 
      Unadjusted OR (95% CI) for procedure 1,401 1.00 1.06 (0.61 – 1.82) 1.26 (0.73 – 2.19) 
      Adjusted OR (95% CI) for procedure  1,401 1.00 1.06 (0.61 – 1.82) 1.26 (0.73 – 2.19) 
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2.2 Chemotherapy – anti-neoplastic agents only  
(Procedure codes: 96199-00, 96200-00, 96201-00, 96202-00, 96203-00, 96204-
00, 96205-00, 96206-00, 96207-00, 96208-00, 96209-00)      
      %  of women with diagnosis who had procedure* 1,401 9 (11.3%) 63 (8.9%) 95 (15.6%) 
 
• Age OR= 0.95 (0.94 – 0.97) 
• Private insurance with extras 
yes vs no  OR= 2.07 (1.35 – 3.16) 
• [Annual household income $70,000 
yes vs no  OR= 1.16 (0.68 – 2.00) a non-
significant confounder] 
• Cohort: rural non-farm vs. urban  
OR= 0.57 (0.37 – 0.88) 
      Av. distance (km) (95% CI) from residence to health service for first procedure 159 71.1 (20.3 – 122.0) 82.5 (49.5 – 115.5) 15.8 (2.9 – 28.6) 
      Unadjusted OR (95% CI) for procedure 951 1.00 0.70 (0.29 – 1.61) 1.23 (0.53 – 2.84) 
      Adjusted OR (95% CI) for procedure    951 1.00 0.84 (0.35 – 2.01) 1.47 (0.62 – 3.49) 
2.3 Radiotherapy  
    (Procedure codes: 15100-00 - 15269-09) 
     
      %  of women with diagnosis who had procedure 1,401 <5 20 (2.8%) 12 (2.0%) 
 
      Av. distance (km) (95% CI) from residence to health service for first procedure  71 162  ( - ) 98.8 (32.9 – 164.6) 13.0 (5.1 – 20.9) 
 
 
* Chi-square test of proportions between resident groups significant to .05 level. 
Bold text – Odds ratio significant compared to farm resident referent group to .05 level 
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8.4.1   Cancer therapies in men 
• Prostate cancer 
Farm men were significantly more likely to have a prostatectomy than rural non-farm men, with 35% 
higher odds of the procedure. Younger age and private health insurance with extras were positively 
associated with prostatectomy. The average distance to treating health service for prostatectomy was 
progressively longer from urban, to rural non-farm to farm resident group, but this was not a significant 
factor in the likelihood of having a prostatectomy. Urban men also had significantly less distance to travel 
for chemotherapy, radiotherapy or brachytherapy than the other two resident groups.  
Small case numbers in the referent group affected calculation of odds ratios for both radiotherapy 
and chemotherapy for prostate cancer, resulting in wide confidence intervals that did not exclude the null 
value. With this in mind, farm men were more likely than rural non-farm men to have radiotherapy for 
prostate cancer. Conversely, farm men had lower odds of undergoing chemotherapy for prostate cancer 
than rural non-farm and urban men. Older age was positively associated with both radiotherapy and 
chemotherapy, private health insurance with extras was also positively associated with chemotherapy, 
but negatively associated with radiotherapy in the adjusted model.  
In contrast, urban men were significantly more likely to have brachytherapy for prostate cancer. The 
odds of brachytherapy for urban men were almost three times that of farm men and twice that of rural 
non-farm men. Higher household income, greater average distance from treating hospital and private 
health insurance with extras, were positively associated with brachytherapy.   
• Colorectal cancer 
Farm men were more likely to have a surgical procedure for colorectal cancer than rural non-farm and 
urban men respectively, but differences between groups were not significant. Younger age was associated 
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with colorectal cancer surgery. Both farm and rural non-farm men travelled significantly further for 
colorectal surgery and chemotherapy than urban men. 
Urban men had higher odds than both farm and rural non-farm men of undergoing chemotherapy for 
colorectal cancer, the latter being significant. Younger age was positively associated with chemotherapy. 
Men who had private health insurance with extras had almost three times the odds of having 
chemotherapy for colorectal cancer than those who did not.  
8.4.2   Cancer treatments for women 
• Breast cancer 
There was little difference between residence groups for surgical procedures of the breast. Farm and 
rural non-farm women had a significantly greater distance to travel for surgical treatment than urban 
women, but distance was not associated with having surgery in final models. Older age was associated 
with mastectomy; but younger age and those with above median household incomes were more likely to 
have an excision of breast lesion.  
Significantly, urban women had 2.2 times the odds of farm women of undergoing chemotherapy for 
breast cancer; and rural non-farm women 1.5 times the odds of farm women, although the latter was not 
significant. Younger age, above median household income and lesser average distance to travel, were 
positively associated with chemotherapy. Women with private health insurance with extras coverage had 
2.4 times the odds of undergoing chemotherapy for breast cancer. Less than five farm women in the 
cohort underwent radiotherapy for breast cancer, so models were not generated. Urban women had 
significantly less distance to travel than other groups for breast cancer chemotherapy and radiotherapy. 
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• Colorectal cancer 
There was little difference between farm, rural non-farm and urban women in the odds of undergoing 
colorectal surgery. The average distance to a treating hospital increased significantly from urban to rural 
non-farm, then farm groups, but again, this was not a significant factor in the likelihood of surgery.  
Similar to findings for men, urban women were significantly more likely to undergo chemotherapy for 
colorectal cancer than rural non-farm women; and more likely than farm women, although the latter was 
not significant. Younger age was positively associated with chemotherapy; and women who had private 
health insurance had twice the odds of having chemotherapy for colorectal cancer than those who did 
not. Results for radiotherapy were inconclusive, with less than five cases in the farm group. 
8.5   Discussion 
There were no significant differences between resident groups in the odds of having surgery for 
breast or colorectal cancer. However, farm men were significantly more likely to have surgery for prostate 
cancer than rural non-farm men. In contrast, urban men were significantly more likely to have 
brachytherapy than the other groups. Urban men were also the most likely to have chemotherapy for 
prostate cancer, significantly more so than rural non-farm men. Likewise, urban women were significantly 
more likely to have chemotherapy for breast cancer than either of the other groups. Urban residents 
were also significantly more likely than rural non-farm counterparts to have chemotherapy for colorectal 
cancer. There were insufficient farm resident cases to examine likelihood of radiotherapy for breast and 
colorectal cancers; and whilst farm men were more likely to have radiotherapy for prostate cancer than 
rural non-farm men, this difference was not statistically significant.  
Lesser distance to a treating hospital was a significant factor for breast cancer chemotherapy. 
Conversely, greater distance from health service, higher income and private health insurance with extras 
were associated with brachytherapy. Private health insurance with extras was also associated with 
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chemotherapy for prostate, breast and colorectal cancers; and with prostatectomy. Higher income was 
also positively associated with breast conserving surgery (excision of lesion) and chemotherapy, in breast 
cancer cases.   
While farm specific data are unavailable, findings in the Australian literature for the provision of 
prostate, breast and colorectal cancer therapies to rural populations, are mixed. Some studies have 
reported comparable levels of cancer-related surgery and chemotherapy in urban and rural cancer 
patients.10-13 Others have reported lower rates of prostatectomy, breast conserving surgery, radiotherapy 
and chemotherapy in rural areas.2, 11-15 
Apart from socioeconomic difficulties related to travel, availability of specialist services can be an 
issue in rural areas.2  Historically, limited access to specialist urologists was one reason suggested for 
lower rates of radical prostatectomy in rural areas in the 1990’s;16-17 but farm and rural non-farm men 
were not disadvantaged compared to urban men in our study. Farm men underwent more 
prostatectomies, but this may have been because urban men were more likely to have chemotherapy and 
brachytherapy as alternative treatments. Brachytherapy is a viable alternative to radical prostatectomy 
for early prostate cancer, but is available in less than half of all Australian radiation oncology facilities.18 
This may help to explain the higher uptake of this therapy amongst urban men in our study and the 
simultaneous reduced reliance on prostatectomy.  
Interestingly, while urban residents had the least distance to travel for a first brachytherapy 
procedure; greater distance was associated with brachytherapy in the final model. There was no evidence 
of collinearity, so the apparent contradiction is likely related to derivation of the distance measure used in 
logistic regression modeling, where a dichotomous outcome for therapy was required. This calculated 
average distance to health services for all prostate cancer case records over the period, for those who did 
and those who did not have brachytherapy. Relating back to limited supply of radiation oncology facilities, 
those who had therapy were likely to have travelled further than the nearest health facility to have done 
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so, even in urban areas. That is, regardless of cohort residence, brachytherapy was associated with a 
greater distance to travel to obtain the service.  
Surgery for colorectal cancer was reportedly lower amongst rural compared to urban residents in 
Queensland, but comparable in South Australia.10, 13 Early surgical management for breast cancer in rural 
and urban patients by an ACT facility was also reportedly comparable.12 In contrast, the proportion of 
breast conserving surgeries or overall surgical procedures for breast cancer, was lower in rural women in 
Queensland and Western Australia, compared to urban counterparts.11 13, 19 Our study did not have 
sufficient numbers to assess radiotherapy, which was also reportedly lower in rural women with breast 
cancer.11-12    
Chemotherapy was highest amongst urban people for all three cancers examined in our study. 
Delayed or lower odds of chemotherapy for breast and colorectal cancer patients in rural NSW have been 
reported previously.14-15 In contrast, studies from South Australia and Western Australia  have reported 
similar levels of chemotherapy administration for breast and colorectal cancer patients in urban and rural 
patients.10-11 In these states, more centralised treatment models have developed to service sparse 
populations outside capital cities, which contrasts with rural NSW where there are sizeable regional 
populations.10    
Findings for chemotherapy and radiotherapy in our study should be considered with some caution, 
due to low case numbers, impacting upon confidence intervals and the potential significance of 
differences observed. Validation studies have also found these procedures to be underreported in the 
APDC; and prostate cancer therapies less accurately recorded for non-urban cases. Potentially, the latter 
could lead to a positive bias toward higher odds of prostate cancer therapies amongst urban men. In 
contrast, surgical treatments and brachytherapies are usually well captured.20-21   
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Other limitations include the 45 and Up Study cohort not being completely representative of the NSW 
population, although linkage with population datasets has shown that biases are limited.4, 22 Also, the 
definition of a ‘farm resident’ in this study was also open to respondents’ interpretation of a ‘farm’ and 
could include small holdings used for commercial, recreational or both purposes. Consequently,  
exposures, practices and lifestyles of farm residents may vary or are not clearly defined.23 This could 
affect the representativeness of sub-groups and internal validity of comparisons made. However, 
misclassification errors are likely to be non-differential and independent of other risk factors, leading to a 
null bias and underestimation of relationships between farm residence and cancer screening. 
Notwithstanding these limitations, our study found that cancer-related surgical services were 
generally comparable between farm, rural non-farm and urban residents for breast and colorectal 
cancers. Farm men were more likely to have a prostatectomy, but this may have been related to higher 
utilisation of chemotherapy and brachytherapy as alternative treatments by urban men. Age, distance to 
health services, income and health insurance factors contributed to differences in non-surgical care 
between groups.  
The significantly higher utilisation of non-surgical services by urban residents in this study (up to 
2012), supports earlier reports of disadvantage in specialist cancer services in rural areas.2  In addition, 
our study suggests the disadvantage is similar across farm and rural non-farm resident groups. Challenges 
for oncology service provision in rural areas include rural demographics, communications technology, 
recruitment and retention of technically qualified personnel and the planning and coordination of 
surgical, pathology and oncology services.10, 14, 18, 24 Ongoing development of the Rural Cancer Centres 
initiative, telemedicine and CanNET cancer networking services, are likely to address rural-urban 
imbalances and improve the accessibility, quality and coordination of rural cancer services in the years to 
come.24-25  
282 
 
8.6   Acknowledgements  
The 45 and Up Study is managed by the Sax Institute in collaboration with major partner Cancer 
Council NSW; and partners: the National Heart Foundation of Australia (NSW Division); NSW Ministry of 
Health; NSW Government Family & Community Services - Ageing, Carers and the Disability Council NSW; 
and the Australian Red Cross Blood Service. We would like to thank the many thousands of people 
participating in the 45 and Up Study.  
8.7   Appendix  
283 
 
Table 8.3: Comparison of chemotherapy procedures performed on farm, rural non-farm and urban men with a prostate or colorectal cancer diagnosis on any 
hospital admission record 2006-2012, using different APDC chemotherapy code ranges  
 
 
Chemotherapy procedures 
for those with selected 
cancer  
Anti-neoplastic agents only (main analyses) 
(Procedure codes:  96199-00,  96200-00, 96201-00, 96202-00, 96203-00, 96204-00, 96205-00, 
96206-00, 96207-00, 96208-00, 96209-00) 
All chemotherapy codes, including steroids, anti-infectives and others (sensitivity analyses)  
(Procedure codes:  96199-00 - 96209-00) 
       Total n         Farm         Rural           Urban 
Factors remaining  
in adjusted model 
    Total n           Farm           Rural           Urban 
Factors remaining  
in adjusted model 
 Prostate cancer 
 
   
 
     
n (%) of men with a 
diagnosis who had a 
procedure 
5,638 
8  
(2.2%) 
78  
(3.0%) 
119  
(4.5%) 
 
• Age OR= 1.04 (1.03 – 1.06) 
• Private insurance with 
extras yes vs. no  
OR= 1.56 (1.15 – 2.10] 
• [Av. distance to health 
service (per 10 km)  
OR= 0.96 (0.93 – 1.00) a 
non-significant confounder]  
 
5,638 
15  
(4.0%) 
187  
(7.1%) 
201  
(7.6%) 
 
• Age OR= 1.05 (1.03 – 1.06) 
[Household income over 
$70,000/yr  yes vs. no  
OR= 1.11 (0.82 – 1.50)  a 
non-significant confounder]   
•  [Av. distance to health 
service (per 10 km)  
OR= 0.99 (0.99 – 1.00)  a 
non-significant confounder] 
Av. distance (km) (95%CI) 
from residence to health 
service for a first  procedure 
164 56.05 (22.0 – 90.1) 
49.0 
(30.0 – 68.0) 
11.0 
(8.0 – 14.1) 292 
44.9 
(24.6 – 65.2) 
52.9 
(35.9 – 70.0) 
11.0 
(8.8 – 13.1) 
Adjusted OR (95%CI) for 
procedure 
5,600 1.00 1.14 (0.54 – 2.42) 
1.33 
(0.62 – 2.88) 4,665 1.00 
1.36  
(0.76 – 2.45) 
1.20  
(0.66 – 2.18) 
 Colorectal cancer  
 
   
      
n (%) of men with a cancer 
diagnosis who had a 
procedure  
1,878 
9  
(9.4%) 
86  
(9.4%) 
145  
(16.8%) 
 
• Age OR= 0.98 (0.96 – 0.995) 
• Private insurance with 
extras yes vs. no  
OR= 2.97 (2.11 – 4.17) 
• [Annual household income 
over $70,000/yr  yes vs. no  
OR= 1.30 (0.89 – 1.90)  a 
non-significant confounder] 
•  [Av distance to health 
service (per 10 km)  
OR= 0.97 (0.93 - 1.02)  a  
non- significant confounder] 
• Cohort: rural non-farm vs. 
urban OR= 0.62 (0.44– 0.90) 
 
1,878 
17  
(17.7%) 
156  
(17.0%) 
215  
(24.9%) 
 
• Private insurance with 
extras yes vs. no  
OR= 1.98 (1.57 – 2.49) 
• Cohort: rural non-farm vs 
urban OR= 0.67 (0.53– 0.84) 
Av. distance (km) (95%CI) 
from residence to health 
service for a first procedure 
221 
64.2 
(0  – 156.5) 
48.4 
(30.4 – 66.5) 
9.6 
(7.8 – 11.4) 
227 
91.8 
(25.0 – 158.6) 
46.9 
(31.3 – 62.4) 
9.1 
(7.7 – 10.5) 
Adjusted OR (95%CI) for 
procedure   
1,510 1.00 
0.78 
(0.37 – 1.67) 
1.25 
(0.58 – 2.72) 
1,877 1.00 
0.99 
(0.57 – 1.73) 
1.49 
(0.86 – 2.58) 
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Table 8.4: Comparison of chemotherapy procedures performed on farm, rural non-farm and urban women with a breast or colorectal cancer diagnosis on any 
hospital admission record 2006-2012, using different APDC chemotherapy code ranges  
 
Chemotherapy 
procedures for those with 
selected cancer  
Anti-neoplastic agents only (main analyses) 
(Procedure codes:  96199-00,  96200-00, 96201-00, 96202-00, 96203-00,   96204-00, 96205-00, 96206-
00, 96207-00, 96208-00, 96209-00) 
All chemotherapy codes, including steroids, anti-infectives and others (sensitivity analyses)  
(Procedure codes:  96199-00 - 96209-00) 
Total n         Farm        Rural      Urban 
Factors remaining  
in adjusted model 
 Total n        Farm      Rural      Urban 
Factors remaining  
in adjusted model 
 Breast cancer 
 
   
 
     
n (%) of women with a 
diagnosis who had a 
procedure 
3,188 22 (12.2%) 234 (15.5%) 382 (25.6%) 
• Age  OR= 0.97 (0.96 – 0.98) 
• Annual household income 
over $70,000/yr yes vs no  
OR= 1.37 (1.07– 1.75) 
• Private health insurance 
with extras yes vs no   
OR= 2.42 (1.91 – 3.05) 
• Av distance to health service 
(per 10 km)   
OR= 0.97 (0.94 – 0.995)   
• Cohort: rural non-farm vs 
urban OR =0.70 (0.55 – 0.88) 
3,188 27 (15.0%) 272 (18.0%) 416 (27.8%) • Age  OR=0.98 (0.97 – 0.99) 
• [Annual household income 
over $70,000/yr yes vs no   
OR= 1.39 (1.09– 1.76) a  
non-significant confounder]   
• Private health insurance 
with extras yes vs no   
OR= 2.22 (1.79 – 2.77) 
• Cohort: rural non-farm vs 
urban OR=0.68 (0.55 – 0.85) 
Av. distance (km) (95%CI) 
from residence to health 
service for a first  procedure 
624 
57.4  
(29.4 – 85.5) 
49.9  
(38.0 – 61.7) 
9.5  
(8.5 – 10.5) 
770 
58.9  
(34.2 – 83.6) 
46.8  
(35.9 – 57.8) 
9.4  
(8.4 – 10.4) 
Adjusted OR (95%CI) for 
procedure 
2,330 1.00 
1.56  
(0.88 – 2.77) 
2.24  
(1.25 – 4.04) 
2,342 1.00 
1.62  
(0.95 – 2.75) 
2.36  
(1.40 – 4.00) 
 Colorectal cancer  
 
   
 
     
n (%) of women with a 
cancer diagnosis who had 
a procedure  
1,401 9 (11.3%) 63 (8.9%) 95 (15.6%) • Age OR= 0.95 (0.94 – 0.97) 
• Private insurance with 
extras yes vs no   
OR= 2.07 (1.35 – 3.16) 
• [Annual household income 
$70,000/yr  yes vs no   
OR= 1.16 (0.68 – 2.00) a  
non-significant confounder] 
• Cohort: rural non-farm vs 
urban OR= 0.57 (0.37 – 0.88) 
1,401 12 (15.0%) 128 (18.0%) 126 (20.7%) • Age OR=0.98 (0.96 – 0.99) 
• Private insurance with 
extras yes vs no   
OR= 1.68 (1.20 – 2.36) 
• [Annual household income 
$70,000/yr yes vs no   
OR= 0.97 (0.60 – 1.59)  a  
non-significant confounder] 
 
Av. distance (km) (95%CI) 
from residence to health 
service for a first 
procedure 
159 
71.1  
(20.3 – 122.0) 
82.5  
(49.5 – 115.5) 
15.8  
(2.9 – 28.6) 
221 
67.3  
(17.9 – 110.8) 
57.1  
(35.9 – 78.3) 
14.3  
(3.7 – 24.8) 
Adjusted OR (95%CI) for 
procedure   
951 1.00 
0.84  
(0.35 – 2.01) 
1.47  
(0.62 – 3.49) 
951 1.00 
1.07  
(0.51 – 2.23) 
1.28  
(0.61 – 2.68) 
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Chapter 9:   Discussion 
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9.1   Context  
The central aim of this study was to compare cancer indicators between Australian farm 
residents and their non-farm and urban counterparts. Information on the comparative cancer profile 
of Australian farm residents has the potential to contribute to the evidence base on which rural 
health policy and resourcing decisions are made. Farmers and farm families have particular 
characteristics regarding their age profile, employment, lifestyle, potential environmental exposures 
and socio-economic conditions. This has raised questions elsewhere as to whether farmers have a 
different cancer profile to other rural or urban people. The majority of farms and farm families in 
Australia are located in inner and outer regional areas; so they are likely to share some 
characteristics of the larger rural population of which they form a part.1-2 
An overview of cancer in rural Australia provided background context to the research. Generally, 
urban residents had lower cancer incidence and mortality than rural people. Regional areas tended 
to have the highest incidence and mortality from melanoma, prostate and colorectal cancer. Remote 
and very remote areas tended to have the highest incidence and mortality for lung cancer and the 
highest mortality for all cancers. Patterns for breast cancer and lymphoma by remoteness category 
were variable. 
Measures of cancer screening and treatments can provide some insight into health service 
access and utilisation in different areas. Compared to urban areas, there are some indications of 
higher health system utilisation and screening in regional areas, which then fall as areas become 
more remote. A range of socio-demographic characteristics, rather than geography itself may be 
important in influencing general health and cancer indicators. In rural areas these include older age, 
higher levels of risky health behaviours, income and educational disadvantage, lower utilisation of 
preventative health services, limited access to some healthcare services; and a higher proportion 
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Indigenous Australians.1, 3-9 Geographic distance may also contribute both to delays in diagnosis and 
decisions regarding cancer treatment.1 10  
Given limited Australian studies of cancer risk in farmers, a review of the international literature 
was conducted. The strength of evidence for an excess risk in farm groups in the review of studies 
published since 2003 was generally weaker than in previous reviews. Most studies in our review 
reported neutral findings. Overall deficits in all cancer, lung and colorectal cancer risk were 
suggested, similar to previous reviews. A deficit or neutral risk of breast cancer and neutral risk of 
melanoma was also suggested; with mainly neutral but some excess risk suggested for 
lymphohaematopoietic cancers. Previous reviews and one Australian study had reported higher 
prostate cancer risk in farmers, so this was the subject of a specific review for this Project, published 
in 2014. Essentially, neutral or mixed findings were apparent for prostate cancer risk in farmers, 
depending on study methods and location, such that the overall evidence for elevated prostate 
cancer risk in farmers was also weak. 
The cancer risk profile of farmers may have improved in recent years, but review findings may 
have been a result of greater control for confounders in more recent studies. In any case, there was 
little evidence for an excess risk in farmers for most cancers, with the possible exception of prostate 
and some lymphohaematopoietic cancers, for which the evidence was still weak. There was 
insufficient evidence on differences in cancer stage at diagnosis or treatment between farm and 
non-farm groups; and the evidence on differential cancer screening practices was also low or lacking.  
Information on Australian farm residents was extremely limited and there was very little 
information on health service related factors. This was the background to the series of data linkage 
studies undertaken in this Project, to determine if there were differences between NSW farm 
residents, compared to non-farm rural and urban residents, in cancer incidence or mortality; stage at 
diagnosis, screening and selected cancer therapies; or in common risk factors that might be 
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associated with these cancers. The 45 and Up Study cohort enabled identification of farm residents, 
not otherwise identifiable in standard population-wide health reports. Comparison of cancer 
indicators between groups was then made possible through data linkage to administrative health 
datasets.  
9.2   Findings and contribution of component studies to the literature 
With no previous Australian and very few international studies comparing cancer indicators 
between farm, rural non-farm and urban residents, this series of studies offers a unique contribution 
to the cancer epidemiology literature.  
9.2.1   Mortality 
The first study examined cancer mortality and cancer risk factors in farm, rural non-farm and 
urban residents of the 45 and Up Study cohort. Data for the cohort were linked with NSW death 
registrations and cause of death data for 2006 - 2012. Direct age-standardised mortality ratios and 
adjusted hazard ratios were compared between groups for all cancers, prostate, breast, lung and 
colorectal cancers, NHL and melanoma.  
Farm, rural non-farm and urban residents in the cohort differed in a range of characteristics, but 
most notably, farm residents were younger than the other cohorts. Therefore, it was important to 
control for age in all comparisons. Differences in smoking status, alcohol consumption, 
overweight/obesity, tannability and family history of selected cancers were generally small. Farm 
residents had noticeably higher average sun exposure and red meat consumption; and considerably 
more urban residents had annual household incomes over the median level.  
Consistent with the direction of review findings, farm residents had lower all cancer mortality 
risk than rural non-farm or urban residents, but confidence intervals for fully adjusted measures did 
not exclude unity. There was a significant deficit in the all cancer SMR in farm men compared to 
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rural non-farm and urban men. Farm men also had a considerable deficit in colorectal cancer 
mortality, although this was not significant. Also consistent with review trends, there were slight 
non-significant elevations in melanoma and prostate cancer mortality in farm men. There was also a 
non-significant reduction in NHL mortality risk in farm men. The latter was consistent with an overall 
neutral review finding, although the review more commonly reported slight elevations rather than 
deficit risk in farmers.  
Farm women had a similar all cancer SMR to farm men, although differences between groups 
were not significant. In contrast, breast cancer SMR in farm women was significantly lower than 
unity; and mortality hazard two-thirds of and significantly lower than rural non-farm women, when 
controlling for other risk factors. Findings for lower melanoma risk were tempered by low numbers; 
and while colorectal and lung cancer mortality was also lower in farm women, this was not 
significant.  
Risk factors of particular interest were smoking and sun exposure. Current smokers had 16 - 18 
times the adjusted hazard of mortality as that of never smokers; and risks of melanoma and several 
other cancers were higher amongst those with very limited sun exposure of less than 1 hour/day, 
compared to those with regular exposure of 1-4 hours per day.   
Overall, farm residents in this cohort had a neutral or non-significantly lower cancer mortality 
risk profile compared to rural non-farm and urban residents.  
9.2.2   Incidence 
The second study compared cancer incidence and linked 45 and Up Study cohort data to NSW 
Cancer Registry data for the years 2006 - 2009. Direct age-standardised incidence ratios and hazard 
ratios were compared for all cancer, prostate, breast and colorectal cancers, melanoma and NHL.  
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The adjusted hazard ratio for all cancer incidence in farm men and women was around 10% 
lower than in rural non-farm and urban counterparts; and significantly lower than combined rural 
non-farm and urban groups. Farm women also had a significantly lower adjusted all cancer hazard 
than rural non-farm women. Differences in all cancer incidence were mainly due to lower lung 
cancer incidence risk in farm residents. Although not significant in itself, lung cancer incidence and 
likelihood in farm residents were one half to two-thirds that of rural non-farm and urban residents. 
The direction of findings for all cancer and lung cancer, were largely consistent with review findings.  
Farm women had by far the lowest melanoma incidence, being highly significant, but caution is 
advised due to low case numbers. There was little evidence of any difference in incidence of breast 
or colorectal cancers; and results were inconclusive for NHL.  
Regarding risk factors, hazard ratios for lung cancer were 18 times higher in men and 9 times 
higher in women who were current compared to never smokers. Minimal sun exposure of less than 
an hour a day was associated with higher hazard for several cancers, including melanoma. Whilst 
there is some evidence of this effect elsewhere,11-14 it is feasible that minimal sun exposure may 
have also been a proxy for limited physical activity in this cohort.  
Similar to mortality, findings suggest farm residents in this cohort were not at a disadvantage 
regarding risk of prostate, breast, lung and colorectal cancers, melanoma or NHL; with similar or 
non-significantly reduced risk for most of the cancers examined.  
9.2.3  Stage at cancer diagnosis 
The third study in the series also used NSW Cancer Registry records from 2006-2009, to compare 
the adjusted odds ratio of non-localised cancer stage between resident groups for prostate, breast 
and colorectal cancers. Caution was advised with results for prostate cancer, as one third of cases in 
the NSW Cancer Registry had no recorded stage. Rural non-farm men were significantly less likely 
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than urban men to be diagnosed at later stage of prostate cancer, while farm men were not 
disadvantaged compared to either group. In contrast, farm men had a greater proportion and twice 
the odds of the other groups of being diagnosed with later stage colorectal cancer, although 
confidence intervals did not exclude unity. 
Farm women were least likely to be diagnosed with later stage breast cancer; and less likely than 
rural non-farm women to have later stage colorectal cancer, although results were not significant. 
Higher household income was associated with later stage breast and prostate cancer, but private 
health insurance with extras associated with earlier stage prostate cancer.  The different patterns of 
risk, especially between farm and rural non-farm men were not explained by the risk factors 
assessed.  
Our findings for prostate cancer in men and for breast and colorectal cancer in women were 
similar to the limited evidence in the literature on cancer stage in farm versus non-farm groups.15-16 
When considering rural versus urban patterns, findings were also consistent with other studies in 
Australia for breast cancer and colorectal cancer.17-19 Although not significant, the higher odds for 
later colorectal cancer in farm men compared to both urban and rural non-farm men warrants 
further investigation, as it may have implications for screening and earlier or more appropriate 
diagnostic services in rural areas.  
9.2.4   Screening 
The fourth study compared cancer screening practices between resident groups for participants 
under 75 years in those without prior cancer. Self-report data from the 45 and Up Study baseline 
survey were compared for prostate, breast and colorectal cancer. Data linkage with the MBS 
enabled comparison of the average number of screening tests and General Practitioner visits per 
person (age-adjusted), claimed by service providers for the 2004-2011 period. For cervical cancer 
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screening, data were linked with NSW Pap Test Register records for 2006-2012. Age-adjusted 
comparisons were made using general linear regression and logistic regression.  
Farm residents were significantly least likely to visit a GP, but screening practices between farm 
and rural non-farm residents were generally similar. Urban residents, however, had significantly 
more prostate specific antigen (PSA) tests, Pap tests, mammograms and colonoscopies than either of 
the other groups; and more likely to report ever having a mammogram or colonoscopy. In contrast, 
farm and rural non-farm residents had significantly more FOBTs than urban counterparts; and were 
around one third more likely than urban residents to report ever having a FOBT. Farm residents 
were most and significantly more likely than rural non-farm men to report ever having a PSA test - 
and both rural groups significantly more likely than urban counterparts to report ever having or ‘any’ 
form of colorectal screening test.  
Overall, screening practices of farm and rural non-farm residents were similar. However, results 
suggested that compared to urban residents, both rural groups had lower utilisation and perhaps 
reduced access to procedural screening services. Other Australian studies have reported lower 
cancer screening rates in rural compared to urban areas,20-21 although participation in population-
based breast, cervical and colorectal cancer screening programs, have generally been higher in 
regional rather than urban areas.22-24 Lack of access to specialist colonoscopy services may have 
explained the relatively higher usage of FOBT’s by farm and rural residents.  
9.2.5 Cancer therapies 
The fifth and final study of the series examined differences in common cancer therapies for 
prostate, breast and colorectal cancers. The 45 and Up Study data were linked with data from the 
NSW Admitted Patients Data Collection (APDC) for 2006-2012. Surgical, chemotherapy, radiotherapy 
and brachytherapy procedures were compared for those with a diagnosis of prostate, breast or 
colorectal cancer over the period. Average distance to treating hospital for each therapy was 
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determined and logistic regression used to compare the odds of receiving treatment, controlling for 
age, income and private health insurance status. 
Farm men were significantly more likely to have a prostatectomy than rural non-farm men, but 
differences for breast and colorectal cancer surgery were not significant. Farm and rural non-farm 
residents were significantly less likely to have brachytherapy; and had lower odds of chemotherapy 
procedures than urban counterparts. In particular, farm and rural non-farm women were 
significantly less likely to have chemotherapy for breast cancer than urban women. Rural non-farm 
residents were also significantly less likely to have chemotherapy for colorectal cancer; whilst urban 
men had almost three times the odds of having brachytherapy. Age, distance, income and health 
insurance factors contributed to differences in non-surgical care between groups.  
In general, cancer-related surgical services for breast and colorectal cancer were comparable 
between groups. Findings for chemotherapy and radiotherapy in our study should be considered 
with caution due to the small number of farm cases used to calculate odds ratios, present in the data 
set. However, findings suggest farm and rural non-farm residents may have been disadvantaged in 
relation to non-surgical therapies for prostate, breast and colorectal cancer. This is consistent with 
findings of other studies on rural versus urban cancer services.25-28 Difficulties for rural cancer service 
provision include communications technology, recruitment and retention of technically qualified 
personnel and the planning and coordination of services.25, 29 There was no comparable farm specific 
data in the literature with which to compare our results for higher odds of prostatectomy in farm 
versus rural non-farm men, but this shall be discussed in light of our own earlier findings on 
mortality, incidence, stage and screening for this cohort, in the following section.  
9.3   Patterns in cancer indicators across studies 
This section aims to examine the pattern of cancer indicators across studies. Firstly, it needs to 
be reiterated that most differences in cancer indicators between resident groups, were not 
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statistically significant; so inferences are largely exploratory. However, it is logical and indeed 
possible that some of the indicators examined in each study separately, may be having an impact 
upon other indicators, for any one cancer.  
• Prostate cancer 
For prostate cancer, there was little difference between groups in cancer incidence risk; and 
whilst there were some differences between groups in mortality and stage of diagnosis, most 
confidence intervals did not exclude unity. Acknowledging this, SMR was 20-25% higher and 
adjusted hazard 10-20% higher in farm residents compared to other groups. If indeed true, this 
pattern could potentially reflect less effective or perhaps later detection of prostate cancer in 
farmers compared to others. Stage at prostate cancer diagnosis was similar between farm and urban 
men, but the adjusted odds for rural non-farm men was two-thirds that of other men. This may have 
contributed to the slightly elevated mortality in farm residents, at least relative to rural non-farm 
men. Unfortunately, the high level of unrecorded stage for prostate cancers in the NSW CR data, 
does limit inferences that can be made of how stage at diagnosis might influence other indicators.  
Cancer screening may provide some insight as to whether prostate cancers were being detected 
at an earlier stage, when treatment is likely to be more effective. Results for PSA testing in the MBS 
suggested PSA screening was significantly lower in farm compared to urban men, but similar to rural 
men. So, while farm men were more likely to be diagnosed at later stage than rural non-farm men, 
(although not significantly), screening practices appear to be similar between these two groups. 
Conversely, screening was significantly lower in farm men than urban men, yet these had similar 
stage of diagnosis profiles. These seemingly unrelated associations for screening and stage, may be a 
symptom of the unrecorded stage component and low case numbers in the farm group; or could 
suggest that less comprehensive screening is not necessarily linked to higher mortality.  
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While cognizant that the low case numbers in the farm group impacts upon the power to detect 
a difference between groups for some analyses, the other factor examined that may have been 
associated with higher mortality in the face of similar incidence rates, were cancer treatments. Farm 
men had significantly greater odds of prostatectomy than rural non-farm men, and non-significantly 
greater odds than urban men. Clinically, prostatectomy is a common therapy for early prostate 
cancer, with the aim of removing the lesion before it spreads beyond the prostate gland and 
adjacent tissues. Chemotherapy, radiotherapy and brachytherapy regimes may or may not be 
provided as an additional support to surgical measures. Alternatively, non-surgical therapies are 
often used without surgery in advanced prostate cancer.30-31  
Relating treatments back to stage data, while farm and urban men had similar odds for later 
stage diagnosis, farm men were far less likely to have chemotherapy or brachytherapy. Significantly, 
the odds of brachytherapy in farm men were only one third that of urban men; and a non-significant 
three-quarters that of rural men. Therefore, whilst acknowledging confidence intervals for prostate 
cancer mortality risk did not exclude unity, can the higher risk of mortality in farm men be partly 
explained by fewer farm men having non-surgical or combined therapies for prostate cancer than 
other men?   
• Breast cancer in women 
Differences in incidence of breast cancer between groups were not significant, but farm women 
had slightly lower adjusted hazard and 13-14% lower SIR than either of the other two groups. 
Several common cancer risk factors were controlled for, including sun exposure, which was 
significantly higher amongst farm women in this cohort and has been linked to lower breast cancer 
risk elsewhere.13-14 However, as previously outlined, higher sun exposure may also be acting as a 
proxy for greater physical activity. This is known to be protective against breast cancer, but was not 
controlled for in this study.32  
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The difference between groups in breast cancer was more prominent for mortality, where 
significantly, farm women had a lower SMR than other groups; and lower adjusted hazard ratio than 
rural non-farm women. When examining stage at diagnosis, farm women also had the lowest odds 
of being diagnosed at later stage, though non-significant. This may also contribute to lower mortality 
in farm women. The factors underpinning why farm women were less likely to be diagnosed at later 
stage are unclear. Both MBS and self-reported screening results suggest breast cancer screening in 
this cohort was actually higher amongst urban women; and differences in frequency were not 
significant. While MBS data excluded participants of the free mobile Breastscreen program 
promoted particularly well in rural areas, self-reported screening was also lower amongst farm 
women. Screening patterns do not appear to adequately explain why farm women had lower 
mortality or odds of later stage diagnosis although low farm case numbers were also a likely issue.  
There was very little difference in the adjusted odds of breast cancer surgery between groups, 
whether for breast conserving excision of a lesion, or radical mastectomy. However, farm women 
were much less likely to undergo chemotherapy for breast cancer, with odds two thirds that of rural 
non-farm women and significantly less than half those of urban women. Chemotherapy is not 
necessarily indicated for women who are at early stage of disease, unless tumours are larger or the 
risk of breast cancer recurrence is high.33 This may well fit with the greater odds of earlier stage 
breast cancer diagnosis in farm women. Whilst clinical treatment decisions are made on a case by 
case basis, this may be one reason farm women as a group had less chemotherapy, rather than there 
being a lack of access to breast cancer chemotherapy services. If the latter was the case, the odds of 
chemotherapy and mortality risk of farm and rural non-farm women would be similar, but they are 
not. Conversely, both the odds of chemotherapy and risk of mortality from breast cancer for farm 
women was significantly lower than for rural non-farm counterparts. 
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For this cohort, although not significant, slightly lower incidence and odds of later stage 
diagnosis of breast cancer in farm women; together with significantly lower rates of chemotherapy 
suggestive of cancers treated at an earlier stage, may all combine to produce a significantly lower 
breast cancer mortality profile in farm women. The role of screening in leading to earlier diagnosis 
was not apparent in the data; but Breastscreen monitoring reports and previous studies of screening 
in this cohort suggest participation is better in regional areas.34-35 Others have reported a 15-30% 
reduction in mortality in women aged 50-69 years who screen for breast cancer.36 Promotion of 
Breastscreen has been strongly supported in rural areas by community organisations, including the 
Country Womens Association. Farm women may have benefited most from higher rates of breast 
screening in regional Australia.  
• Colorectal cancer in women 
There was little difference in the SIR or hazard ratio for incidence of colorectal cancer in women. 
However, colorectal cancer mortality in farm women was around two-thirds that of other groups, 
although this was not a significant difference.  As with breast cancer, it is possible that farm women 
were being diagnosed and treated at an earlier stage, compared to rural non-farm women at least, 
even though FOBT screening patterns were similar for the two rural groups. Farm and rural non-farm 
women, both had significantly more FOBT’s than urban women, but colonoscopies were significantly 
more likely amongst urban women then either rural group, suggestive of higher access to this service 
in urban areas.  
For surgery, farm and rural non-farm women had lower odds of surgery than urban women, 
although not significantly so. The odds of chemotherapy for both farm and rural non-farm women 
were around two-thirds that of urban women, being significantly lower for rural non-farm women.  
This scenario is suggestive of a disadvantage for rural women in access to both surgical and 
chemotherapy services, although again, small numbers may be responsible for observed patterns.  
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Lower colorectal cancer mortality in farm women remains unexplained, although compared to 
rural non-farm women, earlier stage of diagnosis may be a contributing factor, despite similar 
screening and treatment patterns between these two groups. As suggested for breast cancer 
mortality, the protective effect of greater levels of physical activity amongst farm women, may have 
contributed to better survival from colorectal cancer.32 It cannot be ruled out however, that lower 
mortality amongst farm women, was a consequence of the relatively low case numbers in the farm 
group and may have been due to chance. A longer follow-up time likely to produce more stable odds 
ratios for comparative purposes.  
• Colorectal cancer in men 
There were no significant differences in incidence or mortality due to colorectal cancer between 
groups of men, although the hazard for incidence in farm men was slightly lower than rural men; and 
mortality hazard in farm men around two-thirds that of other groups. This is despite the odds of 
later stage diagnosis in farm men, being twice that of rural non-farm and urban men (though not 
significant); and screening patterns in farm men being similar to rural non-farm men.  
Screening patterns for colorectal cancer in men were similar to women. That is, farm men had 
significantly more FOBT’s than urban counterparts, but a similar likelihood to rural non-farm men. 
Colonoscopies were significantly higher amongst urban men than the rural groups, suggestive of 
higher access to this service in urban areas. It is also possible that urban men may be having suspect 
lesions removed during colonoscopy as they are detected, without requiring more invasive surgery 
at a later time.  
Although not significant, odds of colorectal cancer surgery for farm men were around a third 
higher in farm men than other groups. In contrast, the odds of chemotherapy were lower in farm 
and rural non-farm men than urban men, the latter significantly so. This suggests perhaps more 
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limited access to chemotherapy treatment options in rural areas. Again, whilst farm case numbers 
were small and most differences not significant, taken together, the greater odds of later stage 
diagnosis in farm men and lower odds of chemotherapy for both farm and rural men, may be a 
concern for provision of early colorectal cancer diagnosis and care in rural areas. However, the 
question remains:  if farm men have greater chance of later stage diagnosis and both farm and rural 
non-farm men have less optimal treatments, why does this not translate to higher rates of 
mortality? This may be an artefact of data limitations in this study, or perhaps as for women, lower 
mortality observed in farm men may be a consequence of factors affecting survival other than stage 
and treatments that were not controlled for in this study, such as physical activity.  
• Incidence and mortality due to lung cancer, melanoma and NHL  
 
There were insufficient newly diagnosed cases of lung cancer, melanoma and NHL in the farm 
group to examine and compare stage at diagnosis or treatments in this study. However, comparing 
incidence and mortality for these cancers may provide insights on what may be happening at a 
group level. However, considering the impact of small case numbers and wide confidence intervals 
upon the strength of conclusions, discussion should be considered exploratory.   
For lung cancer, the SIR of farm men was considerably one third lower than rural non-farm men, 
with this difference maintained for SMR. When controlling for other risk factors farm men still had 
around 15% lower adjusted hazard than rural non-farm men for both incidence and mortality. 
Maintenance of these relative group differences between incidence and mortality, controlling for 
common risk factors, suggests that the combined effects of stage at diagnosis and /or treatment on 
mortality risk, were likely to be similar for the two rural groups. In contrast, the gap between SIR / 
incidence hazard and SMR / mortality hazard for urban men closed or ‘improved’ relative to other 
men. This suggests either earlier diagnosis or better access to specialist treatment for lung cancer in 
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urban areas, as has been previously proposed.37 Conversely, low case numbers may have been 
responsible for the patterns observed.  
Similar to farm men, farm women had considerably lower incidence and hazard ratios, being 
around half as likely to be diagnosed as other women. However, whilst farm women still had lower 
mortality, their relative advantage from SIR to SMR had halved; and the adjusted hazard had 
become similar to rural non-farm women; although still lower than urban women. The drop in the 
initial advantage of farm women between indicators is similar to farm men, so might suggest a 
similar phenomenon regarding less access to cancer treatments. If that were the case, one would 
expect corresponding disadvantage for rural non-farm women - which does not appear to be the 
case. Again, only a small number of farm women were diagnosed with lung cancer in the period 
covered by this study, so caution is advised with incidence findings. 
For melanoma, the differences in adjusted hazard ratios for incidence and mortality between 
groups were maintained, with farm men having around 10% higher risk. Farm women had a 
significant mortality advantage, but there was little difference to other groups in incidence. Caution 
is again advised with interpretation due to low case numbers. 
Differences between groups in SIR and SMR for NHL in men were maintained, with farm men 
having the lowest rates and urban the highest. For women, differences were also maintained 
between groups for SIR and SMR. Farm women had the highest SIR, but SMR was even higher. Again 
case numbers were low in the farm group, so caution is advised in the degree of difference, if not 
the rank. For both melanoma and NHL, in light of low numbers, maintenance of differences between 
groups for incidence and mortality may also suggest that stage at diagnosis and access to optimal 
treatments were perhaps equitable.  
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• A summary of patterns across indicators 
Acknowledging data limitations, poorer stage of diagnosis, screening and treatment profiles for 
prostate cancer in farm men may have transferred to a slightly adverse effect on mortality, albeit not 
significantly. In particular, limited access may have led to the significant difference in brachytherapy 
utilisation by rural residents, especially farmers. This important differential may have contributed to 
the slightly elevated prostate cancer mortality outcomes of farm men in this cohort, not apparent 
for most other cancers.  
In contrast, despite similar incidence and later stage, colorectal cancer mortality was 
considerably lower in farm men, though not significantly. Farm women had a similar colorectal 
cancer profile to men regarding incidence and mortality, although stage at diagnosis was similar to 
other groups. Breast cancer mortality risk was also lower in farm women than other residents - and 
significantly better than rural non-farm women, despite minimal differences in incidence and stage 
between groups. It has been suggested physical activity which was not controlled for in this study, 
may have impacted upon survival for these cancers, but the answers remain largely elusive.  
In the absence of staging and treatment data on lung cancer, less than optimal treatment for 
farm and rural non-residents was alluded to by a relative gap closure or ‘advantage gain’ for urban 
residents against others, when comparing corresponding measures from incidence to mortality. 
Differences in melanoma and NHL, were generally maintained between incidence and mortality 
indicators, suggesting treatment options were not remarkably different.  
Maintenance of relative group differences between incidence and mortality, controlling for 
common risk factors, suggests that the combined effects of stage at diagnosis and /or treatment on 
mortality risk, were likely to be similar for the two rural groups. In contrast, the gap between SIR / 
incidence hazard and SMR / mortality hazard for urban men closed or ‘improved’ relative to other 
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men. This suggests either earlier diagnosis or better access to specialist treatment for lung cancer in 
urban areas.  
This discussion has attempted to explain the differences seen between groups in cancer 
indicators, from incidence through to mortality. Comparisons across several indicators can assist in 
identifying patterns that may have implications for rural health services and resource allocation. 
Most differences were not significant and case numbers were small. Suggested trends and 
inferences need to be confirmed with: (1) greater case numbers over longer periods of time; and (2) 
in other cohorts comparing farm, rural non-farm and urban residents.  
9.4   Strengths and limitations of studies 
There are a number of strengths of this research comparing cancer indicators between farm, 
rural non-farm and urban residents. The robust sampling methods of the original 45 and Up Study 
have resulted in enlistment of approximately one in ten residents aged over 45 years in NSW and a 
good representation of farm residents due to the oversampling in rural areas. 
 This study has also been able to identify and separate farm residents from rural non-farm 
residents to compare with urban residents - which has not been done in Australia and rarely done 
elsewhere in a cohort of this size. The ability to compare cancer indicators between resident groups 
of women has also addressed a lack of cancer indicators for women in occupationally defined studies 
of cancer in farmers.  
The ability to link data to state and national health databases has been a significant advantage, 
capturing all health system interactions for a range of cancer-related services. Being able to compare 
indicators for the same cohort across the spectrum from cancer incidence, stage at diagnosis, 
screening, treatment and mortality, albeit at a group level, has also been an advantage not seen in 
other studies. Consequently, this study is unique with regards to the comprehensiveness of the 
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analyses undertaken. Due to the 45 and Up Study being an ongoing longitudinal study, it also 
provides the potential to repeat these analyses over a longer period of time, to re-assess findings.  
There are also a number of limitations related to the study. Despite its large cohort size and the 
fact that it represented 16-17% of the population of NSW aged over 45 years at the time, this 
proportion means it cannot be claimed to be truly representative of the population of NSW. In 
addition, despite its large size, cancer events are rare, so numbers for some analyses were small, 
particularly within the farm resident cohort. This has resulted in low power for some analyses and 
wide confidence intervals, contributing to the lack of significance within the findings. The differences 
where case numbers are small, warrant conservative interpretation to avoid placing weight on point 
estimates with sometimes fluctuating and slightly unstable hazard or odds ratios.  
Low numbers in the farm referent group also meant that caution needed to be taken with 
results for the less common cancers examined; especially when modelling and controlling for 
multiple risk factors. This meant that analyses including stage at diagnosis and treatments for lung 
cancer, NHL and melanoma could not be undertaken with confidence; and therefore were not. 
The above limitations related to low numbers and wide confidence intervals are largely a 
consequence of limited follow-up time for events to occur since recruitment into the study. A longer 
follow-up period would also incorporate possible changes in cancer indicators that may have 
occurred since the significant investment in rural cancer services in New South Wales that has 
occurred over the past 5 years. 
 The farm cohort for this study was defined by residence, but not all farm residents are 
occupational farmers - and not all occupational farmers are farm residents. Whilst it has been 
described that the majority of farmers are indeed farm residents, the lifestyle and exposures of 
recreational versus occupational farmers will blend along a continuum.1, 38-39  This may have affected 
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both the representativeness of sub-groups and internal validity of comparisons made. However, 
classification of residence is independent of other risk factors that affect cancer outcomes, so errors 
arising from misclassification are likely to be non-differential. This would tend to cause a bias toward 
the null and underestimation of any relationship between farm residence and the cancer outcome 
measured. Lastly, the definition of farm, rural non-farm and urban residents was based on the 45 
and Up Study baseline questionnaire. Residential status and risk factors are not necessarily static and 
the status of these may have changed over time, again likely to weaken potential differences 
between resident groups.   
The quality of data also varied by variable and by dataset. Measures have been taken to 
minimise data entry errors, but a proportion will remain. Also, self-report survey data is sometimes 
regarded as less robust than administrative population-wide data, although some studies have 
reported relatively good correspondence between self-report and administrative health data for this 
cohort;40 and for self-reported ‘intention to screen’ data elsewhere.41-42 Other dataset quality issues 
include the large proportion of unrecorded stage in the NSW CR for prostate cancer cases;43  leading 
to lower confidence in results for prostate cancer.   
There was also the likelihood that not all mammograms, PSA tests, FOBTs or colonoscopies in 
the MBS were purely for screening purposes, because similar tests are used with symptomatic 
persons. It is not known if this is independent of residential classification or not, but it does 
potentially affect the validity of measures used to assess screening differences. Relatively poor 
capture of chemotherapy and radiotherapy treatments for Cancer Registry defined cases in the 
APDC were reported by some authors;44-45 although cancer cases were identified differently in the 
current study using APDC admission diagnoses fields. Nonetheless, these studies suggest there is the 
potential for a positive bias toward higher odds of prostate cancer therapies amongst  
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urban men.44-45 In summary, data quality limitations as detailed for each analyses, should be taken 
into consideration when interpreting results. 
For analyses with a larger number of variables included in the base models, collinearity may 
have been present to some degree, even though checks were undertaken to ensure this was not 
excessive. This study has also undertaken multiple comparisons and analyses of the 45 and Up 
cohort. Statistically, a proportion of analyses will produce significant results due to each analysis 
being a member of a population of analyses, to produce false positive results. However, this problem 
is more of a concern where multiple analyses are conducted simultaneously - or in comparing 
multiple groups.46 In this study, only three sub-groups were compared, with the number of possible 
outcomes being dichotomous or minimal. Additionally, analyses generally progressed longitudinally 
and were often conditional, rather than being independent and simultaneous as required by the 
assumptions of Bonferroni and other correction procedures.47  
Lastly, this study progressing from incidence, staging, screening, treatment and possible 
mortality of the selected cancer, has been a comparison of group indicators. In reality this 
progression is an individual journey.  
9.5   Implications for health services and for further research  
This study has generally found that farm residents had more favourable all cancer incidence and 
mortality profiles than rural non-farm or urban residents, but most differences between groups 
were not significant and there is a need to assess these trends over a longer period of follow-up 
time. However, if confirmed in other studies over longer periods of time, there are differences that 
warrant further investigation.  
Firstly, there is more to learn about the prostate cancer profile in farm men.  Data limitations 
aside, if incidence, screening and odds of non-surgical treatments are truly similar between the two 
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rural groups, why did farm men have more prostatectomies - and why was mortality higher in farm 
men? Do farm men have more aggressive forms of prostate cancer that may have been evident if 
more cases had recorded stage? In addition, compared to urban men, is the significantly lower 
utilization of brachytherapy and chemotherapy in both rural groups due to inadequate access?   
For breast cancer, farm women had mildly lower incidence, but considerably lower mortality. 
Longer follow-up time to assess incidence data would confirm if farm women in this cohort actually 
do have the lower incidence rates suggested in this study. If so, why might this be the case? Do 
certain lifestyle features of living on a farm lower the risk of breast cancer incidence? We have 
proposed that perhaps greater physical activity and exposure to sunshine may be contributing 
factors. However, other factors not assessed in this study may also make a difference, such as 
education levels, self-employment and sense of control; or perhaps fresh fruit and vegetable 
consumption.  
Why do farm women have such better mortality outcomes than other women for breast cancer, 
significantly better than rural non-farm women? Is this related to potentially lower incidence and 
earlier stage at diagnosis? And why do farm women have better mortality outcomes with seemingly 
less chemotherapy? Is this also related to earlier stage at diagnosis, such that chemotherapy is less 
likely to be required? It is unlikely to be related to lower health service access, because farm women 
had less chemotherapy than rural non-farm women, yet more favourable mortality outcomes. Again, 
these trends need to be confirmed over a longer period of follow-up. This would determine if the 
significant investment in rural cancer services in NSW in recent years has made a difference to rural 
cancer indicators. The role of screening, which did not appear to be better in farm women in our 
data, could also be investigated further, particularly in relation to the role of promotion campaigns 
previously conducted by rural community organisations.  
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For colorectal cancer, there seemed to be little difference in cancer incidence for men or 
women, but whilst not significant, farm residents had considerably better mortality than other 
groups. Again, if putting data limitations aside, questions arise as to why farm men are more likely to 
be diagnosed at later stage. In addition, if both farm and rural non-farm residents have less optimal 
colorectal cancer treatments than urban counterparts, why did farm residents have much lower 
rates of mortality? These questions have implications for health services and colorectal cancer care 
in rural areas.  
For other cancers, lower incidence and mortality were generally suggested in farm residents, 
particularly lung cancer incidence in farm women. This had been found elsewhere with exposure to 
endotoxins on farm a suggested explanation.48-50 Longer follow-up would confirm the trend for this 
cohort, as small numbers were a limitation. However, there is also potential to confirm whether on-
farm exposures are associated with reduced incidence in this cohort; which would be a significant 
sub-study. Findings may have ramifications for immunological research into the future for protecting 
against the development of lung cancer.  
For melanoma, there is also the potential for further exploring how moderate-level occupational 
sun exposure might be less harmful and protective against melanoma, compared to intermittent 
intense recreational sun exposure. This might be achieved by confirming trends shown in this study; 
or by a more detailed sub-study on sun exposure patterns. Results in this study for NHL were largely 
inconclusive, likely related to low numbers. Again, further follow-up may reveal whether cancer 
indicators vary between farm, rural non-farm and urban residents.  
Amongst the many questions raised that could be investigated further, there are three avenues 
that are the most important or potentially efficient in solving unanswered questions and meeting 
unmet needs. These are: 
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1.  The need to confirm the trends suggested in this cohort over a longer period of follow-up 
that encompasses data since more recent investment in rural cancer services; and by 
investigating other cohorts. If findings of the current research are confirmed: 
2. There is a need to address health service-related factors regarding: 
• higher risk of later stage diagnosis of colorectal cancer in farm men 
• lower rates of brachytherapy, chemotherapy and combined therapies for prostate 
cancer in farm men 
• ongoing attention to wider rural disadvantage in non-surgical cancer treatments for 
prostate, colorectal and breast cancers; and perhaps lung cancer.  
3. Further investigation of the possible reasons why farm residents have generally better 
incidence and / or mortality profiles for breast, colorectal and lung cancers; that might 
inform ways to reduce the impact of these cancers upon individuals and wider communities. 
In particular, this might include investigation of: 
• lower lung cancer rates and possible farm exposures - particularly on dairy farms, where 
international studies have suggested links with endotoxin exposures48-50 
• lower breast cancer in farm women -  the possible roles of physical activity and sun 
exposure 
• lower colorectal cancer in farm residents - the possible roles of physical activity and diet. 
Addressing these questions will contribute to a greater understanding of the epidemiology of 
cancer in Australian farm residents.  
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